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ABSTRACT 
 
Kelly Amanda Raspberry: Conflicted Conceptions: An Ethnography of Assisted 
Reproduction Practices in Argentina  
(Under the direction of Sue Estroff) 
 
 
In this ethnography, I focus on the community of reproductive medicine 
professionals in Argentina to examine how assisted reproductive technologies (ART) are 
transformed according to local conditions of practice, as well as how they are 
transformative of the societies they newly inhabit. Based on three continuous years of 
ethnographic, interview and archival research conducted primarily in Buenos Aires, my 
findings reveal that the production of ART in a given place is not a culturally-neutral 
process, but rather involves local forms of science, medicine, modernity, morality and 
choice. 
In chapter one, I give a contextual history of how ART began in Argentina, and 
locate today’s Argentine infertility specialists within a transnational network of training, 
scientific prestige, innovation and competition. In chapter two, I examine the specificities 
of the local production of ART in Buenos Aires, which include a series of moral positions 
on family, motherhood, and the role of the Catholic Church in medical practice, as well 
as creative maneuverings around legal, economic and political constraints. In chapter 
three, I analyze the practice of gamete donation in Argentina, in which beliefs about 
genetic inheritance, options for family making, and the market-side of reproductive 
medicine all intersect. In chapter four, I focus on the problematic of the morally and 
 iv
legally ambiguous embryo, and examine two techniques in particular, embryo 
cryopreservation and preimplantation genetic diagnosis (PGD), to illustrate how medical 
and scientific protocols are translated to fit local conditions of practice. Throughout these 
chapters I argue that the production of these medical technologies are shifting deeply 
rooted beliefs about the sanctity of human life and the role of technology in manipulating 
that life. I conclude that currently in Argentina the reproductive medicine professionals 
who provide ART to the public are society’s moral guardians, diagnosing the healthy 
body and family, defining when personhood begins, and dictating what protections are 
due human life. In the last instance, this cultural analysis is revealing not only of assisted 
reproduction practices in Argentina, but also circulates back to inform the production of 
ART as a global medical technology. 
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INTRODUCTION 
 
LIFE UNDER THE MICROSCOPE AND THE CULTURAL POLITICS OF 
ASSISTED REPRODUCTION IN ARGENTINA 
 
 
 
 
Figure 1. Tradition and modernity in Buenos Aires, Photo by Kelly Raspberry, 2002. 
 
Encountering reproductive medicine in Buenos Aires, Argentina 
Buenos Aires, Argentina on an early fall morning in March 2003.1 I’m walking 
down a busy street in the microcentro on my way to Center for Studies on Gynecology 
and Reproduction (Centro de Estudios en Ginecología y Reproducción), or CEGyR. In
                                                 
1 Argentina is in the southern hemisphere; the seasons are the reverse of those in the Northern 
hemisphere—i.e. winter is June-September; summer is December-March. 
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1986 CEGyR became the first infertility center in Argentina to succeed at in vitro 
fertilization, and though by 2003 approximately 16 other clinics in the city have joined 
CEGYR in offering in vitro fertilization (IVF) and other assisted reproduction procedures 
to the Argentine public, CEGYR continues to proclaim itself the “pioneer institution in 
reproductive medicine.”2 How “pioneering” CEGYR actually is as a reproductive 
medicine center is debatable, but within the Latin American reproductive community its 
reputation as “one of the best” clinics in Argentina remains solid. 
The center is a half-hour walk from my apartment in the middle-class 
neighborhood of Palermo, and this daily excursion on foot exposes me to the diversity of 
the city and its people. Very shortly after arriving, I realized that working primarily in a 
private assisted reproduction clinic can create a sort of social bubble of ignorance—the 
doctors and biologists around me at this private clinic—and their patients—don’t talk 
about politics (except to question me about the unanimously-opposed US war with Iraq), 
are stylishly dressed, and chat about weekends spent playing golf or relaxing in their 
countryside quintas. From this insular work-realm, I can go to the upper class 
neighborhoods of Recoleta or Barrio Norte where clothing boutiques and home design 
stores are full of shoppers and upscale restaurants are always crowded on weekend 
nights. As an educated white US citizen I am treated as an honorary member of 
Argentina’s upper-middle class. This is a lifestyle completely disparate from the poverty 
that the newspapers declare that half the nation lives in. The unequal distribution of 
wealth is obvious enough once you start actually seeing the city: the “cartoneros” 
                                                 
2 Throughout this ethnography I use pseudonyms for institutional and personal names, except when the 
actual name is appropriate for the historical record (as in this case), or when already part of the public 
record (as in newspaper articles). The majority of those I interviewed consented to the use of their name. 
When I fictionalize names it is to protect the identity of those who wish to remain anonymous.  
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(cardboard collectors)—mostly children— who scavenge through the trash every night in 
my neighborhood looking for cardboard; the unemployed worker’s protests that take 
place weekly in Plaza de Mayo; the occasional newspaper articles, especially in the 
leftist daily newspaper, Pagina 12, that decry the deaths of children from malnutrition in 
northern Provinces; or, the crumbling conditions of the “villas” or shantytowns whose 
borders inch outwards a little more every year. Once I go through the door of the ART 
center, these conditions of basic survival are shut out, as if they exist in a different world 
from this private modern medicine. 
 As I walk through this commercial area, tall buildings shade the street, 
effectively blocking the bright sun and casting shadows across entire blocks. Cars and 
taxis whiz by one after another until red traffic lights make them halt. CEGyR is located 
in the downtown area of the city, a few blocks from an underground subway stop, the 
national theater, the Supreme Court building and the Avenue 9 de Julio, Buenos Aires’ 
major traffic artery. The buildings in this area are filled with cafés offering quick lunches 
and espressos, kiosks offering an array of quick-mart products, banks, and law and 
finance offices. In the block ahead I see what I’m looking for: the pink and white sign of 
the clinic, unmistakable—though discreet if one isn’t looking for it—in its symbolism of 
fertility. The sign’s logo summarizes the promise of the center with two half-moon pink 
circles open to the entry of a squiggly and active sperm. The clinic’s name is written 
boldly in black below this imminent fertile encounter.  
CEGyR occupies all three stories of a renovated French-style building and part of 
an adjoining newer building on this busy street. A security-guard opens the door after I 
buzz, and a ground-floor receptionist gives me permission to go up the stairs to the 
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clinic’s first and second floors. I have been coming to CEGyR daily for several months, 
so most of the staff recognize me by now. The administration office—where patients pay 
for procedures and present insurance coverage—is across from the receptionist. There is 
also a bathroom here designated in the mornings for men who need to give a sperm 
sample. Behind a non-descript wooden door on this ground level is the entire surgical 
area, including the two surgery rooms, a utility area for cleaning instruments, a patient-
recovery room, a physician changing area with lockers, and a storage room for liquid 
nitrogen tanks and the cryopreservation machine. I go past the patient recovery room, 
through the swinging double-doors to the surgical area. I quickly put on a set of green 
scrubs, and hang my clothes in an empty locker. The ground floor is where the “messy” 
work of ART is done: where the money is exchanged, where the unpredictable physical 
body is encountered, examined, and sometimes “repaired” with the tools of surgery. All 
week I have observed the operating rooms and endured the smells of burning flesh (a 
surgical removal of an ovarian cyst), the sounds of unconscious moans of pain during 
follicular aspirations (procedure to remove the egg from inside the ovary), and the tense 
rush of hopes and expectations during embryo intrauterine transfers. Today I will go 
upstairs to return to the laboratory, where it smells of rubbing alcohol, work is done in 
concentrated silence, the surfaces are kept clean and sterile, and failures are not dwelled 
on but instead quickly discarded into the trash and recorded on the patient’s charts. 
First I check in on the overall productive climate of the center for the day. On the 
first floor the consultation and clinical work of ART is conducted throughout the day: 
here is the general waiting area, the associate directors and medical staff offices, the 
ultrasound room, and the nurse’s office for blood tests and hormone injections. There is 
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also a large conference room where the doctors meet for case rounds and colloquia 
presentations at lunchtime every week. The central room on this floor is the waiting area, 
which is large and feels charged with desires and anxieties. Today at 10 am, a peak hour 
for appointments, patients and staff are continually coming, going and waiting, and there 
is an overall energetic atmosphere. The floor is tiled black and white, the chairs are 
green and cushioned, end tables offer stacks of (mostly women’s) magazines, and a TV 
presents the day’s news items from the corner of the room. There is also a free coffee-
machine vendor against one wall, and a busy secretarial area where several women 
make appointments and monitor the patient consultation visits, using a combination of 
computers and hand-written charts.  
I continue on to the top level (representing a physical enactment of the center’s 
professional hierarchy) where the two clinic co-director’s offices are located. Accessed 
from the first floor by an elegant, twisting wooden staircase, here the small waiting area 
is decorated to look more like a living room than a clinic. The walls here are cream 
colored and the arched ceilings are oval-shaped, painted a light green with detailed 
woodwork. There are gray and beige leather couches coffee tables with magazines, and a 
ficus tree (as opposed to a television) in the corner. Soft classical music plays in the 
room. On a small table a water cooler and tea bags are set out, alongside a copy of each 
of the directors’ recent patient-guidebooks on assisted reproduction. Since one director is 
a gynecologist and the other an andrologist, the books reflect their specialty areas. There 
are also three large frames of assorted baby pictures on the walls, visual reminders of the 
purpose and motivation behind each patient’s visit. Each director has his own personal 
secretary, they share a work space behind a half-door that looks onto the waiting area. 
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Those who can afford the high consultation fees of the center directors—approximately 
five times the associate doctors’ fees—enjoy this more serene waiting area, a contrast to 
the active atmosphere below.  
Also on the second floor, behind a door that patients do not often pass through is 
a hallway that leads to an upper-level outside patio area used by the staff, and access to 
the embryology laboratory. For the convenience of the laboratory staff, the embryology 
laboratory also physically connects to the ground-floor surgical area via an outdoor 
staircase, and an internal dumbwaiter system for materials. I go down the hallway and 
glance through one of the laboratory’s windows, covered by partially-open blinds. The 
laboratory is a large square room, with granite countertops along two white-tiled walls, 
two incubator machines along another and a work chamber and two more incubators 
against the last wall. Sitting on the countertops is a variety of ART equipment, most 
importantly a micromanipulation microscope and two sperm-processing centrifuge 
machines. There are three people working today—an embryologist and two biologists. I 
can see that they are in the middle of an egg aspiration procedure, and I quickly open the 
door to the entry-room—separated from the laboratory by another door—and put on a 
set of sterile booties, haircap and face mask. I knock softly on the inner laboratory door 
and look through the window so they can see that it is me—the resident anthropologist 
with her many questions and library of notebooks to be fill. I’m granted permission with 
a wave and a smile. After several months of my observations, the lab staff is accustomed 
to my presence, as are the clinicians downstairs. Though my ethnographic work isn’t 
well-understood by most, it is at least humorously tolerated. With my notebook and pen in 
hand, I begin watching the day’s laboratory work, which began at 7:30 this morning and 
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will continue until around 5 in the afternoon. Today’s observations will add further 
confirmation to my forming impression that the laboratory is where the hopes of the 
consultation visit, and the messiness and expectations of the surgery room are 
transformed into the production of human life.  
 
*** 
 “I am a HALITUS baby…and I already have more than 9000 ‘siblings’” reads 
the caption at the top of a full-page advertisement placed in June 2001 in the daily 
Argentine newspaper Clarín by Halitus, an assisted reproduction center in Buenos Aires. 
Underneath the caption is a photograph of a toddler, “Olivia Dumas,” wearing a chef’s 
hat, and to the right, a first-person narration of “Olivia’s story”: her mother and father 
were having trouble getting pregnant, so they came to Halitus. 3 After a cycle of assisted 
fertilization, Olivia was conceived. Olivia’s narrative continues on to say that she is one 
of more than 1,400 babies that have been born as a result of assisted reproduction 
techniques at Halitus. Her narration then refers to “the large Halitus family” (numbering 
over 9,000 babies overseen by the medical group at Halitus) who are spread across the 
world, and solicits its “family members” to email with their stories. An informational 
sidebar introduces Halitus as “the most prestigious and well-known reproductive 
medicine institution in our country,” and subsequently provides detailed information 
about the center’s services and contact information. This advertisement, apparently one 
of the first of its kind in Argentina, caused a stir within the reproductive medicine 
community in Buenos Aires. The ethics committee of another assisted reproduction 
                                                 
3 The choice of Olivia’s paternal line is a popular culture reference in Argentina. “El Gato Dumas” is a 
well-known chef in Buenos Aires. 
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center in Buenos Aires, Institute of Gynecology and Reproduction (IGyR), met shortly 
after to compose a letter to the Argentine Society for Reproductive Medicine in protest of 
what they considered Halitus’ misleading self-aggrandizements. The objections to this 
advertisement raised at this meeting, and later by other clinical practitioners, revolved 
primarily around the slippage between the total number of births at Halitus (9,000) and 
the much smaller fraction that are reported as actually a result of assisted reproduction 
techniques at the center (1,400); the suggestion that Halitus has an international clientele; 
and the proclamation of Halitus as the best clinic in Argentina.  
I begin with this advertisement because it provides an entry point for identifying 
the amalgam of actors and interests involved in producing assisted reproduction in 
Argentina. In the last 30 years, international developments in science, medicine and 
technology have created a variety of high-tech conception possibilities, such as in vitro 
fertilization (IVF), intracytoplasmic sperm injection (ICSI), and cryopreservation of 
embryos.4 Throughout this ethnography, I reveal how the production of these assisted 
conception technologies in a given place—in this case Buenos Aires—depends upon the 
local articulation of a global network of people, materials, knowledge and practice. I 
argue that assisted reproduction is everywhere an apparatus of complex actors, and 
invites a social analysis that can discern inherent cultural differences. For instance, the 
claims made in this advertisement, as well as the responses it provoked from others in the 
reproductive medicine community in Buenos Aires, elucidate the particularities of 
                                                 
4 In vitro fertilization is a process by which eggs are surgically removed from a woman’s ovarian follicles, 
mixed with sperm in a petri dish and incubated. The fertilized eggs are then transferred into the woman’s 
uterus two or three days later. Intracytoplasmic sperm injection differs from IVF only in the method of 
insemination of the egg.  ICSI injects a single sperm directly into the cytoplasm of an egg, using a glass 
micro-pipette. Cryopreservation is low-temperature storage that preserves viability long-term, usually of 
embryos or gametes. 
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assisted reproduction practices in Argentina. I suggest that at the crux of this specific 
controversy is the fundamental notion among many in the reproductive medicine 
community in Buenos Aires that assisted reproduction is first and foremost a medical 
practice, rather than a profit-making business. This advertisement is therefore seen as 
violating an invisible boundary between “biology”—what medicine is concerned with— 
and “society”—which is outside the realm of true science and medicine.  
As I discuss in the following chapters, the majority of practitioners within the 
reproductive medicine community in Buenos Aires prefer not to discuss their 
professional practices in social (whether economic, political or cultural) terms. Instead, 
assisted reproduction is legitimized as a medical treatment for the biological disease of 
infertility. Clinic directors in particular justify these high-tech procedures, which include 
in vitro fertilization and embryo cryopreservation, in the service of a “universal right to 
reproduce.” The lack of a public (i.e. state subsidized) in vitro fertilization program in 
Argentina, and therefore the limited number of the population who can afford such 
services, is further lamented by these practitioners as an “ethical” problem in need of 
redress by the government. These assisted reproduction professionals thus see themselves 
as engaged in “projects of life”: helping the human species reproduce. In other words, the 
supply of private assisted reproduction services in Argentina is predicated upon a 
common assertion that, in the words of the Latin American regional director of a major 
pharmaceutical company, “reproduction should not be a luxury. Everyone has the right to 
reproduce.” It is my contention that statements such as these require a critical cultural 
analysis: in what ways are local circumstances and histories at play when reproductive 
medicine experts in Argentina assert that biological reproduction is a universal right for 
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every individual? I propose that an ethnographic analysis of assisted reproduction 
practices makes visible the internal logics of medicine, technology and science as they 
play out in daily dramas of human desires and practices. 
Specifically, this ethnography focuses on the community of reproductive 
medicine specialists in Buenos Aires, Argentina and asks: what are the social processes 
and motivations guiding the acceptance and mobilization of assisted reproduction 
practices in Argentina? Throughout these chapters I begin to explore the kinds of human 
and hybrid actors and social circumstances emerging from the production of ART in 
Argentina. While some practices of assisted reproduction—like artificial insemination—
are not unique to the 20th century, in general the transformative impact of reproductive 
technologies on contemporary social life is unprecedented. In discussing the “new” of 
“new reproductive technologies,” Adele Clarke asserts, “What they are transforming is 
conceptions of what it is to be human, male, female, reproductive, parent, child, fetus, 
family, race, and even population” (1995:149). I suggest that in Argentina these high-tech 
options for making babies are indeed transforming not only “conceptions” but also 
material realities of personhood, family, modernity, and “being Catholic.”  
In addressing these themes, I propose to contribute to the anthropological project 
of disrupting and denaturalizing the divisions placed between nature and culture, bodies 
and society, science and morality. The main purpose of this ethnography is to reveal how 
assisted reproductive technologies are transformed according to local conditions of 
practice, even as they transform the societies they newly inhabit. This ethnography thus 
joins a growing body of literature that examines the global spread of assisted 
reproductive technologies and reveals that the circulation of biotechnology around the 
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world is not a value-free process of “technology transfer.” Rather, as these ethnographic 
analyses demonstrate, patients and professionals enact and experience ART in culturally 
specific ways (Becker 2002; Ehrich et al. 2006; Franklin 1997; Kahn 2000; Thompson 
2005). My work particularly speaks to a recent ethnographic focus on the “margins” of 
production—the non-Western sites of high-tech medicine (Bharadwaj 2002; Handwerker 
2002; Inhorn 2003; Inhorn and Van Balen 2002; Roberts 2006). Indeed, contextual 
analyses of reproduction and reproductive technologies serve to denaturalize and make 
uncertain the “biological facts” of reproduction and kinship, and to disrupt the traditional 
dichotomies of nature and culture (Franklin 2003; Franklin and Lock 2003; Franklin and 
Ragoné 1998; Morgan and Michaels 1999; Rapp 1999; Thompson 2001; Strathern 1992).  
In building on this literature, I examine the technical apparatus of assisted 
reproduction as it is produced in Argentina for local variations in practice. Questions 
central to my research included: are treatment protocols in Argentina also predicated 
upon a standardized form of technological promise? To what extent does the enactment 
of a global apparatus of assisted reproduction translate into local forms of science and 
medicine, desire and “choice” in Argentina? What does an interrogation of biotechnology 
practices in a region traditionally considered “developing” reveal about the conditions of 
modernity and globalization? The analysis that I present is therefore an investigation into 
how local conditions—social, political, economic, historical ones—play through and 
influence the work of assisted reproduction in Argentina, and how this local performance 
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of ART in turn produces new (but old) forms of family, health, modernity, medicine, and 
life itself. 5  
In the following chapters I suggest that the professionals in Argentina produce 
and participate in a “local culture of assisted reproduction,” one that is different from 
those produced for example, in England or the United States—even though these are sites 
of reference for Argentine specialists. In starting with the notion of a “local culture of 
assisted reproduction,” I call upon a particular branch of social constructivism within 
science studies in order to tell the history of objects of knowledge, both human and non-
human, as actors (Haraway 1991; Latour 1988; Latour and Woolgar 1986 [1979]). This 
“culture” then, refers to a network of international actors, each following their own 
squiggly trajectories, perhaps originating in and traveling to very different places, but at 
some point all rallying at the node of analysis: a delineated slice of the local arena where 
specific practices take place. In other words, this “culture of assisted reproduction” is 
without boundaries, and depends on a transnational flow of techniques, knowledge, 
equipment, people, genetic material, and biological media. And yet, at the sites of 
ethnographic analysis, this culture is a discernible nexus of interaction: how these 
international agents come together, and what they produce, is localized, and contingent 
upon the particular specificities of the history, place, time, and power relations involved, 
                                                 
5 I do not attempt to provide an analysis of ART in all of Latin America here, as that would entail making 
general statements about a large and diverse region. As one doctor told me, Latin America is like 
“curanto”—a traditional stew from the south of Chile:  
“Latin America is like a curanto, like a pit into which the pig, the fish, the meat, the corn, 
everything falls in together. […] In a good curanto, individuality is maintained, even though 
everything acquires a little bit of their neighbors. I think Latin America is also very different, in 
the way of doing things, Central America or the Caribbean countries are completely different from 
the Southern countries.[…] But these different ways exist more in some countries than in others.” 
Where appropriate to my local analysis of ART in Argentina, I do describe relevant practices in other parts 
of Latin America, particularly in neighboring Chile. 
 13
not only at the local level but at the international as well.6 Thus, instead of relegating 
facts and nature to one side, and interpretation and society to the other, I seek to explore 
all the players, the objects and subjects, as situated, located elements in this story that has 
multiple narratives. In the following analysis, I therefore use the notion of a “local culture 
of assisted reproduction” in Argentina to concretely examine the ways in which ART is a 
contingent historical and material reality, productive of hybrid knowledges and bodies 
specific to the locale of practice.  
The story of assisted reproduction in Argentina that I tell in this ethnography is a 
partial and interested one, motivated by the contention that the reproductive medicine 
community in Buenos Aires provides a dynamic vantage point for identifying local 
variations in ART. With the birth of twins in February 1986, Argentina became the third 
Latin American country to achieve IVF success, eight years after the world’s first “test-
tube” baby was born in England. Today approximately 22 private clinics provide high 
complexity assisted reproductive techniques to a national population of 36 million; 16 of 
these centers are in the greater Buenos Aires area. All of these clinics are located within 
the elite sector of private medicine, and services are accessed primarily by heterosexual 
upper-middle class members of society. The concentration of clinics in the capital city 
reflects the fact that Buenos Aires is the nation’s center of economic, political, cultural 
and social production; one-third of the country’s citizens reside in the greater Buenos 
Aires area.7 Alongside this growth in centers, the core of the professional community of 
                                                 
6 In their “Introduction” to the seminal text, Conceiving the New World Order, Rapp and Ginsburg discuss 
a similar non-geographical delineation of local and global processes (Rapp and Ginsburg 1995:8-9). 
 
7Since Buenos Aires is the center of ART production in Argentina, I focus this ethnography on the clinics 
within the capital. There are many differences between the greater Buenos Aires metropolitan area and the 
surrounding provinces, and by referring to “Argentines” and “Argentina” I do not mean to conflate the city 
of Buenos Aires with the entire nation, nor present a homogeneous view of the country. A fascinating 
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experts (the clinic directors and chief biologists) in the country remains a relatively small 
and close-knit group. Five principal centers, all located in Buenos Aires, perform 70% of 
the (approximate) total of 4,000 procedures of IVF and ICSI produced per year in 
Argentina. The majority of this first generation of ART doctors and scientists trained at 
least partially in the U.S or Western Europe on fellowship, and now, as the directors of 
the largest centers and labs, are responsible for guiding the next group of local ART 
specialists.   
The last ten years mark a major period of growth and transition for the 
reproductive medicine community in Argentina. Around the world the industry of 
assisted reproduction has been expanding, and in Argentina this growth is visible in terms 
of an increasing number of centers and the incorporation of new techniques every year. 
As a result of this expansion, assisted reproduction centers in Buenos Aires increasingly 
compete with one another in efforts to provide the most successful and “modern” services 
in the area. One clinic director in Buenos Aires who recognizes this shift within the 
industry told me, “Medicine is becoming more and more of an enterprise, and like other 
businesses, it needs to: one, take care of clients, and two, market its services. The 
difference is that we’re not only dealing with clients, but with patients and their 
illusions.” He went on to state that the use of advertising to raise public awareness (and 
thus increase desire for assisted reproduction) is a beneficial one, a view that is shared by 
most in the community. Perhaps partly in response to this increase in public marketing, 
the current situation in Argentina is one in which institutional growth has been 
accompanied by a rise in public demand for assisted conception services. In recognition 
                                                                                                                                                 
follow-up to this research would be to examine more closely the production of ART in the provinces, and 
how it is similar to and different from that in Buenos Aires. 
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of this “created demand,” one clinic director pointed out that common approaches to 
dealing with infertility have changed in Argentina: “People used to not have children, or 
they would adopt. Now, they will try assisted reproduction.” For those who can afford to 
try ART, adoption is relegated to the status of a “last step” in the path to making a family. 
This preference for assisted reproduction in Argentina is built on traditional values of 
motherhood and family. This ideal of having “a child of one’s own” is precisely the 
hopeful promise of ART. 
Argentina is the second highest producer of ART practices in Latin America after 
Brazil, and houses some of the most reputable specialists of the region.8 Because of this, 
it is a site for a people-based form of “technology transfer” in which professionals from 
the provinces and from other Latin American countries come to do residency programs or 
training workshops at the principal centers in Argentina. The knowledge circuit is thus 
not only a North to South flow from the US and Europe to Latin America, but within the 
region as well. Within Latin America, ART production is also growing, as evidenced by 
the rapid expansion of the Latin American network of assisted reproduction (Red 
Latinoamericana de Reproducción Asistida) or RED—a collaborative network of private 
assisted reproduction centers in Central and South America, which formed in 1995. In the 
2003 RED registry, with a total of 117 centers reporting figures, there were 21,034 ART 
cycles initiated (including IVF, ICSI, GIFT, cryopreservation, egg donation), with 6,268 
babies born from ART in Latin America that year (Zegers-Hochschild and Galdames 
                                                 
8 The total number of initiated ART cycles for Argentina was 4,126 in 2003, thereby making up 19.6% of 
all ART done throughout Latin America. Brazil produces 47% of all cycles in the region and has 48 centers 
(Zegers-Hochschild and Galdames 2004:3). 
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2004:2).9 These numbers are admittedly much lower than those in the North—in the 
United States for example 411 centers contributed to a CDC report stating that there were 
127,977 assisted reproduction cycles undertaken, and 49,458 babies were born in 2004 
(CDC 2006:11). However, what is of interest here is the unabated increase over time in 
Latin American production of ART, from 4,496 cycles in 1992 to 21,034 in 2003 
(Zegers-Hochschild and Galdames 2004:10).  
  The emergence of assisted reproduction as a socially-acceptable option for 
parenthood is not without its opponents in Argentina. Like most of Latin America, 
Argentina is a predominantly Catholic country, and Catholic values strongly influence 
public morality and national policy decisions. Approximately 90% of the population in 
Argentina identify as Catholic, though most are not practicing. The Roman Catholic 
Church has mounted the strongest international opposition to assisted reproduction, on 
the grounds that these practices evidence a disrespect for the “right to life” of all 
fertilized gametes, and attempt to remove conception from the realm of “marital 
intercourse” (Pellegrino, Harvey and Langan 1990). In 1987 the Sacred Congregation for 
the Doctrine of the Faith in Rome issued an international doctrine, Donum Vitae, in 
which assisted reproduction practices are evaluated in terms of two fundamental 
principles: “the life of the human being called into existence and the special nature of the 
transmission of human life in marriage” (Pellegrino, Harvey and Langan 1990:8). 10 This 
understanding of assisted reproduction as a set of moral violations has specific 
                                                 
9 Rates of assisted reproduction are calculated according to “cycles” per year, rather than in terms of people 
or single procedures. One “cycle” is measured by the start of the first phase of a given technique, for 
example when a woman begins taking hormone drugs for IVF. Thus in one year, the same woman may 
undergo multiple cycles of IVF. In addition, the number of live births is usually lower than the number of 
babies born because multiples (twins, triplets) are counted as one live birth.  
 
10 The full name of the Donum Vitae is: Instruction on Respect for Human Life in its Origin and on the 
Dignity of Procreation, Replies to Certain Questions of the Day. 
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implications for practice. A biologist in Buenos Aires who is a practicing Catholic 
explained the Church’s judgment scale to me this way:  
The Church has the concept that everything must arise from the [conjugal] union, 
in a natural way. Even though insemination isn’t spontaneous, it is like one is 
giving a little push so that it [conception] will occur spontaneously. In other 
words, one isn’t forcing fertilization. There used to be, it’s almost fallen into 
disuse, the GIFT method which definitely was fertilization inside the fallopian 
tubes. In the case of ICSI, someone puts the sperm inside the egg. It is a totally 
man-made process. One is forcing the natural laws. 
 
From an orthodox point of view, a practice such as gamete intrafallopian transfer (GIFT), 
which allows a transferred sperm and egg to fertilize within a woman’s body, is more 
acceptable than in vitro fertilization, in which conception occurs in an incubated dish 
inside the laboratory.11 The dominance of Catholicism within Argentine society surfaces 
in different ways, including through a traditional status quo emphasis on marriage and 
family and a conservative code of ethics. As of yet, the national government of Argentina 
has not overtly legislated ethical guidelines or regulations on the practice of assisted 
reproduction. 12 Within-clinic medical procedures and protocols are largely self-regulated 
by the professionals themselves, and contingent upon the director’s own moral and 
ethical principles. Some reproductive medicine practitioners in Argentina refuse to 
perform “laboratory conceptions” in respect of the Catholic Church’s proscriptions, while 
                                                 
11 Donum Vitae wholly condemns in vitro fertilization: “Such fertilization is in itself illicit and in 
opposition to the dignity of procreation and of the conjugal union, even when everything is done to avoid 
the death of the human embryo” (Pellegrino, Harvey and Langan 1990:28).  
 
12 In contrast, Britain in 1990 passed the Human Fertilisation and Embryology Act (HFEA), which 
regulates embryo research and thus infertility services. France, Australia and Canada have also created 
commissions to monitor assisted reproduction. Germany and Italy passed fairly-restrictive laws, while 
Spain approved a more permissive one. Although in the US several regulatory bodies have proposed 
various guidelines for assisted reproduction, at this moment such practices are not overseen by a federal 
advisory commission. Instead, the professional societies the American College of Obstetrics and 
Gynecologists (ACOG) and the American Society of Reproductive Medicine (ASRM) have issued internal 
guidelines for assisted reproduction practices.  
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many others pursue creative ways to reconcile Catholic beliefs with their daily medical 
and scientific practices.  
In accord with this social conventionality, the reproductive medicine community 
in Argentina, as I mentioned earlier, defines assisted reproduction solely as a medical 
response to the biological disease of infertility. As one director of a fertility clinic in 
Buenos Aires told me, “I am convinced that my role in medicine is to cure people and I 
will attempt to make pregnancies occur in the most natural way.” This practitioner, who 
professed that his personal Catholic religious beliefs influence his work ethics, is similar 
to many of his Argentine colleagues in emphasizing that the distinction between “helping 
nature” and “defying nature” is an important one. From this perspective, doctors are 
“giving nature a helping hand” (to borrow a phrase from Sarah Franklin 1997) by 
providing assisted reproduction services to stable heterosexual couples who would 
presumably not be able to conceive and experience biological parenthood otherwise. On 
the flip side, using high-tech medical procedures to create “socially deviant” family 
forms, for instance single and lesbian mothers, qualifies as “unnatural” and beyond the 
purview of “morally responsible” doctors in Argentina. By enacting this morality in their 
clinical practices, Argentine doctors participate in a popular discourse in which only 
stable, heterosexual couples (usually from the upper classes) are socially “fit” to produce 
offspring. As these examples demonstrate, particular constructions and values of nature, 
family, medicine and ethics are operating as guidelines for the practice of assisted 
reproduction in Argentina. Taking these circumstances into account, throughout this 
ethnography I ask, what kinds of reproductive “choices” are being offered within the 
local culture of assisted reproduction in Buenos Aires, Argentina? 
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Figure 2. "With a little help from science." Viva magazine cover-story on ART treatments in 
Argentina. February 10, 2002. 
 
Review of Relevant Literature  
Located at the intimate level of the non-reproductive body, assisted reproduction 
offers a particularly revealing site for analysis of the inseparability of medicine and 
society. The apparatus of assisted reproduction in Argentina engages a complex of social 
values about family and health; conflicting religious and scientific ethics; class, gender 
and regional stratifications of health care access; and ideologies of development and 
modernity. To make sense of these productive intersections, this project draws from three 
complementary bodies of literature. 
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Politicizing and Living Reproduction. 
In the history of anthropology as a discipline, the theme of reproduction has been 
central. In their introduction to the anthology, Reproducing Reproduction (1998), Sarah 
Franklin and Helena Ragoné discuss a recent resurfacing and reconfiguration of 
reproduction as a critical subject in anthropological theory.  They point out that prior to 
the emergence of feminist anthropology in the 1970s, the discipline’s relationship to 
reproduction was a focus on systems of biological paternity and kinship structures, using 
a model of universal, essential woman. The “virgin birth” debates are a prime example of 
this preoccupation with the “biological facts” of reproduction, as separate from the more 
variable forms of “culture” (see Franklin 1997 for a review). Recent anthropological 
work has attempted to deconstruct this essentialized dichotomy between biological and 
cultural aspects of reproduction, leading to a surge in scholarship on reproduction and on 
the old but new problem of kinship in reproductive knowledge. Several recent 
anthropological works have begun to address the uncertainties that reproductive 
technologies pose for Euro-American folk models of kinship (Edwards et al. 1993; 
Finkler 2000; Franklin and Ragoné 1998; Strathern 1992). These works build from the 
premise that new social and biological relations are being produced when more than two 
parties contribute to the creation of a single viable fetus. One particularly striking 
example of this reconceptualization of kinship is an essay by Charis Cussins (1998b), 
which addresses the denaturalization effects of assisted reproduction procedures on 
biological parenthood relationships. 
Reproductive technologies have also been elected as a theme for feminist analyses 
of reproductive health politics within anthropology. In this vein, assisted reproduction is 
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located within a “global politics of reproductive health” (Ginsburg and Rapp 1995; 
Davis-Floyd and Sargent 1997). This scholarship builds from and problematizes prior 
feminist analyses of reproduction to examine how state policies, privatized health 
services, and research in biotechnology interact and articulate with class, gender and 
regional differences in reproductive health between and within countries. The notion of 
“stratified reproduction,” the power differential between those who can afford to 
reproduce and those who cannot, is a recurrent theme in this approach (Colen 1995). For 
instance, Rayna Rapp’s work in the United States illustrates the social stratification of 
reproductive health services according to class, ethnicity, and gender divides (Rapp 
1993;1998;1999). While Rapp points out that amniocentesis has become a routinized 
prenatal procedure in the US, women’s experience of this technology varies widely 
according to certain social variables such as professional and educational background, 
first language, degree of scientific literacy, health care coverage, and religious 
convictions.  
Also of central concern for anthropological inquiry is the potential for 
reproductive and genetic technologies to serve the purposes of a contemporary eugenics 
movement. This work looks at how these technologies can be used to render a certain 
group of people as “unfit” to reproduce, as well as promote the emerging category of the 
“genetically at risk” individual who is responsible not only for her health, but the health 
of her family (Duster 1990; Franklin and Roberts 2006; Novas and Rose 2000; Rose 
2001; Taussig, Rapp and Heath 2003). For instance, in their article on routine prenatal 
diagnostic screening in California, Carole Browner and Nancy Press characterize the 
normalization of these diagnostic tests as  part of a “neo-eugenics movement,” one that 
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differs from previous eugenics movements in that “the intent today is not to select out 
individuals with undesirable social characteristics but rather those with specific physical 
or mental disabilities” (1995:308). Browner and Press argue that the promotion of 
prenatal tests as a necessary practice for ensuring a “healthy” pregnancy, obscures the 
eugenic aspects of selecting out fetuses with “abnormal” conditions, such as Down’s 
syndrome. By placing reproduction—in all its myriad forms—at the center of social 
analysis, these works examine contested forms of cultural production in terms of 
transnational structures of power that play out in daily life experiences.  
Examining the politics of reproductive health practices in Argentina, and their 
contribution to reconfigurations of family-making, is an important component of this 
project. In Argentina as elsewhere, the relatively high cost of private assisted 
reproduction procedures underscores a system of “stratified reproduction.” In practical 
terms, this means that the majority of people who are attempting assisted reproduction 
techniques belong to the middle-to-upper classes of Argentina’s largest cities. As I will 
discuss at greater length in chapter two, practitioners themselves are posing this situation 
as a “reproductive rights” problem, in need of redress through legislation and healthcare 
restructuring. However, when (and if) Argentina’s governmental leaders will give 
legislated support for public assisted reproduction programs depends upon a variety of 
other economic, political and moral circumstances. In all likelihood, Argentina’s recent 
economic crisis and resulting political instability continues to affect how people think 
about the future of the country and their families. In addition, practitioners themselves 
rely upon social criteria to decide who is eligible for high-tech reproduction, at the 
exclusion of “deviant” non-heterosexual family forms. In chapter one, I begin to locate 
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these current assisted reproduction practices within a trajectory of professional’s 
perspectives on the history and future of their country. 
Given the ethical, legal and social implications of these technologies, there are 
surprisingly few ethnographic studies of the use of reproductive technologies, and fewer 
still specifically on assisted reproduction. Most of the ethnographic studies that do exist 
have been conducted in “First World” contexts, and focus primarily on patient narratives. 
Yet ethnographies are essential for understanding the lived qualities of assisted 
reproduction, for all of the parties engaged in these practices. Most high-technology 
procedures involve multiple stages, each contingent on results from the one before. If a 
particular procedure doesn’t work—as is often the case—the whole process must begin 
again. Creating a pregnancy via assisted reproduction thus involves emotional, physical, 
economic, and spiritual work on the part of both patients and medical professionals. 
Anthropological studies of assisted reproduction reveal that from patients’ perspectives, 
undergoing a given procedure, and dealing with infertility, is a long and difficult process 
(Becker 1997; Franklin 1997; Inhorn 1994, 1996; Kahn 2000; Sandelowski 1993; 
Thompson 2005). These “patient narratives” disclose the frustrations and hopes of people 
“living” the medical process in efforts to have a biological child. In particular, Sarah 
Franklin’s (1997) work on in vitro fertilization practices in England explores the ways in 
which technological progress is literally “embodied.” Franklin discusses the management 
of an in vitro fertilization process as a daily regime, in which a variety of clinic 
appointments, hormone injections, and emotional work take precedence over all else. She 
shows how the requirements of an IVF program often dictate a woman’s daily schedule, 
leading some women to describe the experience as all-encompassing, literally “living 
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IVF.” And yet, this “obstacle course” becomes an option that “must be tried” before 
acceptance of biological infertility is possible. In this sense, Franklin argues that the 
“choice” of in vitro fertilization becomes an imperative to exhaust all options for 
biological conception.  
This anthropological work on reproduction provides an empirical foundation for 
recognizing the social, political and economic dynamics inherent to reproductive 
practices. In terms of assisted reproduction specifically, the elaborate contingency of 
these processes clearly necessitate a whole-hearted investment from all parties involved. 
However the experiences, motivations, and understandings of assisted reproduction from 
practitioners’ perspectives have not been fully examined in the existing literature. For 
instance, it is not apparent that patients and professionals share the same goals for these 
practices, particularly given the low probability of a live-birth “success.”  While patient 
ethnographies are important, I argue that professionals’ experiences and understandings 
of assisted reproduction are equally salient for a critical analysis of these technologies. 
This ethnography therefore focuses on reproductive medicine professionals to reveal the 
meanings assisted reproduction has for clinicians and biologists in Argentina.13  
Producing Science, Technology and Medicine. 
A related and complementary group of studies focus on the contingency of 
scientific knowledge production, and medicine and science as professional institutions. 
Ethnographies within science and technology contribute critical approaches to exploring 
the ways “nature” is being remade to serve social projects, and in demonstrating that the 
                                                 
13 In this ethnography I use the general term “biologists” to refer to the people working inside the 
laboratory. Some of them have backgrounds in biochemistry or embryology, but in the local setting of the 
embryology lab they are all called “biólogos”—biologists. Neither is a hierarchical discrimination made 
within the laboratory of “technicians” or “assistants”—the only one used, which I retain, is to identify the 
“chief” or “head” of the laboratory. 
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laboratory and clinic are places where reality is negotiated daily (Hess 1997; Latour 
1988; Latour and Woolgar 1986; Pickering 1992; Rabinow 1996; Traweek 1988). 
Furthermore, studies of medical professionals and the “work” of medicine reveal the 
implicit social hierarchies involved in the daily practices of biomedicine (Atkinson 1995; 
Berg 1997; Freidson 1970; Sandelowski 2000). With respect to this analysis, these works 
are particularly helpful in terms of their theoretical contributions. To analyze assisted 
reproductive technologies as culturally, historically and politically contingent, requires 
the recognition that medical and scientific knowledge and practices are not unvarying, 
culturally-neutral phenomena. Rather, medical and scientific procedures are cultural 
practices, and paying attention to this materiality of culture means examining how 
“conceptual schemes are embedded in techniques and technologies, in buildings, 
gestures, and insurance regulations” (Berg and Mol 1998: 5).  
To better understand the political and highly variable dimensions of assisted 
reproduction as a medical and scientific practice, I find it helpful to invoke feminist 
science historian and cultural critic Donna Haraway, who proclaims: “My goal is to help 
put the boundary between the technical and the political back into permanent question as 
part of the obligation of building situated knowledges inside the materialized narrative 
fields of technoscience” (Haraway 1997:89). In refusing to separate science from politics 
and nature from society, Haraway creates a space for challenging the traditional 
dichotomies and dualisms of “Western analytical traditions” such as nature versus 
culture, animal versus human, sex versus gender. Haraway’s concept of “technoscience” 
is central to her non-binary project. Haraway explains that technoscience signifies the 
interdependent complex of science and technology which currently configures ways of 
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life: “[it designates] dense nodes of human and nonhuman actors that are brought into 
alliance by the material, social and semiotic technologies through which what will count 
as nature and as matters of fact get constituted for—and by—many millions of people” 
(Haraway 1997:50). Technoscience is a dominant mode of life, as well as a practice of 
knowledge production and means of producing new entities. Among the objects 
constructed by technoscience are narratives about nature and society, which are dispensed 
and apprehended under the rubric of “scientific truth.” Furthermore, technoscience is 
productive of not only discourse, but also of bodies—in the example of assisted 
reproduction, this is the literal creation of new human life. Haraway also emphasizes the 
metamorphic quality of categories in technoscience, and asserts that there are no absolute 
divisions between “social” and “technical,” but neither is a dimension ever destroyed and 
replaced entirely by another. Rather, these categories exist simultaneously in different 
patterns at given moments in history.  
Haraway’s concept of “cyborg” is also central to the project of challenging 
dualisms of nature and culture as separate entities, as the distinction between who makes 
and is made becomes blurry when the technical and organic meet in situated 
circumstances (Haraway 1985:97).  Haraway defines cyborgs as: “a fusion of the organic 
and the technical forged in particular, historical, cultural practices”(1997:51). In her most 
recent work, Haraway asserts that cyborgs are creating chaos within the kinship order in 
technoscience, with cyborgs like OncoMouse unpredictably running through the house 
and creating a “mess” of the family. Cyborgs are the prolific rabbits of technoscience: 
from genetically engineered crops such as the FlavrSavr tomato, to the Darwin Molecular 
Company which mimics natural selection to produce drugs, Haraway argues that cyborgs 
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are everywhere (Haraway 1997:56,59). Recent scholarship on cyborgs within the realm 
of reproduction lends support to Haraway’s assertion. That reproductive technologies 
provide fertile grounds for “cyborg” investigations has been recognized by scholars 
within anthropology as well as science and technology studies. Several recent collections 
address this proliferation of human-machine meldings, or “cyborg conceptions” (see 
Davis-Floyd and Dumit 1998; Downey and Dumit 1997; Gray, Figueroa-Sarriera and 
Mentor 1995). In the introduction to Cyborg Babies (1998), editors Joseph Dumit and 
Robbie Davis-Floyd ask, “what are the ethics, the moralities, and the environmental 
realities that will govern us as we continue to cyborgify ourselves and our world?” 
(1998:14). 
Unfortunately, like anthropological studies of reproductive technologies, this 
scholarship primarily focuses on “First World” contexts. Few studies examine the 
topography of technoscience for local variations. Thus far hybrids and cyborgs in 
particular have been analyzed in terms of their transgressions of certain “Western” values 
and dualities. I argue that where different systems of dualities and values are in place, the 
products of ART will also be different. Because ART is both a scientific and medical 
practice, I view it as a relative of technoscience that might better be termed 
“technomedicine.” By focusing on assisted reproduction practices in Argentina as a type 
of technomedicine, I examine how people are making sense of and experiencing these 
cyborg realities of high-tech medical care as part of their daily lives. With this aim, I 
propose that all the facets of assisted reproduction—social, material, political, physical—
need to be examined as together constituting a multilayered reality. I focus in particular 
on assisted reproduction in Argentina as an example of technomedicine metaphorically 
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and literally embodied, in which practitioners and patients together live and produce 
particular ideals of “scientific progress and rationality.” Throughout this ethnography I 
demonstrate that the forms the technical apparatus of assisted reproduction takes depends 
upon the available ingredients of practice. As I discuss in chapter two, within the 
reproductive medicine community in Buenos Aires, these elements include: conservative 
family ideals; out-dated constitutional law; Roman Catholic morality; inequities in wealth 
and social services; post-colonial consciousness; and a full spectrum of motivations and 
desires.  
 
Historicizing Modernity and Development. 
A third relevant body of literature includes Latin American studies on state and 
church policy, questions of development and modernity, and “the making” of the “Third 
World” (Escobar 1995). These scholars problematize the pervasive ideology that 
modernity and development—e.g., in the form of high-tech medicine—are products of 
the “Euro-American North” which can be imported and replicated, but do not originate in 
the “South” (Canclini 1995; Stepan 1991). For instance, Jorge Larrain argues that rather 
than an “external” force, modernization has been a reciprocal and continual component of 
processes of identity construction throughout Latin America’s history (Larrain 2000).  
Throughout history Latin America as a region has been considered subordinate to 
the “North” and the “West.” Part of this subordination entails an international 
development discourse that characterizes Latin America as “underdeveloped.”  As a 
country, Argentina holds a unique position within Latin America as more “developed” 
and cosmopolitan than its regional neighbors. The mix of indigenous and colonial 
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European ancestry that characterizes much of Latin America does not apply to Argentina 
where the indigenous tribes were almost completely decimated during colonial rule.  
Waves of subsequent Western-European migration, particularly from Spain and Italy, 
provided the roots of today’s population. The capital city of Buenos Aires is recognized 
as a focal point for international medical and scientific research within Argentina, and 
Latin America in general.  
However this “modern sensibility” is a tentative one, highly subject to the 
country’s economic and political stability and international relations. Indeed, Argentina’s 
claim to “modernity” has been a difficult struggle throughout the twentieth century, one 
that is far from resolution (Shumway 1991). Ranked as the eighth richest nation in the 
world after World War II, Argentina in the November spring of 2002 when I arrived to 
do fieldwork suffered a devalued peso, high rates of unemployment and political 
uncertainty. With the uncoupling of the Argentine peso and the US dollar in December 
2001, one of Argentina’s primary symbols of “sophistication” was also destabilized. 
Economic upset is not a new circumstance for Argentines, as this most recent devaluation 
of the peso follows more than 10 years of recession. However, the international response, 
including the International Monetary Fund’s displeasure with Argentina’s loan defaults, 
may have lasting material and symbolic consequences. Though two years after the crisis 
the economy (relatively) stabilized under democratic rule, the horrors of the economic 
and political crises of 2001 are not quickly forgotten by Argentines or onlookers. How 
does this translate into on the ground self-perceptions of being “modern” in Argentina? 
One psychologist at a clinic in Buenos Aires referred to North American dismissal of the 
clinical research that comes out of Argentina, saying “They think we live like Indians  
 30
[Native Americans] here.”  She went on to say later that, “Northern countries always 
think that the South is ‘second class.’” A director of a prominent reproduction clinic in 
Buenos Aires, himself Argentine, characterized Argentines as “hablan bien, hacen mal.” 
These words refer to what he regards as the idiosyncrasy of Argentines to say one thing 
and do another—and the many levels of corruption to which this standard contributes. 
This view of Argentina as a contradiction in terms solidly fits with the daily street scenes 
of young children begging on the subway and politicians’ poster-promises to remake 
Argentina into a “serious” country. Yet within the arena of private infertility medicine in 
Buenos Aires this negative characterization was actively contested, and at the same time 
tacitly accepted by the professionals themselves. 
 
 
 
Figure 3. Typical "street scene" in Buenos Aires: child performer in Recoleta neighborhood. Photo 
by Kelly Raspberry, May 2003. 
 
 
This ethnography examines these tensions and the extent to which professionals 
strive to be thought of as “modern” within a global network of assisted reproduction, and 
what it means to be practicing high-tech medicine in an area of the world conventionally 
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deemed as “developing.” To begin with, I follow Lock and Kaufert (1998) in their 
assertion that there is no standardized form of modernity implicit in the practice of a 
medical technology:  
When the flow of ideas and technology is perceived as being from ‘advanced’ 
societies to the ‘developing’ world, then an assumption is often made that 
recipient societies undergo a process of secularization and rationalization, an 
integral part of modernization. It is abundantly clear, however, that no simple 
trajectory occurs, and that reversals and other unanticipated outcomes are 
common, in both ‘developed’ and ‘developing’ societies (Lock and Kaufert 
1998:23). 
 
In chapter one I describe the unique trajectory of the establishment of ART in Argentina, 
to begin to understand why ART primarily travels North to South, though not always in 
expected ways. In chapter two I look more closely at the local modifications made to this 
modern technology in practice.  
In terms of reproductive medicine, the central sites of this worldwide circuit of 
clinics, professionals, equipment, drugs, knowledges and patients, are located in the 
“North,” particularly in the US and Western Europe. This institutional hierarchy positions 
medical professionals in Argentina as on the periphery, they are far from the center of 
innovation and research. Professionals in Argentina strive to meet international criteria of 
what counts as a “reputable” center with high “success rates.” Though this hierarchy of 
quality is based in part on the range of procedures a given clinic performs, the ultimate 
criterion of “success” that all professionals try to achieve is a high rate of delivered 
pregnancies, termed “live births” in the clinic lingo. For the most part clinics in North 
America and Europe set the standards of what counts as a “high” rate of success. Held 
against these Northern standards, ART in Latin America (overall numbers for Argentina 
are not available) is not so distant from the modernity of US medicine: the overall 
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pregnancy success rates for Latin America are 29.8% for IVF and 30.7% for ICSI 
(Zegers-Hochschild and Galdames 2004: 3). In comparison, the CDC reports an overall 
33.7% percent pregnancy rate for combined ART cycles (CDC 2006:19). As I discuss in 
chapter two, based on these pregnancy success rates, the practitioners in Buenos Aires’ 
principal assisted reproduction clinics pride themselves on running “the best clinics” in 
all of Latin America, and clearly think of themselves as part of this competitive 
international network. While these specialists acknowledge the current difficulties facing 
Argentina, they clearly distinguish Argentina as unlike “the rest of Latin America” and 
emphasize the European legacy of specialist medicine here. The image of Argentina that 
many of these professionals present is that of a technologically and medically advanced 
country. Besides making claims to professional prestige, these high-tech experts also 
strive to distance themselves from a characterization of Argentina (and Argentines) as 
corrupt by actively engaging in an affirmation of their medical legitimacy, for instance 
through international approval. Recent work on modernity in dialogue with theories of 
globalization provides a theoretical basis for this possibility of not one European-based 
trajectory of modernity, but of multiple, ubiquitous, and incomplete “alternative 
modernities” (Appadurai 1996; Gupta 1998). Analyzing the processes of alternative 
modernities can reveal unexpected cross-overs and hybrid combinations: “everywhere, at 
every national/cultural site, modernity is not one but many; modernity is not new but old 
and familiar; modernity is incomplete and necessarily so” (Gaonkar 2001: 23).  
My reading of assisted reproduction in Argentina as a “modern” practice draws 
also from Bruno Latour’s (1993) theoretical concepts of “purification” and “hybridity.” 
According to Latour, modernity works through both processes. Purification is the attempt 
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to carve an absolute divide between science and society, nature and culture, things and 
humans. In particular, Latour associates purification processes with a view of the world 
as partitioned into separate, contained and controllable categories of politics, society, 
economics and science. However, like Haraway’s critique of the permeable boundaries of 
technoscience, Latour also suggests that the very work of purification itself produces 
inseparable hybrid networks of these categories.14 Like Haraway’s cyborgs, Latour’s 
hybrids (reminiscent of the Victorians in Foucault’s (1978) repressive hypothesis) are 
proliferating like rabbits and inverting the principles of modernity: “The more we forbid 
ourselves to conceive of hybrids, the more possible their interbreeding becomes” (Latour 
1993:12). Latour calls this productive inversion the “modern paradox,” as modernity’s 
true believers are producing that which they are struggling to prevent. Although Latour 
grounds his argument within a “Western” secular modernity, I propose that this work of 
purification, and the generation of hybrid networks and cyborgs, also takes place—but in 
modified form—in the “subordinated West” of Latin America. 
To provide the necessary historical contexts for understanding these practices and 
positionings of modernity, I also turn to specific studies of state-making and nationalism 
in Argentina. Of particular relevance for this ethnography, are works that address the 
sociology of the recent military dictatorship and legacies of motherhood and family-
making in Argentina (Bouvard 1994; Feitlowitz 1998; Giberti 1987; Taylor 1997; 
Shumway 1991). This literature reveals that Argentina’s twentieth-century political 
history is a highly militarized one, and includes several periods of intensive state 
                                                 
14 In proposing these hybrid networks Latour does not deny the existence of reality, nor does he attribute 
networks to a realm of discursive illusion or social construction, but rather he emphasizes that  “…the 
networks are simultaneously real, like nature, narrated, like discourse, and collective, like society”(Latour 
1993:6).   
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intervention in reproductive health practices. In the 1920s and 1930s a pervasive neo-
Lamarckian eugenics movement took hold in Argentina, which served the interests of 
building and protecting national identity through the use of state-regulated “identity 
cards” and reproduction restrictions to monitor the “color” of the nation (Rodriguez 2006; 
Stepan 1991). More recently, during the dictatorship in the late 1970s, infants and 
children of the “disappeared” were illegally adopted by military families and their 
sympathizers (Arditti 1999; Feitlowitz 1998). In chapters two, three and four I look at 
how this history of state involvement in family and reproductive health interacts with 
current and potential economic liberalization, policies of adoption, and scientific 
embryonic practices. One example of such economic liberalization is that egg donation 
services at private clinics in Buenos Aires give the attending doctor, and not the recipient, 
the responsibility of matching gamete donor to recipient.  
This literature provides theoretical and historical frameworks essential for 
grounding this project within Argentina’s specificities. However, most of these studies do 
not focus specifically on health technologies and medicine as a global phenomenon that 
is nonetheless advanced through particular social relationships. There are particularly few 
social histories of medicine in Argentina to draw from, and the works that have been 
published in English tend to focus on health care reform policies (Armus 2003; Guerrino 
2001; Lloyd-Sherlock 2000; Teixeira, Belmartino and Baris 2000; William 2000). There 
is no published history—social or otherwise—that details the origins of ART in 
Argentina, nor in Latin America. In addition, works that address the forms that science 
and technology are taking in Argentina today, focus on information technologies 
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(Aranovich, Pardo and Noblia 2000; Sebastián 1993).15 This ethnography is therefore 
also a story about the high stakes of modernity involved in producing ART in Argentina, 
and the economic and political constraints in doing so.  
Working from this background literature, I have several important aims in the 
following chapters. First, to examine assisted reproductive technologies outside of what 
is conventionally known as the “First World” in order to better understand local 
variations in the practice of medical biotechnology as a “modernizing” force. Second, to 
interrogate the motivations and understandings about family, health, medicine, modernity 
and religion produced by Argentine health professionals in dialogue with their patients. 
Third, to ethnographically investigate daily negotiations of the local production and 
reception of the global apparatus of assisted reproduction. I am particularly invested in 
exploring the multiple ways in which experts in Buenos Aires personally and 
professionally experience, understand, and thereby transform these new forms of 
scientific knowledge and high-tech medical care; and secondly, how biological 
understandings of reproduction, conception and gene inheritance in turn shape social 
practices and ideologies beyond the clinic and the laboratory. In the last instance, this 
analysis will be revealing not only of assisted reproduction in Argentina, but circulate 
back to “inform” the phenomena of assisted reproduction as a global apparatus as well. 
 
 
                                                 
15 See Brown’s “Test Tube Envy” for an analysis of scientific narrative in Argentine literature (Brown 
2005). See also Sommer 1994, 1998 for a perspective on reproductive and genetic technologies in Latin 
America. 
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Figure 4. Plaza San Martin: downtown Buenos Aires. Photo by Kelly Raspberry, February 2003. 
 
 
Methods of Research 
This ethnography is based on three years of dissertation fieldwork conducted 
primarily in Buenos Aires, Argentina. From November 2002 until August 2005, I focused 
my anthropological gaze on the professional reproductive medicine community in 
Buenos Aires. During this time, my principal research methods included participant 
observation, formal and informal interviews, and archival collection. I observed daily in 
the patient consultation sessions, operating rooms, embryology laboratories, and ethics 
committee meetings of four out of five of the most influential and largest private 
infertility centers in the country.16 My observations also included visits to: a public 
hospital in Buenos Aires, a small ART center in greater Buenos Aires, four satellite 
clinics in the provinces of Argentina, and several private clinics in Chile. I also attended 
                                                 
16 Unfortunately I was not able to observe at one of the five principal clinics in Buenos Aires (through 
passive evasion rather than outright prohibition), though I did do an interview with one of the staff doctors 
there.  
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several international conferences on assisted reproductive technology held in Uruguay 
and Argentina during this time period.  
I laid the groundwork for this project during two preliminary research visits in 
June-July 2000 and 2001, when I met with and interviewed several clinic directors in 
Buenos Aires, Argentina and in Santiago, Chile. However, when I arrived in November 
2002, Argentina as a nation was still jittery from the economic and political 
destabilization of December 2001, and I encountered a different setting than the one I had 
based my proposal on. Given that my research focused on a group of high-tech medical 
professionals in the private sector, I was concerned by how the country’s economic 
problems would be affecting their work, and in turn my own. I soon realized that the 
unresolved economic crisis had affected the upper-middle and upper classes in less 
visible ways than the lower classes. Overall, the widespread economic difficulties 
weren’t deterring many people from finding ways to pay for expensive fertility 
treatments, and so the large centers were operating almost-as usual by the time I arrived 
(I discuss the effects of the crisis in more detail in chapter one). As a result, the majority 
of my fieldwork requests were met with permission and cooperative interest by these 
research participants, particularly by the professionals in Buenos Aires.17 I enjoyed 
                                                 
17 I did meet with some fieldwork difficulties, some of which seem intrinsic to the nature of this project. 
For instance, while observation in the different work areas of the infertility clinic was essential for this 
project, dividing my time up this way seemed also to distance me from the patient experience and made it 
more difficult to track the same patient through a complete treatment cycle (about 2-3 months long). At the 
main center I observed in, many patients pass through the clinic in one day, and I was not always able to 
find out an observed patient’s dates of return.  Many of these practices occur at the same time—usually in 
the morning—so I had to choose between attending one patient’s ultrasound, observing a different patient’s 
in vitro fertilization in the lab, and yet another’s embryo transfer. Although this research always primarily 
focused on professionals, I had hoped to have more of a patient-component than was possible in the course 
of this fieldwork.  
In addition, I was invited to spend 3 weeks observing at the principal infertility clinic in Santiago, Chile as 
a comparison to the work I had been doing in Argentina. Several of the doctors at that center are the 
original founders of the RED organization. Unfortunately however, the clinic’s strict rules, and the 
director’s idiosyncratic reasoning, prevented me access to the laboratory, the surgery room, and doctor 
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access to more clinic areas than I originally expected, and found most everyone tolerant 
of my presence and receptive to my questions about their practices.18  
There are several different spaces in which assisted reproduction work takes 
place, and I spent the majority of my observations in one infertility clinic in Buenos 
Aires, learning what these are and how they vary. My observations were therefore 
divided up into three main work sites: 1) clinical visits (patient consultations, surgeries, 
ultrasound monitoring); 2) the embryology laboratory; 3) staff and committee meetings, 
colloquia, and international conferences.  
Medical Consultations and Procedures 
More than any other space inside the infertility center, clinical visits involve the 
cooperation of a medley of actors, including receptionists, doctors, nurses, psychologists, 
medical residents and of course patients and their family members. I sat in on clinician 
and psychologist patient consultations which included both first-time and returning 
infertility patients. During a clinical consultation, my presence was always explained to 
the patient by the attending clinician, and made optional. These sessions, which lasted 
from half an hour to an hour, allowed me to observe different phases of the treatment 
process. In the surgery room I watched different gynecologists and andrologists perform 
oocyte aspirations, embryo transfers, laparoscopies and testicular biopsies—in a given 
                                                                                                                                                 
consultations. In the end, I was only able to attend doctor meetings, observe in the waiting room and 
conduct interviews with professionals—much less participation than in Argentina. The difficulty that I 
experienced in Chile is revealing of the local particularities of assisted reproduction practices: in Chilean 
society, which is more socially conservative and Catholic than Argentine society, assisted reproduction has 
a more secretive and taboo status. 
 
18 I attribute the relative ease that I had in doing this project (aside from what I outline above) in many 
ways to my status as a researcher from the US. The possibility of name-recognition or prestige that my very 
presence promised to bring to the given center or professionals that I worked with was most likely a prime 
motivating factor. Also, I was working mainly with a group of people who share a value of research. My 
field of expertise (anthropology) was not well understood, but it was not threatening either. 
 39
day, four to five different procedures often take place. My presence in the surgery room 
was also announced to the patient, though in these cases I was one of about seven 
professionals and I blended in with the others. The center that I primarily observed at also 
functions as a training center and has rotating residents for most of the year, this 
smoothed my access into these clinical areas of practice. In all of these professional-
patient encounters I witnessed the difficulties of reconciling medical knowledge and 
doctors’ professional aims with the unpredictability of patients’ bodies and patients’ fears 
and hopes for the treatment process itself. 
 
 
Figure 5. Surgery area in ART center in Buenos Aires. Photo by Kelly Raspberry, January 2003. 
 
 
The Embryology Lab 
The clinical laboratory, where all the processing and manipulation of human 
gametes takes place, is also a key site of the production process, though one physically 
removed from most of the other actors. The crucial position of the lab in determining the 
success of a given assisted reproduction treatment was an important aspect of this 
research, one that I originally underestimated. As a result, early-on I changed my research 
plan to devote more time to laboratory observations. This provided me with not only a 
deeper understanding of the science and technique of lab procedures, but also more 
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opportunities to engage in ongoing, informal conversations with the biologists about their 
views on the meaning of their work. In addition, I was able to observe in different 
centers’ laboratories in Argentina, and saw first-hand how techniques and protocols are 
specific to each center. 
During a typical day in the lab, fresh human sperm samples are processed and 
analyzed, eggs are matured in incubators and fertilized via in vitro inseminations or by 
micromanipulation injection of sperm, and embryos are evaluated for intra-uterine 
transfer and cryopreservation. While in the lab I was most immersed in the specificities 
of the protocols of assisted reproduction work, and at the same time distanced from the 
actual patients undergoing treatment. Human sperm and eggs saved in vials and 
biological medium are at the same time rendered more useful for fertilization purposes, as 
well as abstracted from their origins in particular histories of desires and fears. In the lab, 
conception is reduced to a series of standardized procedures that have nothing to do with 
how much a couple wants to have children, or how long they have been trying to do so, 
but instead depends on the skill of the biologist, the conditions of the lab and the quality 
of the medium being used. Learning to move between these two main work sites—the 
clinic areas centered on patients, and the lab invariably focused on bodily materials—was 
central to understanding the varied components that come together to produce an assisted 
reproduction treatment.   
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Figure 6. Embryology lab and scopes in Buenos Aires. Photo courtesy of Sabrina de Vincentiis, 2006. 
 
Meeting Sites 
My other primary site of observation were the meetings, colloquia, workshops 
and conferences that the assisted reproduction professionals in Buenos Aires conduct and 
attend. At the clinic, these reunions included “case rounds” lunchtime meetings during 
which the doctors and biologists discuss the current patients’ cases, weekly research 
presentations on current reproductive medicine topics (with invited international 
presenters), monthly ethics committee meetings, and patient information sessions open to 
the public. I also spent time observing in clinic waiting rooms, giving me the opportunity 
to talk with patients about their treatments and also to observe the general flow of activity 
and people in the given clinic.  
I also attended several international assisted reproduction conferences that took 
place in Uruguay and Argentina. These included the VII Latin American Federation of 
Fertility and Sterility Societies (FLASEF) Conference which was held in Montevideo, 
Uruguay in November 2002; the VI RED workshop in Punta del Este, Uruguay in March 
2003; and the International Symposium on Advances and Controversies in Reproductive 
Medicine hosted by FLASEF, the American Society for Reproductive Medicine (ASRM) 
and the Argentine Society for Reproductive Medicine (SAMeR) in September 2003 in 
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Buenos Aires.19 All of these scientific meetings were attended by Latin American 
professionals—clinicians, biologists and researchers—as well as a handful of their 
international colleagues from Western Europe and the United States, so I had the 
opportunity to observe international professional relationships and positionings. As these 
meetings also invariably had a social component, I also participated in (and observed) 
valuable informal conversations.  
 
 
Figure 7. Embryos as visual decoration at the FLASEF 2002 meetings in Punta del Este. Photo by 
Kelly Raspberry, November 2002. 
 
 
Interviews 
To compliment my observations and informal conversations, I also carried out a 
total of 72 formal taped interviews. I conducted 68 semi-structured interviews in Spanish 
with gynecologists, biologists, embryologists, psychologists, lawyers and scientists 
engaged in assisted reproduction practices in Latin America. In addition, I did 12 
interviews in Spanish with current and previous patients (some of whom were also 
professionals) who shared with me their experiences of infertility treatments in Buenos 
Aires. Specifically, the group of 56 professionals interviewed included a) 47 reproductive 
                                                 
19 The spanish names of the conferences are: VII Congreso de la Federación Latinoamericana de 
Sociedades de Esterilidad y Fertilidad; VI Taller de REDLARA; Simposio Internacional de Avances y 
Controversias en Medicina Reproductiva. 
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medicine specialists (clinicians, biologists) representing 17 different centers in Argentina 
(13), Chile (2), Brazil (1) and Peru (1); b) 9 non-medical professionals (lawyers, 
researchers, assistants) in Buenos Aires involved in assisted reproduction. I had the 
opportunity to formally interview some of the professionals more than once. Most 
interviews with professionals were conducted in the office of the given professional 
during work hours. I interviewed patients either in a private room at the clinic, or in their 
home. Interviews lasted from 50 minutes to 2 hours, with 75 minutes as the average. 
Everyone interviewed signed a written IRB-approved consent form, which provided the 
option of allowing for their actual name to be used. 
 
Archives and texts 
Archival research was also important for this ethnography. I collected and 
analyzed a variety of historical and contemporary written materials from the clinics, the 
Internet, the library, and public newsstands. These materials include clinic informational 
literature on treatment protocols; popular media discussions of infertility, assisted 
reproductive technologies, and motherhood; and national legal documents on human 
rights. 
 
Chapters Preview 
In the chapters that follow, I seek to uncover the predominant ideologies and 
practices that constitute and are produced by the “local culture” of assisted reproduction 
in Argentina, from the viewpoints of its practitioners. In chapter one, I give a contextual 
history of how ART began in Argentina, identifying the major players and centers that 
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continue to wield influence today. Through telling this history I begin to deconstruct the 
notion that technology transfer is a neutral process, examining how it is actually a 
“translation” of sorts. In chapter two, I examine further the specificities of local 
production of ART in Buenos Aires and the complexities of doing ART day to day. I 
explain that the production of in vitro fertilization in Argentina rests on a series of moral 
positions about the family, motherhood, and the role of the Church in medical practice. It 
also requires a creative maneuvering around local social and material constraints. In 
chapter three I examine again the pronatalist privileging of biological parenthood, and the 
preference of in vitro fertilization using gamete donation over infant adoption in 
Argentina. The practice of gamete donation also clearly exposes the market and 
commodification aspects of ART. Using the examples of positions on paid egg donation 
and surrogacy, I discuss clinic directors’ attempts at separating out their medical practices 
from the undesirable chaos of the market. In chapter four, I focus on the creation of the 
hybrid entity of the morally and legally ambiguous embryo in ART work, and the various 
ways professionals propose to “resolve” this ambiguity. I examine two techniques in 
particular, embryo cryopreservation and preimplantation genetic diagnosis (PGD) to 
illustrate how medical technology responds to a cultural human rights discourse. I 
conclude this ethnography with a suggestion of  how ART will continue to influence 
everyday Argentine life. I also begin to engage in a broader anthropological discussion of 
what this specific cultural account of ART in Argentina reveals about the production of 
biomedicine and biotechnology around the world. 
INTERLUDE I 
Living and Working with Assisted Reproductive Technology 
 
“Buscar un bebé”:‘Searching’ for a Baby and Finding Infertility 
I married very young, I married in 1990 and I was finishing my studies and I 
didn’t want anything to do with having children at that time. […] It was around 1997 that 
we thought “okay.” That’s it. I had already received, I had achieved quite a lot in my 
career and you know, everything has its time in life, and so we began trying to have a 
baby, and it wasn’t coming, it wasn’t coming. And well, then enough time had passed so I 
talked with Emilio [gynecologist] because I always had the impression that it was me. I 
had never had anything done to me and so they began to do all the testing, and 
meanwhile they sent Alejandro [husband] to do the tests, the spermogram, the routine 
tests, like they do with any patient. And then well, they began to do all the routine exams 
on me and they gave me an “everything okay.”  
And Alejandro’s spermogram comes and it’s azoospermic. That was a shock. It 
was a huge blow. Because first, I had always thought that it was me, and in addition to 
that the fact of being azoospermic indicates, that’s it. Even though he could do the 
biopsy, it was…it was a huge blow for him and for me. And then Alejandro came to see 
[andrologist], and we planned the biopsy. He has non-obstructive azoospermia [testes do 
not produce sperm], in other words he had a 60% chance that we wouldn’t find anything. 
So we talked and we decided that if he didn’t have any sperm we were going to adopt. 
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*** 
Laura is a practicing Catholic, an embryologist who works in the laboratory of a 
prominent assisted reproduction center in Buenos Aires, and a woman who has 
personally lived the trials and successes of assisted reproductive techniques. I tell Laura’s 
story because it begins to lay bare the complexity of desires, motivations, choices, 
constraints and conflicts involved in producing and consuming assisted reproductive 
technologies (ART) in Argentina. This Argentine woman’s narrative of her experiences 
with infertility—both as a patient and as a specialist—provides us an analytical window 
into the historical and political, dynamic and embodied ideologies and practices that 
make up a “local culture of assisted reproduction.” Laura and her husband Alejandro are 
from upper-middle class, close-knit Catholic families. Alejandro is an engineer. Laura 
has two sisters, her husband has 13 siblings, and they both want to make a family “of 
their own.” In the following pages I follow her narrative of disappointments, celebrations, 
doubts and certainties as a way to begin to understand the motivations and choices that 
drive this local culture. 
*** 
By the time Alejandro has the testicular biopsy surgery done it is 1999, about a 
year and a half after they first found out about his sterility. Laura describes to me that it 
wasn’t difficult for them to decide to do the testicular biopsy, only that it took time to fit 
the surgery into their busy work schedules, particularly Alejandro’s. The embryology lab 
director does the biopsy and Laura insists on being in the laboratory that day to process 
the sample and look for sperm. It turns out that Alejandro is lucky—there are mobile 
sperm in his testes, so Laura separates the sperm from the tissue and freezes everything 
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for later use. I ask her if it was difficult to make the initial decision to try an ART 
treatment and she tells me that it wasn’t because they were very clear about the limits of 
what they wanted to do. They agreed to try ICSI, but only using their own gametes. They 
were both clear that the use of a sperm donor would not be acceptable.  
Apparently Laura and Alejandro did not experience any tension between their 
Roman Catholic beliefs and deciding to do ART, because in trying to make a family they 
were upholding a traditional value of motherhood and family. For the same reasons, 
Laura herself does not feel conflicted in her work in the embryology lab. She explains, 
“Alejandro has two brothers who are priests, so I talked with a lot of people [in the 
Church]. The reality is that they tell you that they can’t come out and say ‘yes, we are in 
agreement’ because the Pope and the Church have a different opinion, but the truth is that 
they tell you, all the priests that I talked to, that a woman is born to be a mother and 
everything that  she can do, within what is normal, in order to achieve that…is a blessing 
from the Lord, definitively it tells me that He who is going to decide if you are pregnant 
or not, is God. And the work that you are doing, you are an instrument of [God]…”  
When Laura’s gynecologist, Emilio—who is also a colleague—returns to 
Argentina from an international conference in Europe, they begin to plan the treatment 
cycle, paying attention to Laura’s work schedule. She tells me that it was in August, 
several months after the biopsy, that they did the first attempt. She remembers that 19 or 
20 eggs were aspirated from her follicles. Out of these they were able to inject 18 or so 
because the others were immature. The injected eggs fertilized normally. She remembers 
that she wanted to do the ICSI herself, and actually came into the lab directly from the 
surgery room after the aspiration. The lab director tried to talk her out of it. When the 
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moment came to do an injection she became so nervous that she decided that she couldn’t 
do it. The lab director then asked her to leave the laboratory while he did the ICSI, 
because it was too much pressure to have her standing there watching over his shoulder. 
He later called her and told her how many eggs they injected, and the following day they 
checked fertilization together. Laura recalls “they showed me the embryos, I never had 
very nice [looking] embryos.”  
Laura doesn’t remember now how many embryos were transferred to her uterus 
that first time, but she thinks three were. She clarifies in her retelling that at that time the 
clinic was cryopreserving at the pronucleus stage (Day One), not as embryos. (I come 
back to this differentiation of embryonic development stages in chapter four). The three 
embryos to transfer were selected at Day Two—when the cells have had 48 hours to 
demonstrate their dividing power and differentiate themselves—and the rest were put into 
frozen storage. According to Laura, the three that were reserved for transfer weren’t very 
good quality. Laura asked to be anesthetized for the transfer—though this is not common 
practice—because she was scared and because her cervix is ‘difficult.’ 
She explains her hope and expectations in the days following the transfer, “They 
did the transfer, I went home and I rested. After 12 days the test came back negative. That 
was also a shock because I thought, ‘if there are sperm, that’s it.’ You know. ‘I am going 
to get pregnant.’ You know, I was convinced that I was pregnant. Convinced. […] So the 
shock it gave me was terrible. The andrologist and gynecologist called me to Emilio’s 
consultation office and they told me that the test was negative. ‘Okay, it’s okay,’ I told 
them. ‘It’s okay, We will try again,’ and I left and then I realized everything. So I left the 
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center. I felt like I wanted the world to swallow me up, I wanted to disappear from the 
planet. It was terrible.” 
Despite her inside-knowledge of the relatively low implantation rates with ART, 
Laura was sure that she would be one of the successful ones on the first try. This hope is 
part of what drives the industry of in vitro fertilization. Women and their partners first try 
ART as “an option” that they need to “rule out.” Often they come back again and again, 
despite low odds, hoping that “this time” it will work.  
 
If at first you don’t succeed… 
After that first failed attempt Laura describes that she tried again, “After that I 
picked myself up. I transferred the frozen ones [pre-embryos] and I didn’t get pregnant. 
At the end of the year we tried again and I didn’t get pregnant. [Kelly: another attempt?] 
Yes, another ICSI attempt. It was more or less similar in terms of the quantity of eggs. 
But I didn’t get pregnant.” When I comment that it must have been difficult to try again 
she agrees but tells me that she already knew what it was like, and didn’t have as high 
expectations the second time,” It’s like I already knew what it was like. I wasn’t as 
convinced that it was going to work out. Even so the blow is hard, but it was less. By 
May or so of the following year the frozen pre-embryos from the second attempt were 
transferred and again I didn’t get pregnant. So Emilio told me that he would like to look 
at my uterus because as I wasn’t getting pregnant and they were transferring embryos, 
supposedly…He told me, ‘I am going to do a hysteroscopy on you.’ Based on what he 
told me, I said ‘put me to sleep and do a laparoscopy on me. Do everything and look at 
everything.’ So I went under and they did a laparoscopy and a hysteroscopy and I had 
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endometriosis.” I ask why the previous studies that Laura did, in the beginning, didn’t 
show the endometriosis. “It didn’t show up because the endometriosis wasn’t in the 
ovary. It was in the Pouch of Douglas and there was very little. But the ovary didn’t have 
any, when they took the eggs out, you know during the aspiration, the follicles looked 
perfect so…” 
The time it takes for the doctors to realize that there is more going on with Laura 
and Alejandro than just male infertility—in this case endometriosis as well—highlights 
the pervasive unknowns that characterize the field of reproductive medicine and 
infertility treatments. The biology of human reproduction is not well-understood nor 
easily dealt with. The commonly-cited infertility pie graph attributes a 30% to both 
female and male infertility problems, and another 30% are known as “combined 
infertility” cases. “Combined infertility” means that the difficulty in conceiving or 
gestating a pregnancy stems from a combination of problems from both sides—the 
female and the male. The remaining 10% of cases that practitioners see are left to the 
realm of unknowable—“infertility without apparent cause.” The rapid diagnosis of 
Alejandro’s azoospermia reflects a major shift in the field to pay more attention to the 
male partner. Traditionally in this field there was a bias to first examine the woman and 
to test the male partner only as a last step. Assisted reproductive techniques were 
originally conceived to help with female infertility problems, for instance in vitro 
fertilization was developed as a means to overcome problems with blocked fallopian 
tubes. Andrology however was a slower field to develop, particularly in Argentina.  
Laura describes the process of treating the endometriosis and deciding to try yet 
another ART cycle: “I began with the treatment for endometriosis. So I began with 
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Lupron [a synthetic hormone], I was menopausal for 5 months…and after that, Emilio 
told me, ‘okay, let’s try again.’ And I wanted to go somewhere, I didn’t want to do it here 
because for me it was a lot of pressure, from the security person to, in other words 
absolutely everyone knew that I was in treatment, that I had done a transfer, when I had 
done the beta test [pregnancy test], how the beta test came back. For me it was a lot of 
pressure. So I said, ‘I’m leaving.’ I’m not going to go to another center, ‘the biologist 
from […] that goes to […].’ No way. So I said I’m going to Cornell.” 
To avoid public speculation and scrutiny, Laura decided to leave Argentina and 
try doing ICSI at a center in the United States that she judged as reputable. However, as 
can happen, world events changed her plans. It was September 2001 by then, and Laura 
was 34 years old, her husband was 38 years old. They had already tried ICSI twice, as 
well as two transfers of cryopreserved pre-embryos. 
 
Global events, local treatments 
Laura remembers clearly the plans for her third ICSI treatment: “So well, we are 
going to Cornell or we are going to Cornell. We did all the paperwork and everything. 
Emilio was going to stimulate me here. And Emilio was going to accompany me, even 
though he can’t work in the US, he was going to accompany me. We had everything 
planned, I began with the Lupron to inhibit the ovulation…and the twin towers fell.”  
Laura states this calmly, like checking off a list of conditions and it takes me a few 
seconds to realize what she means. She repeats to make sure I understand. “The accident 
with the twin towers, the 11th of September.” I realize what she is talking about. She 
continues, “I needed to travel to New York at the end of September. It was chaos. I would 
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have had to bring with me the frozen biopsy [testicular biopsy with the sperm]. Imagine 
traveling with a tank of liquid nitrogen, ‘what do you have here, what is this…So Emilio 
tells me, ‘do it here.’ ‘No, no, I am not going to do it here.’ ‘Come on, but do one here, 
there’s nothing to lose, you have already bought the medicine, you began the 
inhibition…in other words the chances [of pregnancy] from not doing anything is zero, 
from doing something is something.’ ‘No but the pressure, but I don’t know, but I don’t 
know how much.’ Allright. You know, when you have already decided. And my husband 
also, ‘come on, come on, come on. There’s nothing to lose, come on, come on.’ You 
know when you do it, saying, ‘okay, it’s okay.’ So we did it at the center again. […] We 
did the attempt, I don’t remember if it was the 27th or the 26th of September…and they 
transferred three embryos, we froze embryos this time. So I still have frozen embryos in 
storage. They did fragment reduction and [assisted] hatching on the embryos.” 
By this third ICSI attempt, three years after the first try, Laura’s—and the 
center’s— position on the acceptable treatment of an embryo has changed. Whereas 
before she did not even cryopreserve beyond Day Two of embryonic development, now 
she is doing highly-manipulative techniques on the embryo (fragment removal and 
assisted hatching), as well as freezing at Day Three. I come back to these changes in 
laboratory practice and embryo manipulation in chapter four. 
Laura continues her narration of the third try and her certainty that the treatment 
failed yet again, “I left that day to rest, and I stayed at home two days. The transfer was a 
Saturday so I think I returned to work Tuesday. Monday I stayed home and Tuesday I 
started work. Tuesday afternoon I arrive at home and I have spotting.” Laura was so 
worried that she calls the center and comes back in to see her gynecologist. “Emilio tells 
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me ‘it’s not possible that you have already started to menstruate because the implantation 
is recent, it’s impossible.’ So he says, ‘okay, let’s see, get on the exam table and we are 
going to give you more progesterone. So they started giving me injectable progesterone 
[a shot].” Laura explains that the spotting stopped to her surprise. “I didn’t feel, I didn’t 
feel anything strange, nothing different from the other times that I didn’t get pregnant. 
And the thing about the stimulation, it makes you have, or at least it does to me, 
menstrual pains during that time, above all when you are getting closer to the date, you 
have menstrual pains. So I was saying that I was already beginning to menstruate. The 
day before doing the beta test [beta hCG blood test]20 we had a dinner at [colleague’s] 
house. So we went to dinner and diagnostic lab director was there. He tells me, ‘I hope 
tomorrow I can give you good news.’ Well, that was just one more thing along with 
everything else. I came home and I gave myself an Evatest [a home pregnancy test], that 
came back negative and I said to myself, that’s it. And I had those menstrual pains. When 
I got up, I hadn’t thrown away the Evatest, I had left it there, and in the morning when I 
get up I see two lines, I say, ‘hmm, what’s this?’ So when I get here [to the center] I ask 
[a gynecologist], and she tells me, ‘no, when that much time passes this oxidizes’ and she 
gives me the explanation like telling me that it isn’t that the test is positive. I had terrible 
menstrual pains. So I said to myself, ‘bye, that’s it.’ But they took my blood anyway.  
We were doing a laboratory course, in other words there were a ton of biologists 
inside the laboratory that day. Around 10 in the morning, 10:30, the secretary tells me it’s 
urgent, it’s the diagnostic lab director. I answer and he tells me, ‘Laura it came back 
                                                 
20 The “beta” test is also known as the beta hCG blood test for pregnancy.  In an ART treatment cycle, the 
hormone levels of hCG in the blood are measured in a lab 12 days after the embryo transfer. Because hCG 
is produced during a pregnancy, the levels of the hormone should double every 48-72 hours. An initial level 
above 30 IU/ml is considered a positive indication of pregnancy. 
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140!’ So the first thing that occurred to me was to tell him that maybe he was confused. 
‘No, no I’m not mistaken.’ So I hung up and I continued talking to the biologists that I 
was giving a class to, explaining to them, and one of the lab biologists was looking at me, 
like saying, ‘tell me something!’ and suddenly it hit me and I came close to her and I told 
her, ‘it was 140’ and she hugged me and I left the laboratory, I had to go because I 
couldn’t with the doctors there, I had to tell my husband, I had to go. I couldn’t, I had 
to…so I left the laboratory, I called my husband. He couldn’t believe it either and I left to 
look for Emilio. Emilio hadn’t arrived yet.  
It was [the lab director’s] birthday that day. […] So I entered his office, and I 
remember that he was on the computer, very…so I tell him ‘I have a gift for you.’ He 
asks me ‘what did you bring me,’ and I tell him, ‘no, the beta was positive.’ We hugged 
and we all started to cry and then we heard Emilio, he was coming up the stairs, and we 
called Emilio to the office and we told him and we hugged and we all cried, and that 
was…I couldn’t return to work in the laboratory obviously. I was sitting here and…I 
don’t know if you do this in the United States, but here, when fiancées get married, after 
they leave the Church there is what is called ‘the atrium’ which is like a patio that the 
Church has, and they say, the bride and groom will be greeted in the atrium. So the bride 
and groom are there and everyone comes to greet them. Well, I seemed like the fiancée 
because I was here and everyone at the center came to greet me, to visit me, to hug me. 
[…] And I was immensely happy, but Emilio told me to lower my excitement because it 
was a high beta positive but only a positive beta, and so to calm down.” 
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“The best time of my life” 
Laura, ecstatic that she was pregnant, did not want to listen to her gynecologist’s 
caution that this was only a biochemical pregnancy at this point. She would have to wait 
two more weeks to do the ultrasound. “So Emilio told me, ‘stop.’ And I was saying, ‘but 
I never lived this moment before, let me live this moment even if it’s not, I never had a 
positive beta, so let me live this moment.’ And two days later we did the beta again and it 
again went up, it doubled. And then we did an ultrasound, and there were two. There was 
a sack [embryonic sack] that was showing up perfectly, and another sack that showed up 
very small. So…well, obviously there were two and one stayed. Afterwards we began to 
do the ultrasounds and to see the heartbeat and to see that the other one was totally 
receding. So Emilio told me, ‘look, if you have spotting, it will definitely be this one.’ 
Fortunately Emilio told me that Nicolas was well positioned above and this one was 
lower, in other words if it detaches, it isn’t at all going to complicate the other one that is 
higher. And in truth I didn’t have spotting, I didn’t have anything. I had a fantastic 
pregnancy. I didn’t have any pain, I didn’t have vomiting, I wasn’t dizzy, I came to work 
up to two days before having him…It was great.  
It was the best time of my life. Great. Great, great. Well, I was very scared, every 
week I made Susana do an ultrasound on me. I have a collection of videos and photos 
of…because once you already have a belly and you feel the baby moving, it is 
moving…but until then I didn’t know, so, ‘Was it taking hold? Will it take hold? Will it 
continue?’ Because I didn’t have any symptoms and as I was feeling so good, nothing felt 
different, so Juliana did ultrasounds on me every week.” Laura remembers that the 
pregnancy, which she had waited so long for, was a wonderful experience. But because it 
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was so desired, she was terrified that she would lose the fetus. Without signs from her 
body that the pregnancy was going well—referred to here as “symptoms” of the 
pregnancy, Laura turned to technological assurance that the pregnancy was progressing 
well.  
In a demonstration of the normalization of medical technology, Laura’s reliance 
upon monitoring doesn’t end with her ultrasounds, but extend to the birth itself, “They 
did an ultrasound every week. Jorge Ramiro was in charge and told me that the baby was 
going to come out saying “cheese!” like with the camera. Then in December they did an 
ultrasound and they told me that it was a boy, I was convinced that it was a girl but no, a 
boy. And so, there was Nicolas. In 2002. He was born after 38 weeks, actually that was 
also…Emilio wanted it to be a natural delivery and I asked him for a cesarean, because I 
was scared. I fought so much to have her that any risk, I was afraid that he would come 
out with the cord twisted around him, that the ultrasound showed that, it made me scared. 
So, actually I had the date for the 20th of June…and two weeks earlier we did the 
cesarean.”  
 
Next Steps 
Since the ICSI treatment finally worked on the third try, Laura and her husband 
are not content to stop with just one child. Nicolas is now one year old, and they have 
cryopreserved embryos that are waiting for them to use, pulling on their sense of Catholic 
responsibility. Laura is vague about how many there are in storage, but not about the 
need to transfer the waiting cryopreserved embryos. She tells me, “I don’t remember if 
there are four or five. I think five. Not very good quality…well, they are frozen. I think 
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before the end of the year I am going to transfer them. And well, if it doesn’t work, next 
year we will try again, already knowing that it’s the last ICSI try because…Because they 
don’t have much more of the sample.” 
Laura is sure she wants to do another full ICSI attempt because they want to try 
until Alejandro’s frozen sperm sample is used up. “Yes, I would like Nicolas to have a 
sibling, so that he isn’t an only child. And if not, we will have Nicolas.” However this 
desire to give her son a sibling doesn’t extend to an immediate consideration of adoption, 
like most people who turn to ART, Laura tells me they prefer to exhaust their 
reproductive options first. Laura explains, “Maybe to adopt later, it isn’t that I closed the 
theme of adoption, not at all. But it is… now it’s like…well, great, I have little Nicolas, I 
have frozen embryos. I have other options, but not to discard the option of adoption, not 
at all. But for further ahead.”  
Laura also emphasizes that for her husband, giving their stored and frozen 
embryos a chance at life is very important. To freeze embryos in the first place was a 
gradual decision that Alejandro came to accept with time and increased biological 
understanding of embryonic development. Laura explains that over these three years of 
ART attempts, Alejandro’s Catholic beliefs of conception and personhood have gradually 
expanded to include a more scientific perspective on in vitro embryos: “Of course, from 
not understanding, from coming from a Catholic family, for him, for example, to freeze 
an embryo, he believed that it is a baby frozen, so it seemed horrible to him. From that 
time, as I began to explain to him how it was, he began to internalize more the biology, 
the process of embryo formation. […] It is like the fact of having frozen embryos still 
gives him a certain fear, a fear that…not fear because he thinks that it is a baby in a flask, 
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but he is afraid…Valeria my friend who is the mother of this baby girl [motions to a 
photograph], after [doing IVF] she got pregnant on her own and last year her husband 
died from a heart attack, and they have frozen embryos. So, what happens to those 
embryos? Valeria is going to donate them. The fact is that…you are donating embryos 
from a person who had a baby with myelomeningocele21, who is going to want them? It’s 
like, it’s hard. That is what my husband fears, today what we are afraid of is that 
something might happen to us, and then what will happen to those frozen embryos? That 
is what he is afraid of, it makes him think that we have to transfer them as soon as 
possible.” 
According to Laura, her husband is worried about the fate of these frozen 
embryos that they have stored in nitrogen tanks at the clinic. Though he no longer thinks 
of them as frozen babies per se, they still represent human life that he is responsible for. 
His solution is therefore to “take care of them”—by attempting a transfer cycle—as soon 
as possible. When I comment that all five cannot be transferred at once, because of the 
potential for a multiple pregnancy, Laura agrees. “No, but they are frozen in different 
tubes and they aren’t good quality. So I think that they [the biologists] will thaw three of 
them, and maybe one will not…in other words they need to thaw three and we will see 
what quality those three frozen ones have after the thawing, and then we will see for a 
second frozen transfer opportunity or if we should thaw the rest.” 
                                                 
21 Myelomeningocele is a type of spina bifida where the spinal cord is exposed through an opening in the 
spine. 
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Post-script  
In November 2003, four months after our interview, Laura was ready to transfer 
her remaining cryopreserved embryos. She decided to thaw all five of them at once as 
they were all poor quality before being frozen. The process of cryopreservation and 
thawing is taxing on an embryo, and many times a poor quality one will not be viable 
after thawing. All five of the embryos were still viable after thawing, but her gynecologist 
only wanted to transfer three to avoid the risk of a multiple pregnancy. In what appears a 
means of “ethical” disposal of the problematic other two viable embryos, the lab then 
began to “refreeze” the two that were left. However mid-way through the cryo-process 
they turned black and degenerated, and so were discarded. According to another 
biologist, to thaw and refreeze is akin to direct disposal as embryos do not survive such 
extreme processes. In fact, this is the first time I have heard of a case where “refreezing” 
was attempted. It seems that giving the embryos a chance at being thawed and then re-
frozen was a conscience-appeasing manner of “taking care” of two poor-quality embryos. 
This frozen transfer did not result in pregnancy. The last time that I talked to her, Laura 
had decided to try ICSI one last time—which will make four times total—with the 
remaining amount of Alejandro’s frozen sample.  
 
Collaborative Choreography 
As Laura’s experience demonstrates, most high-technology procedures involve 
multiple stages, each contingent on results from the one before. If a particular procedure 
doesn’t work—as is often the case—the whole process must begin again. For instance, 
the process of non-donor IVF includes a sequence of clinical procedures: 1) infertility 
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diagnosis (through tests, possibly surgery), referral, and selection of IVF program; 2) 
preparation for first cycle, including new clinic tests to update previous ones; 3) ovulation 
induction (2-3 weeks of daily hormone injections, regular clinic visits for urine and blood 
tests); 4) in-clinic egg aspiration procedure (hormone injections before hand and 
ultrasound-guided removal of eggs); 5) procurement of sperm sample (via masturbation 
or a sperm bank) and sperm “washing” (to improve motility); 6) in vitro insemination or 
sperm injection of aspired eggs (48-72 hours incubation for cell division); 7) embryo 
transfer (after successful fertilization and division in laboratory); 8) pregnancy testing 
(via blood sample after 12 days); 9) prenatal monitoring (if pregnancy has begun); 11) 
birth of one or more babies.  Other procedures follow a similar pattern of progressive 
decisions and techniques to first achieve pregnancy, and then a live birth.  
The elaborate contingency of these processes clearly necessitate a whole-hearted 
investment from all parties involved. In the following chapters I examine the experiences, 
motivations, and understandings of assisted reproduction from the perspective of 
reproductive medicine professionals in Argentina. In the next chapter I look specifically 
at how doing an ICSI treatment in Buenos Aires was made possible for Laura, and others 
like her, by tracing today’s production of ART in Argentina back to its early beginnings 
in the mid-1980s.
CHAPTER ONE 
THE GESTATION AND BIRTH OF ART IN ARGENTINA 
 
The Tucumán Twins Turn 18 years Old 
 
 
Figure 8. Clarín article: "The First Babies Created by Fertilization in the Country Turn 18 Years 
Old." February 7, 2004. 
  
On February 7, 2004, headlines in Argentina’s national newspapers celebrated the 
18th birthday of twins Eliana and Pablo Delaporte, the first babies born from in vitro 
fertilization procedures in Argentina. The daily newspaper Clarín emphasizes the 
importance of this event by publishing two related articles on the novelty of the Delaporte 
family’s experience that began in the winter of 1985, complete with photographs of the 
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18-year old twins, their parents and two siblings (Iglesias 2004). In what reads as a tale of 
pioneering scientific modernity, the first article describes the techniques themselves, and 
the improvements that have been made over two decades of their production in 
Argentina: 
The news surprised all Argentines in 1986: Eliana and Pablo Delaporte were the 
first babies born from in vitro fertilization in the country. Today, the twins from Tucumán 
are blowing out 18 candles and such births aren’t surprising anymore. This is because 
from 1986 to today, fertilization techniques have become very sophisticated and genetics 
has also advanced. 
“The joy was tremendous. We were in the laboratory looking at human embryos, 
we couldn’t believe it” Santiago Brugo Olmedo emotionally remembers. He is the 
director of Center for Studies on Gynecology and Reproduction (CEGyR) and one of the 
professionals that did the treatment in the winter of 1985. 
The specialist recounts that they inseminated the eggs with sperm, that six 
embryos formed and that they immediately did the intra- uterine transfer, with success. 
The group included the doctors Roberto Nicholson, Roberto Coco and Nicolas 
Neuspiller. Since then hundreds of thousands of babies in the world have been born 
thanks to fertilization techniques. 
“In that time everything was home-made. The culture media were variable, they 
took a long time to make and their efficacy was low. Every attempt had a 10% chance of 
success, today we have 40%” Brugo Olmedo says. 
To obtain eggs, women had to submit to a surgery (laparoscopy) that lasted more 
than an hour. Today eggs are aspired in 15 minutes using a transvaginal ultrasound. The 
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catheters for inserting the embryos today are more delicate: they don’t damage the 
uterus, which produces a higher number of pregnancies. 
The hormone treatment for women has also changed: “The drugs that they used 
were urinary gonadotrophins, now they are recombinant hormones, produced through 
genetic engineering. They are more pure and they have fewer secondary effects.” 
One improvement is that it’s no longer necessary to use multiple embryos: two in 
women under 38 years old and three for women over this age. Another development 
occurred in 1993, when the first ICSI (injection of sperm into an egg) was performed. 
With respect to the future, this specialist says that research points to the selection of a 
single embryo for implantation into the uterus, achieved through the development of 
preimplantation genetic diagnosis: “It will increase the probabilities of pregnancy and 
will avoid the multiple pregnancy.” 
The risk of having multiples is used by health insurance companies as an 
argument for not covering fertility treatments. In Argentina couples with fertility 
problems who don’t have enough money aren’t able to have children. And it’s estimated 
that 15% of couples of reproductive age have such problems in becoming parents. 
(Iglesias 2004).22 
With its emphasis on technological developments and increased knowledge in the 
field, this piece glowingly presents assisted reproductive technology (ART) today as 
modern medicine that has become “sophisticated” with time, and optimistically promises 
further developments.23 As this article indicates, the birth of these twins in a Buenos 
                                                 
22 All newspaper and interview translations are mine. 
 
23 Though techniques and materials used in ART have improved over the years, I judge this retelling as 
overly-simplistic in its appraisal. For instance, a 40% success rate depends on many variables, such as age 
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Aires clinic in the summer of 1986 marked the beginning of a new era of reproductive 
medicine in Argentina. This is an era in which such alien Spanish acronyms as FIV, ICSI, 
GIFT, ZIFT, DO, and IIU have become common banter in the waiting areas and 
consulting rooms of private medical centers across the country, and at the same time, the 
act of “making a family” remains under the purview of the Catholic Church but suddenly 
need not involve heterosexual procreation.24 Looking closely with an anthropological 
lens at this era reveals a tale of scientific modernity and hybridity, of desire and choice, 
morality and hypocrisy, individualism and collaboration, protocols and creativity, 
constraints and progress. In this chapter I follow the historical trajectory of the first IVF 
in Argentina from England, Australia, and the US down to Buenos Aires in a series of 
interconnected—and in many cases serendipitous—pathways of knowledge, 
technological expertise, economic resources, and ideological investments. While assisted 
reproductive technologies were first developed in England almost thirty years ago, they 
are now practiced around the world in varying forms. In this chapter I begin to examine 
the local specificities in Argentina that enabled the first travel of this biotechnology to 
Buenos Aires, and its local transformation in practice.  
Much of the early anthropological scholarship looking at reproductive 
technologies focused on Western Europe and North America and as a result, perpetuated 
a notion that the technology apparatus of in vitro fertilization itself is standardized and 
homogeneous (Becker 2000; Cussins 1998a; Franklin 1997; Franklin and Ragoné 1998; 
                                                                                                                                                 
of the woman and type of infertility; aspirations can often take longer than 15 minutes; and multiple 
embryos are transferred in higher numbers than reported here. Furthermore, it is unlikely that in the future 
PGD will be used routinely for IVF as a means to avoid the risk of multiple births, a point I will come back 
to in chapter four. 
 
24 These are the Spanish acronyms for in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), 
gamete intrafallopian tube transfer (GIFT), zygote intrafallopian tube transfer (ZIFT), oocyte donation 
(OD), and intrauterine insemination (IUI). 
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Strathern 1992). For example, Sarah Franklin’s (1997) early work on IVF in England 
contends that the “hope technologies” of assisted reproduction tacitly coerce the lasting 
cooperation of infertile couples through an unvarying logic of “science as progress.” In 
this manner, these studies lend to the conclusion that biotechnologies are culturally 
neutral and bring a standard form of scientific modernity to any setting in which they 
appear. Throughout this ethnography, I suggest that the reproductive technologies 
themselves are value-laden and transformed according to their place of practice. I 
propose that the term “technology transfer” is too static and unresponsive. These 
technologies are not just “transferred” to one place, they are actively selected, engaged-
with, practiced, and therefore transformed. I argue that this process is a form of 
“translation,” in which protocols and techniques are translated into local idioms through 
practice.  
In doing so, I am building on recent work in anthropology that has responded to 
what has become a “global spread” of reproductive technologies outside of the “First 
World,” including an examination of ART practices in Egypt, India, Israel, China and 
Ecuador (Bharadwaj 2002, 2003; Handwerker 2002; Inhorn 2002, 2003; Kahn 2000; 
Roberts 2006).25 The majority of these ethnographies, while insisting on a local cultural 
analysis of these technologies, do so by examining patients’ experiences. For instance, 
Marcia Inhorn’s work on the expansion of reproductive technologies in Egypt contributes 
                                                 
25 I am also of course in dialogue with work on the circulation of biomedical technologies in general around 
the world. Unfortunately there are few nuanced ethnographic analyses of the localization of different 
medical technologies. Most commonly, medical technology movement is explained by a model of 
“diffusion” or “transfer.” For instance, the innovative entrance of CT scanners from Europe into US 
medical practice in the 1970s was described primarily in terms of a “diffusion” model, based on economic 
cost and clinical efficacy (Baker 1979; Banta 1980; Trajtenberg 1990). Furthermore, most of these recent 
ethnographies that look at ART outside of the “First World” continue to frame the global spread of this 
medical technology as technology “transfer.” One striking exception to the “transfer” notion is Margaret 
Lock’s (2002) compelling analysis of how resuscitation techniques used in cases of brain death depend 
upon local constructions of life and death.  
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one of the first in-depth ethnographic analyses of ART not located in a “First World” 
setting (Inhorn 2002, 2003). In Local Babies, Global Science Inhorn (2003) calls for 
further examination of the “varying religious moralities and ‘local moral worlds’” that 
arise from the practice of these technologies around the world, and reveals the 
particularities of patient experiences of infertility and “test tube baby-making” in the 
Muslim Middle East (Inhorn 2003: 19-21). In dialogue with this literature, I argue that in 
addition to studying ART production outside of the First World, the experience and 
understanding of the professionals engaged in producing ART also needs examination. I 
suggest that a close analysis of professionals will aid in understanding the local 
“translations” of the global apparatus of ART. I further I argue that the notion of 
reproductive technology “transfer” that much of this work calls upon is too passive. 
“Transfer” predicts that technologies are picked up and set down in a different place 
unchanged. In contrast, in this ethnography I contend that there are regimes of training 
and protocols of practice that are modified according to the local needs and desires of 
Argentina’s reproductive medicine community (Berg 1997; Latour 1987, 1988).  
In this chapter I begin to address the question, “What roles do Argentina’s 
political and cultural histories, as well as current social values of family, science and 
modernity, play in the present accessibility and demand for these practices? To answer 
this, I begin with a social history of how these procedures first began in Argentina in the 
mid-1980s, and what factors have enabled and constrained their expanded production 
over the last twenty years. In looking at the international factors involved in Argentina’s 
local culture of assisted reproduction, I follow Sarah Franklin and Helena Ragoné in their 
assertion that, “it is essential to recognize not only the local, regional or national 
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dimensions that impinge upon a particular case study or field setting, but increasingly 
also to appreciate the international and global formations that exercise a distinctive and 
distinctively cultural influence” (Franklin and Ragoné 1998:5). With this in mind, 
through this local history I seek to show how ART in Argentina is both ‘local’ and 
‘global.’  
The story that I tell here focuses primarily on life histories of several individuals, 
as the predominant method of technology “transfer” in this instance is through certain 
people. At moments this chapter may read as a medical history text, full of names and 
events, experiments and discoveries. However, in focusing on local experts situated 
within an international network, I seek to demonstrate that this is an embodied practice, 
performed by individuals engaged in social worlds of production. As I discuss, these 
practices and innovations are grounded in particular historical, political, economic and 
social circumstances.  
 
Pioneers in the South 
The original team at CEGyR who worked together in the early 1980’s to produce 
Argentina’s first IVF birth was made up of eight men trained in the interrelated fields of 
embryology, gynecology, andrology, biochemistry and genetics. By 2002 when I arrived 
to begin fieldwork, all of these specialists but one had left CEGyR, and several were 
directors of their own fertility clinics.26 Talking with me in 2003, one of the original 
                                                 
26 In November 2005, CEGyR underwent yet another internal political and structural shift. The second-to-
last remaining member (a director) also left the center along with one of the biologists, and opened his own 
private center in Buenos Aires in August 20006. This left just one person at CEGyR who was part of the 
original 1985 IVF group. Since these events occurred “post-fieldwork” they are beyond the speculative 
scope of this ethnography. At this point I do not know the specific reasons for these events, but I do suggest 
that they reflect the political and personal elements of producing ART within a given center. 
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members of the 1985 IVF team at CEGyR aptly summarizes both their early innovation 
efforts and subsequent expansion of the market over the years, as each professional 
opened their own center: 
I am a firm believer that Roberto Nicholson was a true pioneer of his time, and 
when he created CEGyR, which was the first center there was in this country, it 
was a true explosion of activity. He worked a lot and he made pretty good money. 
Then with the passing of the years…things changed a little. Why? If you count all 
the directors in the other centers of Buenos Aires today, everyone came from 
CEGyR. All those people left to set up their own center, and CEGyR began to 
lose a little force, not only because the people that made it up separated, but also 
because the pie had to be portioned out into many little pieces. There were more 
centers and people were going from one place to another…and so the activity 
wasn’t as it had been in the beginning, in the years ’84, ’85, ’87 it was 
overwhelming, and there wasn’t anyone to compete with because there was only 
CEGyR. 
 
As this professional says, the pulse of ART practices in Argentina has grown stronger 
over time, with the opening of additional clinics and the training of doctors and scientists 
in the field every year. Though he views this dispersion of clinic directors as cutting the 
reproductive medicine market into ever smaller pie pieces, I argue that the proliferation 
of infertility centers actually has had the effect of creating demand for assisted 
reproduction practices and expanding the market. The near-simultaneous opening and 
expansion of several assisted reproductive centers in Buenos Aires in the early 1990s put 
assisted reproductive practices within the grasp of possibility for middle class couples, 
due to competitive prices and increased public awareness. With a range of private clinics 
offering ART services in Buenos Aires today, the demand for and acceptance of such 
practices as a valid family-making option has increased since the first IVF birth in 
Argentina.  
On the other hand, as I discuss throughout this ethnography, the production of 
ART in Argentina is not unproblematic. The local culture of assisted reproduction in 
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Argentina continues to be marked by ideological controversy and periodic fluctuation of 
specialists and clinics, characteristics which mirror (and draw from) the country’s volatile 
political and economic life. Later in this chapter I detail the efforts of a few of these Latin 
American pioneering individuals, the context within which they work, and their roles in 
creating this new era of technological baby-making in Argentina. First, to understand 
present-day performances of ART in Argentina—which I take up in chapter two—we 
travel back in time to IVF’s international debut in 1978. In giving this history, I use this 
medical technology’s travel routes through Europe and the United States in the 1970s and 
1980s to examine how the primary agents of influence in the North connect to those in 
Latin America.
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Year Event and Place 
1976 Military coup in Argentina; Dictatorship and “Dirty War” from 1976-1983 
1978 First IVF birth in world: Louise Brown in Oldham, England (Drs. Edwards & 
Steptoe)  
1980  First IVF birth in Australia (2nd in world)   
1981 First IVF birth in US (Norfolk, VA: Jones Institute) 3rd in world 
1983 Democratic elections in Argentina 
CEGyR center founded in Buenos Aires 
First birth using donor egg (Melbourne, Australia) 
1984 First IVF birth in Latin America—Chile  
First birth from cryopreserved embryo (Australia) 
1985 First GIFT birth in Latin America—Chile;  
Second IVF birth in Latin America—Colombia 
1985 Foundation of IFER center in Buenos Aires 
Foundation of LER center in Buenos Aires 
1986 February 7: First IVF birth in Argentina (CEGyR); 3rd IVF birth in Latin America 
1987 Halitus center founded in Buenos Aires 
CER Medical Institute founded in Buenos Aires 
1988 IMAGEM center founded in Buenos Aires 
1989 Menem elected president in Argentina 
Fecunditas center founded in Buenos Aires 
1990 First birth after using PGD in the world (England) 
First Latin American Registry of ART published (Chile) 
1992 First ICSI birth in the world (Belgium) 
1993 Modern CEGyR forms (Nicholson Sr. sells to Brugo Olmedo and Chillik) 
1994 ICSI first performed in Argentina (CEGyR) 
ICSI first performed in Chile  
1995 RED network of Latin American ART centers founded  
Consenso published  by RED 
1997 San Isidro Infertility Unit founded in Buenos Aires 
1999 PGD first performed clinically in Argentina 
Procrearte center founded in Buenos Aires 
2001 December: political and economic crisis in Argentina  
President De La Rua resigns 
2002 January: Duhalde takes over as president 
Peso devalued 
2003 May: Kirchner elected and assumes presidency, peso begins to stabilize 
2004 November: Lawyer Rabinovich appointed legal guardian of all cryopreserved 
embryos in Buenos Aires 
2006  April: Rabinovich resigns as legal guardian of cryopreserved embryos 
July: Hospital de Clínicas opens first public ART program in Argentina 
December: Argentine ART centers agree to a census of stored frozen embryos  
 
Table 1. Chronology of significant political and ART-related events for a contextual history of ART 
in Argentina  
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International Recipes 
“The emergence of in vitro fertilization really revolutionized the sub-specialty 
[reproductive endocrinology] and began to totally dominate our activity because, 
obviously, a more complete field was opening in terms of the understanding that one 
could have of the human reproductive process and how to control it. I know that there 
was a generation of doctors that...that it called to us, those between 30 and 35 years old, 
and that almost all were affected by the development of this technique.” gynecologist at 
Santiago Center of Reproduction in Santiago, Chile, Nov 2003 
 
The birth of the first “test tube” baby in the world, Louise Brown, in Oldham, 
England on July 25, 1978, captivated public imagination and fueled the aspirations of 
scientists around the world. Following this first in vitro fertilization (IVF) conceived  
birth, a handful of groups around the world worked at replicating and perfecting the 
procedure, as one Chilean gynecologist told me, “trying to repeat the cooking recipe.” 
Without precise instructions and ingredients, this was a difficult recipe to make. Over the 
next few years, the recipe often changed depending on what country it was being 
recreated in, and many of these early procedures were more akin to experiments than 
accurate scientific methods. Indeed, though Louise Brown was already eight years old by 
the time the IVF twins in Argentina were born, the techniques used for IVF continued to 
be experimental and variable for several years after Argentina’s entry into the world of 
ART.  
The success of human in vitro fertilization in England was not a matter of 
overnight spontaneous discovery. Scientific research on human fertility and reproduction 
was in progress for approximately a century before in vitro fertilization and live birth 
were achieved in humans. While the first recorded scientific experimentation with in 
vitro fertilization of mammalian eggs was in 1880, this procedure wasn’t performed 
successfully until the 1950s, despite many efforts with rabbits and other laboratory 
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animals in the intervening years (Jones 1995). Results from experiments with rabbits 
published in 1934 claimed to prove fertilization in vitro, but were actually what is today 
known as gamete intrafallopian tube transfer (GIFT), in which the collected egg and 
sperm are immediately transferred to the fallopian tubes where fertilization then occurs 
(Pincus and Enzmann 1934). The mastery of laboratory fertilization of mammalian eggs 
in 1959 at Harvard led to further experimentation with embryo development in vitro 
(Chang 1959). In the 1960s, human eggs were successfully fertilized in the laboratory, 
though it took another 10 years of experimentation for the transfer of the fertilized human 
egg to the uterus that resulted in a live birth.  
By the 1970s, there were several groups working concurrently on IVF around the 
world. One was the now infamous Robert Edwards and Patrick Steptoe team in Oldham, 
England which became the first in the world to succeed at IVF. Two other groups were 
working on human fertilization and embryo development in Melbourne, Australia at the 
time. In the US, a group in Norfolk, VA joined in later, after the English success. 27 
According to published accounts, there were many visits and scientific exchanges 
between these groups in England and Australia, and between England and the US in the 
1970s and early 1980s. There were also several near-successes before Louise Brown’s 
birth in 1978. In 1973, one of the teams in Australia registered two chemical pregnancies 
after an in vitro fertilization embryo transfer, but the pregnancies did not progress 
(Leeton 2004). In 1975, Edwards and Steptoe registered a pregnancy following the 
                                                 
27 There was another researcher in the US working on human in vitro fertilization in the 1960s and 1970s, 
Landrum Shettles, at Colombian Presbyterian Hospital in New York.  By the 1970s, Shettles worked alone 
in a borrowed laboratory without institutional support, and his research has since been discredited. 
However he claimed to have successfully fertilized and transplanted the first human embryo as early as 
1962, though he did not publish anything at the time and did not announce these results until 11 years later. 
In 1973 Shettles attempted to perform the first embryo transfer following an in vitro fertilization in the US 
for the Del-Zio couple, but the procedure was prematurely discontinued by hospital administrators. See 
Henig 2004 for a more detailed account of Shettles’ research and the Del-Zio trial filed in 1974.  
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transfer of a fertilized egg, however it was ectopic (implanted outside the uterus) and had 
to be removed. After several more years of in vitro fertilizations and embryo transfers, 
the first successful IVF procedure in the world finally took place in England, under the 
direction of the geneticist Edwards and the gynecologist Steptoe (Steptoe and Edwards 
1978).  
Further advances in the techniques and performance of in vitro fertilization 
procedures were claimed most notably by groups in Australia, the US and France, as well 
as the original team in England, though scientists around the world were engaged in 
experimentation in the 1980s. At this time there were still many unknowns in the biology 
of human reproduction, and some misconceptions as well. The success of the technique 
in creating Louise Brown was in part a matter of luck, demonstrated by the slow 
progression of further successful procedures. It took several more tries even for Edwards 
and Steptoe to again produce a birth from IVF, which they did in 1979. 28  The third 
successful IVF birth in the world was in Melbourne, Australia in 1980, and the US 
followed a year later, in December 1981, in Norfolk, Virginia.  The process of IVF was a 
difficult one at the time, as the only method for retrieval of the human egg was through a 
particular type of surgery, called laparoscopy (invented by Patrick Steptoe). In the early 
years of IVF, egg retrieval rates were less than 50% per mature follicle, and rates of 
laboratory fertilization of those collected eggs were only 10-15% (Leeton 2004: 496).   
Unknowingly Edwards and Steptoe propagated certain misunderstandings and 
protocols about how to do IVF based on their first successful performance of the 
                                                 
28 Two years after this second IVF birth (a boy), Edwards and Steptoe created the now well-known (in the 
field of reproductive medicine) private IVF center Bourn Hall in England which continues to operate as a 
private center for ART. Several professionals in Argentina have since trained at Bourn Hall, as I discuss 
later in the chapter. 
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procedure. First, because the originally-successful IVF in England was with a “natural” 
cycle of ovulation, in which hormone stimulation was not used, Edwards and Steptoe 
continued to advocate and experiment with the natural cycle for several years. When 
hormone stimulation is not used, the chance of pregnancy is lower, as only a single egg is 
retrieved from the ovarian follicle using laprascopy, fertilized in the lab, and transferred 
to the uterus. Across the Atlantic from Edwards and Steptoe, the US group at the Jones 
Institute (in Norfolk) pursued hormone stimulated ovulation cycles, which allowed the 
doctor greater control over the timing of ovulation, and multiple maturing follicles to 
retrieve eggs from. This proved successful and the first IVF birth in the US in 1981 was 
from a stimulated ovulation cycle.  
Hormone stimulation was not the only ingredient in Edward and Steptoes’ 
original recipe that was found problematic. Indeed in his account of experimenting with 
IVF in the US, the gynecologist Howard Jones details his team’s realization of some of 
the inaccuracies unwittingly spread by Edwards and Steptoe (Jones 1995). These 
corrections to the original misunderstandings are now very basic requirements in an 
average IVF program, such as the size of needle to use for the egg retrieval, and the time 
needed between fertilization of the egg and its transfer to the uterus. The early accounts 
reveal the extent of the unknowns of the field at the time, and the incredible luck 
involved when the techniques were successful. Assisted reproduction clearly began as an 
embodied practice, dependent on individualistic performances in which the “secret” of 
the magic of conception was not a standardized potion that could easily be reproduced.  
Over time this knowledge has become relatively standardized and disseminated, however 
there remains an embodied-practice element which continues to depend on individual 
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finesse and performance. In Latin America, this “magic” materialized into an IVF-created 
embryo six years after England’s first birth. 
 
 “Alchemy” Made Science in Latin America 
In the early 1980s in Latin America, reproductive specialists in Chile, Colombia, 
Argentina and Brazil were all working to reproduce England’s renowned success. Their 
triumphs occurred close together in time, indicating the scientific fervor of that prevailed 
[and the ripeness of the technology]. Reconstructing this Latin American creation story is 
not clear-cut historiography. Unless personally relevant, such historical details are hazy 
in the minds of today’s reproductive specialists in Latin America unlike the heavily-
publicized histories of England and the US, and the events are not well-documented in 
public media. I found most specialists focused on the present and future of reproductive 
medicine, leaving me, the anthropologist, to try to make sense of what has already 
happened in the field. Furthermore, when historical recollections were brought to light, 
distinctions were given to the centers and specialists in Latin America that are currently 
and consistently successful with assisted reproduction techniques. The account that I give 
here is based on the histories told to me during interviews with reproductive medicine 
professionals in Argentina and Chile, and is therefore largely speculative and self-
consciously partial.  
At the outset, there is a disputed claim over where the first Latin American IVF 
birth took place. The website for the Colombian Center of Fertility and Sterility (Centro 
Colombia de Fertilidad y Esterilidad), run by Elkin Lucena proudly claims to have 
produced the first “bebé de probeta,” (test tube baby) in Bogotá, Colombia in 1985, as 
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well as the first baby born from a cryopreserved embryo in 1986.29 However, the most 
corroborated story seems to be that the first birth from in vitro fertilization in Latin 
American occurred in Santiago de Chile, the capital, a year earlier in 1984.30 After Chile, 
Colombia came in second in 1985, and Argentina followed in February 1986 as the third 
country in Latin America to accomplish IVF.31 Here I follow this chronology and begin 
with Chile before describing events in Argentina. 
 
Chilean Magic at the Military Hospital 
In Santiago, Chile, two groups were experimenting with in vitro fertilization in 
the early 1980s: one group led by Alberto Costoya at the Military Hospital (Hospital 
Militar); the other at Las Condes Clinic (Clínica Las Condes) with Fernando Zegers- 
Hochschild. In Argentina the power of the military dictatorship was ebbing by the early 
1980s, but in Chile the dictatorship endured for a full 17 years, from 1973 until 1990. The 
military dictatorship in Chile was a strong underlying influence during the early years of 
assisted reproduction in Chile. As the following summary makes clear, the Military 
                                                 
29According to the center’s website, the list of “firsts in Latin America” for this clinic also include first 
birth after using preimplantation genetic diagnosis in 1995, and first egg cryobank in 2004 (using technique 
of vitrification developed by Japanese doctor). (see http://www.cecolfes.com) 
 
30 In a dramatic contrast of technological development, by the time of Latin America’s first IVF birth in 
1984, assisted reproduction techniques had multiplied throughout Australia. Though the first birth in 
Australia was not until 1980, scientists there had been experimenting for about 10 years and techniques 
quickly advanced after their initial success. In a unique national accomplishment, by 1984, there were 
seven IVF units throughout the country, with similar results throughout, and a total of 365 babies born from 
IVF techniques in those four years of practice (Leeton 2004: 499). Furthermore, Australia lays claim to a 
series of “IVF firsts in the world” in terms of birth using a donor egg (1983); birth following embryo 
cryopreservation (1984); multiples (twins in 1981; triplets in 1982; quadruplets in 1984) (Leeton 2004). 
Most other countries in the world were nowhere near as advanced in assisted reproduction techniques at 
this time. 
 
31 Notably, most of the reproductive medicine specialists in Argentina, even those who were part of the first 
team to do IVF, do not remember where the first IVF in Latin America took place. Some think it may have 
been Argentina, but also suggest Colombia, Chile or Brazil.  In contrast, they all remember Louise Brown, 
and also the US’s success as occurring prior to Argentina’s. The details of Latin America’s history have not 
been recorded in their memories, either because of its irrelevance to them or out of indifference. 
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Hospital was the site of the first IVF baby in Chile and in Latin America, in 1984. 
However for political reasons the group at the Military Hospital disbanded after several 
years and although the hospital continues to operate, it no longer provides any assisted 
reproduction services. The reproductive medicine unit at Las Condes Clinic, founded one 
year before the dictatorship ended, is today the most prestigious ART center in Chile, and 
the birthplace of the Latin American network of assisted reproduction (Red 
Latinoamericana de Reproducción Asistida), or RED. I come back to the significance of 
this network in chapter two. 
The story of the first in vitro fertilization in Chile, like that of Argentina, follows 
today’s leading experts and clinic directors back in time and to various places around the 
world. Alberto Costoya, who is currently a gynecologist and formerly the director of a 
reproductive medicine unit at a small private clinic in Santiago, was the head of the group 
at the Military Hospital in the 1980s. Costoya received his medical degree the year that 
the military dictatorship took over power, in 1973, from the University of Chile, in 
Santiago. He then earned a fellowship to specialize in obstetrics and gynecology at the 
Catholic University in Santiago, graduating in 1976. He started work at the Military 
Hospital in 1977—one year before the announced success in England—and in 1981 went 
to Canada for further training.  
The year that the first IVF baby was born in the United States, Costoya traveled to 
the University of British Columbia to work under Professor Victor Gomel, who he 
describes as “not one of the people but the person who made for the world all the history 
of gynecological microsurgery and laparoscopy.” Today Gomel is recognized 
internationally for his work in microsurgery, and for founding the UBC Fertility 
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Endocrine Clinic where the first IVF baby in Canada was born in December 1983 (after 
Costoya had already returned to Chile). With Gomel, Costoya did extensive microsurgery 
on ovarian tubes, which was to be an important skill for future work in assisted 
fertilization.  
Early in vitro fertilization began as a solution to female infertility caused by 
problems with the ovarian tubes. Unfortunately, with microsurgery alone only 25-30% of 
women with tubal problems were able to get pregnant. In a comment indicative of the 
assumptions about family formation that many Latin American specialists continue to 
uphold, Costoya remembers that “we had to tell 60-70% of the patients that we had, ‘Bye, 
adopt a kid, there is no other solution.’” I come back to an analysis of this notion that the 
“only” way to make a family is through a medical intervention in chapters two and three. 
Here this comment serves to demonstrate the motivation that Costoya felt for developing 
in vitro fertilization techniques to aid in such cases of female infertility. 
In the early 1980s, only a small handful of scientists were privy to detailed 
information on in vitro fertilization protocols.32 Costoya remembers that even by 1982 
little was published on the “how-to” ingredients of in vitro fertilization. Without this first-
hand knowledge, there were many unknowns in the biology of reproduction and success 
with IVF was elusive. In Costoya’s mind, it was still a mysterious pot of magic, or at best 
alchemy:  
 …there was very limited literature in 1982. In fact, Steptoe and Edwards didn’t 
publish for a long time after Louise Brown, their, the details of the laboratory. It 
was like magic, all these “broths” and these things.  They came from these 
alchemists that were throwing things (into the pot)… 
 
                                                 
32 Indeed, the first international meeting on IVF was held at Bourn Hall in August of 1981, by invitation 
only. It is unlikely that any Latin American specialists were in attendance. 
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The Latin American specialists, with little access to scientific journals, relied primarily 
upon their personal relations with experts in Europe and the US to increase their 
knowledge of IVF.  
In 1982, Costoya and another Chilean doctor, Jose Miguel Schmidt, presented a 
proposal to the Military Hospital—the hospital with the most resources at the time—to 
begin clinical in vitro fertilization procedures. As preparation, the two of them then went 
to an international workshop on in vitro fertilization held at the Jones Institute in Norfolk 
Virginia. They stayed for six weeks in Norfolk where Costoya dedicated himself to 
perfecting the clinical aspects of in vitro fertilization: ovulation induction and aspiration 
through laparoscopy. Schmidt learned the laboratory aspects of the technique. According 
to Costoya, the two didn’t arrive in Norfolk with “zero” knowledge, they were already 
versed in the practices of enabling and recuperating the egg and sperm before they went 
to Norfolk. However what they learned at the Jones Institute was essential: “the magic of 
the biological culture media.” In order for in vitro fertilization to succeed, the biological 
culture media has to be adequate to enable fertilization and subsequent cell division “in 
the dish” of the laboratory. In the early 1980s, little was understood about the pH 
requirements for biological media, and so it fell in the realm of “magic” to concoct 
successful culture media.  
Armed with this “magical” insight developed at the Jones Institute, Costoya and 
Schmidt returned to Chile in 1983 and formed a group at the Military Hospital to begin 
the techniques of in vitro fertilization with patients. Because this was during the military 
dictatorship, the group needed authorization from the army to do IVF, which was initially 
granted. In 1984 their efforts were rewarded with the birth of a baby boy, the first IVF 
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birth in Chile and Latin America. According to Costoya, the account of this birth was 
never published, nor was the one in Colombia. Despite this early success, the Military 
Hospital’s IVF program was short-lived, as it was subject to the whims of the military 
government and their appeasement of the Catholic Church. In 1987 when the Vatican 
made public the Catholic Church’s disapproval of assisted fertilization, the director of the 
Hospital discontinued the IVF program. As a result Costoya left the Military Hospital and 
joined two other doctors (one from the Military Hospital team) in creating a reproductive 
medicine unit at Las Nieves Clinic, which opened in 1992, and where he continues to 
practice today.33  
Meanwhile, the researchers at Las Condes Clinic—which according to Fernando 
Zegers- Hochschild were himself and Emilio Fernandez— were not having any success 
with their attempts at IVF. The two gynecologists had started working on IVF together in 
1984, a year after this general medicine clinic opened in the wealthy foothills 
neighborhood of Las Condes. After repeated failures with IVF, Zegers- Hochschild and 
Fernandez decided to enlist the help of a fellow Chilean who was working in San 
Antonio, Texas at the time, Jose Balmaceda. Balmaceda in collaboration with an 
Argentine gynecologist, Ricardo Asch, had just developed the technique gamete 
intrafallopian transfer (GIFT) in the United States (published in Lancet, Asch et al. 
1984).34 Fernandez knew Balmaceda from his time in San Antonio, when he did a 
                                                 
33 Las Nieves Clinic does between 150-160 ART procedures a year, placing it in the mid-range of case-
loads of centers in Latin America. 
 
34 One of the most notorious scandals in the United States from the early period of IVF involves 
Balmaceda, Asch and a third Latin American doctor, Sergio Stone (Chilean). The three were working 
together at the Center for Reproductive Health, run by the University of California, Irvine. In 1995, they 
were accused of donating patients’ eggs without consent, insurance fraud, and general misappropriations of 
funds. Though Asch and Balmaceda developed GIFT, their names in US circles today are more readily 
associated with this scandal than with their scientific achievements. Stone is the only of these three who 
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fellowship at the University of Texas Health Center. With Balmaceda’s help, Zegers- 
Hochschild and Fernandez began experimenting with GIFT and achieved the first 
pregnancy in Latin America from GIFT in 1985. From then on, Las Condes Clinic 
continued to make improvements in efficiency and reproducibility. The reproductive 
medicine unit of Las Condes Clinic was established in 1989, and has since become the 
most prestigious and reputable center in Chile, with the highest case load in the country.  
 
Argentine Connections and Diffusions  
As mentioned earlier, the story of ART’s beginnings in Argentina is also the 
history of the foundation of a particular center that continues today, and the dispersion of 
an original group of reproductive specialists. Because the beginning of this story is also 
closely connected to events at the Jones Institute, in Norfolk, VA in the United States, I 
travel between the two countries in this narration. 
The first building in Buenos Aires, Argentina, where IVF was successfully 
performed is now a hotel located a few blocks from the clinic that today continues to 
carry the original center’s name. This laboratory and surgery room were housed in a 
private general medicine clinic, called “Clínica del Sol,” or Clinic of the Sun. A few 
blocks away, in a separate building, the doctors had their consultation offices. Like the 
building, the directors and medical staff have changed over the last 20 years, as have the 
procedures. But the original purpose remains the same: to provide efficient in vitro 
fertilization treatment. In this predominantly Catholic country the principal controversy 
                                                                                                                                                 
eventually stood trial and was convicted on criminal charges, though the other two were also indicted in 
that trial. I spoke with Balmaceda at Las Condes Clinic where has been working since 1996, he is 
considered a fugitive of the US justice system (and was arrested for this in Buenos Aires in 2001 but fled 
back to Chile where the US law cannot reach him). Apparently Asch is now working in reproductive 
medicine in Mexico. See Dodge and Geis 2003 for more details. 
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has also changed little: the ambiguous biological, moral and social status of the in vitro 
embryo.  
To trace back, I begin with Aníbal Acosta, an Argentine gynecologist who has 
acted as the scientific director at CEGyR for the last 10 years, and who has lived and 
worked in Norfolk, Virginia for the last 30 years. Aníbal Acosta is in his mid-70s, a tall 
man with a paunch, who always wears a suit and tie during his semi-annual month-long 
visits to the clinic. He speaks English fluently and is very friendly during my interactions 
with him. He is a Professor Emeritus at the Jones Institute for Reproductive Medicine at 
the East Virginia Medical School, and was part of the team that produced the first IVF 
baby in the US in 1981 at that center. This was the third IVF birth in the world, after 
those in England and Australia. Acosta was born in Argentina, studied medicine at the 
University of Cordoba and graduated in 1952, then trained in surgery and oncology in 
Buenos Aires. Acosta trained in gynecology at Johns Hopkins for about 6 months.35 At 
this time Georgeanna Jones (who becomes an important figure later in this history), 
opened a new department on infertility and reproductive endocrinology at Johns Hopkins 
and Acosta was accepted as a fellow with her for a year and a half. Acosta then came 
back to Argentina to establish a new gynecological training program similar to the one he 
had experienced at Johns Hopkins. He taught this in Cordoba for the next 12 years.  
Acosta remembers this period in Argentina as the “dark ages” which culminated 
in the dictatorship period of 1976-1983, but its roots were evident in a widespread decline 
in the 1960s. He describes it as such:  
                                                 
35 In yet another example of the circulation of people and the serendipity of personal connections, Acosta 
says he was accepted at Johns Hopkins partly because of a personal connection at the University and the 
presence of departmental chief who liked Latin Americans. 
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And without recognizing that part of the history, you are never ever going to be 
able to correct the country. So I saw that, you know, academia in this country was 
going down the drain. The University was working in such a way that it looked 
like secondary schools, high schools, whatever. The level of research was almost 
zero. The society, the scientific societies were not scientific societies… 
 
Acosta characterizes this as a slow process of deterioration that no one noticed day to 
day. He tells me that the populist governments of the times were promising people 
everything they wanted, and that the government and civilian population were not paying 
attention to the decline.  
By the mid-1970s, Acosta was in his early 40s and decided he needed to leave the 
country. He tells me that he realized he couldn’t be “useful” anymore, and so he wrote 
letters to his contacts in the US, including to Howard Jones (Georgeanna Jones’ husband 
and colleague). The year was 1976, and a new medical school in Norfolk, Virginia, called 
the Eastern Virginia Medical School, was being established. At the same time, in 
Argentina the military took control of the government through a coup on March 24, 1976.  
Acosta saw the potential for influence and growth at this new university in Virginia, and 
accepted a faculty position in the division of Reproductive Endocrinology, and moved his 
family there. What I find striking about Acosta’s account to me of accepting this US 
faculty position,  is that he did not mention the concurrent military takeover in Argentina, 
nor its influence on his decision (though surely it must have). As part of an international 
network of professionals, Acosta was able to leave the politically-charged situation of a 
dictatorship-ruled Argentina and continue work in a calmer environment of a small city 
in the US.  I take this as one instance, of many, in which the majority of professionals 
prefer not to frame their medical work in social (economic, political and cultural) terms. 
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*** 
Interval: “El Proceso,” “The National Reorganization Process” 
Here I pause Acosta’s professional narrative for a moment to clarify that more 
than half of the original IVF team in Argentina were younger than Acosta, and therefore 
were finishing medical school during and at the end of the six-year dictatorship, today 
commonly referred to as Argentina’s “Dirty War.”36 This dictatorship period is recorded 
as officially beginning with the military coup of March 1976, under the leadership of 
Jorge Rafael Videla, and ending in 1983 with the democratic election of Raúl Alfonsín. 
However, as Acosta mentioned, political chaos and guerilla attacks began in the 1960s. 
The country was under the leadership of military governments throughout the 1960s, with 
the first general elections held after 10 long years in 1973. Stability was not fully 
regained with the election in 1973, due to continued violence between Peronist and anti-
Peronist factions. The following three years saw continued chaos, violence, and economic 
downfall with the election of Juan Domingo Perón as President once again in September 
1973, his unexpected death in July 1974, and the disastrous assumption of power by his 
third wife Isabel. These events led to a military coup on March 24, 1976 that promised to 
“restore order” through a government program known as “El Proceso”—the National 
Reorganization Process. Indeed, some describe the military coup as initially welcomed by 
the majority of Argentina’s population, as order was at last restored (Feitlowitz 1998; 
Taylor 1997). However this “order” quickly turned Argentina into a country of silence 
and fear, full of ghosts of “los desaparecidos,” “the disappeared,” as the military 
government kidnapped, tortured, and murdered those considered “subversives” and 
                                                 
36 Argentina’s political history in the 20th century is marked by periodic cycles of dictatorship and military 
rule, with nine civilian-supported military coups between 1930 and 1976 (Shumway 1991; Rock 1987; 
Romero 2002). 
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terrorists. The total number of people disappeared during this reign of terror is disputed, 
but human rights groups estimate the number to be 30,000 people, most of whom left-
leaning students and intellectuals in the middle class.37 Though most of the doctors that 
today are directors of ART centers were in Buenos Aires—the epicenter of the 
violence— completing their medical degrees throughout the dictatorship period, it is 
rarely a topic that they raise for discussion.  
 One exception is Ester Polak de Fried who, in the male-dominated field of 
reproductive medicine in Argentina, was the first woman to open her own infertility 
center in Buenos Aires.38 During an interview, Polak de Fried makes an oblique mention 
to the dictatorship, when she tells me that the best medical education for years in 
Argentina was through the University of Buenos Aires, even through the 1980s:  
…Unfortunately in Argentina, historically, the government has never invested 
enough money into education and health. This situation was difficult 
for…fundamentally for the patients and of course also for the doctors, the doctors 
and the researchers. Because we had a lot of intellectual curiosity, we were very 
well trained. In that era, the medical training…You graduated from the national 
university very well trained. The UBA [University of Buenos Aires] was the best. 
(Kelly: You mean in the ‘70s and ‘80s?). Without a doubt. Incredible. In the 
decades of the ‘60s, the ‘70s, and the ‘80s, in spite of all the terrible history of the 
repression. Well, personal formation was very important and the doctors in 
Argentina, as different from other countries, we were very used to adapting to 
situations of scarcity [of resources]. 
 
In Polak de Fried’s memory of this time, the strengths of the medical tradition in 
Argentina are emphasized, even while acknowledging the downsides of training in a 
country where the government does not invest in education and health, and indeed 
                                                 
37 A disproportionate number of the disappeared were Jewish: 10% of the total missing, though the general 
population in Argentina was only 2% Jewish (Feitlowitz 1998).  
 
38In 2001 Polak de Fried was also elected President of the Argentine Society of Reproductive Medicine 
(SAMeR, formerly known as SAEF). She is the only woman who has served as President since the society 
was founded in 1947. I will come back to a discussion of SAMeR in chapter 2.  
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tortures its own citizens. Polak de Fried emphasizes the creativity and resilience of 
Argentines to make the most of what little is available, characteristics that I come back to 
in the following chapter. 
 
*** 
North-South Migrations 
Back in Virginia, in July 1978, Howard and Georgeanna Jones, who were retiring 
from Johns Hopkins, joined Acosta in Norfolk at the Eastern Virginia Medical School. At 
the same time that the Joneses were moving into Norfolk, the birth of Louise Brown in 
England made headlines as the first IVF baby in the world. The way that Acosta 
described it, the Joneses gave a local interview response to this world event, “and we told 
them the truth, that the technique didn’t seem to be that difficult but we didn’t have any 
money because there was…in the US federal money was not available for that kind of 
research. So therefore we didn’t have any grants to apply for.” By chance, one of 
Georgeanna Jones’ former patients from Hopkins read the newspaper interview, offered 
to fund a team to develop this technique in the US, and gave them a modest donation to 
begin a program. 
According to Acosta, these three doctors specialized in areas necessary to IVF: 
Georgeanna Jones had experience with ovarian stimulation, Howard Jones with surgery 
and Acosta with laparoscopy (to retrieve the oocytes).39 The impetus to begin an IVF 
program in the US was also related to the Joneses’ personal familiarity with Edwards and 
                                                 
39 In addition, Jairo Garcia, a Colombian who had also been a Fellow in reproductive endocrinology at 
Johns Hopkins with Georgeanna Jones was hired on as a faculty member and became part of the team. The 
embryology laboratory was headed by Lucinda Veeck, who has since become a leading embryologist (and 
in the late 1990s trained one of the biologists at CEGyR in her current lab at Cornell University). 
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his work. In the summer of 1965, Robert Edwards came to Hopkins on a research visit, 
and worked with the Joneses on experiments with the fertilization of human eggs in vitro. 
Their personal relationship continued after Edwards returned to England. By 1978, the 
Joneses had visited Edwards’ lab in Cambridge several times, and were following his 
research developments with interest. Information and knowledge exchange between 
England and the US continued over the next few years. In December 1978, Patrick 
Steptoe visited Norfolk to give advice to the Joneses on doing IVF, and Howard Jones 
attended a private scientific meeting given by the Royal College of Obstetricians and 
Gynecologists in London in January 1979, which he later said was full of unintentionally 
inaccurate advice on the techniques (Jones 1995). Edwards and Steptoe did not publish a 
report on the protocol they used until September 1980 in the British Journal of Obstetrics 
and Gynaecology (Edwards, Steptoe and Purdy 1980). 
After some bureaucratic delay, in 1980 the Norfolk team began to implement their 
knowledge of IVF procedures and became the first center in the US to repeat Patrick 
Steptoe and Robert Edwards’ success in England. Acosta describes the time as very 
intense, with phenomenal public interest that peaked after the first birth in December 
1981, resulting in a waiting list of up to 2000 patients. Acosta says that he took trips to 
Latin America a few times a year to talk about the techniques. Patients also came from 
Latin America, as there was no successful IVF center in Latin America yet and the Jones 
Institute was the most well-known center in the US with the added attraction of several 
Spanish speakers on the medical staff. Acosta describes the first few years of the program 
as extremely busy, with up to ten fertilizations a day. The Jones Institute also began an 
informal fellows training program at this time, in order to teach US and Latin American 
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doctors the techniques of assisted conception. Acosta’s narrative to this point reveals the 
international flows and exchanges of knowledge and expertise involved in the making of 
ART in the US. To further examine the circulation of assisted reproductive technology 
through key people, I look now at several central figures in Argentina. 
I shift narratives now, to that of one of the fellows whose training at the Jones 
Institute leads in part to Argentina’s first IVF success, Santiago Brugo Olmedo. When I 
meet him in 2002, Brugo Olmedo is a tall man in his late 50’s with thick gray hair and a 
welcoming smile. Shortly after our introduction, I find out that like some of the 
reproductive medicine professionals, he is also a practicing Catholic. Here outlining 
Brugo Olmedo’s professional history allows us to pick up the thread of the first IVF birth 
in Argentina.  
In 1977, one year into Argentina’s Dirty War, Brugo Olmedo finished his basic 
medical training at the University of Buenos Aires, and from there specialized in 
andrology, a new field at the time. Brugo Olmedo did a residency rotation at the 
Children’s Hospital under the direction of Vergadá, an andrologist who focused on the 
function of the testes.40 While Brugo Olmedo was at the Children’s Hospital, he also 
worked with two specialists, geneticist Roberto Coco and biochemist Juan Cayetano 
Calamera. A few years later, the three of them once again worked together at CEGyR, 
and formed part of the original IVF team. Brugo Olmedo, in a fashion characteristic of 
the majority of Argentina’s ART pioneers, left to study in Spain for one year, at the 
prestigious Urology and Andrology unit of the Puigvert Foundation in Barcelona.  
Brugo Olmedo returned to Argentina in 1981 (when the dictatorship was already 
beginning to weaken) and took over as chief of the Andrology department at Hospital de 
                                                 
40 In 2003 Vergadá was the president of the National Academy of Medicine in Buenos Aires. 
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Clínicas, the University of Buenos Aires teaching hospital. Hospital de Clínicas is the 
largest general public hospital in the city and is dedicated to public health care, teaching 
and research.41  Brugo Olmedo tells me that he had already been using what is known as 
the “hamster test” to analyze the fertilization-capacity of semen. With the “hamster test” 
the oocytes of hamsters are extracted and inseminated with human sperm to see if they 
fertilize. At Hospital de Clínicas they progressed from hamsters to working with human 
oocytes, which were retrieved during diagnostic laparoscopy surgery. They also began 
doing “swim-up” tests with sperm, which tests the sperm’s motility. Brugo Olmedo 
describes this time of experimentation and discovery as artisanal, they sterilized the 
pipettes and tools themselves, and made their own media culture. Apparently the base of 
media culture is ultra-pure water, which no one had experience in making and using prior 
to this homemade culture media.  
Brugo Olmedo judged that he needed foreign training in order to perfect these 
techniques, and so in 1982 he wrote a letter to his fellow Argentine citizen, Acosta, at the 
Jones Institute. Though he knew Acosta by name only at the time, Brugo Olmedo 
requested permission to train in the Jones Institute’s laboratory. Acosta answered that 
Brugo Olmedo would be welcome at the center, but he would have to wait three years for 
an opening—as the most famous center in the US, there was much demand to train there.   
In the meantime, in September 1983 in Argentina, gynecologist Roberto F. 
Nicholson Sr. decided to establish CEGyR as the first private reproductive medicine 
center.42 Prior to founding CEGyR, Nicholson was the head of a consultation unit on 
                                                 
41 Hospital de Clínicas opened its doors in the 1880s. 
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sterility, and the director of the Postgraduate Department at the Hospital de Clínicas. We 
can surmise that Nicholson’s authority to form a private center derived from his standing 
as a senior physician with access to a patient population, and professional connections. 
Nicholson Sr. invited Santiago Brugo Olmedo, Roberto Coco, Nicolas Neuspiller, his son 
Roberto E. Nicholson Jr., Juan C. Calamera, Juan C. Mannara and Eduardo Gonzalez 
Fabbrizzi to join him in attempting assisted reproduction procedures. In 1984 they began 
to assemble a laboratory equipped to do IVF. Talking with me in July 2004, one of these 
original members remembers the early days of reproductive medicine at CEGyR in the 
mid-1980s: 
In fact, just today a 19 year old patient came to see me today for the first time for 
a gynecological problem and she told me that I attended her delivery 19 years 
ago, in 1984. And she asked me, ‘But you weren’t a doctor yet,’ ‘Yes, yes, I was 
already specializing’ I told her. I already had the degree. And she is the daughter 
of [Nicholson Sr.’s] patient who was being treated for sterility and already at this 
time I was operating. We were doing microsurgeries with him, laparoscopies and 
open surgeries, of ovarian tubes and everything. 
 
At the time, CEGyR was the only center in Argentina attempting to address infertility 
problems along the lines of the Jones Institute and Edwards and Steptoe’s practice in 
England. 
In 1985, the Jones Institute finally had an opening and both Brugo Olmedo and 
Roberto Coco went to the Jones Institute to take notes on the laboratory, the clinic and 
the ultrasound methods. Brugo Olmedo stayed for three months, from January to March 
1985, and trained in the laboratory, improving upon the fertilization techniques he had 
already been experimenting with. In the fall of April 1985, upon Brugo Olmedo’s return, 
the eight-member group at CEGyR was assembled formally and they began to work on 
                                                                                                                                                 
42 Unfortunately I was not able to talk to Roberto F. Nicholson Sr. myself, as he was ill and not seeing 
visitors when I tried contacting him. I was given referrals from both his son and Eduardo Gonzalez 
Fabbrizzi (who considers Nicholson his ‘padre profesional,’ his mentor).   
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assisted reproductive techniques in earnest. As a reflection of the importance of the Jones 
Institute’s training—and advancements in the field—the first clinical attempt of IVF 
resulted in pregnancy, as did many of the following attempts. And so, in the summer of 
1986, two years after the re-establishment of democracy and a time of cautious hope, the 
first test-tube babies—twins of parents from Tucumán—were born in Argentina. This 
success established CEGyR as the first ART institute in Argentina. 
 
 
Figure 9. "IVF 1985" with names of original CEGyR team. Hanging on the wall in a laboratory area 
in Buenos Aires. Photograph by Kelly Raspberry, 2004. 
 
A few months after the success with the Tucumán couple, Brugo Olmedo was 
invited back to the Jones Institute to work, and he accepted and left Argentina in October 
1985 with his wife and children.43 At the Jones Institute, Brugo Olmedo met yet another 
visiting Argentine, Claudio Chillik, who was training there for two years, the second as 
result of a Rockefeller research grant. When Brugo Olmedo decided to return to 
Argentina (he missed his native country too much) he asked Chillik, with Nicholson Sr.’s 
                                                 
43During this second stint at the Jones Institute, Brugo Olmedo was part of the team on a Sunday when the 
Jones Institute performed the highest number of cases in one day in the history of the center, 
commemorated with a thank-you letter signed by the Joneses (which hangs framed in Brugo Olmedo’s 
office). 
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permission, if he would like to join him at CEGyR. The two returned to CEGyR together 
in 1986, and later took over directorship of the center from Nicholson Sr. in 1993. As I 
explain in the next section, why and how CEGyR shifted in directors and staff has as 
much to do with the emergence of an ART market in Argentina as it does with personal 
desires and ideological conflicts.  
 
Ideological Dispersions—The birth of a new market in assisted reproduction 
The original team at CEGyR only endured a few years, as professional aspirations 
and ideological differences created irreparable divisions among this pioneering group of 
ambitious and expert scientists and clinicians. The team of specialists at CEGyR, when it 
formed, worked under the direction of Nicholson Sr., the clinic’s founder. However 
practical and ideological differences grew stronger over the years and split this group up. 
One source of conflict was the practical make-up of the eight members: the group was 
disparate in terms of ages and training levels, with Nicholson Sr. and Calamera the oldest 
by 10-15 years, Coco and Neuspiller about 15 years older than Brugo Olmedo and 
Chillik, and the others even younger. Twenty years later, seated in his own research lab, 
one of these doctors tells me that in those early years at CEGyR, there was only one 
authority figure who made the decisions: Nicholson Sr., who was the most senior and 
also a practicing Catholic: 
We left because Roberto Nicholson, who in reality was like our professor, was 
obviously older than us, and I don’t want to say ‘close-minded;’ but it was harder 
for him to adapt to all those new changes that were coming. And us, being 
younger, we wanted to do other things and in the end it was for that reason. […]. 
It’s not that we fought or anything like that, it was just necessary to say ‘well, 
maybe we have different opinions,” in other words, we wanted do more things 
than he did. And Roberto Nicholson, in reality he has a very Catholic formation, 
and it was difficult to reconcile that very Catholic position and we had to make a 
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total adaptation to what was the egg, what was  the fertilized egg,  the syngamy, 
or that, or the other thing, because he couldn’t interpret it simply as a biological 
question from the beginning. Why? Because his Catholic background weighed 
heavily on him.  
I’ll give you an example. Suppose, in the IVF laboratory from the 
beginning one of the principle tasks was to try to verify if fertilization had 
occurred, if it was normal or abnormal. Simply, if an egg is penetrated by two 
sperm, it’s an abnormal fertilization. So, as a doctor, if they are giving you this 
task, you have to, at least at that time, discern what was okay from what was bad 
[fertilized abnormally]. And in terms of what was bad, obviously the patient was 
informed and that was thrown out. So, for someone who has a religious position 
and thinks that life begins at that moment [at fertilization] and that is already a 
person, it is like throwing out a person. So it was already pretty difficult,  it was 
like a series of saying, well, we see that it has three pronuclei, if we discard it 
before it reaches syngamy, our conscience felt better, but it’s an illusion because 
neither does it [personhood] begin after syngamy. 
  
  As this doctor describes, in addition to the practical problems of a team oddly-matched 
in aspirations, age and experience, the group also differed in their perspectives on 
embryos and reproductive technologies. Half of the specialists, including Nicholson Sr., 
were practicing Catholics. This doctor however was not, and explains that Nicholson’s 
reluctance to pursue technical advancements and biological understandings that 
countered the Catholic Church’s doctrine became a source of conflict in the clinic. This 
doctor’s description illustrates that Nicholson—despite having opened a private center 
dedicated to performing assisted reproductive techniques—had great difficulty in 
reconciling his religious beliefs with his scientific and medical practices. Because 
Nicholson’s Catholic formation seeped into the laboratory, fertilizing human eggs in vitro 
was of serious moral consequence. Beginning in the early years of CEGyR, biological 
questions, such as the determination of normal fertilization, were (and continue to be) 
inseparable from fundamental philosophical questions of when personhood begins. For 
Nicholson, personhood began at conception, when the sperm fertilized the egg. The 
example given here of an egg penetrated by two sperm—an abnormal and non-viable 
 94
fertilization but conception nonetheless—reveals the fundamental difficulties in 
reconciling laboratory protocols with Catholic views of conception. This problematic, 
between deep-seated Catholic beliefs and desires to pursue scientific advances, is a 
central component of performing ART in Argentina. I will come back to this repeatedly 
in following chapters. For the moment, I use this as an example of differing approaches 
to the practice of ART, from which a market for assisted reproduction emerges in 
Argentina.  
Coco and Neuspiller, the two next in seniority at CEGyR, were the first to leave 
in 1987, leading to an irreparable shift in staff and direction at the center. However before 
following and Neuspiller out the door of CEGyR and into the “brave new world” of ART 
in Buenos Aires, I will summarize the evolution of CEGyR into its present-day form. 
Shortly after Coco and Neuspiller freed themselves from the constraints imposed by 
Nicholson’s relatively-cautious approach to reproductive technologies, two other 
specialists also decided to leave—the gynecologist Eduardo Gonzalez Fabbrizzi (who 
now directs his own clinic, IMAGEM), and Juan Calamera, a biochemist (who today runs 
a hormone and sperm diagnostic laboratory, LER). During interviews, Fabbrizzi was 
vague, saying he left “for a variety of reasons,” while Calamera clearly stated that 
conflict between ART work and his Catholic principles was the primary factor for his 
departure.  
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*** 
Interval: One Scientist’s Means of Resolving Catholic Conflicts  
     
 
Figure 10. Painting on wall inside diagnostic reproductive medicine lab (L). Cross hanging inside 
director’s personal office (R). Photos by Kelly Raspberry, 2004. 
 
 
Before discussing the “modernization of CEGyR” and the expansion of the ART 
industry in Argentina, I take another short detour. Here I follow the path that Calamera 
took to resolve this apparent religious conflict in order to remain an engaged reproductive 
medicine professional. His solution is instructive as it illustrates the permutations 
involved in reconciling religion and science, “resolutions” that I revisit in chapters two 
and four. Though he was part of the first team at CEGyR to do IVF, Calamera had 
reservations about his future working in assisted reproduction. In an interview Calamera 
describes to me that when the Vatican issued a doctrine against in vitro fertilization in 
1987, he knew his misgivings were founded and he could not pursue this line of work any 
longer. He explains his early involvement in the development of IVF in Argentina this 
way (looking back in 2004):  
In fact, the first person that Roberto Nicholson offered the embryology laboratory 
to was me, but I didn’t want to take on that job, because I knew that I wasn’t 
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going to be able to develop it in the future, and in fact in a few years, in ’87 
Ratzinger’s document came out and it prohibited in vitro fertilization…It was a 
period in which I had already known Santiago Brugo Olmedo. So, I recommended 
him to Roberto Nicholson and he began working in CEGyR, in the laboratory. 
 
Calamera’s solution, once the Catholic Church publicly disapproved of in vitro 
fertilization, was therefore to devote himself fully to running a diagnostic andrology lab, 
Laboratory of Reproductive Studies (Laboratorio de Estudios en Reproduccion)or LER, 
which he had founded twenty years earlier.44 Calamera explains that his interests have 
always been in sperm analysis, and so he found a way to follow this scientific interest and 
stay true to his Catholic beliefs, by opening LER as an autonomous business in 1985. 
LER offers diagnostic andrology, hormone analysis, and some biochemical clinical 
analyses that are associated with reproduction. Calamera is emphatic that this laboratory 
work is consistent and guided by his Catholic faith: “I direct the andrology [lab] within 
the margins that the principles of the Catholic religion allow me to.” Calamera’s 
interpretation of these margins allow him to stay involved in reproductive medicine as 
long as he is not directly practicing assisted reproductive technologies. 
As a diagnostic center, therefore, LER does not directly perform assisted 
reproduction procedures, but it does provide assistance with making ART possible at 
other centers. Clinics that provide IVF and ICSI, like CEGyR, send semen and blood 
samples over to LER for analysis, and based on those tests make decisions about how to 
                                                 
44 The roots of Calamera’s diagnostic laboratory go back to 1966, when he and four other specialists, an 
andrologist, a urologist, an endocrinologist, a gynecologist and himself, a biochemist, decided to join 
together and open a center for reproduction. They bought what is today the bottom floor of LER, almost 20 
years before Nicholson successfully opened CEGyR as an integrated center for gynecology and 
reproduction. Calamera tells me regretfully that the center failed because of personal reasons—the amount 
of dedication to the business varied by person, and teamwork was in short supply, “Each person maintained 
his own consultations and had his own ‘quintita’ [little plot of land].” One by one, the other four 
professionals sold their share in the center until only Calamera was left, a process that lasted about 20 years 
and included Calamera’s expansion into the first floor level of the building. Calamera today directs LER as 
a diagnostic center, not a center for reproduction. 
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treat the couple’s infertility problems. Sometimes patients are sent directly to LER to 
complete a series of baseline tests before treatment begins. LER may also receive blood 
samples following an embryo transfer, to test if the woman is pregnant following an IVF 
or ICSI procedure. The equipment that LER has makes it also technologically capable of 
“enhancing” a given semen sample to make it more “potent,” using procedures that 
concentrate and filter out the speedier, more fertile sperm for use in an insemination or an 
in vitro fertilization procedure.45 However Calamera is emphatic that LER is a diagnostic 
laboratory, and does not provide such services. That type of semen processing is done at 
the given ART laboratory.  
In what could become shady territory if not closely monitored, Calamera has 
constructed boundaries that allow him a clear conscience about his work in reproductive 
medicine. For Calamera, restricting his involvement to the diagnostic stage of a treatment 
plan exempts him from actual engagement in ART: 
I do the preliminary study of the patients. […] But afterwards, I don’t know what 
is going to happen with that patient, nor do I ask. I don’t know if he is going to 
continue on, if he is not going to continue, if he is going to change, if because of 
my test result he is going to enter in one [treatment] plan or another. That I don’t 
know. They come here, and I help everyone that comes to do an analysis but I 
don’t ask what they are going to do with it, because I think that I don’t need to 
know…not that I don’t need, I don’t have the right to know.  
 
He reasons that his role is only to provide information, with which the patient can make a 
decision to use assisted reproductive techniques or not. Not following up on the patient’s 
decisions for treatment means that Calamera can retain a comfortable “unknowing” as to 
how his work in many cases leads to in vitro fertilization and ICSI procedures. 
Calamera does not see his work as incongruous with the Church’s position on in 
vitro fertilization. He also judges ART practices along a scale of acceptability that in part 
                                                 
45 See Schmidt and Moore 1998 for a humorous analysis of “technosemen” production in the ART lab.  
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follows the degree of technological intervention: low-complexity ART, such as hormone 
stimulation and sperm inseminations are fine, he has no problems with couples doing 
that. As for high-complexity techniques, he refers back to the Church’s position, and tells 
me that GIFT (the sperm fertilizes the egg inside the woman’s body), is acceptable. He 
adds that in some cases IVF (the sperm fertilizes the egg in the lab) could be acceptable, 
but he’s not sure about that. This is a more permissive stance than the Catholic Church 
officially takes. In his estimation ICSI (the sperm is injected into the egg in the lab) is 
very problematic, as it crosses a line that should be respected between “nature” and 
“science.” However, Calamera adds that it’s not his problem now to decide the limits of 
acceptability, since he has dedicated himself to other work.  Though he’s part of the 
whole process of ART, he claims a “hands off” position. It is important to note that 
LER’s most steady referral center over the years, and still today, is CEGyR, one of the 
most important ART centers in Argentina. 
In the next section I return to the chronology of ART in Argentina and examine 
two aspects of the market that contribute to what I call the “modernization” of CEGyR. 
The modern form of CEGyR that I encounter in 2002 developed out of two changes 
during the 1990s: first, a younger team with fewer Catholic-based scruples replaced the 
older generation as directors of the center, and reconfigured the clinic. Second, the 
overall industry of ART in Buenos Aires exploded as neo-liberalism and economic 
entrepreneurial behavior took over, giving CEGyR much competition that continues 
today. 
 
*** 
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Making CEGyR Modern, Part One 
In 1993, Brugo Olmedo and Chillik, the two most senior professionals remaining 
after Nicholson Sr. himself, asked to become partners. Nicholson Sr. instead decided to 
leave the center and sold the clinic to Brugo Olmedo and Chillik. Nicholson’s son left at 
the same time, and set up his own gynecology consultation office. Thus at CEGyR, 
Brugo Olmedo and Chillik took over as directors, and opened investment-shares to other 
doctors who wanted to be part of the new CEGyR team, as a means to finance the 
purchase of the clinic. The four who bought in are a diverse group of practitioners, 
selected according who can afford to invest. Some had already been part of CEGyR, 
while others were new. The two partners—one a Catholic embryologist and andrologist, 
the other a Jewish gynecologist—were (and are) the most well-known of this new(er) 
generation and remain CEGyR’s directors for the next 12 years. The other four new 
investors— an embryologist, a laproscopic microsurgeon, and two gynecologists, also 
continue at CEGyR and make names for themselves in the community.  In an interview 
ten years after buying CEGyR, Brugo Olmedo imagines with hindsight that if Nicholson 
Sr. had stayed on at CEGyR, he would have continued to grow with them and today 
would enjoy an honorary status at the center and in the field of ART. Brugo Olmedo tells 
me conversely, that Nicholson Sr. is alone, has not worked for years, and is not much 
appreciated by those running ART centers in Argentina today.  
In the 1990s, a regional form of “technology transfer” through people and 
networks of clinics also began, and continues on today in the form of fellow residency 
programs, satellite clinics and workshops. This circulation of training is often multi-
directional, though it usually follows the route of metropolitan area to small city. People 
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in the provinces of Argentina, or from other countries in Latin America with a less-
established ART industry, come to Buenos Aires to learn techniques and expertise then 
take them back to their provincial cities. Brugo Olmedo remembers that during the early 
years of CEGyR, many Brazilian specialists came to learn the techniques, in a form of 
regional technology movement from south to north, “Everyone, those in Sao Paolo, those 
in Porto Alegre, everyone. All who today are the most important, they were in CEGyR at 
one time learning. That’s why we have many friends in Brazil.” He says the Brazilians 
would come for a week or so, to learn what they needed and then leave. Olmedo 
emphasizes that none went for a year to the US or Australia to “really learn things well,” 
like the Argentines did. He characterizes this type of quick training from the nearest 
source as very Latin American (and so by extension makes a claim that Argentines do not 
share this Latin American trait since most of the first generation of ART specialists 
trained in the US or Western Europe). He also tells me that he and Chillik also went to 
Brazil to help with the first cycles of IVF for one of the most important Brazilian groups 
today.46 
In the mid-1990s, after taking over CEGyR from Nicholson Sr., directors Brugo 
Olmedo and Chillik wanted to further “modernize” CEGyR, and make it a center similar 
to that found in the US. They repeatedly asked Acosta—who was still working at the 
Jones Institute— to act as the center’s scientific director. They wanted Acosta’s 
experience with working in the US as input in their project to reconfigure CEGyR. 
Looking back, Acosta admits he was reluctant to return to Argentina where you can 
“work like an ox and not accomplish anything,” but he finally agreed and took a leave of 
                                                 
46 One of the most well-known doctors in Brazil today, however, Roger Abdelmassih in Sao Paolo did not 
come to CEGyR to train, most likely he did not train in Latin America. 
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absence from Eastern Virginia for three years, from 1996-1999. After this initial three-
year period of on-site assistance, Acosta agreed to continue to make consultation visits 
twice every year. Under Acosta’s guidance, CEGyR incorporated the components that 
Acosta considers essential to running a top clinical institution, regardless of its location in 
the world: an ethics committee, an institutional review board, and a research committee. 
The center also has a research fellowship training program, a clinical fellowship 
residency program, yearly workshops on special topics in the embryology lab, and is 
affiliated with two Argentine universities: University of Buenos Aires and Maimónides 
University.  
 
Neo-Liberalism and Reproduction in Buenos Aires  
The 1990s, also known as the “Menem era” after the President during that decade, 
was a profitable one for assisted reproductive centers in Argentina. During his ten-year 
(two-term) presidency, Carlos Menem instituted many neo-liberal policies, privatized 
much of the nation’s economy, and in 1991 pegged the national currency, the peso, one to 
one with the US dollar. During this time, ART centers expanded in services, including 
the four that today with CEGyR make up Argentina’s five principle clinics: Fecunditas, 
Institute of Gynecology and Fertility (Instituto de Ginecología y Fertilidad) or IFER, 
Halitus, and Procrearte. Looking back, a center director in June 2003 describes the 
expansion of the ART market and the positive effects of the national economy during the 
1990s:  
What happened is that beginning in ’83 and ’84, democracy in Argentina was 
being established again, after our dictatorship. And there were a lot of 
expectations. However the first years, from ’80 to ’83 were very hard, because in 
spite of a democratic government, the Alfonsín era, which was before Menem, 
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was difficult because there was incredible inflation. Afterwards, with the Menem 
government, the panorama changed because he took us to the ideal position of 
“one to one” with respect to the dollar and so it was an interesting time, like for 
the equipment for the institute. People talk a lot about the Menem era, when many 
businesses closed, many factories, many offices. But it’s also true that there was 
the opportunity, for example for us, there was the opportunity to grow structurally 
[in equipment and buildings] and technologically because what we were earning 
was equal to what you in the United States were earning, so it was possible to buy 
the latest equipment. With respect to today, the panorama is completely different. 
Now we have to multiply by three, so the panorama is more complicated, since 
these last two years. I don’t know how things will continue, I would tell you that 
practically from ’89 to 2000, it went well. But I don’t know what will happen 
now. 
 
This director’s memory of the 1990s is very much influenced by where he stands at the 
time of the interview—in a private clinic suffering from the economic and political crisis 
of late 2001. In contrast to the uncertainty of the present, this director positively 
remembers the 1990s as a time of growth and advancement. Though Menem’s 
privatization policies were in the long term disastrous for the country, some sectors of the 
economy, like the newly-emerging assisted reproductive technologies market, benefited 
from the initial influx of dollars and economic growth, and were able to buy costly 
equipment and expand services.47 It is not surprising then that this was a time when 
assisted reproduction began to flourish in the country—the majority of the 22 clinics in 
Argentina today were established during the 1990s, geographically concentrated in 
Buenos Aires.  
                                                 
47 As I discuss in chapter two, Menem’s government was also close with the Catholic Church, and almost 
allowed the passage of a restrictive ART law. In what can be described as an unsurprising hypocritical 
reversal, in 2003 Menem and his new wife, Cecilia Bolocco (a former Miss Universe), used ICSI to have a 
child together at Las Condes Clinic in Santiago—though the assistance of ART was not well-publicized. 
Instead, the fact that Menem was having another child, and therefore his demonstrated “virility” at 72 was 
used as part of his campaign for presidency against Kirchner in 2003.  
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After leaving CEGyR, Coco and Neuspiller opened their own center for assisted 
reproduction, Fecunditas, in 1989—the year that Menem took office.48  Located near the 
University of Buenos Aires’ medical school—about 15 blocks from CEGyR—Fecunditas 
continues today under the directorship of Coco, Neuspiller and a third doctor, Gismondi. 
Coco claims that this was the first center in Argentina to be “fully integrated”—the model 
that is the norm today— in which all clinic components are housed under one roof: the 
consultation offices, the ultrasound area, the surgery area and the ART laboratory and a 
research laboratory. Fecunditas accomplishes this through the use of all three floors of an 
office building dating from the mid-1970s. Though Coco claims that Fecunditas was the 
second ART center in Argentina, at least in planning, chronologically by the time 
Fecunditas opened its doors, another clinic IFER wais also offering assisted reproduction 
services to the public.  
The clinic IFER occupies four floors of a tall (10-floor) medical office building a 
few blocks from the Hospital de Clínicas and is within a 10-minute walking distance 
from Fecunditas. According to its website, IFER was founded in 1985 by four doctors, 
none of whom worked at CEGyR. Two of the founding directors were working at 
Hospital de Clínicas when fertilization in vitro was developed. Deciding that it would be 
impossible to expand assisted reproductive techniques at the public hospital, they opened 
                                                 
48 I was told by another gynecologist, Carlos Carrere, one of the founders of the clinic Procrearte, that 
Mannara also left CEGyR at the same time as Coco and Neuspiller. According to Carrere, he and Mannara 
joined Coco and Neuspiller in founding Fecunditas in 1989. However, Coco made no mention of Mannara 
nor of Carrere, nor does Fecunditas’ website document the clinic’s original founders. Carrere recalls that in 
1998 Fecunditas was doing badly economically and there was a crisis among the associates of the clinic, at 
this time he and Mannara left Fecunditas and started Procrearte. I was not able to interview Mannara to 
confirm these events. Coco’s neglect of this detail could be linked to the general syndrome in Argentina of 
ignoring past events and remaking history through active-forgetting. Or perhaps Coco deemed these details 
irrelevant to the story at hand, or left them out merely as an oversight.  
 104
a private center instead.49 Today IFER, with approximately 25 gynecologists, has perhaps 
the highest case load of assisted reproduction in Argentina, and is the only of the five 
largest centers in Buenos Aires that is not a member of RED (apparently for 
personal/political reasons).50  
In the late 1980s, several more clinics opened, almost simultaneously. In 1987 
Halitus was founded, with Sergio Pasqualini as the director. Halitus today is one of the 
five largest centers in Argentina, and the one with the most aggressive marketing 
department.51 Halitus offers the widest spectrum of services of the principal ART centers, 
from basic OB-GYN to esoteric mesotherapy (treatment for cellulite). Halitus is located 
in a restored three-level French building on the same street as IFER, about four blocks 
and the Hospital de Clínicas separate the two clinics.52 At this time, smaller centers are 
also founded, taking advantage of the country’s economic opportunities. One example is 
CER Medical Institute, established in 1987 by Ester Polak de Fried, the first woman to 
open an assisted reproductive center. CER Medical Institute remains one of only two 
centers directed by women today in Buenos Aires (a third is a small center in the 
Corrientes province), and is mid-sized in terms of cases and services offered. In 1988, 
after leaving CEGyR, Gonzalez Fabbrizzi, opens a small center of his own, Institute of 
                                                 
49 According to Coco, IFER’s claim of doing IVF in 1985 is not entirely true, as it is based on IFER 
sending a patient to the Jones Institute to do the actual IVF treatment. The patient then returned to 
Argentina to give birth in 1985. I was not able to validate this assertion. 
 
50 I was never given a direct answer to this decision, but I was obliquely told that the directors at IFER do 
not agree with the principles behind RED, nor the direction of the network. 
 
51 This marketing effort includes a weekly cable television program that the director designed and co-hosts, 
called “Sentir y Pensar”—‘Feel and Think’ which claims to bring topics in science and health together. For 
example, a show airing in mid-November 2006 has an invited guest (a female doctor who works at Halitus) 
to discuss “female health after 40 years” and then a side-topic of how to talk about sexual education with 
your children. 
 
52 IFER and Halitus are the two centers that Nicholson Jr. refers his patients to after leaving CEGyR—those 
needing IVF or GIFT are sent to IFER, those doing  ICSI are sent to Halitus. 
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Fertility and Reproduction or IMAGEM, dedicated to the theme of infertility, from basic 
studies to IVF (the clinic does about 50 cases a year). Several other mid-sized clinics in 
Buenos Aires were founded in this decade of prosperity.  
From these private, stand-alone centers, the desire to do ART extended into the 
hospital-realm, beginning with a reproductive endocrinology team at the municipal-run 
Hospital Durand in Buenos Aires.53 However there was no funding for advanced 
techniques, so the program transformed into what it is today: basic low-complexity 
infertility services (hormone stimulation and insemination) and referral to the private 
sector for more high-tech needs. Several private hospitals then follow, attempting to 
establish ART units, but most of them also outsource the actual assisted reproductive 
techniques to a separate center’s lab.54 Once established in the capital city, during the 
1990s ART traveled out to the provinces, first to the closest big cities, like Rosario and 
Córdoba, and then to smaller or further away places—Bahia Blanca, Pergamino, 
Tucumán, Mendoza, Salta—through satellite clinics operated by the larger institutions in 
Buenos Aires. 
 Procrearte, the fifth principal clinic today in Argentina, arrived in 1999, relatively 
late to the ART scene. Competition between the four largest centers—CEGyR, 
Fecunditas, IFER and Halitus— was already well-established when Procrearte opened its 
doors. However Procrearte has managed to find a niche in the market, even at the end of 
the boom years of the ‘90s. Unlike the other centers, Procrearte has a horizontal structure 
                                                 
53 This endocrinology team began at the public Hospital Álvarez in 1978 then moved to Hospital Durand in 
1986 in order to expand services. However they have never reached the level of providing IVF/ICSI. 
 
54 Given the history of assisted reproduction as a private, individual-based effort in Argentina, the model 
was set and continues to be that of an out-patient stand-alone center dedicated to assisted reproduction. In 
contrast, in Chile, assisted reproduction teams are housed in a reproductive medicine unit that is part of a 
larger clinical institution. There are only a handful of these in Argentina, including Hospital Italiano, the 
San Isidro Fertility Unit, and some of the provincial satellite clinics. 
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overseen by its six medical founders, which means that it provides a centralized staffed 
laboratory and surgery room for an affiliated group of gynecologists to use periodically 
for their assisted reproduction cases. Affiliation is open to all gynecologists who wish to 
participate, making the potential network of medical members extensive. The number of 
affiliates—and therefore the number of cases performed at the center—grows every year. 
Within 5 years of opening in Buenos Aires, Procrearte expanded to include three satellite 
centers in the provinces (La Plata, Neuquen and Bariloche). Notably, other clinic 
directors in Argentina told me that Procrearte’s reputation is not on par with their own 
conventionally-structured fertility centers. This refusal on the part of some of Argentina’s 
reproductive medicine community to accept Procrearte as a “reputable” center is puzzling 
since Procrearte’s case load and success rates suggest that it is equal to the other centers. 
In 2003, looking back on the first 15 years of ART in Argentina, one center 
director identifies a market that grew quickly and without forethought, and now has to 
face the consequences: 
…it seems to me that a group of gynecologists without knowing anything about 
reproduction believed that this was a good business, to make money from. And it 
seems to me that it’s not so much like that. Assisted reproduction and high-
complexity reproduction is expensive, for the investment and the personal 
aptitude that is necessary to do it. So, for example in Argentina, in Buenos Aires, 
if one looks, it is crazy, how there are Halitus, CEGyR, IFER, CER, Fecunditas, 
five centers with the same hierarchy. It [assisted reproduction] was invested in 
five times over and we have to split up the same patients, because Argentina has 
this population and that’s it. But that was because each one wanted to have his 
own center, it was important.  
It seems to me that it was a mistake, each one could have had his center and there 
would have been a laboratory for everyone to share. Understand? Each one could 
have seen their patients, but then all used the same laboratory. So, the situation is 
that now there are less patients for the centers because we have to divide them 
between the five, and on the other hand, the investments that these procedures 
require, still nothing is made in Argentina because we are past the Menem era 
when we were buying everything. It was cheaper to buy quality outside of the 
country and not here. 
 107
  
As this director describes, the economic setting of the 1990s allowed many centers to 
open and flourish, creating a market that by 2003 feels cramped and not as profitable as it 
once was. The industry that has developed is one based on individual egos, all looking to 
differentiate themselves from the doctor next door. On the other hand, for the consumer 
this competition provides a variety of options. A gynecologist at another center thinks the 
market accommodates these small centers in the Buenos Aires area because consumers 
aren’t well-informed about the best place to go:  
Many people don’t understand. So they go wherever. Maybe it’s close to their 
house, or a friend or relative sends them there or…You see? Or simply that a 
doctor works at that clinic, ‘no, come here where we work well, it’s good’. And it 
isn’t like that most of the time. So they do two, three treatments in small clinics 
and then they go to the four or five large centers. 
 
Rather than seeing these small centers as providing consumers with more options—the 
ability to “shop around”—this gynecologist views them as consumer “errors” in 
judgment. In his mind, the only centers of significance are the large ones.  Other 
professionals, like the center director quoted above are more cautious about the field’s 
rapid expansions.  
 I would suggest that evaluated in terms of the available population figures, 16 
clinics to serve the greater Buenos Aires area of over 11 million people (out of a country 
population of 36 million) is not so inundated after all (INDEC 2001).55 For comparison, 
in all of Brazil there are 48 official (RED) clinics for a total population of 182 million; 
Israel has the highest per capita number of clinics in the world which in the mid-1990s 
translated to 24 centers for 5.5 million people (Kahn 2000). In addition, as the cultural 
                                                 
55The most recent population figures for Argentina are from the census in 2001. INDEC (Instituto Nacional 
de Estadistica y Censos de la Republica Argentina), Censo Nacional de Población, Hogares y Viviendas 
2001. Insitituto Geográfico Militar (IGM).  
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and economic epicenter of Argentina, Buenos Aires draws in people from the interior of 
the country. Half of the patients at CEGyR for example, come from provinces in the 
interior because Buenos Aires has a reputation for the best medical care in the country:  
It’s not like in the United States where each city is lively, independent. Here 
everyone from the interior comes to the Capital to do a treatment, to see the 
doctor when there is a serious problem, they come 1000 km, to be assisted here. 
These things don’t happen in the US in general.[…] Everyone doesn’t go to New 
York to do it. […]Every city has good clinics. But here it’s not like that, so 
everyone comes to Buenos Aires. 
  
Though professionals recognize the need to open more centers in the interior, it is seen as 
expensive and not easy to do so, given the investment and training involved. In the 
meantime, the infertility market and its experts in Buenos Aires are well-established, 
meaning that any future clinics in the nation’s capital may need to change their business 
model to one of cooperative mergers rather than individual enterprises. Procrearte, with 
its inclusive network, centralization of investment costs, and satellite clinics in the 
provinces, may be the future model for ART in Argentina.56 
 
                                                 
56 In the last few years Halitus has expanded into the interior of the country with a “network of 
representatives” of doctors in Bahía Blanca, Cipolletti, Junín, Tandil, Tucumán. These satellite clinics 
apparently work under the “scientific counsel” of the director of Halitus. 
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A Country in Crisis 
 
 
Figure 11. Bank Boston in the downtown area of Buenos Aires, Photo by Kelly Raspberry, November 
2002. 
 
“Stop thinking you are the best in the world until you can demonstrate that you really are 
the best of the world. We are living an illusion here. In a bubble. We don’t look at the 
reality of the country. And even when we are in the worst situation, we still believe we 
are better…It’s not enough to tell you that we were the best European country in Latin 
America back in 1930.” (July 2003) gynecologist Facundo Martín 
 
In 2001, enormous defaults on world debt, in part the result of the economic 
mistakes of the 1990s, reached a critical boiling point. The president elected in 1999 to 
replace Menem, Fernando de la Rúa, proved incapable of assuaging skyrocketing 
unemployment and inflation across the nation. Dire economic conditions across the 
country made it obvious that maintaining the peso one-to-one with the dollar was 
straining the local economy. Political protests and riots attested to the fragility of the 
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nation’s stability and the impending economic collapse. By the middle of 2001, people 
across the nation were suffering from the government’s apparent neglect of the poor and 
unemployed and public assistance programs were canceled. Then at the end of November 
the corralito (a freeze of bank deposits) wreaked havoc: under orders from the federal 
government, the private banks issued severe limits on the amount of cash available for 
daily withdrawal.57 Public rallies against the government continued, including protests by 
the middle classes against the corralito. Demonstrations reached a peak on December 20, 
2001, when protesters from across the nation congregated at the Plaza de Mayo, the 
public square in front of the Casa Rosada (the federal government building in Buenos 
Aires). Faced with demands he could not resolve, de la Rúa resigned and flew away in a 
helicopter that night.58 Over the next two weeks, a series of five politicians stepped up as 
President, each resigning within days of taking office. Finally Duhalde took over on 
January 2, 2002 and stayed for the next year and a half, until national elections were held 
in 2003. In 2002, the peso was officially devalued and released from its imposed 
equivalence to the US dollar. Immediately the peso’s value spiraled downward, 
fluctuating between three and four pesos per dollar over the next two years before 
stabilizing somewhat at 2.80 at the end of 2003.59 This devaluation was devastating for 
those who had savings and checking accounts in the banks: overnight these accounts 
became worth one-third their previous value; with one federal decision, the money that 
used to be 1:1 with the US dollar was converted into a devalued peso amount.  
                                                 
57 The term “corralito” can be likened to animals (in this case money) not let out of the corral.  
 
58 At least a dozen people (protestors) were killed during the December 20, 2001 protest though official 
counts are disputed. 
 
59 Inflation again accompanies this relative stability, by mid-2005 the peso hovers at 3.1 per USD, and still 
remains there at the time of this writing (December 2006). 
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Figure 12.  Tanks and Armed Police in front of the Casa Rosada in Buenos Aires. First anniversary 
of 2001 protest: December 20, 2002. Photo by Kelly Raspberry, 2002. 
 
 
 
 
 
 
Figure 13.  Red Cross volunteers. First anniversary of 2001 protest: December 20, 2002. Photo by 
Kelly Raspberry, 2002. 
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When I arrived to Buenos Aires in November 2002 (after brief stays in July 2000 
and July 2001) nearly a year had passed since the apex of the crisis, but the consequences 
of the calamity were still fresh. The city that I met at the end of 2002 was not the 
glamorous metropolis known as the “Paris of the South,” but her struggling Latin 
American cousin who was riddled with debt, corruption, unemployment, and most of all, 
instability. The main offices of the national banks in the downtown area had their 
windows and doors boarded shut for security reasons. These barriers to keep out a 
protesting public were covered in graffiti that accused the foreign banks of being 
“thieves” for stealing their clients’ money. Six months after my arrival, Nestor Kirchner 
was elected as President. He ran a campaign—against Menem—built on the promise to 
make “un pais en serio”—to return Argentina to being a “serious” country again, both as 
viewed by its population and by the international spotlight. However recovery was slow; 
it took until March 2005 to reach an agreement for debt repayment with the IMF. 
 
 
 
Figure 14.  Las Madres de la Plaza de Mayo protesting payment of the external debt. Photo by Kelly 
Raspberry, June 17, 2004. 
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The crisis also affected the reproductive centers, though not as severely as it 
might have. The main effect was an overall reduction in available resources for clinic 
operations, thus non-essential costs were cut including: new equipment, research, 
international conferences, and international publications. In addition, since the country’s 
currency had changed, the cost of the services charged the public also changed to a value 
in pesos. One clinic director explains the effects of the crisis to me in 2003, giving a 
contextual view of the field over the years: 
The centers are going to continue because, you know, not one, now that they have 
everything set up, is going to shut down unless they go bankrupt. That is going to 
be one thing. I am telling you, if you were asking me…I think that from the year 
1985 until now, assisted reproduction was increasing. Why? Because more is 
known, more is published, patients know more, so someone who is trying for one 
year, two years to get pregnant and doesn’t, knows very well that she can go to 
any center and be taken care of.  The flow of patients increased. In spite of there 
being five centers, there are more people who are turning to assisted fertilization. 
Now, until 2000, for us to do the procedure here was cheaper than in the northern 
hemisphere. But it was cheaper because it cost around $4000 US dollars. But I 
repeat, why did it cost $4000 US dollars, because the culture media, the 
disposable supplies, the aspiration needles, the uterine transfer catheters, they 
were all imported supplies.  
Now, when the convertibility was cut, we had to continue working. So, it’s 
not that we said ‘it cost $4000 US dollars, times it by three, makes 12,000 pesos 
per procedure.’ It’s not like that, [now] we charge around 5000 pesos. If we 
divide it by three, it gives us about 1500 pesos, $2000 US dollars. That basically 
serves to buy the supplies. In reality, there are no doctor fees with respect to high-
complexity assisted reproduction. For example, for us it is much more convenient: 
the act of offering this service serves to attract patients. So the patient that doesn’t 
need assisted reproduction, for us it’s more advantageous because we don’t have 
to invest, we don’t have to spend, and in that case, yes we charge doctor fees, for 
a consultation, a surgery, a treatment program.  
But in reality, today high complexity assisted reproduction is like a luxury 
that we are trying to maintain until we see how our future economy will be. But 
that is the reality. If today we would say look, this costs 12000 pesos, there is no 
patient who could do it. Because if in Argentina half the country is poor, 40% of 
the population is unemployed, it is impossible. The health insurance plans (obras 
sociales) don’t cover it and they don’t cover it because there is no legislation yet. 
There is no legislation. So, in the meantime while there is no legislation, the 
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health insurance plans or medical insurance companies (obras sociales o 
medicinas prepagas) don’t want to hear any talk about the issue.60 
 
Though this director exaggerates the number of unemployed in the country, his point 
rings true that if the post-crisis cost of assisted reproduction techniques were still priced 
at their pre-crisis value, they would be far out of the financial reach of almost all 
Argentines. Even in the peso-denomination, the services are “a luxury” for the richest 
sectors of Argentina, a point I return to in chapter two.  
At another center, a gynecologist also explains that having fewer patients, and 
charging lower prices (while paying the same price for imported supplies) has meant 
cutting costs at the center:  
The quantity of work went down, a little. And well, that meant that we had to 
close certain areas. Research was reduced, the library shrank, staff was cut. In 
other words, we had to cut down a little, not a lot, but we had to downsize. When 
you cut down, you don’t grow, you see? The crisis means that people don’t have 
money to do treatments, so if people aren’t doing treatments, instead of having 
everything on a large scale, you have to reduce everything. 
 
Like any business in an economic downturn, the market of ART in Argentina is 
vulnerable to the pinch of fewer resources circulating. Coping with the economic crisis 
also involved a certain amount of ingenuity to stay afloat, as this biologist explains with 
respect to the embryology laboratory: 
With the devaluation we had to do some juggling in order to figure out how we 
were going to continue without lowering the quality. How to lower the costs a 
little bit, in terms of the culture media that we were using because that it was all 
priced in dollars. We could buy the media from here but the quality control of the 
media here is very bad, so there is no way we would trust the media made in 
Argentina, we buy it from the United States or from Europe. But we had to think 
                                                 
60 Here I’m translating “obras sociales” as health insurance plans and “medicinas prepagas” as medical 
insurance companies—there are no direct translations for these words as they are unique to the system of 
health care in Argentina, in which public health care plans are provided through employment (originally 
based on unions), and private medical insurance plans are also provided through employment or can be 
paid for directly out of pocket. There is also free access to nationally-run public hospitals where type (or 
proof) of health insurance is irrelevant. 
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wisely to see how to lower the quantity of media we used without jeopardizing the 
results because we didn’t want to do that. So we said, okay, instead of using a 
large dish, which you know is not necessary, we will use a smaller one and so we 
use less than half [of the media]. So that’s how we thought about everything and 
we corrected ourselves. 
 
In a sense, the economic crisis forced this center at least to become more efficient with 
their supplies in order to maintain the quality of work they were accustomed to 
producing. This creative way of “cutting corners” is common in Argentina where 
resources are often in short supply. 
The overall sentiment in the reproductive medicine of Buenos Aires when I 
entered the field was proud and slightly nostalgic about the progress made in 20 years, 
but with reservations about the future of ART work. As I discuss in chapter three, these 
worries were short-lived—within two years (by 2004) the ART market is growing once 
again, particularly with respect to an increased demand for egg donation. By 2005, 
centers are again introducing new advanced techniques, such as preimplantation genetic 
diagnosis, which I discuss in chapter four. On the other hand, the impact of the crisis was 
so great that concerns for the country’s economic future linger and never completely 
fade. In February 2004, two years after the devaluation of the peso, I ask one of the clinic 
directors what the most important issues are for Argentina in the next 5 years. He returns 
again to the economy, saying it still needs a lot of work. He characterizes the creditors 
that Argentina owes as “vulture capitalists” that for ten years have been taking money out 
of the country. However, like most Argentines, this reproductive medicine professional 
has pride for his country and hope for the future, “I am convinced that if there were…if 
there were no corruption and there were laws in this country, this would be a paradise. 
This country would be a paradise.”  
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Figure 15. "We are all Argentines." Government ad for a public celebration of 25th of May (the 
national revolution day) at the Plaza de Mayo. Photo by Kelly Raspberry, May 25, 2004. 
 
 
 
Conclusion  
The production of ART in Argentina involves global interconnections of people, 
knowledge, skills and materials.61 As I discuss in this chapter, assisted reproductive 
techniques have circulated—on a global scale—in large part through key individual 
experts, who teach their skills to others through demonstrations and performances. In the 
early years of concocting assisted fertilization procedures, groups were isolated from 
each other and it was harder to share innovations and experiences. Today, technology 
transfer is much faster and accessible and has a greater reach, as one gynecologist 
summarizes: 
What happens is that technology transfer can’t be done the same way in the 
present as how it was in the past. It’s not acceptable for example, today for a 
center that is just starting, for it to start with the level of understanding that we 
had back in 1984. And with the isolation that there was. Because today…if you 
think that between the year 1979 [sic], when the birth of Louise Brown was 
declared, to the year 1984, when the first baby in Latin America was born, there 
                                                 
61 I discuss the materials of ART (the culture media, lab equipment, etc) in chapter two.  
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are 5 years…ICSI was declared for the first time in the year 1992, and in ’94, at 
the end of ’93, it was already in Latin America. In other words, the velocity of 
technology transfer is different. That is the first concept. The second, is that the 
introduction of technology and the level of people with knowledge and capable of 
doing the technology transfer is so great today that it doesn’t seem acceptable to 
me to offer patients the results from the start of the program if it doesn’t have 
technological support and the people to do it. This is an example that we have 
developed in Latin America, of technology transfer through people. That is how 
we began ICSI here. We brought a biologist from the US for a year and a half. In 
1994.” (emphasis mine). 
  
The system of moving technology through people is now a common one in Latin 
America. When a new technique is developed, experts in that technique are brought 
directly to the local lab to train and add the service to a clinic’s repertoire. This is how 
centers in Buenos Aires and Santiago incorporated ICSI techniques in 1994, just two 
years after they were first developed in Belgium. As I discuss in chapter four, this form of 
“technology transfer” is also how CREAR began the latest of these techniques, 
preimplantation genetic diagnosis—by bringing an Italian expert to the center to give on-
site training.  
The history of ART production in Argentina that I give in this chapter also reveals 
that private infertility centers in Argentina participate in an international reproductive 
medicine network from a peripheral position of influence. Today there is a global circuit 
of clinics, professionals, knowledges, techniques and patients, which is structured by a 
North American-European hierarchy of scientific standards and quality. Within this 
system, the central sites of biomedicine are located in the West and North of the globe, 
particularly in the United States and Western Europe. However, within Latin America, 
these private centers in Buenos Aires compete to be recognized as the “best” in the 
region, the closest to conform to the Northern model. As I discuss further in the following 
chapter, in this context, being the “best” is often also connected to being the “first” in the 
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area to begin a given technique with desirable results. In this modern world of “discovery 
and results,” professionals’ genealogy of training is also a significant factor in status 
positioning. As this history reveals, many of the reproductive medicine specialists that are 
now clinic directors did specialized training abroad, most often in the United States or 
Western Europe. Personal connections to internationally recognized programs and 
experts—usually from research or clinical centers in the US and Europe— are therefore 
emphasized in the telling.    
Producing ART in Argentina is a local story with global connections, and 
examining the history of this medical technology begins to reveal the messiness and 
multitude of factors in play in producing ART in Argentina today. As places where these 
practices were first developed and implemented, the United States and Western Europe 
continue to be the model sites for scientific and clinical training. However, I argue that 
what appears to be a “replication” or “transfer” is actually a translation of sorts, in which 
technical procedures and guidelines are transformed to meet local conditions of demand. 
In chapter two I discuss more closely how and why the technical apparatus of ART is 
translated in practice in Argentina by examining more closely the processes by which 
these Argentine professionals tinker with these imported practices to accommodate 
traditional social values, Roman Catholic beliefs, and economic and political tensions 
particular to Argentina. 
  
Figure 16. Chart of International Relationships and Formation of ART clinics in Argentina 
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INTERLUDE II 
 
“High Complexity” Aspirations and Transferences:  
The In Vitro Meeting of Egg and Sperm in a Buenos Aires Infertility Clinic62 
 
 
 
 
Figure 17. Surgery area—where aspirations and transferences are performed—in an infertility clinic 
in Buenos Aires.  Photo by Kelly Raspberry, 2003. 
 
It is 8:50 am on a Sunday at the end of March (in 2005), in the post-operation 
recovery area of an assisted reproductive technology center in Buenos Aires. In 
Argentina, doctors usually go to lengths to avoid scheduling a surgical procedure such as 
                                                 
62 The following is an ethnographic description that details the work of an ICSI procedure, both in the 
operating room and in the embryology lab. I gleaned most of this information of the process from months 
of observing and asking questions while in these two clinical settings. The very specific laboratory details 
are taken from informal conversations (during which I took extensive notes) that I had with laboratory 
biologists at times when they were not in the middle of the procedure itself. My “knowledge” of the 
biology and medical components that I present here are therefore local to what I witnessed and was taught 
by these Argentine experts, rather than taken from a textbook. 
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a follicular aspiration on the weekend, particularly on a Sunday, the day of rest. 
Sometimes the hormone stimulation protocol is manipulated for this convenience of the 
calendar. In this case the protocol was not readjusted, perhaps because this is a “repeat 
patient.” Everyone is here, the lab and operating room staff, the attending gynecologist, 
the patient herself, who now rests in the white bed with her husband at her side, and me, 
the resident anthropologist. Like other couples here during the week, this woman and her 
partner are awaiting the visit by the gynecologist that will tell them how many mature 
eggs were retrieved from her ovaries, and what steps are to follow. Because of past 
experience, she knows very well how high the risks for failure are, and will be, over the 
next few days as her eggs are fertilized and perhaps develop into embryos in the 
laboratory. This is the fourth ICSI (intracytoplasmic sperm injection) treatment she has 
pursued over the last six years, with only the last of the previous three procedures leading 
to the birth of her first child, a little girl now 3 years old. Over the course of the following 
two weeks, many actors will come together in a precise choreography of clinic and 
laboratory, sperm and egg, values and desires.63 Following this dance of expertise and 
desire reveals the many contingencies crucial to the successful creation of an embryo, a 
pregnancy and the birth of a baby. 
Upstairs in the immaculately clean laboratory with its white tile walls and grey 
marble counters, there are 16 human eggs sitting in a clear plastic dish of nutritious pink 
biological media, inside an incubator kept at the internal human body temperature of 37 
degrees Celsius. The eggs have been tallied up and evaluated based on their degree of 
maturity: twelve are metaphase two (MII); three are metaphase one (MI); one egg is 
completely immature, prophase one (ODS—oocyte disassociation syndrome). In this 
                                                 
63 See also Thompson 2005 for a brilliant analysis of the “choreography” of the IVF clinic. 
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world of laboratory-assisted fertilization, metaphase two is the desired stage of 
maturation. A ripe egg, one that under other circumstances would be ovulated from the 
ovaries, thus having reached a point of readiness for fertilization, is metaphase two. With 
luck, after a few hours in the incubator, the three metaphase I eggs will mature into 
metaphase II.  
The arrival of these eggs to this laboratory’s incubator is part of a process initiated 
two months prior, when Augustina began taking hormone stimulation drugs. The drug 
protocol used for assisted reproductive treatments suppresses the body’s typical hormonal 
fluctuations and imposes one carefully designed to aid in high-tech fertilization. On Day 
21 of her menstrual cycle in late February, Augustina began taking Lupron—a drug that 
suppresses ovulation. Lupron is injected every day into the subcutaneous flesh of the 
stomach area, until the gynecologist is sure that ovulation will not occur—usually a time 
period of two to three weeks. After menstruation, a new cycle begins and Augustina’s 
levels of estradiol are checked with a blood test between Days 2 and 5. When estradiol 
levels are below 30-35 international units per milliliter (IU/ml), this indicates that indeed 
ovulation has been suspended. Once suppression is established, Augustina can continue 
to inject Lupron as convenient for planning, until the doctor and she agree on a date to 
begin the stimulation-treatment hormones. 
As per protocol, the day in March that Augustina begins the stimulation hormones 
is designated Day 3 of her cycle in the medical charts. With the use of synthetic 
gonadotrophin releasing hormones (GnRH), gynecologists can incite multiple follicles in 
the ovaries to collectively “grow” their eggs at the same time. (In a non-stimulated 
hormonal cycle usually only one egg matures and is released).  These hormones, which 
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cause the pituitary to secrete luteinizing hormone (LH) and follicle stimulating hormone 
(FSH), are administered every day, usually in the form of an injection also into the 
stomach flesh. Patients at CREAR are taught by the nurse how to inject the daily shot. 
For an IVF or ICSI procedure, the dose of GnRH depends on whether the woman is 
expected to be a “normal” responder to the hormones, a dose of 300 IU/ml per day; or a 
low responder (takes more hormones to stimulate the ovaries) with a dose of 450 IU/ml 
per day; or a high responder (needs less hormones) with a dose of 150-225 IU/ml per day. 
(Hormone stimulation is also used often for artificial insemination, but the dose is much 
lower—around 75 IU/ml per day, calculated to stimulate only 3 follicles at once). 
Augustina has an average response to the hormones, and so takes 300 IU/ml of Gonal F 
(a common brand of gonadotrophin in Argentina) every day. As the follicles grow in size, 
they expand and exert pressure on the bladder and stomach. The last few days of 
stimulation treatment can be physically uncomfortable and are described by some women 
as feeling like their ovaries are the “size of grapefruit.” Other side-effects can include 
headaches, nausea, dizziness, inflammation of the injected area, rashes and low blood 
pressure. 
This phase of corporeal maturation is controlled and monitored with hormone 
doses, ultrasound checks and computerized measuring devices over a period of ten to 
thirteen days. The first check is done on Day 6 of the treatment schedule, and Augustina 
must present herself to the gynecologist and nurse in the morning. First an ultrasound on 
the ovaries and uterus is performed in order to measure the size of the follicles, the 
thickness of the endometrium, and to check the shape of the uterus. Then the nurse takes 
a blood test to measure the level of estradiol in the blood. These tests continue either 
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every day or every other day, depending on the growth progress of the follicles. The 
assumption is that the follicles will grow 2 micrometers every day. If they are slower or 
quicker than that, the frequency of the tests are adjusted accordingly. When a computer 
diagram generated through an ultrasound of the ovaries indicates that three to four of the 
follicles are 17-18 micromillimeters (mm) or larger, and the endometrium is a thickness 
of at least 7mm, the eggs are deemed ready for their final preparatory injection. For 
Augustina, this occurs on Day 11 when eight follicles are found to be at least 17mm in 
size. Since the eggs mature at different rates, not all the growing eggs will be of adequate 
size and maturity—some are still metaphase one— but the status majority has to be 
respected. If the doctor waits too long, the frontrunner egg will induce a spontaneous 
ovulation, incite luteinization and the rest of the eggs will die in the follicles, forever 
“lost.” A final hormonal shot, this time of human chorionic gonadotrophin (hCG), is 
administered at this point to facilitate the remaining hours of corporeal maturation of the 
eggs. 
The surgical procedure to remove the mature eggs from the woman’s body, called 
an oocyte aspiration or “egg pick-up” is scheduled for 34 to 36 hours after the hCG shot, 
and always in the early morning. The term is quite adequate, as the “aspirations” of all 
involved—the woman (and her partner), the gynecologists, the embryologists—are to 
retrieve as many mature eggs as possible. For Augustina, the scheduled hour is 8 am on a 
Sunday. On this day of aspiration, Augustina and her husband arrive at the clinic fifteen 
minutes before the procedure is to start. She disrobes and puts on the pink disposable 
gown provided and shuffles into the operating room wearing the standard CREAR 
slippers that are too big—white with the clinic logo in pink. Her husband waits in the 
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recovery room for her, having already provided a sperm sample during a testicular biopsy 
six years prior. He has obstructive azoospermia (his testes produce sperm but he does not 
ejaculate them) and so can not provide a fresh sperm sample. A portion of his frozen 
tissue sample will be retrieved from a nitrogen tank by the lab staff later in the morning. 
Because the sperm were obtained through testicular surgery, they do not meet the 
mobility and concentration requirements for an in vitro fertilization procedure, in which a 
measured quantity of sperm (300,000/ml of motile Grade 3) are placed into a dish with 
media alongside the eggs and left in the incubator overnight to fertilize on their own. 
Instead, the condition of azoospermia calls for the newer technique of intracytoplasmic 
sperm injection (ICSI), in which the attending biologist manually selects and injects one 
sperm into each egg using an inverted microscope with micromanipulation system (with 
magnification level up to 400x).  
 At CREAR, aspirations are done under general anesthesia, and so there is a 
cardiologist and anesthesiologist on hand, as well as the gynecologist, the nurse, and a 
resident fellow in the operating room. As the non-essential person in the room, I’m 
standing to the side of the room, out of everyone’s way, but with a good view of what is 
happening. I have my notebook out and furiously scribble away as the procedure unfolds. 
For aspiration procedures, other centers in Argentina use only a mild sedative for 
relaxation and a local anesthetic—applied to the inside of the vagina—which avoids the 
need for an anesthesiologist and allows the woman to recover from the procedure more 
quickly. CREAR’s policy is perhaps a left-over of the way that things “have always been 
done.”  
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The anesthesiologist and cardiologist begin their work, and soon Augustina’s eyes 
close and she appears to be sleeping. She is lying on her back, with a thin gown and 
disposable sheet covering her. The resident fellow, a woman, quickly pulls back the gown 
and sheet, exposing Augustina’s lower body, and arranges Augustina’s limp legs into 
stirrups. With the sleep of anesthesia, Augustina has become a malleable body that needs 
to be monitored and prepared for operation. The resident sterilizes Augustina’s pubic area 
with sterile water while the gynecologist scrubs his hands and arms up to the elbows with 
yellow soap and water. Because of the general anesthesia, she has heart monitors attached 
to her chest and a plastic tube down her throat. The resident inserts a metal speculum into 
Augustina’s vagina to ensure an open passage, and a sterile glove is pulled over the 
phallic-shaped ultrasound device to which a small needle is attached inside a plastic 
guide. The harvesting is done using this very thin ultrasound-guided needle that enters the 
woman’s body through the vagina and accesses the follicles by puncturing the lining of 
the ovaries. The ultrasound’s images appear on a small black and white monitor next to 
the surgical bed. The nurse stands by with a manual syringe attached to the aspiration 
needle, which provides the necessary force for sucking the eggs out of the ovaries. The 
overhead lights are turned off and the heart monitor beeps away. On the monitor, the 
follicles appear as black spots in a fuzzy grey background, and the guide containing the 
needle as a thin gray line. When punctured and emptied of fluid, the blackness 
evaporates, and follicle’s outline blends into the grayness of the rest of the screen. The 
gynecologist uses this fuzzy image on the monitor to find and puncture the follicles. 
Several minutes later, the eggs floating in follicular fluid inside Augustina’s 
ovaries are gently carried along a sudden current, sucked into a needle that has been 
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flushed with biological media, down a narrow tube and come to rest in a vial. When full, 
the vial of fluid, eggs and blood, all mixed together, is immediately sent from the surgery 
room to the laboratory. A mechanized dumbwaiter tunnel connects the two areas, the 
laboratory is upstairs and so the vial travels upwards, stopping when it reaches the cargo-
door to the lab. A beep signals that it is there. The laboratory is ready, having been 
alerted through an intercom system that these precious orbs are on their way.  
Under the scope the tiny egg, a small nugget of DNA, is searched for within the 
river of red viscous fluid that fills the vial. More vials are sent up, some are found lacking 
an oocyte, others have more than one. There are many vials and they accumulate at the 
sterile workstation, waiting their turn for analysis. The biologist quickly reaches for a 
vial, pops the plastic top off, and pours the fire-engine red fluid into a shallow circular 
dish. The dish is set underneath the scope’s lens (with a maximum magnification of 10x), 
on a thermal warming plate set to 37 degrees Celsius. The empty vial is quickly examined 
under the scope, to make sure that no egg has stayed behind in the tube, and then 
discarded. The scope’s gaze now focuses on the liquid spread across the dish, and a 
micropipette waits eagerly for the spotting of an egg. The biologist moves the dish in a 
circle, slightly jostling the contents to have a better look. Finally an egg is identified and 
scooped up into the pipette, out of the mixture of blood and cells, and dropped into a 
waiting dish of specially prepared media that sits on a thermal plate nearby. The 
remaining extracted follicular fluid is poured into another yet another dish, where it joins 
the discarded remains of the other vials. This fluid will be checked one more time at the 
end, for any overlooked eggs, before finally being discarded.  
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 The biologist must work quickly, as human eggs are environmentally-sensitive 
and the laboratory is not an optimal milieu. Each second that the eggs are sitting out in 
the room—even under controlled conditions—wears away their viability. Direct sunlight 
and fluorescent lighting are particularly damaging to an egg (the radiation affects the 
structure of the egg chromosomes), so the overhead lights have been turned down and the 
blinds are partially closed.64 The scope shines a direct beam on its point of focus. 
Potential air pollutants are also damaging to the egg, hence the need for a laboratory 
positive-pressure air purifier (which constantly forces filtered air into the laboratory to 
prevent contaminated air from coming in each time the door is opened to the outside) and 
the performance of this work at a special work chamber with its own air filter (called a 
horizontal laminar flow cabinet). The C02 level in the incubator is also measured every 
day and maintained at 5%, along with a 100% humidity level, and the requisite 37 
degrees Celsius. The biological media bathing the eggs while they are outside the 
incubator, called HEPES human tubal fluid, was prepared the day before and kept in the 
incubator until now to ensure proper temperature, C02 and humidity levels. Though long 
exposure to HEPES can be harmful to the eggs, this media protects the eggs from 
environmental changes for the short periods of time that the eggs are outside the 
incubator. A dish of non-HEPES media, also prepared the previous day, await the eggs in 
the incubator. All media and lab liquids are imported from a lab in California (Irvine 
Scientific). The culture media provide a stable pH balance of 7.2 to 7.3 (that of human 
cells), and all surfaces that the eggs are placed on (including when they travel up the 
dumbwaiter) are heated to an approximate 37 degrees Celsius. Early on in my 
                                                 
64 Unlike previously thought however, biologists need not attempt to work in the dark and “replicate” the 
conditions inside the female body. The type of light used in the scope, and a soft light from the workstation 
are not thought to be harmful. 
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observations of the embryology lab, I learned that human presence in the laboratory is 
also contained: everyone in the lab wears a set of scrubs, disposable booties over their 
shoes, a hairnet, and a face mask that covers their mouth and nose. We wash our hands 
upon entering the lab, and after procedures, to reduce contaminants introduced to the lab 
environment.  
 
 
 
Figure 18. Scope and Thermal Plate in Workchamber. Photo courtesy of Sabrina de Vincentiis, 2006. 
 
 
The biologist sitting at the work chamber scope has finished examining all the 
vial contents, now it is time to begin preparing the eggs for the impending injection. 
Mature eggs have an outer fluffy layer called the “cumulus ooforus” surrounding them, 
followed by a more condensed and compacted layer, the “corona radiata,” with the zona 
pellucida as the inner layer before the cytoplasm. The cumulous and corona act as 
barriers that the (normal) sperm must cross in order to reach the penetration zone—the 
zona pellucida. Sluggish and weak sperm will fail to complete this journey, but the more 
virile ones will compete to be the first to reach the zona pellucida. However, for an ICSI 
procedure, the cumulus and corona layers must be removed so that the egg can be quickly 
and easily injected mechanically with a sperm. Therefore at this point the 15 MII and MI 
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eggs are submerged in an acidic substance given the nickname “hydase” (hyaluronidase) 
for thirty seconds, which loosens the cumulus cells from the egg. Prolonged exposure to 
hydase is harmful for the eggs, referred to as “stressing” the eggs—this is avoided in the 
lab by carefully timing the egg’s submersion in the hydase baths, and rinsing the enzyme 
off afterwards with a HEPES solution. Following this rapid immersion, and one to two 
hours of incubated rest, the remaining egg layers will be suitably loose, ready for a final 
mechanical stripping. 
Using a micropipette, the “stressed” and washed eggs are now transferred to a 
non-HEPES media dish which goes into the incubator. Within the dish—which has 
Augustina’s last name written on the underside— there are several distinct drops of 
media, all covered by a layer of protective oil. The three metaphase one eggs have been 
placed into their own drop, separated from their more mature cohort as a method of 
distinction. The maturation classifications and time of day (8:50 am) are recorded on a 
chart, and the eggs are left to “rest” in the warm humidity of the incubator. At this point 
the HEPES media dish for the ICSI is prepared, as it needs four to five hours in the 
incubator to stabilize and achieve adequate environmental conditions. Using disposable 
pipettes, six drops of media are placed in the circular dish and covered with oil.  Two of 
the media drops are replaced with a substance called PVP (polyvinylpyrrolidone) which 
is slippery and will slide if not placed over the space held first by the media drops.  At the 
time of injection, the eggs will be placed in the media, the sperm in the PVP. 
Downstairs in the operation room, the surgery is completed and the lights are back 
on. Before taking the speculum out, the gynecologist practiced the embryo transfer by 
inserting a plastic catheter through the vaginal canal and to the uterus. This check alerts 
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the gynecologist to particularly narrow cervix passageways that are difficult to navigate 
with the thin and flexible catheter. Augustina is no longer under anesthesia, the tube has 
been taken out of Augustina’s throat, the IV removed from her arm, her legs are taken out 
of the stirrups and her gown pulled down to cover her. A few minutes later she comes to 
consciousness and asks how many eggs were found—upon hearing “16” she comments 
that she is a “hen” to have all those eggs and the doctor laughs and says “hopefully with 
golden eggs” as in the fable. The nurse and resident transfer Augustina to a stretcher and 
she is wheeled back to the recovery room where her husband waits. Because of the heavy 
sedation, her experience of the aspiration resides in her subconscious—a cloudy memory 
of abdominal pain and loud voices—it most likely will not rise to the surface. Some 
women cry out and moan during the procedure, despite the anesthesia their bodies 
register the violent intrusion of sharp metal objects and extraction of bodily materials. For 
the following day, Augustina’s abdominal area and vagina will feel tender and sore, but 
after an hour at the clinic she is free to go home and rest. 
At 10:17 am, one hour and twenty-seven minutes after being placed into the 
incubator, the eggs are taken out and looked at once more under the workstation scope. 
The 15 MII and MI eggs will now be mechanically stripped to further peel away the 
unwanted cell layers. Cumulus cells that did not come off with the hydase alone are 
pulled away with the use of a very narrow pipette—the egg is sucked up and down the 
pipette several times, the narrow diameter cuts away the cumulus and attached cells that 
do not fit into the tube. Following the rule of least-invasion, the biologist begins with a 
pipette with a diameter of 150 mm, if the cells are strongly attached and resist the 
stripping, a pipette of 135 mm in diameter is then used. Any cells that remain stuck to the 
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egg after this combination of enzymatic and mechanical peeling are left there, since to 
further pry them away would be to risk damaging the egg itself. The peeled eggs are now 
perfect orbs under the microscope, ready for injection. They return to the incubator and a 
nutritious dish of media to wait yet again. Before the actual injection, the eggs need four 
to six hours to stabilize and recuperate from the morning’s manipulations.65  
 
 
Figure 19.  Eggs Ready for ICSI injection, after hyaluronidase wash and stripping of the cumulus 
cells. Photo courtesy of Sabrina de Vincentiis, 2006. 
 
After the eggs are peeled, the biologist retrieves a small frozen vial, half the size 
of chapstick tube, from a large nitrogen tank. The vial contains three light pink 
luminescent “pearls” of concentrated and frozen tissue obtained from the testicular 
biopsy performed six years earlier. One last vial of this sample, also containing three pills 
                                                 
65 The minimum amount of time between aspiration and sperm introduction—whether through IVF or 
ICSI— is four hours, a time that is necessary to allow the retrieved eggs to stabilize after they have been 
prepared for the given procedure. Therefore it is most common to do both IVF and ICSI four to six hours 
after the aspiration. The in vitro introduction of sperm to eggs must be done no longer than 8 hours after the 
eggs have been collected. With IVF, the sperm are placed in the same dish as the eggs, and left on their 
own in the incubator to seek out the egg, penetrate, and fertilize. The sperm therefore need time to do what 
is done in ICSI by the biologist in the lab—to pass through the cumulus and cell layers to penetrate the egg. 
Conversely, with ICSI, the injection of sperm into egg can be done up to 12 hours after the aspiration since 
the biologist has already done much of the “work” of penetration and fertilization. 
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of tissue, remains in the tank for future use. The pink color of the frozen sample comes 
from a cryoprotectant that protects the sperm during the freezing process.  
Before being frozen into drops, this tissue sample underwent a selection process 
in the laboratory. There are two common sperm selection processes, one is called a 
“swim up” test which is reserved for mobile, healthy sperm, and the other is the use of a 
centrifuge.66 Testicular biopsy sperm—such as Federico’s—are immature and therefore 
immobile, so they do not qualify for the “swim up” test. Instead, a portion of the tissue 
sample is combined with media in a tube, and subjected to five minutes of gentle 
centrifugal force (300g), during which time the sperm clusters together and forms a 
concentrated pellet. It is important that the sperm pellet is “clean”—that there are no 
white blood cells or other body cells that will impede motility. This pure pellet of sperm 
is then combined with culture media and diluted with one part cryoprotectant to one part 
media, and mixed well in a tube. The freezing process is then done in stages, beginning 
with submitting the tube to 20 minutes in the refrigerator. Small pill-shaped holes are 
then made in a block of dry ice and filled with drops of the sperm sample. The 
cryopreservation vials are submerged into a shallow bath of the liquid nitrogen. When the 
drops have cooled and hardened—after about 5 minutes in the ice—they are picked up 
with tweezers and distributed into the cooled cryovials. The vials are transferred directly 
into the liquid nitrogen tank, kept at –196 degrees Celsius, where they can remain frozen 
and biologically viable indefinitely. 
                                                 
66 Swim up selection is used for sperm samples that already have normal concentration or motility. For a 
“swim up” test a portion of the ejaculate sample, which includes sperm and sperm plasma, is transferred to 
the bottom of a test tube, underneath a layer of pink enriched culture media. Over the next hour, the mobile 
and healthy sperm will separate from the sperm plasma and “swim” upwards to bathe in the upper layer of 
the enriched media. The very top layer of the media will therefore contain the healthiest sperm, 
demonstrated by their ability to go the furthest distance. The less mobile sperm will stay behind in the 
plasma at the bottom of the tube.  
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Today the biologist oversees the thawing of Federico’s next-to last frozen vial of 
sperm. It takes only five minutes for the pink drops, still inside the cryovial, to thaw at 
room temperature. The liquid sperm sample is now washed with culture media to remove 
the cyroprotectant. A pinprick of the fluid is looked at under the microscope to check the 
concentration and mobility of the sample. Usually a cryopreserved sample is taken out of 
the cryopreservation tank at least one hour before its intended use.67 This gives the 
biologist time to thaw it, wash away the cryoprotectant, add media and check the motility 
and concentration of the sperm.  
Concentration and motility of sperm in a given sample are evaluated using a 
device called a Makler counting chamber and a microscope. The Makler is a circular, 
reusable glass and metal slide with a yellow-lined grid on the bottom and a clear viewing 
area. Before use, the Makler is placed on a thermal plate to heat it to body temperature, 
37 degrees Celsius. If a cold Makler is used, the sperm will go into shock. The 
microscope platform is also heated to body temperature. A drop of the sperm is placed on 
the Makler grid and looked at under the microscope. There are ten rows and ten columns, 
the number of sperm (both moving and static) in each square of one row and one column 
are counted up for a total. If there are 20 sperm total in a row and 20 in a column, that is a 
normal concentration of 20 million per milliliter.  
 
                                                 
67 In the case of a fresh sperm sample, the sperm needs at least 20 minutes after ejaculation before it is used 
in any procedure. The fresh sample is very viscous and needs time to liquefy.  
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Figure 20. Makler Counting Chamber (L). Sperm under Makler counting chamber (R). Photos 
courtesy of Sabrina de Vincentiis, 2006. 
 
The second most important quality of sperm is its motility. Grade 3 motility are 
sperm that are active swimmers who swim in a straight line. Grade 2 are also active, but 
they may go sideways sometimes rather than straight ahead. Grade 1 are in-situ, barely 
shaking or not moving at all. Ideally, motility should be above 50%, made up of grade 3 
and grade 2. In a sample from a testicular biopsy, the sperm is usually immature in which 
case they will all be immobile. This is found to be the case for Federico’s frozen biopsy 
sample, which when looked at under the microscope are static squiggles. However the 
biologists have on hand a substance called pentoxyfylline, which has near-magical 
powers to “awake” the immature sperm and induce temporary mobility in those that are 
viable after a half-hour of contact. In this manner, the biologist selects the viable and 
activated sperm from the dead and static ones. The pentoxyfylline is washed away before 
the sperm are counted and selected, with the resulting mobility-effect usually lasting from 
about 10 minutes to one hour. The administration of the pentoxyfylline is thus reserved 
until half an hour before the ICSI is scheduled. 
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Figure 21. Micromanipulation microscope. Photo courtesy of Sabrina de Vincentiis, 2006. 
 
After a quick lunch break, at 3 o’clock in the afternoon, preparations for the ICSI 
procedure begin. The manipulator-microscope is checked, pipettes are fitted into the two 
manipulation “arms”. Oil is flushed through the system to prevent air bubbles in the 
pipettes. Attached to the left arm is a “holding” micro-pipette with a flat round end which 
will be used to hold the egg in place during the injection. The injection micro-pipette is 
inserted into the right arm, distinguishable by its slanted sharp point. The injection pipette 
is filled with PVP—this fluid is dense and slows the sperm’s movement, making the 
sperm easier to control. Usually a drop of the sperm sample is placed into one of the PVP 
drops in the dish, but because this is a testicular biopsy and the sperm are not very motile, 
it is put first into a drop of culture media. The eggs are carefully transferred with a pipette 
to two drops of media in the dish, with eight in one and seven eggs in the other. The filled 
dish is then placed under the micromanipulator microscope’s lens. Carefully, the pipette 
on the right side is lowered into the sperm dish and the focus is adjusted so that the 
microscopic sperm can be seen. A camera attached to the microscope relays the image 
under the lens to a TV monitor on the wall above the microscope. Everyone in the room 
can see what the person actually looking into the microscope sees. With this visual 
technology, the meeting of the egg and sperm becomes a public spectacle, no longer 
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taking place strictly within the intimate confines of a woman’s body, but instead viewed 
by whoever wants to watch (and is given access to the laboratory to do so). While fellows 
are usually as curious as the anthropologist to watch every step of the injection process, 
the trained biologists in the room are often busy with their own tasks, and only 
occasionally glance at the screen.  
Whereas in a typical ICSI with an ejaculate sample most of the sperm will be 
swimming straight ahead, evidently intent on reaching some as-yet unknown destination, 
because this is a tissue sample the sperm are barely shaking in place. The shaking 
activity—induced by the pentoxyfylline— is a sign of potential viability. Some sperm are 
hardly moving at all, others are clearly lifeless, the biologist avoids these, noting what 
proportion they make up of the total sample. The injection pipette with its sharp end, 
creeps up on one of the particularly active sperm and sucks it up into its PVP-filled tube. 
The active sperm are picked up several at a time and then all are pushed out of the pipette 
into an empty drop of PVP. The sharp end of the pipette makes a slight break through 
their tails, thus curtailing the sperm’s ability to swim or move. Once immobile, the 
biologist takes a close look at each selected sperm’s morphology. If any of the sperm are 
found to have an irregular shape, the biologist will attempt to find a more-standardized 
form among those still wildly swimming around in the other PVP drop. If morphology 
defects cannot be avoided because there are no other mobile sperm, then certain problems 
are chosen over others. For instance, the fertilization prognosis of a slightly-small-head is 
better than an irregular neck. In a testicular sample, the biologist usually has no choice 
over which sperm to select because there are so few—mobile or not—to pick from. 
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Once the sperm’s morphology has been checked and the biologist is satisfied with 
the selected sperm, their tails are broken far below the neck. Injection of a mobile sperm 
into the egg will damage the egg. When the sperm penetrates the egg on its own—
whether in the laboratory dish or the human body—the egg releases a chemical on first 
contact which immediately blocks any other sperm from entering. In addition, only the 
head of the sperm—which does not move on its own—fully enters the egg, the tail is not 
necessary for fertilization. Under the microscope, a cut on the tail immobilizes the sperm 
without killing it, and makes the sperm easier to manipulate. This incision also pulls 
gently on the head of the sperm, which mechanically activates the sperm for the 
impending fertilization. I know from many conversations with the biologists that what 
looks “easy” on the screen is actually a much-practiced technique. Finesse and skill are 
required here—if the force applied is too gentle, the head will not respond and the sperm 
will not fertilize the egg, if too strong, the force can break or disturb the mid-piece of the 
sperm between head and tail, thus destroying the sperm’s fertilization ability completely. 
The sperm is then let go and sucked up through the pipette, tail first. This process is 
repeated several times, until there are 5 sperm all lined up inside the pipette head to tail, 
with space and PVP in between them. Depending on how many active sperm there are to 
choose from, and how many are needed, this sperm collection can take anywhere from 30 
seconds to two hours or longer. 
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Figure 22. Micropipette and sperm selected for ICSI. Photo courtsey of Sabrina de Vincentiis, 2006. 
 
 
The microscope is then adjusted for a view of the waiting eggs, which are almost 
19 times larger in volume than the sperm (the head of a sperm measures 7-8 micrometers, 
the diameter of an egg is 120-125 micrometers). The eggs appear as large circles, with a 
concentric smaller circle inside and one small circle between the larger and smaller circle  
(the polar body). The microscope is adjusted so that one egg fills the entire view, and the 
holding pipette on the left hand side, with its flat end, is used to gently rotate the egg so 
that the polar body is at 6 o’clock and the pipette holding the egg is positioned at 9 
o’clock. When the pipette pushes against the egg’s outer covering, the egg looks elastic 
and bouncy. The right side pipette comes into view at 3 o’clock. It is time for the 
injection. The sharp pipette containing sperm approaches the egg, and almost bumps off 
the side of it. The pointed end comes in again, with more force this time, and punctures 
the outer layer, sliding into the middle of the egg. The pipette quickly but smoothly 
inhales some of egg’s inner cell material, then spits it out, releasing one of the sperm, 
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head first. The pipette withdraws from the egg, leaving the same way it came in. Cell 
matter quickly rushes to fill the empty space that the pipette’s pathway created, and a 
minute later the pipette’s intrusion is barely visible. The only visible evidence of this 
disturbance is the unmoving sperm that is now stuck inside the middle of the egg, but the 
very presence of the sperm has already set into motion subtle chemical changes of 
fertilization.  
 
 
 
Figure 23. ICSI: two seconds post-injection of sperm into egg, the mark of the pipette is still visible. 
Photo courtesy of Sabrina de Vincentiis, 2006. 
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The microscope view switches over to the next egg, and the process is repeated 
until five eggs have been injected. The technician must now return to the drop of sperm 
to select five more sperm and repeat the entire process until all the eggs are injected. (The 
number of sperm collected at a time depends on the technician doing the injection. Some 
biologists load the pipette with only one sperm at a time, for fear of accidentally releasing 
more than one sperm into the egg. This obviously makes the entire injection process 
much slower—especially if there are 15 eggs to fertilize). 
By 3:40 in the afternoon, all 15 eggs have been injected with one sperm—even 
the three that were still MI, just in case they fertilize despite their immaturity. These 
injected eggs are now transferred to a dish of non-HEPES media that was prepared that 
morning and has been waiting in the incubator for this moment. The HEPES media is 
washed off, then the eggs are put all together into a large drop of media with the three MI 
slightly below the others. They are left on their own for the rest of the day, in the dark 
warm heat of the incubator. The early stages of fertilization, the formation of two 
pronuclei inside the egg, occur during the night when the lab is empty of people and the 
only sound in the room is the quiet electric hum of the incubating machines.68 
The following morning the biologists return at 7 am, and begin the morning 
routine of turning on the lights, the air conditioner, checking the levels of C02 and 
temperature in the incubators, and the air pressure in the room. Three aspirations are 
scheduled for this morning, the first at 8am. After this first aspiration, the fertilization of 
Augustina’s ICSI from the day before is checked under the scope—approximately 18 
hours after fertilization. At 9am, nine of the 15 injected eggs show 2pn (2 pronuclei 
                                                 
68 After the sperm enters the egg, two pronuclei form. One is the nucleus of the egg, containing the 23 
chromosomes from the egg, and the other is the nucleus of the sperm with the sperm’s 23 chromosomes.  
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which indicate that fertilization has occurred and cell division will soon begin). One 
injected egg shows 1pn, and five eggs show no pronucleus at all. The six non-fertilized 
eggs are selected out, put into a dish and discarded into the bio-waste garbage. The 
remaining nine are transferred to a new dish of non-HEPES media (prepared the day 
before) and returned to the incubator. 
The following day, 48 hours after the egg pick up (known as “Day Two”), embryo 
cleavage is checked under the scope. All nine fertilized eggs have developed from the 
pronuclei stage into a “pre-embryo.” The two pronuclei in each egg have merged to form 
a nucleus of 46 chromosomes. Eight of the pre-embryos have at least 2 cells (the 
minimum number of cells to show that the embryo is beginning to develop) and one pre-
embryo has 4 cells. On Day 3, 72 hours after the aspiration, the embryos are checked 
again. Good cell division is measured as having 5-8 cells at this point. The embryos are 
classified now based on the quantity and quality of cells that they have achieved (quality 
goes from high to low, with Class I being the “worst” and Class IV being the “best”): five 
embryos are Class I or Class II; three embryos are Class III; one embryo reaches the 
sterling status of Class IV because it has 7 cells and no fragmentation.  
 
 
 
Figure 24.  Nine Day Three embryos (not Augustina’s), varying in quality. Five to eight cells. Photo 
courtesy of Sabrina de Vincentiis, 2006. 
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In an attempt to reduce the rates of multiple pregnancies, CREAR imposed a new 
protocol in 2002 that restricts the number of embryos for transfer to two or three at a 
time, depending on the age of the woman, the etiology of infertility, and the quality of the 
embryos for each case.69 A basic rule is that women 35 years of age or younger receive 
only two embryos while those over 35 are given three. Because Augustina is over 35 
years old, she qualifies to have three embryos transferred to her uterus. There are nine 
embryos total, this means that six embryos will be cryopreserved and stored for a later 
date. With these additional embryos effectively “in the bank,” at a date in the future 
Augustina can avoid the stimulation and aspiration stages of the treatment protocol, and 
immediately schedule what is known as a “frozen transfer” in which at least four of the 
cryopreserved embryos are thawed and transferred to her hormone-primed uterus 
(because frozen transfers have lower success rates than fresh transfers, usually at least 
one additional frozen embryo is transferred).70  
Up to this point, everything has gone well—an adequate number of eggs were 
retrieved from Augustina’s ovaries and enough good-quality embryos formed from the 
fertilized eggs to require both an embryo transfer and cryopreservation for a future 
transfer. Having reached this stage of success, all involved dare to desire a more remote 
and improbable victory—that the transfer will go smoothly and at least one embryo will 
implant within the uterus, creating a pregnancy. At this clinic, as in others, the “magic” of 
ICSI for women over 35 years old is an infrequent one—only 35-38% become pregnant. 
                                                 
69 I discuss the issue of multiple pregnancy at greater length in chapter two. 
 
70 This thinking-ahead can also result in the accumulation of unwanted, often poor-quality, cryopreserved 
embryos in nitrogen tanks. Such was the case in Great Britain when an estimated 3,000 frozen embryos 
were discarded after five years in unclaimed storage in 1996 (In 1991 the newly-created UK Human 
Fertilisation and Embryology Authority imposed a five year maximum on  unclaimed frozen embryos). In 
Argentina—where no law exists— this type of accumulated frozen storage is a subject of debate, which I 
will discuss in more detail in chapter four. 
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However Augustina’s odds are better now than they will be in five years, success rates 
for women 40 years or older are an abysmal 18% (in cases of male-factor infertility). 
On Day Three, six embryos are cryopreserved—five of the Class I/II embryos and 
one of the Class III. Cryopreservation can be done at several different stages of 
development, almost always on the same day or the day following the fresh transfer. The 
earliest stage of viable cryopreservation is the pronuclear stage, 24 hours after 
fertilization, when the genetic material from the egg and the sperm have not yet been 
exchanged. Cryopreservation can also be done on Day Two, or 48 hours of development, 
or on Day Three, 72 hours post-fertilization. By Day Two the fertilized egg has 
developed into a pre-embryo and divided into at least four cells. A Day Three embryo 
should have five to eight cells. The advantage to cryopreserving on Day Three is that 
with an additional day of development, the quality of the embryo is more clearly 
differentiated, and the best ones can be selected for immediate transfer. On the other 
hand, waiting until Day Three also subjects the embryo to further time in the less-than-
ideal conditions of the laboratory.  Embryos can also be frozen on Day Five, which is the 
blastocyst stage (a Day Four embryo must not be disturbed—not removed from the 
incubator—as this is a critical and vulnerable stage). Some centers keep embryos in the 
incubators until Day Five in order to reduce the cryopreservation of marginally-viable 
embryos that most likely won’t survive the freezing and thawing process. If an embryo 
reaches the blastocyst stage in the lab, it has proven itself as a viable quality embryo and 
is then cryopreserved.  
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Figure 25. Small Cryopreservation Machine. Photo courtesy of Sabrina de Vincentiis, 2006. 
  
 
 
 
Figure 26. Cryopreservation tank. Photo courtesy of Sabrina de Vincentiis, 2006 
 
 
The process of cryopreserving embryos takes longer than that of sperm as the 
embryos are more delicate and must be dehydrated and introduced to the cold slowly. 
Embryos are first dehydrated using two baths of special dehydration media known as F1 
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and F2 embryo freeze media. The embryos are left in the first bath of media (F1) for 10 
minutes at room temperature, and in the second bath (F2) for only 30 seconds. They are 
then transferred with a pipette to a labeled cryovial—equal to the one used for sperm—
with the cryoprotectant. Only four embryos “fit” into each tube because of the necessary 
proportion of embryos to cryoprotectant solution. Because Augustina has six embryos to 
store, they are split up into two tubes with three embryos in each one. These tubes are 
then inserted into a programmed cryopreservation machine filled with liquid nitrogen 
which will drop the temperature down to –30 degrees Celsius over the course of one hour 
and 45 minutes.71 Halfway through this process the biologist manually induces 
“seeding”—the orderly formation of ice crystals inside the tubes—by pinching one spot 
on the tube with cold tweezers. From the cryopreservation machine the tubes go directly 
to the storage tank of liquid nitrogen which is kept at a steady temperature of –196 
degrees Celsius.  
In Augustina’s case, the selected day for cryopreserving the embryos is the day of 
the embryo transfer. The transfer is most commonly done on either Day Two or Day 
Three of embryo development, and may depend on the quality of the embryos or the 
attending doctor’s preference. This procedure will move the embryos from the lab’s 
incubator to the uterus of the woman. Sometimes this procedure is mistakenly referred to 
as “implanting” the embryo. Technically speaking this is inaccurate, since successful 
transfer of the embryos into the uterus does not guarantee implantation into the uterine 
lining. The cells in the embryo will either attach to the uterus and continue to develop, or 
not, over the next week.  
                                                 
71 The temperature and freezing stages are different depending on what is being frozen (sperm, pronuclear 
stage, embryo, blastocyst). 
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To prepare for the transfer, which for scheduling reasons almost always takes 
place in the afternoon, a special transfer media is concocted in a dish in the lab. The 
“best” embryos (according to cell division and fragmentation) are selected for transfer 
and placed in special drop of media about an hour before the time of the transfer. The 
best quality embryos are selected for immediate transfer, as the patient is paying to get 
pregnant as soon as possible. In addition, the cryopreservation process is mildly 
damaging to the embryo, so it is preferable to transfer the best embryos first and 
cryopreserve the inferior ones.  
Augustina’s embryo transfer takes place on Day Three of development, at noon 
on a Tuesday. As with the aspiration, Augustina enters the operating room in a pink 
disposable gown, and lies down on the examining table, putting her feet up into stirrups. 
Embryo transfer procedures are usually done without any anesthesia, so today there are 
fewer people in the room than during the aspiration. Occasionally the male partner also 
comes in, wearing scrubs, to watch the manual insertion of the embryos into the uterus. 
The ultrasound machine is set up and the ultrasound device is covered in plastic, rubbed 
with gel, and placed over Augustina’s abdomen. The lab sends down the prepared 
media—the same as that covering the embryos—which is used to wash the vaginal cavity 
and prepare the way for the catheter. The ceiling lights are turned off and a spotlight is 
held, pointed at the vagina. The gynecologist inserts the metal speculum into the vagina 
and waits. 
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Figure 27. Monitor in the surgery room connected to microscope in the laboratory, used to view  in 
vitro embryos. Photo by Kelly Raspberry, 2003. 
 
 
Upstairs in the laboratory a call comes over the intercom that the surgery room is 
ready for the transfer. The three embryos are taken out of the incubator and the dish is 
placed on the micromanipulator microscope. Close-up black and white images of the 
multi-celled embryos appear on the monitor in the lab, as well as on the monitor in the 
operating room where Augustina can see them. Everyone exclaims how nice-looking 
(“que lindos”) the embryos are. One is Class IV and two are Class III. Digital photos are 
quickly taken of each embryo as they are seen under the microscope, then the dish is 
whisked over to the work chamber. The biologist loads the three embryos into the 
catheter along with media using a syringe at the top, inserts the end of the catheter into a 
protective outer covering, puts the entire catheter into its original plastic packaging, 
closes the top with tape and sends it down the dumbwaiter to the surgery area. 
Downstairs the catheter is taken out and the thin, flexible part is inserted into the 
vaginal cavity. It takes several minutes for the gynecologist to navigate the curves of 
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Augustina’s cervix, but once past the cervix the gray line of the catheter comes into view 
on the ultrasound monitor. As the gynecologist pushes down on the end of the catheter’s 
syringe, the monitor shows a spurting of white fluid—the media and hopefully the 
embryos— entering the black space of the uterus. The catheter is then sent back to the 
laboratory where the syringe is flushed with media and the liquid is checked under the 
scope to make sure the embryos have been released and weren’t stuck inside the plastic 
tubing. Several tense minutes of waiting pass before the lab calls over the intercom “okay 
on the transfer” and everyone smiles. Augustina is told to stay at  CREAR for the next 
hour or so, then to rest in bed at home for the next 24-48 hours so as not to dislodge the 
embryos. (Post-transfer proscriptions also include no baths, no swimming, no bicycling, 
and no heavy physical exertion for two days, though the clinicians openly admit to 
patients (and enquiring anthropologists) that these recommendations are idiosyncratic to 
CREAR, and not scientifically proven in the literature to improve implantation). This 
advice seems to be a left-over from the early years of IVF procedures when the biology 
of the implantation process was even less understood than it is today, and the 
undemonstrated benefits of bed rest continue to be debated in the field (see Amarin and 
Obeidat 2004; Botta and Grudzinskas 1997; Edwards, Steptoe and Purdy 1980; Sharif et 
al. 1998;Woolcott and Stanger 1998). 
Twelve days later, the awaited moment arrives. What will be the outcome of this 
elaborate investment of months of clinical monitoring, of laboratory finesse and care, of 
anticipation and longings? That morning Augustina presents herself to the clinic nurse to 
take a blood sample, which will be sent to a hormone analysis center, and tested for the 
level of beta hCG hormone. Above 30 IU/ml will indicate biochemical pregnancy. 
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Augustina dares not hope too much, and spends the morning working. Incredibly, that 
afternoon the test results show 40 IU/ml—a biochemical pregnancy. Forty-eight hours 
later, a second beta test shows that the level has duplicated to 80 IU/ml. A third beta test 
48 hours after the second test confirms that the levels have again duplicated to 160. 
About 30 days after the transfer, an ultrasound confirms a clinical pregnancy: there is one 
fetal sack growing in her uterus with a technologically-registered heartbeat. The ICSI was 
successful, based on the most-important criteria of there being “a pregnancy.”  CREAR’s 
involvement as a fertility center now fades into the background. Because Augustina’s 
gynecologist will carry on as her obstetrician, she will continue to come to the clinic for 
ultrasound check-ups throughout the pregnancy. The birth data will be added to the 
clinical and lab records.  
CHAPTER TWO 
IDEOLOGIES IN VITRO AND THE DAILY PERFORMANCE OF ASSISTED 
REPRODUCTIVE TECHNOLOGIES 
 
 
Figure 28. Nativity scene in Entre Ríos province of Argentina. Photo by Kelly Raspberry, December 
2004. 
 
 
“Thus, IVF began a new chapter in the biology of early human reproduction. It has 
required participation in the discussion attempting to develop a consensus about matters 
which hitherto have been the domain of philosophers and moral theologians. Both the 
scientific and social aspects of IVF continue to evolve.” (Jones 1995: 42). 
 
 
Making ART in Argentina 
“In context when one looks at history one thinks that sometimes it doesn’t matter so much 
to be the first, but yes, it does to be the best. In Latin America, things are probably in 
general, less systematic, less ordered, they are based less on written and published 
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experience. People tend to, doctors at institutes, tend to base themselves on experience, 
their experience that was never tabulated, calculated and submitted to statistics to see if 
it truly is like that or not. So the reasons are less scientific and less technical and more 
based on intuition, which of course fails more often.” Tomás Navarro, a director at 
CREAR  
 
Out of the 16 infertility centers in the city of Buenos Aires, five principal clinics 
are directed by Argentina’s most renowned gynecologists and embryologists. These five 
clinics combined perform more than 70% of all the ART cases in Argentina, with each 
one doing between approximately 400 and 900 IVF and ICSI treatments a year. A variety 
of reproductive technology procedures are performed at these centers, including low and 
high complexity fertilization techniques. The directors of these five main centers pride 
themselves on achieving pregnancy rates equal to those at the best clinics in the world, 
and indeed each one self-identifies as “the best” in the country, and often in the whole 
region of Latin America.72 Because the population of Argentines who need, want and are 
able to afford an infertility treatment is finite, competition among these five clinics is 
predictable and tangible. In this competitive environment, each center continually strives 
to distinguish themselves from the others by providing the latest procedure, with the best 
results. This competition in part drives the desire for technological advances: if one clinic 
begins specializing in a new technique, the others feel pressure to follow suit for fear of 
losing potential patients (I discuss this at greater length in chapter four with the example 
of preimplantation genetic diagnosis). 
                                                 
72 There are two scales used to define “the best” clinic: a stringent one for centers world-wide, and another 
context-dependent one for Latin America. The best centers world-wide are those that consistently generate 
not only high pregnancy rates, but also technological innovations, publications, and international prestige. 
Within Latin America, technological developments and international name-recognition is considered 
beyond reach, and so the centers that produce comparatively good results and publish internationally are 
esteemed as the best in the region. 
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As participants in an international community of reproductive medicine experts, 
Argentine infertility practitioners place high importance on being perceived as “modern” 
by their local and international colleagues. The plush waiting areas and high-tech 
laboratories in these principal private clinics in Buenos Aires resemble those of private 
centers in the US, and they are devoid of religious iconography or any other evidence of 
non-modernity.73  Despite Argentina’s economic and political collapse in 2001, these 
health professionals maintain their claim on modernity by insisting that Argentina is a 
Latin American nation only by location. In response to my interview queries they 
repeatedly assert that Argentina—and by connection its medical care— is more European 
(read: modern) and therefore superior to its “underdeveloped” neighbors in South 
America. For instance, I opened this chapter with a statement declared by Navarro which 
encapsulates this type of negative evaluation of “the rest of” Latin America. Navarro, one 
of the directors of CREAR, asserts that medicine in Latin American operates more on an 
“intuition-based” level rather than a modern “evidence-based” model. He judges that this 
reliance on personal knowledge and experience is not as reliable as a more modern 
approach with rational statistics and scientific “proof.” In making this judgment, Navarro 
later identifies his center and his own clinical work as distinct from this non-modern 
“Latin American” way of doing things. I come back to this later in the chapter. 
One of Navarro’s colleagues, Marta Romero, a biologist at CREAR, also 
verbalizes a common sentiment among Argentine professionals: 
I think that in Argentina there are the best assisted reproduction clinics, in Brazil 
there is one and another one in Chile, but I think that the best reproduction clinics 
are without a doubt in Argentina. I think when the Argentine is a good 
                                                 
73 In a couple of the small, marginal centers, religious values are at the center of the practice and proudly 
displayed. For instance, at Reproductive Medicine Institute (RMI) and the Laboratory for Reproductive 
Medicine. I will come back to these examples later in the chapter. 
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professional, he is a very good professional and stands out in the United States or 
stands out anywhere. That doesn’t happen, or it happens but on a lower scale with 
the rest of the countries in Latin America. […] You have seen a little of the 
Argentine’s attitude that he thinks he is the best in the world; Argentines are 
always mocked because we believe that we are very important and we are far 
from that, but I think that…well, the Argentine, the Chilean, the Uruguayan, we 
are the most European for Latin America, the rest is like it has more of a mix of 
the native. Argentina has a different status than the rest of Latin America, cultural 
status, social status and intellectual status. Even if today Argentina is in a terrible 
moment, in Argentina the education and the status is very different from what you 
can find in Bolivia, or in Peru, Venezuela. 
 
Indeed, in my interviews with professionals, some combination of four of the five 
primary centers in Buenos Aires (CEGyR, IFER, Fecunditas, Halitus) are always 
identified as the best in the region, occasionally along with Las Condes Clinic in 
Santiago, Chile, and two in Sao Paolo Brazil.74 I discussed in chapter one, the directors of 
these leading centers trained in the United States and Europe and are some of the original 
“IVF pioneers” in Argentina. Yet despite these symbols and assertions of modernity, 
being “modern” is a lived concern for these specialists, who struggle with the seepage of 
religion and society into their scientific and medical practices, a theme that arises 
throughout this ethnography (Latour 1993). Futhermore, these “claims to fame” and 
reputation (also discussed in chapter one) seem to rest on successful replications of 
medical and scientific procedures in the “subaltern West” of South America. To practice 
assisted reproduction in Argentina does not invoke prestige on its own, but requires the 
qualification of “Western” affiliation or comparison—as Romero tells us, the proof of a 
good Argentine professional is that s/he will stand out in the United States.   
                                                 
74 Centers that Latin American professionals most commonly evaluated as the best world-wide include: The 
Center for Reproductive Medicine and Infertility at Cornell (US), The Institute for Reproductive Medicine 
and Science of Saint Barnabas (US), Instituto Valenciano de Infertilidad (Spain), Bourn Hall Clinic 
(England), Center for Reproductive Medicine at UZ Brussel (Belgium). 
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In Argentina there is no law regulating assisted reproductive techniques, nor is 
there medical consensus across the centers on guidelines for practice. Since ART 
practices in Argentina are not officially regulated, clinical standards depend primarily on 
the individual professional codes of training and ethics in place at a given clinic. There is 
often a diversity of personal opinion among professional staff within each center, 
however as they are members of an institution, a common protocol directs practice. These 
clinical protocols, along with other forms of self-regulation like ISO certification and 
within-clinic ethics committees, thus serve as more than medical guides. In practice they 
become also social judgments, investments in modernity, and a means of profit. Assisted 
reproduction circulates in various networks of practice, each exerting constraints and 
requirements.  In this chapter I analyze this complex field of actors that converge to 
produce a local culture of assisted reproduction in Argentina. This production of assisted 
reproduction practices in Argentina is necessarily one of mutual influence—dependent on 
local conditions, but also shaping them in turn. Although presented here as semi-
disaggregated, these localized facets—a Latin American “superiority,” the importance of 
family and motherhood, ambiguous legislation, Catholic influences, modern investments, 
financial limitations, creative maneuverings—are intertwined and dynamic forces in the 
making of assisted reproduction in Argentina. 
 
Restricted Access 
“Not all babies are conceived in bed, body to body. Some, for different reasons, begin 
their existence in places less intimate with the intervention of specialists that help to 
concretize the desire to have a child. Even though the heroines of the telenovelas 
invariably become pregnant, ‘their first—and only—time’ this is not usual for women 
who inhabit this side of the screen. Far from the television melodramas, for each 
menstrual cycle there is a 20% chance of pregnancy if the woman is under 35 years old, 
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according to doctor Claudio Chillik, president of the Argentine Society for Reproductive 
Medicine (SAMeR). […] Even though there are still more failures than successes for each 
assisted fertilization attempt, every day around the world there are more couples with 
reproductive problems who can’t ‘make a baby’ in bed or out of it.” Article in Clarín, 
November 29, 2005 (Aguilar 2005). 
 
As in other parts of the world, use of ART in Argentina is highly stratified by 
social class and region (Colen 1995; Ginsburg and Rapp 1995). Access to these private 
centers is largely restricted to the mobile upper and upper middle class who can afford to 
pay the relatively high costs out of pocket. Although the prices of IVF and ICSI 
techniques in Argentina are about one-third of what they are in the United States—
between $2000 and $5000 USD—these costs are beyond the reach of the average (middle 
class) Argentine whose monthly salary is approximately $300 USD.75 As discussed in 
chapter one, with the devaluation of the peso in 2001, these techniques (whose cost is 
calculated partly in USD) are prohibitively expensive for Argentine consumers who have 
even less purchasing power than before the country’s financial crisis. Argentina has 
nationally funded universal health care, however the free public hospitals do not provide 
assisted reproductive services, and only one public hospital (located in Buenos Aires) 
offers low complexity techniques such as intrauterine sperm insemination and hormone 
stimulation. In July of 2004, the government passed a law dictating that private health 
insurance plans must cover the prenatal, birth and neonatal care of ART-conceived 
babies.76 However the larger battle (mostly being fought for by patients of these 
                                                 
75 In 2003, the prices at CREAR were as follows: one cycle of IVF cost $2000 dollars ($5000 pesos plus 
$250USD for disposable materials); one cycle of ICSI cost $2300 dollars ($6000 pesos plus $300USD); 
medication for either technique cost $1300 dollars  ($4000 pesos). Any additional service, such as 
cryopreservation and storage of embryos is added to the total. As the economy continues to stabilize each 
year, the prices of techniques are also increasing. 
 
76See Gioberchio 2004; Iglesias 2003; Navarra 2004; Riós 2004.  
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services), to mandate that private health insurance cover assisted reproduction techniques, 
is far from being won.77   
Though most reproductive medicine professionals agree that “everyone—the 
whole population” should have access to assisted reproduction services, they also 
concede that this is not the reality in Argentina today. Economic circumstances are 
primarily identified as restricting access: “That [access for everyone] doesn’t happen 
because the treatments are expensive, you see? And people don’t have money to do a 
treatment. As this [ART] isn’t done in any [public] hospital, it’s a problem, because 
people who don’t have economic resources can’t do the treatments.” In this manner, 
equal access to ART in Argentina fits with the ideal of being a modern nation that 
provides high-quality health care to all of its citizens. The reality of restricted access is 
therefore lamented by these health professionals in Argentina, who often compare their 
nation to countries in Europe where ART programs are offered in public hospitals.  
Possible solutions proposed to remedy this limited access in Argentina include a law 
mandating that health insurance plans cover the costs of treatment, or a state-funded ART 
program with subsidized patient costs at a public hospital. In the meantime, most of the 
largest private centers in Buenos Aires have a non-profit clinic foundation that subsidizes 
                                                 
77For patients and for their attending physicians, insurance coverage for ART services can have drawbacks. 
In 2006, one of the private health insurance companies in Argentina, OSDE, voluntarily began covering 
IVF and ICSI as part of their three most-expensive coverage plans. This coverage, which only the upper-
class can afford to buy, comes with strings attached. OSDE agrees to pay for one treatment per year, but 
prohibits embryo cryopreservation, and mandates the transfer of only two embryos (regardless of woman’s 
age). Neither is this insurance a good deal for the private center, as OSDE reimburses the clinic 300 pesos 
for doctor consultations and 1000 pesos for all clinical and lab costs. In contrast, each IVF treatment costs 
the clinic at minimum 2800 pesos, only counting the cost of supplies. Private centers therefore lose money 
with OSDE, and patients are restricted in what they can do. For now, OSDE is the only private health 
insurance company that covers ART. 
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the costs of treatment for a set number of people every year.78 The criteria for qualifying 
for this assistance varies by center, but it is primarily based on demonstration of financial 
need.79 There is a hope that like other expensive medical procedures that are now offered 
at public hospitals without a fee, ART will also one day be incorporated into public 
medicine: “Before it was thought that angioplasty for example, couldn’t be done in a 
[public] hospital and today it’s done all the time. So hopefully the moment will come 
when this is seen as a necessity.”  
However, as I discuss in this chapter, this wished-for transformation of ART from 
an elite form of medicine into routine medical care is fundamentally predicated upon the 
notion that ART is only appropriate as a treatment for the biological disease of infertility. 
This notion that ART should only be used to overcome biological obstacles to pregnancy 
and birth, viewed as “nature’s failures,” is a social construction which further restricts 
access to ART and promotes particular ideologies of family and health. The value that 
ART should be accessible to “everyone” therefore begins with a circumscribed definition 
of the eligible population, one that has nothing to do with economics. It turns out that the 
“everyone” most medical professionals speak of actually includes those who fit the 
following profile: heterosexual couples in which the woman is not older than 50 years in 
age, and who have biological difficulties becoming pregnant. This ideological restriction 
of access is exemplified in the operation of the clinic foundations. Though designed to 
                                                 
78These foundations sometimes have other functions as well. At CREAR, the Foundation, formed in 1994, 
oversees the finances of three areas: low-income patient assistance; teaching/training courses; research 
projects. The teaching component includes providing two year-long training positions every year to 
gynecologists who want to learn reproductive medicine at CREAR—the fellowship applicants are usually 
from the provinces of Argentina. CREAR’s foundation receives donations from grateful patients and 
pharmaceutical companies. 
 
79The low-income patients who qualify for Foundation assistance pay a small fee to the foundation, all 
medical exam fees, and medication costs. They are assigned to the gynecologists who are doing residency 
on scholarship, that way paying patients are not subjected to the “teaching/training” component at CREAR. 
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facilitate access to ART services, these within-clinic foundations only consider 
solicitations from heterosexual couples, and place restrictions on the specifics of the 
treatment. These policies have more to do with ethical and moral judgments than with 
financial limits of the foundation. For instance, the President of CREAR’s foundation is a 
devoutly Catholic woman (not a medical professional) who told me during an interview 
that she thinks of ART as a service to help married couples have children of their own. In 
her mind, gamete donation is un-ethical as it brings in a third-party to the conjugal unit. 
Under her direction, CREAR’s foundation has clear moral parameters for who is 
“eligible” for financial assistance which exclude single women, lesbian couples, women 
over 42, and any heterosexual couple who needs gamete donation.  
  Reproductive medicine professionals maintain that persuading the government 
and health insurance companies of the necessity of providing ART care rests upon the 
fundamental notion that ART is a treatment for the disease of infertility, hence the 
insistence on heterosexuality and pre-menopausal women.80 The following dialogue with 
a gynecologist at CREAR clarifies the core of this position: 
Doctor: One thing, which is also in our law project, is that infertility be 
considered a disease. And as such that the State provide coverage for it. The 
principal problem for why some women don’t have children in Argentina is that 
they don’t have enough money to pay for the necessary treatment to achieve a 
pregnancy, this is a difference from what occurs in Europe, for example. I think 
that is something that you have to fight and you have to try to obtain it. 
 
Kelly:  But do you think that can happen here? 
 
Doctor: Yes. Why not? 
 
                                                 
80 A gay woman or man might also have a biological infertility problem, but because they are not 
heterosexually reproductive, they would not qualify under this treatment rationale. Similarly, a woman who 
is unable to have children because she is post-menopause, though infertile, is not classified as suffering the 
disease of infertility, and therefore is not eligible for ART services.  
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Kelly: Because the State has so many other things, that people say are more 
important and that this is something… 
 
Doctor: How much does a bone marrow transplant cost?” 
 
Kelly: I don’t know. 
 
Doctor: The State covers it. With a bone marrow transplant you can feed I don’t 
know how many thousands of malnourished children. The fact that a problem 
exists doesn’t mean that you don’t have to dedicate other solutions for that 
problem. If I do not do a bone marrow transplant, a child dies, but I save the lives 
of thousands. I think that it isn’t…That is the estimate of what needs to happen. 
And if they don’t give coverage, because there aren’t the means, it’s okay, it 
doesn’t seem bad to me. But they [the State] have to recognize infertility as a 
disease. And fundamentally the health insurance plans have to cover it. 
 
In this schema, the economic inequality of access to private ART services can only be 
addressed if the State regards infertility as a biological disease, and ART as a disease 
treatment. However, defining ART as only appropriate for biological infertility problems 
has widespread social consequences. In validating ART as a medical service, these 
professionals are also propagating a traditional social estimation of family, which I 
discuss below. This construction of ART as solely a medical treatment for the disease of 
infertility has its roots in Latin American guidelines for ART created in 1995, to which I 
now turn. 
 
A Latin American Consensus 
“More than 150,000 couples in the entire world have seen their efforts to be mothers and 
fathers achieved. At least 200,000 children have been born and are evidence that science 
and technology are once again at the service of mankind.” (Consenso 1996: 3) 
 
Reñaca is a seaside resort town in Chile, a two hour drive from the country’s 
capital city of Santiago de Chile. In the spring of 1995, 83 Latin American assisted 
reproduction specialists gathered at a hotel in Reñaca to exchange ideas about how to 
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proceed with a Latin American professional organization dedicated to assisted 
reproduction. At this workshop, the assembled professionals, representing 42 centers 
across Latin America, produced a document of consensus on ethical guidelines for 
selected aspects of ART, entitled “Latin American Consensus on Ethical-Legal Aspects 
Related to Assisted Reproduction Techniques”.81 Ten years later, these principles 
continue to direct the practice and provide the rationale for assisted reproduction 
techniques in many clinics throughout Latin America, including in Argentina.  
Though they are non-binding and voluntarily implemented, the guidelines were an 
attempt to begin to standardize ART procedures across the countries of Latin America in 
the absence of legal oversight. The guidelines specifically cover the issues of: access, 
gamete donation, embryo cryopreservation, preimplantation genetic diagnosis, and 
embryo research. These five areas were chosen because of their status as “the most 
controversial” in legal discussions and public debate in 1995, and indeed these topics 
continue to be problematic. Although these guidelines are now ten years behind the 
technology, they have not been updated. Despite their age, the outlined parameters 
continue, by the default of time, to stand in for more formal national statutes.   
 The Consenso is based on the premise that assisted reproduction techniques are 
“science at the service of humanity,” a “pro-life” technology that helps infertile couples 
become parents (1996: 7). As such, these techniques are defined as a biomedical 
treatment designed to overcome biological obstacles to pregnancy. The guidelines 
therefore uphold and reinscribe the construction of infertility as a biological disease that 
requires medical attention. Assisted reproduction techniques step in to enable procreation 
                                                 
81 In Spanish the title is: “Consenso Latinoamericano en Aspectos Ético-Legales Relativos a Las Técnicas 
de Reproducción Asistida.” 
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when heterosexual intercourse is ineffective. Accordingly, all the social aspects of 
assisted reproduction practices must be pared away, leaving only biological dysfunction 
within the purview of professional experts.   
On this basis, recommended access to ART services is narrowly limited to include 
only stable heterosexual couples who have been trying for at least one year to become 
pregnant. In what reads as a local compromise that runs counter to Catholic Church 
teachings on procreation within the marital unit, the Consenso states that a marriage 
requirement is discriminatory, as is a minimum period of cohabitation. This decision 
reflects the differentiation between ‘family’ and ‘married couple’—it is socially 
acceptable to make a family without being legally married, provided you are a stable 
heterosexual couple.  On the other hand, according to the Consenso, these techniques 
should not be used as a “voluntary” alternative to “natural” heterosexual reproduction, 
therefore single women are explicitly excluded as technically they do not suffer a 
biological problem. The Consenso (1996:10) states:  
…the techniques of assisted reproduction would be indicated for infertile 
heterosexual couples for whom other therapeutic alternatives are ineffective, or 
whose theoretical efficiency would take an unacceptable amount of time for the 
couple. 
 
Access to ART services, according to the Consenso, is therefore only medically 
appropriate for heterosexual couples, and should not be used for single women, lesbian 
couples or gay male couples seeking help making a family. Notably, having defined at 
the outset that ART techniques are medical procedures for heterosexual infertility, the 
Consenso does not explicitly address the subject of homosexual couples. Instead, the 
Consenso guidelines, through their prescription of ART only for heterosexual couples, 
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implicitly and effectively promote traditional ideologies of a nuclear family as the ideal, 
and the “healthy body” as heterosexually reproductive one. 
  I will return to the Consenso recommendations, as well as the Reñaca workshop, 
later in the chapter. First I take a closer look at how these guidelines translate into daily 
medical practice in infertility centers in Argentina, practices that in turn reflect and 
reproduce traditional social values. 
 
Diagnosing a Healthy Family 
*** 
One day at the end of January 2004 I am at CREAR, sitting in the waiting room 
and observing patients coming in for their appointments. I venture a guess that most are 
here as part of their treatment program of assisted reproduction—either artificial 
insemination, IVF or ICSI. However, occasionally a pregnant woman comes in and I’m 
reminded that the clinic also has OB-GYN consultations. Today is one of those very hot, 
sticky, summer days, with high humidity. A very pregnant younger woman walks into the 
room alone wearing a halter top and a mesh sweater unbuttoned, highlighting how 
pregnant she is. Shortly after, a young couple comes in, this woman is also pregnant and 
wearing a short, stretchy bright-orange tank dress. Both this young couple, and the 
pregnant woman before them, attract looks from the others waiting. A middle-aged 
looking woman comes in alone and sits down across from the two young pregnant 
women—she looks sad to me. She glances at the pregnant women a couple times, then 
closes her eyes and puts her head down as if to take a quick nap. When she opens her 
eyes it looks to me like she might be crying. Her name is called and she leaves the 
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waiting area. As an observer of the scene—both part of it and outside of the emotional 
tension— I am confronted yet again with  the high emotional stakes involved in doing 
assisted reproduction.  
*** 
“Every day there are more methods of assisted fertilization and more couples that aren’t 
able to fulfill their dreams.” Article in Clarín, November 29, 2005 (Aguilar 2005) 
 
The image of the pregnant woman in the city of Buenos Aires is one of visibility 
and adoration. During the heat of summer, pregnant bellies are bared like fashion 
statements of the flesh, and caressed by strangers in public. They are trophies to be proud 
of and declared visually. All year round, and particularly on mother’s day, advertisements 
for various products from watches to health insurance commonly use pictures of babies 
and pregnant bellies—the woman herself may be left out of the picture— as symbols of 
hope, renewal and happiness.82 These visual reminders of motherhood contribute to the 
widely-held notion in Argentina that a healthy and esteemed female body is one that 
bears children. 
Reproductive specialists in Argentina also uphold and reinforce traditional 
societal values of family and health. Many doctors profess that being able to help a 
couple have a child is a primary motivation for their work. For instance, one center 
director emphasizes that he takes pleasure in helping couples to have children: “I think 
the possibility of contributing, in some way, to solving the problems that make a married 
couple or a couple not be able to have a child, is one of the greatest professional 
opportunities that one can have.” Following the ideology laid out in the Consenso 
                                                 
82 These visuals extend into the political realm as well: the political party PRO (Partido para una república 
con oportunidades), in January 2003 paid for an advertisement in the subway system that pictured an 
ultrasound of a fetus and the caption “the beginning of the new politic.”  
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Figure 29. Full-page advertisement in a magazine: "The ticking clock that you carry within.” 
 
 
 
 
 
 
Figure 30. Logo for a shop inside the Abasto shopping mall in Buenos Aires that sells baby 
accessories. Photo by Kelly Raspberry, November 2002.
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guidelines, these health professionals justify their practices of reproductive technologies 
by defining infertility as a biological disease that requires medical treatment. As a result, 
the majority of clinics in Argentina voluntarily deny single women and homosexual 
couples access to assisted reproduction services on the grounds that they are not 
“biologically infertile.” Although purportedly based on a medical foundation of disease, 
this denial of access confers and expresses a social judgment, supported by the Catholic 
Church, that only stable heterosexual couples are morally fit for making a family.  
The underlying principle for limiting access to heterosexual couples only, is 
therefore not a medical one, but rather depends on social constructions of family and 
reproductive health. This is stated as a concern for the well-being of the child that will be 
born. Within this logic, children have a right to be raised within a family, and here 
“family” necessarily means mother and father. Biologist Marta Romero represents this 
sentiment in her view of what constitutes a family:  
Single women, I don’t know. I don’t think they have to be married with a 
certificate, a stable couple seems okay. But I think it is important for the child to 
have a good family and I consider a good family one that has a father and a 
mother. So I don’t think a single woman is adequate for the child, I am not talking 
about if it’s okay socially or not, only that I am thinking of the child. That baby 
needs a father and a mother. 
 
Though Romero states she is not making a social judgment when she approves of assisted 
reproductive services only for heterosexual couples, her rationale is inextricable from 
traditional Catholic ideals of family. A single woman, or two women in a couple, are not 
viewed as able to provide a “healthy” family environment for raising a child. An 
andrologist conveys this same ideology with different words:  
What I think is that a child needs to be raised in an environment where the father 
and mother figures are clearly visualized. The child can’t be raised by two women 
or two men. There comes a point at which the father and mother are irreplaceable. 
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From this point of view, which is not based on “evidence” or literature citations, only the 
nuclear structure of a mother and father make up a “healthy” suitable family, and so 
assisted reproductive techniques are reserved for those who fit this heterosexual profile.  
This strict definition of family is tightly held on to by many, perhaps in part 
because cracks in the foundation are already appearing. Such is the case at CREAR 
where there is not unanimous agreement among the professionals of the center, and so the 
institution must abstain from declaring an official position on who is eligible for services. 
One gynecologist in particular has separated himself from this conservative pack by 
publicly providing ART to a lesbian couple, which I discuss below.  However most of the 
professionals at CREAR agree with Romero and refuse to treat single women and 
lesbians due to the possible “harm” to the child. The following dialogue between me and 
one of the directors of the center reflects this traditional position on family: 
Doctor: But it’s not the institution’s decision. That is to say, CREAR doesn’t 
oppose it, but CREAR is never going to…bah, ‘never’ I don’t know, but right 
now it doesn’t support that type of treatment, neither does it keep statistics to 
publish somewhere, nothing like that.  
 
Kelly: And what is the objection against, for example lesbians? 
 
Doctor: That we aren’t sure that the child that is born is going to have favorable 
conditions for his development, because the concept of family that exists in 
western society is a concept of ‘father and mother.’ Or otherwise, a concept of 
‘divorced mother’ or ‘divorced father’ or ‘widow’ or ‘widower,’ but not two 
women…today. Within twenty years or fifty years maybe this will be different, 
but today we as CREAR, we do not want to be responsible for the birth of a child 
in this type of society. 
 
The heterosexual construction of family that is the norm in Argentina is here allied with 
“western” society, in emphasis that this is not just an “Argentine” concept. I would add 
that this is also a version promulgated by the Catholic Church in which ‘family’ is 
predicated on standards of marriage and procreation. 
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The “healthy body” is thus defined narrowly as a heterosexually reproductive one 
both inside and outside of the fertility clinic. In this society, a heterosexual couple 
without children—whether by choice or due to infertility— is by default atypical and 
unhealthy.  The social standard is to start a biological family soon after marriage and 
those who do not conform are seen as abnormal, living outside of social conventions. A 
single male biologist in his early 30s told me he has still time to marry and have children 
but that he feels pressure to do so: 
People who do not have children live like they are outside of what would be a 
social mandate. It forms part of a fantasy…or a popular imaginary in which a 
person has to carry out a certain type of life and if there is something they don’t 
fulfill, ‘why doesn’t this person have children?’ 
 
Such expectations place an extra responsibility on women, as in this society “woman” is 
often conflated with “mother.”As several female doctors told me (based on personal 
experience), the pattern of questions asked of a woman in her early twenties follows this 
sequential format: “Do you have a boyfriend? If you do, when are you getting married? If 
you’re married, when are you having a baby? If you have a girl already, when are you 
having a boy? And then, when are you going to give them another playmate?” As this 
line of questioning reveals, social expectations to have children can be all-consuming for 
heterosexual couples, and particularly for women. Many Argentine women thus 
experience the pressure to have children as a “social mandate.” Pilar Di Paola, a lawyer 
who works in the area of reproductive technologies, explains this pressure:   
In our society there is a mandate on the woman, it’s still not like the European 
woman, or you [in the US] either, they don’t see it [a career] as a life project here. 
You can be intellectually brilliant but you are not a mother and you are, in other 
words, you haven’t fulfilled the social mandates. I imagine that it is because of 
that, because in the end you become aware that it isn’t really like that. But still it 
is a mandate that weighs on all of us. 
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Though there are some women who choose to not have children, the social norm is to 
value motherhood above all else for a woman.83 
Alongside the unquestioned social expectations of women to have children, the 
value of parenthood is undisputed and primary. The following exchange summarizes the 
principal role that parenthood captures in the Argentine imagination. Immediately after 
telling me that it is fine if some couples decide not to have children, one clinic director 
underscored the apparent triviality of life without children: 
Doctor: For me, paternity is something fundamental. I wouldn’t feel fulfilled as a 
man if I didn’t have children. […] One of the most important things of a person, 
as a human being, is to have children. 
 
Kelly: But why is the desire to have a child of one’s own so strong? 
 
Doctor: Because they are your genes. It’s the only thing unique to you the day that 
you die. The day that you die, the only thing that is yours that is going to remain 
are your genes. 
 
Kelly: But why do your genes matter? 
 
Doctor: Well, it is the only thing that you are going to leave in the world. All the 
works, the books that you write, the good acts that you do, are going to disappear 
a few years after you die. 
 
This view, that the only meaningful legacy that one can leave the world is through 
biological parenthood, is common throughout Argentine society.84 Another doctor, after 
telling me that the most important thing in life is to have a child, said that someone who 
does not agree needs to see a psychologist. Though he laughed afterwards, this “joke” 
reflects the social importance of parenthood. This valorization of parenthood in turn feeds 
                                                 
83 A book published in Buenos Aires in 2005, called “¿Hijos? No, Gracias” (“Children? No, Thank You”) 
purports to examine the traces in Argentina of an increasing global trend of women choosing to not have 
children. This book begins from the standpoint that within Argentine society it’s difficult to imagine a 
woman feeling fulfilled if she is not a mother (Soraci 2005).  
 
84 I come back to the meanings and importance of genes and genetic contribution in chapter three. 
 170
desires to pursue assisted reproductive techniques over adoption, a point I return to in 
chapter three’s discussion of gamete donation.  
 
The Porteño Postmodern Family 
“Times have changed. Families aren’t what they were, and the idea of ‘everything in the 
past was better’ lost support years ago. How to dare to revise the alleged goodness of 
some traditions, how to treat your neighbor with respect, and how to accept diversity, 
will clearly be the social and human challenges that are coming.” 
Article in the Sunday edition of Clarín, August 21, 2005 (Elustondo 2005). 
 
Alongside these hetero-normative ideals, currents of social and moral change are 
disturbing the traditional order, and the picture is more complex than social conservatives 
might wish. With the help of assisted reproductive technologies, the arrival of the 
“postmodern family” to Buenos Aires’ shores is no longer dreaded speculation, but a 
social fact. In December 2003, La Nación published a special full-page article describing 
the postmodern family in Argentina, historically located at the end of the 20th century and 
the beginning of the 21st. Detailed characteristics of this new family structure include: the 
average age of women at marriage is 27 years old; the average number of children is 2.5; 
a decrease in legal marriages and Catholic Church weddings; women working outside the 
home for long hours; a large increase in single-parent families; legalization of civil 
unions for gays; and the spread of assisted fertilization techniques. This portrait is 
contrasted to the “modern” family that predominated at the beginning of the 20th century, 
in which women married at the average age of 20 years old and had 6.5 children; 
marriage was formalized through the civil registry and the Catholic Church; women 
stayed at home to raise children; and extended families predominated (Arenes 2003).  
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 In this changing social milieu, the boundaries around formerly fixed policies of 
access to ART are blurring. In the last few years a few gynecologists in Buenos Aires 
have begun discretely providing intrauterine donor sperm inseminations to lesbian 
couples as well as single women. The first slip in practices outside of protocol to become 
public news concerned the use of donor insemination for a lesbian couple in 2002. On 
June 18, 2002 a headline in the Society section of Clarín announced that “a lesbian 
couple will have a child through assisted fertilization” (Aizpeolea 2002). While the 
Argentine couple is not publicly named, the article does quote the doctor who attended 
them, a gynecologist and an associate director at CEGyR.85 The reporter tells us that this 
couple has been together for eight years, and they are having their first child together, 
through the use of a practice called “donor insemination”—intrauterine insemination 
using a donor sperm sample.86 In the newspaper piece, the gynecologist clarifies that this 
is a simple procedure and that “we are facing a treatment where there is no infertility in 
the couple. The woman who is going to be a mother was submitted to basic tests, to see if 
she was in physical condition to have a child (if the ovarian tubes are permeable and the 
uterus is in condition to ovulate).” This gynecologist though open to helping lesbian 
couples have children, also reflects the conservative society that he lives in when he calls 
only the woman carrying the pregnancy “the mother.”  
Overall, this doctor has a more open understanding of what makes a family than 
his colleagues within the reproductive medicine community in Argentina. During an 
interview in 2003, he told me that for him, the decision of making a family as one that is 
up to the single woman, or the lesbian couple. As a doctor, he sees his role as helping 
                                                 
85 I was not able to find out how or why this story came to the attention of the media. 
 
86 I specifically discuss sperm banks and the use of donor sperm in Argentina in chapter three. 
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them in that decision. He affirmed this in terms of helping single women become 
pregnant:  
Because a single woman can raise a child, isn’t that right? In fact, I would say that 
one of every four couples...one of every four…or one of every five children grows 
up without a father, you see? Because they are separated or because they are 
single mothers…I think a woman can raise a child. Of course it’s not the ideal. 
The ideal is that there is a father and a mother. But well, there are also uncles and 
aunts, there are grandparents. 
 
Part of this gynecologist’s justification for considering insemination appropriate for 
single women is the social fact that women are already single mothers through other 
circumstances. Though he also registers single mothers as not the ideal, unlike others he 
views the extended family as a remedy. He also tells me that the most important thing to 
give a child is love, not a traditional heterosexual family form. Like other professionals, 
he speaks of the well-being of the child as the primary interest, but unlike many of the 
others, he recognizes that the child’s welfare is not at risk with lesbian couples, single 
mothers and gamete donors. This use of assisted reproductive techniques in a case where 
there is no biological infertility runs counter to the main legitimization of ART in 
Argentina as a treatment for a disease, and can be seen as a market experiment with 
social consequences. In our interview in 2003, this doctor predicts that this 
experimentation will become the norm with time: “What happens is that the first impact 
is hard. But after that people begin…it starts to be something more common.” 
The openness of this gynecologist to providing ART services to single women 
and lesbians underscores the rigid limits on family that the majority of professionals 
espouse currently. In the original Clarín exposé on the lesbian couple (Aizpeolea 2002), 
the opinions of doctors who work at two other ART institutions in Buenos Aires are also 
quoted. Sergio Pasqualini, the director of another well-known clinic, Halitus, is also 
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noted as in favor of treating lesbian couples, but only after a psychological evaluation has 
been done. (At other centers psychological consultation is also required for any case of 
gamete donation. I return to the theme of gamete donation in chapter three). Nicolas 
Neuspiller, one of the directors of Fecunditas and former president of the Argentine 
Society for Reproductive Medicine, reveals a decidedly traditional view of family, 
embedded within a superficially-open position, when he is quoted as saying:  
[M]edicine accepts homosexuality. Two women can carry this type of pregnancy 
to a good end, even though it is not known what will happen in the future with a 
child raised without a father. In any case, it is clear from the consultations that we 
have had with lesbian women that in the majority of cases they hide their 
condition and present themselves as single mothers. In general, their preference 
comes out in the psychological evaluations. In order to allow to this type of 
request, we require the approval of at least three psychologists. 
 
Though Neuspiller professes that his clinic Fecunditas has open doors for lesbian 
couples, his doubts about the future of a child with two mothers have imposed the barrier 
of three separate psychological evaluations. In contrast, the gynecologist who helped the 
lesbian couple is quoted as insisting on rights of access to ART, albeit within an appraisal 
of motherhood: “At the very least a lesbian is a woman who has the same rights as any 
other woman to be helped by a professional and the same longings to be a mother,” a 
view that is decidedly in the minority for now.87  
Disturbances in established clinic protocol are also being caused by increasingly 
audible demands for ART services by single women in Argentina, and doctors who are 
                                                 
87 Social constraints are revealed anew when three years later, on August 20, 2005, the birth of a child to a 
lesbian couple in the city of Córdoba is again a media sensation  (see http://www.lanacion.com.ar/731689). 
In fact, an article published on this date in La Nacion about the child’s birth points out that without 
legislation, only the woman who gave birth to the child will be legally recognized as the mother. 
Furthermore, the women request anonymity to avoid both press attention and legal attention—they don’t 
want the child taken from them. Two days before this birth announcement, on August 18 and 19 2005, a 
gay male couple from New York caused headlines in all three of the national newspapers: La Nacion, 
Clarín, and  Pagina 12. They were considering moving to Argentina with their five year old twins, created 
through the use of donor eggs and a surrogate from New York (see Downes 2005; Elustondo 2005a; La 
Nación 2005; Ochoa 2005). 
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responding. On August 21 2005, Clarín ran a story on single women in Argentina using 
assisted fertilization techniques, entitled “Single women who are doing everything to 
have a child” (Elustondo 2005b). When I first began fieldwork, five years before this 
newspaper story was published, no one that I talked to was openly in favor of helping 
single women become pregnant. However, by 2005, Chillik is quoted in this national 
newspaper as saying that CEGyR has about 30 cases per year of single women who come 
for donor insemination. Sergio Pasqualini states that Halitus provides single women with 
donor inseminations. However Pasqualini’s affirmation implicitly colludes with 
traditional social values of motherhood and heterosexuality: 
they are usually women who are 38 or 40 years old who see that the time to be 
mothers is passing them by and they don’t want to deceive a man. A thirty year 
old woman has never come here to get pregnant on her own. In general we solve 
this with a semen donor insemination, but we also evaluate that the woman is 
conscious of what she is going to do. 
 
By emphasizing that his clinic only sees older single women, who might “miss out” on 
their chance to be a mother if not aided by ART, Pasqualini implies that the ideal for a 
woman is to marry a man and become a mother—and if marriage is not currently an 
option, motherhood still can be through donor insemination. Along these lines, being a 
mother is more important than being a wife. Though the market in Argentina is more 
open to single women than ever before, these quoted gynecologists are in the minority in 
their willingness to provide ART access. Most professionals in reproductive medicine in 
this country are on the side of Ramiro Quintana, from IFER, who declares,  
Single women have come here asking for fertility treatments, but we don’t 
inseminate single women. We don’t think it is something bad, there are no 
prejudices, but we feel that our mission is to help form families and we believe 
that, in that way, we would be contributing to the formation of incomplete 
families.  
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As Quintana reveals, the predominant ideal of family still does not allow for deviations 
from the heterosexual nuclear norm, despite their existence in the country. This 
heterosexual model is also reflected in the realm of adoption. Though single women are 
legally permitted to adopt, preference is given to married couples. The article cites that 
21.4% of proposed applicants to adopt in 2004 were single women, but only 8% of 
children actually adopted were given to single women. In addition, single women who 
want to adopt usually have to accept an older child or a child with a disability. 
Furthermore, homosexuals—whether in a couple or not—are not legally permitted to 
adopt.88 In this context then, use of private ART services is an attractive option for single 
women and lesbian couples who wish to become parents.  
 
Regulating ART Practices 
 
*** 
On a June day in 2003, I am interviewing the director of an embryology 
laboratory in his office. The interview is interrupted by a series of phone calls concerning 
how many embryos to transfer for a case later that day.  
Doctor: That's Latin America...He wants more embryos for his patient because 
she wants more embryos. The patient, and the ob-gyn, they want more and they 
say ‘come on, instead of two, three.’ No, we defined two. Because if we do three, 
we have a higher multiple-gestation rate. ‘But this is my patient.’ No, we are so 
sorry. Don’t be mad, but that's exactly Latin America. But because we are not like 
                                                 
88 Civil rights for homosexuals made progress in Argentina with the legalization of civil unions in the city 
of Buenos Aires in 2003. However this legal status does not provide for inheritance rights within the 
couple, nor does it permit adoption. Then-president of the Homosexual Community of Argentina (CHA), 
César Cigliutti was quoted in La Nacion  as saying that CHA’s efforts to include “family” in the civil union 
law were rejected before it was passed: “In the enunciation of rights we were talking about family and 
partners, but they objected precisely to the word family. We realized that was still intolerable for some 
sectors of society and, as the important thing was to get the law out, we accepted it. But the future national 
law about gay relationships will have to include two big themes: inheritance rights and the right to adopt” 
(Arenes 2003).  
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this, we fight with the people. We fight with the ob-gyns and we decide two… and 
they have two…but they are always arguing. 
 
Phone rings again and the doctor answers: Yes, yes. Two. Two embryos. What 
else? Okay, yes, bye. 
 
Kelly: You don't always… you don't always get to have the final say, like that, do 
you? Don't sometimes the other doctors just decide on their own? Or is it always 
a mutual…? 
 
Doctor: They can't decide other things than the normal protocol... They have to 
decide, [other doctor’s first name] can’t decide whatever he wants. But I’m not 
talking about just any doctor, I’m talking about an associate, who already knows 
[the protocol].  
 
Kelly: Yes. 
 
Doctor: And nevertheless…And I don’t want to get angry, because I value him, he 
is a good guy. So I have to waste five minutes of my time to explain to him why he 
can’t do something that he already knows he can’t do. 
 
*** 
 
Figure 31.  National Congress Building in downtown Buenos Aires. Photo by Kelly Raspberry, June 
2004 
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“The problem isn’t technological, the problem is how to use the technology. Or if it is 
feasible or not for biomedical or psychosocial reasons. The other [reason] is the 
regulations around doing it.” Gustavo Ortega, director of Santiago Clinic of 
Reproductive Medicine (CERS) speaking on the global flow of ART around the world 
 
In December 2002, the clinic board of directors at CREAR approved a new set of 
goals for the following year, the first of which was to reduce the number of high-order 
multiple pregnancies, in other words to reduce the number of twins, triplets and 
quadruplets to no more than 15% of all pregnancies (previously it was as high as 25 to 
28%).  The way they agreed to do this was by setting a new stringent protocol for the 
number of embryos to transfer for each case of IVF or ICSI. Each viable in vitro embryo 
that is transferred to the uterus has a chance of implanting, therefore if four embryos are 
transferred, there is an increased chance for triplets or quadruplets. This protocol set strict 
limits, different from those used before, that all attending doctors at CREAR were 
required to follow to ensure high pregnancy rates of singletons only.89 The protocol was 
predicated on the calculation that “healthier” embryos (those that will continue to develop 
within the uterus and become fetuses) are produced from younger women’s eggs (the 
critical factor is the “age” of the follicles, which can be different from the age of the 
woman herself). In the case of an egg donation, the donor woman’s age is used. The 
guidelines were as follows: if the woman is under 37 years old, two embryos are 
transferred. If she is 38-40 years old, three embryos are transferred. If she is over 40 
years old, four or more embryos may be transferred. This guide included exceptions, 
depending on how many prior cycles of IVF/ICSI had failed, what the cause of infertility 
was, and the assessed quality of the in vitro embryo. The idea was to transfer fewer 
                                                 
89 A technique known as “embryo reduction,” in which “extra” embryos are taken out of the uterus early on 
in development to prevent a multiple pregnancy is not practiced in Argentina. I come back to a discussion 
of multiple pregnancy and embryo reduction later in the chapter. 
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embryos so that the rates of multiple pregnancies would decrease, but not so few that 
overall pregnancy rates would decline.  
Of course CREAR was not the only center in Argentina at that time with 
guidelines for embryo transfer. However I found that the specifics of those guidelines, 
though supposedly based on the same rationale, often varied. For instance, during that 
same year, the guidelines for embryo transfer at SER (Center for Reproductive Medicine) 
were different: for women under 30 years old, two embryos are transferred; between 30-
35 years old, two or three embryos are transferred; after 35 years old three embryos are 
transferred. In some exceptional cases for women over 40 years old four embryos are 
transferred. Though the directors at both CREAR and SER were aiming to produce lower 
rates of multiple pregnancies, they differed in how they attempted to do so. This is due in 
part to different laboratory conditions at each center, and different overall pregnancy 
rates. Furthermore, as these local conditions change—a new biological media is used for 
example that improves in vitro embryo quality—the protocols change as well. This 
example of demonstrates the local conditionality of not only protocols, but also ART 
practices in general.  
As Ortega points out, the main difficulties in producing a medical technology like 
ART is not the procedure itself, but the local meaning that the procedure has—“how to 
use it” and what social, political and economic implications this use holds for the place of 
practice. Therefore the technical ability to do the assisted reproductive technologies is not 
so much the issue of concern, but rather the local conditions of their practice. These 
circumstances include certain conventions that limit or qualify the use of a technique in a 
given place. For instance in Argentina (and much of Latin America), regulation of ART 
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is largely voluntary and more subject to local moral and economic markets and personal 
preferences, than actual laws.90 In the following sections I describe the various forms of 
regulations and constraints that impact the daily practices of ART in Argentina. These 
include: existing national legislation, RED accreditation, ISO certification, within-clinic 
ethics committees, and Catholic Church influences.     
 
The Law 
In Argentina today there is no specific law or regulatory body designed to oversee 
ART procedures.91 There are however several existing legal statutes ostensibly unrelated 
to assisted reproduction directly, but which are often interpreted as relevant according to 
their declarations on the legal protection of human life. In the absence of an explicit law, 
these statutes are often used as guidelines. These include two international treaties, which 
in Argentina were upgraded to the Constitutional level of law in 1994 under Menem. The 
first is the American Convention on Human Rights, Pact of San Jose, Costa Rica, signed 
by Argentina in 1984, which declares in Article 4.1 “every person has the right to have 
his life respected. This right shall be protected by law and, in general, from the moment 
of conception”.92 While this decree clearly recognizes and protects human life at 
conception, the inclusion of the term “in general” creates an ambiguous situation in terms 
of when and where conception is considered to occur. Interpreting this law therefore 
depends on one’s orientation: while the Catholic Church would argue that conception is 
                                                 
90 The main exception in Latin America is Costa Rica, where the Supreme Court banned all ART in 2000. 
 
91 General medical malpractice falls under non-specific (to medicine) torts regulations as referenced in the 
Civil Code and under the Penal Code (i.e. negligent homicide). 
 
92See  http://www.oas.org/juridico/english/Treaties/b-32.htm, accessed from the web November 11, 2006. 
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the moment of union between the sperm and egg, regardless of where it takes place, a 
more liberal reading would counter that the life potential of a human embryo outside the 
uterus is not explicitly protected by this treaty. The second potentially relevant treaty is 
the international Convention on the Rights of the Child, which gives protection to minors 
under 18 years of age. In signing this convention, Argentina made an additional 
declaration that the rights of a child begin at conception. While this declaration is only 
political statement and has no legal authority, some conservatives see it as a legitimate 
reason for protecting an in vitro embryo.  
Another potentially applicable law, also subject to interpretation, is article 70 of 
the Civil Code which proclaims that the existence of a human person begins with 
conception in the uterus, and gives certain protections to this human life from that point 
(though many of these rights are not enforced until the person has been born: “persona 
por nacer.”93 Given that this article was written in 1865, well before reproductive 
technologies made conception outside of the uterus possible, it is not surprising that it 
refers to conception in the uterus (en el seno materno). However, taken literally, the Civil 
Code can be used to argue that human life created outside the uterus is not protected 
under the Civil Code. Also under consideration is the consequence that if an in vitro 
embryo is defined under law as a “person” with rights, the Penal Code would also have 
relevance for assisted reproduction practices, in terms of its prohibition against murder of 
a human person, or possibly the abortion of a fetus. The difficulty lies in that none of 
these rulings explicitly define when life begins, nor do they clarify when such legal 
protections would take effect—whether at the point of conception regardless where it 
takes place, or only once an embryo is implanted in the uterus. In doing assisted 
                                                 
93 Inheritance rights for example are not legally enforceable until birth. 
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reproductive techniques, clinic professionals may therefore be “mistreating” the embryo, 
depending on how the law is interpreted. 
Also pertinent is a judicial decision made by the Civil Appellate court of Buenos 
Aires (Sala I) in December 1999 regarding the status of embryos. This appellate decision, 
which applies only to practices within Buenos Aires, upheld a former judicial decision in 
the lower court that gave embryos personhood rights (a case presented by lawyer 
Rabinovich). This judicial ruling explicitly affirms that: personhood begins at conception, 
no matter if it takes place within or outside the uterus; all rights begin at conception 
(while implying that conception is when the sperm penetrates the egg); fertilized eggs 
and embryos are prohibited from being discarded and used for experimentation. However 
this ruling, which closely follows the Catholic Church’s views on when life begins, has 
never been complied with by the ART centers, nor legally enforced. It is not talked about 
as relevant by reproductive medicine professionals in Argentina, indeed it was only 
referred to once in my interviews. I come back to this legal decision in interlude IV, as it 
bears weight on events and practices regarding the cryopreservation of embryos. 
 
 
Legal Prospects 
“Argentina is country where the Church has much presence and power. […] I think that 
there is a great pressure from the Church against in vitro fertilization, but not so much 
because the Church is against in vitro fertilization, because I don’t think that it interests 
them so much. But for them to achieve what they want, that an embryo be considered a 
child or a son or a person, would prevent any future possibility that abortion is 
permitted.[…] And the way to achieve that is to begin by defining the embryo as if it is 
already a child, as if it were already born.” Nicolás García, gynecologist and a clinic 
director 
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Figure 32. Catholic Church Cathedrals in the city of Salta, Salta Province (L); and San Isidro, 
Greater Buenos Aires (R). Photos by Kelly Raspberry, 2003. 
 
The influence the Vatican has over restricting the practice of assisted reproductive 
techniques is a subject of concern among Argentine infertility professionals. In this 
primarily Catholic society, the conservative values of the Catholic Church are easily 
observed, even in the law, as one lawyer told me:  
The Argentine position was always to speak legislatively, from the moment of 
conception, the protection of the person and the existence of the person from 
conception. That is what the civil code says, which was made many years ago. 
Moreover it is a position that has been endorsed by the Church, it is the position 
that the Church has. And the Catholic Church has a lot of weight in our country. 
 
As I discussed in the introduction, the Roman Catholic Church is against assisted 
reproductive technologies for two primary reasons: because it allows for conception to 
takes place outside the conjugal unit; and, because it manipulates and potentially 
endangers human life at its early stages of development (for the Catholic Church life 
begins at conception therefore anything done to a fertilized egg, pre-embryo or embryo is 
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harmful). Over the last 15 years, the Catholic Church in Argentina has pushed for the 
passage of restrictive legislative proposals and impeded the approval of more liberal 
ones. In describing to me the weight of the Catholic Church in Argentina, the director of 
the embryology lab at the Reproductive Medicine Institute (RMI), a Catholic himself, 
characterizes the Catholic Church as very hypocritical. He tells me that the Church tries 
to tell everyone how to live, including through influencing politicians in Argentina: 
You can imagine that there are a lot of people who continue to go church and 
continue to do assisted reproduction. Doctors who do assisted reproduction 
continue to go on Sundays to take communion…and no one says anything to 
them. Apart from that, it is a question of money. It’s very complicated. The 
church is almost another political party. Do you know what they say? ‘The Fourth 
Power,’ ‘The Fifth Power,’ they get involved in everything. And depending on 
how much the politicians want to be on good terms, they make the laws in favor 
or against. At one time they were about to release a law that directly prohibited 
doing assisted reproduction. Why? Because there was a group of politicians that 
were from a Catholic group within the Church and they were going to achieve it. 
 
This law wasn’t passed, but the power of the Church to pass a similar one is always 
present. Part of the concern of the Church with regulating ART is that if a permissive law 
is passed that does not recognize life as beginning at conception, or that denies 
personhood rights to an embryo, then the grounds against abortion will also be weakened. 
As Nicolás García points out in the introductory quote, the Catholic Church desperately 
wants to keep abortion illegal, and their fight against ART is based partly on that desire. 
There is no doubt that the Catholic Church has influence over legislators—in the form of 
an informal lobby—but until now it has not succeeded in wielding enough pressure to 
push through a prohibitive ART law.  
Furthermore, the persuasion power of the Catholic Church depends in part on who 
is governing the country. Navarro recounts that during the 1990s, the Catholic Church 
had a fair amount of influence over Menem’s government: 
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The Church has a lot of power in Argentina, above all with some presidents, with 
some governments more than others. For example Menem, who was president 
two times in Argentina, was very corrupt. Nevertheless he was a good friend of 
the Church because he supported laws against abortion and for the protection of 
life, etc. […] The issue is that the president, who was the most corrupt in 
Argentina, at the time he had the best relationship with the Church. And so during 
that period a law against assisted reproduction almost was passed, it was very 
prohibitive, it was like the law in Germany. In Germany it’s terrible. Thankfully 
that law wasn’t passed. But the danger is always there. In addition, […], the 
Italian, was telling us that in Italy they are on the point of passing a very 
restrictive law. If that extremely restrictive law comes out in Italy, then Latin 
America is going to have problems because our legislators are going to base 
themselves on that law in order to try to imitate it. In other words for us it would 
be disastrous if Italy comes out with a law like the German one. Germany is 
farther away, it’s not part of the Argentine culture, but Italy and Spain are. So, a 
restrictive law in Italy could reverberate here in Argentina. 
 
Speaking in 2003, Navarro also points out that legislation in Europe, primarily in Italy 
and Spain, can effect what happens in Argentina since these European laws often serve as 
legal models for Argentina. The Catholic Church’s power in Europe in the context of a 
highly polarized political debate was blatantly demonstrated with the passage of an 
extremely restrictive ART law in Italy in 2004. Like Navarro, many Argentine 
reproductive experts fear that this Italian law has potential to be a model for Argentina’s 
legislature, as it is similar in scope to those that have been backed by the Catholic Church 
in Argentina. The Italian law bans embryo cryopreservation, restricts fertilization to only 
three eggs at a time, and requires immediate transfer of all created embryos, thereby 
implicitly prohibiting PGD as well. These strict measures are justified out of “respect for 
the rights” of the human embryo, yet the ruling creates a paradoxical situation in which 
IVF practitioners are now required to protect the life potential of an in vitro embryo 
(regardless of chromosomal normality), but in which abortion following prenatal testing 
is allowed (Benagiano and Gianaroli 2004). On the other hand, if a prohibitive law like 
Italy’s is passed in Argentina, it won’t stop some people—those who can pay— from 
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doing it illegally (like abortion), or for traveling to nearby countries to do it. As one 
professional summarized, “People are not going to stop wanting a child because the law 
says that they can not do it [ART].”  Nor will professionals cease to supply a desire for 
ART—in such case, the professionals themselves are likely to relocate. 94 A biologist at 
Fertility Institute tells me this was already being considered during the 1990s in 
anticipation of the passage of the Catholic Church-backed restrictive law: “In fact, when 
it came out, when they were about to pass that law, everyone—many people were already 
thinking of putting a center in Uruguay. So people were going by ferry to Uruguay.” 
With the approval of a restrictive law, ART practices would change in Argentina, but 
they would not disappear entirely. 
 Between 1995 and 2005, the Argentine Congress reviewed 26 separate legal 
proposals to regulate ART, but passed none into law. As recently as August 20, 2006 La 
Nacion announced that “Assisted Fertilization Will Be Regulated by Law,” revealing that 
there are three law projects currently under consideration in the Senate, fairly similar in 
scope and relatively permissive (allowing cryopreservation and donation of embryos).95 
One of these proposals was crafted and submitted by the Argentine Society for 
Reproductive Medicine (SAMeR) in October 2005 in hopes of preempting a restrictive 
law. The SAMeR proposal to regulate ART begins with the declaration that infertility 
must be recognized as a biological disease. One of the former Presidents of SAMeR 
explains  to me that any legislation must begin under this premise, and proceed from 
there:  
                                                 
94 Many of the Italian ART centers, especially those offering PGD, relocated to nearby countries; Italians 
are now traveling to Switzerland, Spain and Greece to do IVF, ICSI or PGD (Piqué 2004).  
 
95 See Vallejos 2006.  
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Legislation must not begin with assisted fertilization, legislation must begin by 
saying simply that Argentine society recognizes—not the medical society, 
society—the Argentine people recognize infertility as a disease and not as a bad 
word. You see? Today, to speak of infertility is to speak of a bad word. Why? 
Because it is a word that produces expenses for the health insurance and private 
medical plans, so it is not recognized as a disease. 
 
Here again is the notion that in order to increase economic access to assisted reproductive 
techniques, they must be classified as a medical service for a biological disease. Most 
medical professionals working in assisted reproduction profess to support the idea of a 
national law to regulate their practices, however they do not want one that places severe 
restrictions. Many of the proposals that have been considered by Congress in the past 
have dictated strict limits on procedures, including banning many of the techniques 
currently performed (such as embryo cryopreservation).  
Most professionals would rather have no law, and take their chances, than have a 
restrictive one that prohibits them from doing their work. This gynecologist’s position on 
an ART law is a common one, “But only when it’s possible to regulate in an open way, 
no? Because if they begin to prohibit everything, I prefer not have a law. If it is a law that 
is going to permit doing things, yes. But if it is a law that is going to prohibit everything, 
then no.” SAMeR’s permissive proposal calls for the creation of a National Commission 
to oversee the techniques and report the procedures in an obligatory national registry. 
While ensuring regulation, this proposal gives open guidelines for most practices, though 
it prohibits surrogacy and cloning. However, most professionals do not foresee the 
approval of a permissive law such as this. In the past, the restrictive, Catholic-influenced 
laws have always gained more public support. One gynecologist explained, “Because the 
majority of people are against egg donation, sperm donation. Because it is the 
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thinking…of society.” Another professional, a lawyer herself, attributes this legal 
conservatism to a lack of understanding and the taboo nature of infertility:  
There are still people that don’t think about it, assisted fertilization is still 
something kind of strange. It is not an open issue, people prefer not to talk about 
it, infertility is not an open issue. People sometimes don’t even tell their family. 
So that is another difficulty when you try to gain support for a law or when people 
don’t want to say…that they are infertile. 
  
There are still a lot of myths and misconceptions about what ART is, and infertility in 
general is not talked about openly in society.  
Because the lawmakers themselves often do not fully understand the techniques 
of ART, most professionals think there should be limits to what the legislature decides. 
The doctors and biologists who produce ART on a daily basis agree that they are more 
qualified than the legislature to decide the specifics of what they do, though they would 
also like the support of a law behind them. Claudia, a lawyer who underwent ICSI and 
had triplets, told me,  
The problem is, in my opinion, that the legislators can’t establish technical rules 
for what the doctors can do. For example, if a law project says that they can only 
transfer to the uterus three embryos, that is ridiculous. That is what a doctor must 
determine, as it would be ridiculous for a doctor to establish the rules for the 
adoption of embryos because that is what a legislator does. […] Meanwhile what 
the doctors do is to follow what they do in other countries, adapted to fit our 
society. There are things unthinkable in society today, in Buenos Aires, in 
Argentina, not even to speak of the interior. There are things that we are not 
prepared for yet. 
 
According to this argument, those most equipped to decide what is permissible are the 
medical and scientific professionals who work on ART everyday. Society in general is 
not knowledgeable enough about reproductive technologies to confront the specifics of 
certain techniques. Another lawyer agrees, telling me that these technical advances are 
occurring before society is ready to confront the problems that they pose:  
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Many of our centers work very well as you have seen, with much care, 
precaution, respect, etc., and they are truly pioneers because they aren’t acting 
with solid legislative backing, in other words they are ‘drifting,’ as they say. Here 
you have the principal differences with relation to the practice in Europe, where 
the doctor knows very clearly what he can and can not do.[…] It is a matter of 
technological advance. The technology that the US has had for fifty years, in 
other countries it is delayed in arriving. From the moment it arrives, society’s 
demands begin. You can’t look at law in a static way, law is dynamic. What 
happens here is that the problem was detected, here we have a problem, but 
simply, society isn’t prepared to give a clear, complete solution to this problem. 
Because when society is ready, it is going to pressure the legislator and the 
legislator is going to end up passing a law. 
 
This statement brings to mind Rapp’s notion of “moral pioneers” (1999), in this case to 
describe the ART professionals who work in a legal vacuum in Argentina. This lawyer 
also brings up several points of interest. One is a differentiation between ART 
professionals in Argentina and their European colleagues, in terms of external oversight. 
Another is that the law responds to social demands and concerns, and as of yet Argentine 
society in general is not prepared to support any one law regulating ART.   
On the other hand, the atmosphere of the current government in Argentina (led by 
President Kirchner) is a more progressive one that in years past, with the Health Ministry 
for the first time engaging in public debate in August 2006 over the advantages to 
legalizing abortion. This leads some to think that the moment for passing a permissive 
law is at hand. In the meantime, the absence of a law to govern assisted reproduction 
practices, or to define the appropriate treatment of the in vitro embryo, leaves regulation 
to the forces of professional aspirations and the private market. These self-regulations are 
often also driven by a desire to do modern medicine, and the available international 
connections that facilitate putting such desires into practice. For example, as I discussed 
in chapter one, Acosta came from the Jones Institute in the United States to help set up 
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today’s “modern” CEGyR, complete with an institutional review board, ethic committee 
and research committee. 
 
Modern Protocols and Accreditations 
“Obviously the gynecologist has to deliver good quality eggs, a patient well-stimulated, 
and then to do the transfer well, that is another key moment. But I think we [biologists] 
have the most important work. […] If the doctor gives you good eggs but you have a bad 
quality laboratory, if you don’t control a number of factors—there are many—just as the 
gynecologist has various things to control, then it won’t work. The laboratory biologist 
has many details, many things that one wrong move, or one thing that isn’t controlled, 
can make the results terrible.”  Marta Romero, biologist at CREAR 
 
In addition to the lack of an explicit law, infertility clinics in Argentina are not 
required to undergo any kind of national accreditation or certification process in order to 
provide assisted reproduction services to the public. As a consequence standards for 
doing assisted reproductive techniques are not subjected to external regulations and 
depend upon self-imposed monitoring. In each center in Argentina, protocols for ART 
treatment outline the following areas: to whom to give access (heterosexual couples, 
single women, lesbian couples, women under a certain age); which fertilization 
procedures to provide (intrauterine insemination, IVF, GIFT, ICSI); availability of egg, 
sperm and embryo donation programs; number of embryos to transfer; whether to 
cryopreserve embryos and at what stage (pronuclear, Day Two, day Three or blastocyst); 
and optional advanced embryo manipulation techniques (assisted hatching, PGD). Most 
of these protocols are based on international recommendations and then modified to fit 
local concerns. Though these medical protocols stand in as a “quality control” for each 
center, they serve only within-clinic policies, and do not in any way standardize ART 
practices across the country.  
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To counteract the appearance of working in an unregulated zone as opposed to in the 
orderly world of modernity, the majority of clinics in Argentina have developed self-
regulations and forms of “quality control.” One of these is accredited membership in La 
Red de Latinoamericana de Reproduccion Asistida (Latin American Assisted 
Reproduction Network), or RED. Membership in RED requires a minimum standard for 
lab and clinic protocols and provides recommended guidelines for practices in the form 
of the Consenso, discussed earlier. Member clinics undergo an initial on-site evaluation 
conducted by a biologist and physician, who check that the clinic data reported is 
accurate.96 RED also publishes a yearly registry of ART procedures per country, the 
Registro Latinoamericano or RLA. However RED is a private non-governmental 
organization that does not function as a directive or regulatory body. Nor does 
membership in RED ensure standardization of practices across all accredited clinics. 
Indeed, accreditation by RED is not viewed as sufficient by many, as this director of a 
center in Buenos Aires expresses: 
What does it mean to accredit an institution? That a biologist and a medical 
director come and check if you have the basic laboratory equipment, and if you 
fill out the basic forms. Now, in no way does that check-up certify the quality of 
the service that you are providing, the quality of the laboratory work, the 
percentage of success you have, the quality of embryos—you don’t even see the 
rate of fertilization. It’s more than that— today RED comes, and it becomes an 
accredited institution. And tomorrow I decide to change the biologist, I change the 
doctor, I change everything, but the center continues to be accredited simply by 
its name. The professionals are different but no one is going to come back and 
recertify the institute. 
 
                                                 
96 This accreditation process began in 2000 because of doubts that centers were accurately reporting their 
results. The professionals who conduct the evaluations are the leaders in assisted reproduction in Latin 
America, and rotate from year to year. The main consideration is that a professional can not serve to 
evaluate centers in his/her own country. The number of skilled biologists in ART is a much smaller group 
than the physicians (approximately 30 biologists, one-fourth the total of physicians), so the same biologists 
are often called periodically to do accreditations as new centers join the network. 
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As this gynecologist emphasizes, RED accreditation is a largely symbolic form of self-
regulation. While four of the five principal clinics in Buenos Aires belong to RED, the 
actual protocols enacted in each depend more on the orientation and discretion of the 
directors than on any dictate from RED. Directors often depend on word-of-mouth and 
local knowledge of what other centers in the area are doing, in order to not be out-of-step 
with their practices. In chapters three and four I come back to this form of local 
“synchronization” of protocol and practice with the examples of paid egg donation and 
preimplantation genetic diagnosis. 
Since 2002, ART centers in Argentina are also claiming modernity through the 
solicitation of ISO certification. Unlike RED accreditation, ISO certification is an 
international symbol of quality control, recognized in the US and Europe, and as such 
carries more prestige. Achieving ISO certification is a lengthy and expensive process in 
which an external auditing agency checks the efficiency of all aspects of the clinic—
including the secretarial reception, record keeping and of course clinical and lab work. As 
of early 2005, two of the principal centers already had ISO certification and the others 
were considering it; the diagnostic center Laboratory for Reproductive Medicine was in 
the process of applying. The first time I meet him, one of the directors of SER, Mauricio 
Bianchi, proudly tells me that in 2002 his was the first institution in Argentina—and 
possibly in Latin America—to work under ISO 9000 norms. Quality-control through 
standardization is the key aim behind ISO, and what Bianchi seems most proud of 
achieving: “We standardized all the procedures, we oblige everyone who enters to follow 
the same standards and in following the same standards we think we can achieve quality 
of service with the best results.” The idea that a clinic should follow standard norms, with 
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every detail controlled and quantified, is an imported one, and perhaps for that reason, 
holds greater appeal. According to the specialists in Argentina, those on the margins of 
modernity—like themselves—are in greater need of standardization. Navarro explains the 
necessity of ISO certification for centers in Latin America, revealing the tacit acceptance 
of a ‘hegemony of the North’ that is common in the reproductive medicine community of 
Buenos Aires:   
We have difficulty working in an orderly manner, according to protocols, etc. By 
‘we,’ I mean Latin America. The ISO obligates you to write down and work in 
agreement with certain rules and to follow the objectives…it imposes order on 
you. So, in Europe and the US it is important, but here it is even more important 
because it’s not part of Latin American culture. 
 
To maintain ISO certification, a center must submit to an external audit every six months, 
a control-check that ensures that protocols continue to be followed. In this manner, ISO-
certified centers claim external proof that they are working at an “international” level of 
practice. However, a small but important detail that most Latin American advocates of 
ISO certification do not often discuss is that like the clinic protocol that a given center 
uses, the standards regulated through ISO are also decided upon and put into place by the 
center itself. Therefore, different centers with ISO can give themselves different 
standards to comply with, based in part on what they are already accomplishing. For 
instance, Julieta Moretti, a biologist at CREAR, explains to me that they were already 
achieving the 30% overall pregnancy rate that the center set as their objective for the ISO 
certification. She critiques ISO in this respect, while also recognizing that using the 
standards from a good center in the United States would be setting the bar too high:  
Those are the numbers that we have, more or less, the overall rates without any 
polish. So you know that you are always going to be within that because they are 
our results. If I am at another center and my pregnancy rate is 5%, then I am 
going to make my objective to maintain 5%. […] But in truth that is very 
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mediocre, why not use a standard like what is published in the United States, in 
the best centers of the United States? Well, what is the chance of aspiring to that 
and actually achieving it? Because if you compare yourself with…with the rest of 
the clinics here, we have a very good pregnancy rate, but it doesn’t mean that we 
are wonderful. Actually, we are better than the others but maybe it will take us 
light years to become like the Belgium center or I don’t know, Cornell. 
 
Thus the ISO process does not necessarily improve conditions, rather it enforces and 
standardizes them within a given clinic (which sometimes is an improvement in itself). 
These comments also underscore the perceived disparity between a “good” center in 
Argentina, even with RED and ISO certification, and one in Europe or the United States. 
Another means of self-monitoring in the ART centers is through the coordination 
of within-clinic ethics committees. By 2003, the five principal clinics in BA all had some 
form of ethics committee. The oversight power of these committees varied across the 
clinics, and many of them changed in both composition and influence during the three 
years that I was observing.97 In most cases, the purpose of the ethics committee is to give 
non-binding counsel on problematic ethical issues; the center is not obligated to follow 
the committee’s suggestions. An ethics committee thus functions to create new standards,  
and to justify already existing ones. The committees also serve to reassure the health 
professionals that their self-imposed standards are legitimate. Often these 
recommendations and decisions are modeled after precedents already set in the center of 
ART production—the United States and Europe. One member of CREAR’s ethic 
committee, a lawyer who works in the area of family law, explains that the committee 
                                                 
97 The ethics committee that I observed from 2003-2004 at CREAR was formed in October 2002. It 
replaced a more informal committee, and the first few sessions attempted to set up a more formal structure 
with a set number of members coming from distinct backgrounds. The members—who volunteered their 
time—included several lawyers, a philosopher, a former ART patient and the clinic psychologist who was 
there as a liaison between the center and the committee. The committee met once a month, from 5-7pm on 
a weeknight. By late 2005 this committee was shifting yet again in terms of members, but the disciplinary 
composition was intended to remain the same. 
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reads and relies upon various literatures to make decisions and to know “the facts” before 
modifying them to fit Argentina’s circumstances:  
What we try to do is, in taking a decision, we see what is happening in the world 
with this issue because generally we are coming behind. […] We read judgments 
from different committees about different decisions in the United States and in 
England. There are also different ways of working. We adopt the one that works 
best for us, but always based first on the literature, on ‘the facts.’ 
 
Because Argentina is usually “behind” other countries in addressing these ethical issues 
and protecting them by law, the decisions and opinions already made in the US and 
Europe on a given issue thus serve as useful background for the recommendations of the 
ethic committee. In chapter four I discuss CREAR’s ethics committee’s decision on the 
moral status of the embryo. 
 In the absence of formalized and mandatory systems of oversight, these professionals 
in Argentina have elected certain self-regulations in imitation of the norms of the 
Northern Hemisphere. These displays of regulation—clinic protocols, RED accreditation, 
ISO certification and ethics committees—are proffered as proof of participation in the 
modern, orderly world of high-tech medicine, of which the US is the model:  
One difference is that in the United States there is a culture of being more 
organized. It is more scientific and it is more systematic. It is more organized, 
which is a very good thing. We [at CREAR] have learned this over the years. It’s 
not very common in Latin America—having up-to-date data, and having the 
results that I want and publishing in foreign journals—this really isn’t frequent in 
Latin America. I’m not saying that they [Latin Americans] work badly, I’m 
saying that they work differently.  
 
Although this gynecologist claims to not be making a value judgment, he clearly regards 
rigorous standards as a necessary component of doing reputable ART work. 
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Credentials of Association  
As mentioned earlier, as a network organization RED provides only loose 
governance over ART procedures. However, part of being a modern professional is 
participating in professional associations, and this is where RED and the national 
societies for reproductive medicine come in. An important element of being a 
reproductive medicine professional in Latin America is the reputation that you build, and 
the connections that you make with other experts through participation in conferences 
and workshops.98 There are various societies that professionals in Argentina who work in 
assisted reproduction can belong to, but the most important and directly-related are RED, 
FLASEF (Latin American Federation of Sterility and Fertility Societies), and SAMeR 
(Argentine Society of Reproductive Medicine).  
As a multinational society, RED provides a means of communication for the 
professionals across Latin America, and a way to keep abreast of what others in the 
region are doing. At the time of this writing in 2006, RED counts 135 centers in Latin 
America as participants, with the highest number of centers in Brazil, Argentina and 
Mexico. However in comparison with Europe, the procedures per population in Latin 
American countries are very low (21,034 cycles initiated in Latin America in 2003 versus 
324,238 total cycles in all of Europe in 2002, see Andersen et al. 2006; Zegers-
Hochschild and Galdames 2004).99 RED also publishes a regional registry for Latin 
America, the Registro Latinoamericano de Reproduccion Asistida (Latin American 
                                                 
98An example of the international ties of working in this field is the newly- created “Anibal Acosta Prize” 
for the best scientific work presented at the 2007 RED meetings. In honor of the Argentine who worked 
with the Joneses in the US (described in chapter one), the prize is worth $4000 USD. 
 
99 The Latin American registry also reports high numbers of ICSI (50% of procedures in 2003) and high 
rates of overall multigestation: 31.4%, with 7.2% of those pregnancies triplets or quadruplets (Zegers-
Hochschild and Galdames 2004: 4)  
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Registry of Assisted Reproduction) or RLA, which reports on the number of ART 
procedures every year. This registry lends international prestige and recognition to 
centers in Latin America, as a staff member for RLA told me, “the fact of participating in 
the registry is important. Because that way they will be known abroad. The centers like to 
appear among the one hundred and something accredited centers of Latin America.” As 
with other international reproductive organizations (including the American Society for 
Reproductive Medicine in the United States), the pharmaceutical companies Serono and 
Organon have long been financial contributors to RED, sponsoring both the registry and 
the general and regional workshops.  
The formation of RED in fact grew out of the effort to create the Latin American 
regional registry. The RLA was introduced in 1990, at which time 21 centers in Latin 
America contributed data. Zegers-Hochschild describes this initial effort as largely based 
on his contacts in the region, and those of the pharmaceutical company Serono:  
…I called the directors of centers on the phone that I knew, and then also those 
names that Serono gave me at the time—Serono was firmly established  in Latin 
America. I invited them to participate. And thus we made the first registry. I paid 
for it, out of my own pocket, because to whom was this going to sell? To no one. 
And I got out the first Latin American registry. And from there we have continued 
every year up to the present. 
 
Zegers-Hochschild recalls that the first registry was the most difficult to mobilize, as at 
the time, the private ART centers did not know to what purpose the information would be 
put. In addition, IVF was also still relatively new to Latin America, having arrived only 
five years earlier. However after the initial registry was published and confidentiality was 
established, the number of centers participating in the RLA began to increase. By 1994, 
there were 42 centers contributing data to the report, and the first RED conference was 
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convened in the early days of November 1995 in Reñaca, Chile. 100 At this first meeting, 
the Consenso (discussed earlier) was produced along with a structure for a Latin 
American network of ART clinics, including the designation of five Latin American 
regions with regional directors. The five regions were carved out as follows: 1. 
Argentina, Paraguay, Uruguay; 2. Brazil; 3. Colombia, Ecuador, Venezuela; 4. Costa 
Rica, El Salvador, Guatemala, Mexico, Panama, Dominican Republic; 5. Bolivia, Chile, 
Peru.  
Officially, the advantages of affiliation with RED are an invitation to the 
international conference and public status as an accredited center. RED pays for two 
people from each clinic—a doctor and a biologist—to attend its biennial meetings held in 
various resort locations around Latin America. These conferences are sites for expert 
knowledge production and dissemination, as the conference coordinator says: “They are 
well-known people, that are in the field, that do good research, that come to share that 
knowledge and do it through RED or through contacts in the societies.” The list of invited 
speakers always include a smattering of foreign reproductive medicine specialists. For 
instance, the RED meetings that I attended in Punta del Este, Uruguay, in 2003, included 
high-status invitees from the United States and England (translation devices were 
provided for free for the presentations made in English) . 
                                                 
100 RED and the RLA can and often do look to the USA and Europe for models on how to manage data 
reporting on assisted reproductive technologies. In Europe, most countries publish annual national 
registries, and the European Society of Human Reproduction and Embryology (ESHRE) uses this data to 
collate an annual report on ART in Europe. In the US, the Society for Assisted Reproductive Technology 
publishes an annual report summary on techniques performed in the US, however affiliation and data 
reporting to SART is not mandatory and so not all centers in the US are captured in SART’s annual report 
(see http://www.sart.org/index.html for more details). 
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Not all assisted reproduction centers are convinced of the benefits of RED, nor do 
all consider the membership fee of $500 USD a worthwhile price to pay.101 Therefore, the 
monitoring of assisted reproduction practices that RED attempts to bring to Latin 
America falls short. In most countries, there are centers that choose not to participate in 
this organization. Though these centers do not “officially count,” their local impact on the 
production of ART is substantial. For example, according to the RED data, there are only 
two accredited ART centers in Ecuador, both in the capital Quito. In practice, there are at 
least six centers in the country, including two in cities other than Quito (Roberts, personal 
communication).  Nor is this a phenomenon found only in the margins of Latin American 
IVF. In Mexico there are many centers that are not part of RED. In Buenos Aires, one of 
the largest and most reputable centers declines to participate in RED for “political 
reasons.” The numbers that RED reports serve as the “official” statistics, but the actual 
numbers of procedures and babies being born in Latin America are most likely higher.  
 There are also stakes involved in the collection and publication of data on assisted 
reproduction procedures. This is a business that sells as its product a non-guaranteed 
success rate. Distinction between centers is based largely on this percentage of success. 
The temptation then becomes the use of published data for commercial competitive 
purposes. Centers therefore are cautious about sharing success rates on a wide-scale, for 
fear that these numbers will be used against them by a ‘more-successful’ competitor. 
According to one RED member, these apprehensions extend to competition between 
bordering countries in Latin America. From the beginning, the Registry’s by-laws 
dictated non-disclosure of data on specific centers, allowing only summaries of 
                                                 
101 In 2003 the membership fee was $500 USD, it may have increased since then. 
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procedures for the entire region.102 However at the 2003 RED meetings, members finally 
gave approval for the regional directors to have access to country-specific data—
previously only allowed to the executive director of RED and the RLA editors. This 
restriction had been problematic in practice, as the regional directors need to coordinate 
the accreditation of centers for their regions. Zegers- Hochschild also received permission 
from the majority of centers in Latin America to publish country-specific data (including 
success rates) as part of a world registry on ART practices in 2000 (Adamson et al. 
2006). In addition, the fertility societies of Argentina, Brazil, Chile, and Ecuador are in 
the process of creating their own national registries.103 As one gynecologist who supports 
national registries in Latin America told me, the availability of consumer information on 
different clinic’s success rates is an important component of “modern medicine.” 
 
Faith in the Clinic 
“What we have as the beginning of life and the respect for the beginning of life is basic in 
religion. […] The theme of ethics in religion is going to…it is going to limit and also to 
guide.” Fernando Pérez, director of Reproductive Medicine Institute (RMI) 
 
Another “regulating” influence in Argentina is the Roman Catholic Church. For 
some Catholics, the Catholic Church’s opposition to assisted reproduction means a 
                                                 
102Previously the only country-specific data that appeared were the number of centers and ART procedures 
undertaken per country, as well as a named list of the participating RED centers for that year. Thus, the 
2003 registry (the most recent), reveals a total of 117 RED contributing centers with 21,034 cycles initiated 
that year, as well as a breakdown of the number of centers and cycles per country—Argentina had 19 
centers, and performed 4,126 assisted reproduction procedures (Zegers and Galdames 2004:3). The success 
rates of pregnancy or birth for these 19 centers and 4,000 procedures are not specified. Instead, the 21,000 
procedures undertaken—and the resulting 6,268 babies born—throughout Latin America are analyzed 
according to a range of variables, such as type of procedure or age of the birth mother.   
 
103 The Chilean national registry has been published through the Chilean Society for Fertility (Sociedad 
Chilena de Fertilidad) three times so far, with data from 2000, 2001, 2002. In Argentina, SAMeR’s website 
asks centers in Argentina to affiliate with SAMeR and to contribute data from 2004 by April 30, 2006 for 
the first national registry which presumably will be made public sometime in 2007. 
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complete aversion to producing ART—it is categorically forbidden. However for many 
practicing Catholics in Argentina who are specialists in reproductive medicine, various 
compromises are sought between religious and medical principles, in favor of 
engagement in ART. These compromises entail modifying both ART practices, and the 
Roman Catholic Church doctrine. For instance, one biologist who was raised Catholic but 
does not currently go to Church, points out the backwardness of the Catholic Church’s 
position: “I always say that if you can develop the technology in order to do this, if you 
believe in God, it will be because you are enlightened thanks to God, right? God blessed 
you so that you could develop—ICSI for example, so why not put it within reach of 
Catholics. It seems to me that is to deny the changes in the world.” I take two examples 
here of professionals who refuse to renounce their Catholic beliefs, but neither do they 
want to leave the “modern” medical world of reproductive technology.  
The election of the German cardinal Josef Ratzinger as Pope in 2005 had a special 
significance for several members of Argentina’s assisted reproduction community. Josef 
Ratzinger is a familiar name to many who work in ART, as he is the oft-cited author of 
Donum Vitae, the official document proclaiming the Catholic Church’s position against 
in vitro fertilization. In attempts to reconcile the Catholic Church’s intolerance of ART 
with the work they were dedicated to, two of Argentina’s medical professionals wrote 
letters to Ratzinger, in his position as Prefect of the Congregation for the Doctrine of 
Faith, asking for approval for their work. These personal tales elucidate a deeply-felt 
need to reconcile religious beliefs with scientific practice. For some professionals in 
Argentina, resolving this potential conflict has been of primary importance. 
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One of these professionals is Augustín Ortiz, a Catholic scientist who works at the 
Laboratory for Reproductive Medicine. Part of Ortiz’s work is to analyze and diagnose 
sperm, which requires that men provide a small quantity of their semen in a plastic cup to 
the laboratory. Ortiz felt that he needed to find a way to appease the Catholic Church’s 
warning against the “spilling of seed” outside of procreation, and so he “invented” a 
device which he calls the recolector seminal—the semen collector. However Ortiz was 
not satisfied with just his invention—he then sent Ratzinger a letter seeking approval for 
the use of the semen collector. 
The semen collector comes in a square, clear plastic envelope stapled to a sheet of 
instructions for the spermogram. Inside the small plastic envelope is an instruction sheet 
for the use of the collector, as well as a long, conical clear plastic bag and two small 
rubber bands. The collector is to be used like a normal condom, though it is a primitive, 
shapeless one that must be held in place with one of the supplied rubber bands. The 
plastic is by design inert so it won’t harm the sperm cells. The instructions advise that 
“once you have obtained the sample, take off the collector, closing the open end with the 
rubber band. Take the semen collector to the laboratory as soon as possible.” How often 
this collector is actually used is unclear, and imagining alternative ways of carrying the 
filled collector across town to the laboratory becomes graphically comical: perhaps the 
glorified condom held by a rubber band is stored in a ziplock bag and carried in that way, 
or maybe it is placed in a sterile cup with a screw on lid?  
The instructions for the spermogram give the option of obtaining the semen 
sample by either sexual intercourse, using the semen collector, or by masturbation. 
Masturbation is straightforward: the semen must be ejaculated directly into the sterile 
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plastic cup, and the lid placed on the cup. The sample, whether collected through 
masturbation or intercourse, must be brought to the laboratory within an hour and kept at 
room temperature at all times. However, the sample cannot be brought in at any time of 
day, but must be obtained and delivered Monday through Friday between 8 am and 12 
noon, or on Saturday between 8 and 10 am. In bold, the last line clearly forbids obtaining 
the sample before 7 am. The instructions also clearly request that the sample is obtained 
after three to five days of sexual abstinence, absolutely not less than two days and no 
more than five. Though this is not explained, this rule is to ensure the optimum quality of 
sperm, as a sperm of only two days may be immature, and of five days will be too old. 
This laboratory does not provide a special room with magazines or videos, if 
masturbation is chosen, then the only option is one of the bathrooms. 
After telling me about the invention of his sperm collector, Ortiz explained the 
purpose of his letter to Ratzinger: 
I had a double objective there. First, I couldn’t be offering a morally illicit act in 
order to obtain a semen sample if I truly accept what the Catholic Church says. 
And second, for those people who for moral or religious reasons don’t want to 
masturbate, I had to give them a solution in the laboratory. And from that I 
developed the semen collector, and later I sent all my research to the Vatican, and 
to the Congregation for the Doctrine of the Faith. And they authorized its use for 
me. It’s not that I oblige others to follow the religious practice that I do, no. We 
give them all the options, and then we let people do what they want. If someone 
tells me, ‘no, I want to obtain it by masturbation,’ it is fine with me, ‘if you don’t 
have any difficulties I will accept your sample and I will analyze it for you.’ I’m 
not going to impose anything on your freedom to decide, but if I have to solve the 
problem for the person that has a difficulty, then I have to give a serious and 
scientific response. 
 
The “serious and scientific response” that Ortiz settled on is the semen collector, and by 
providing that, Ortiz rests easy that his work is in compliance with Church doctrine. By 
offloading his moral perspective—like a disagreement with masturbation—onto the 
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rationality of science, Ortiz can take the personal out of his laboratory practices. Cardinal 
Ratzinger’s written response to Ortiz’s letter, dated April 2, 1984, assures Ortiz that the 
semen collector is “licit from the moral point of view” and “presupposes a true conjugal 
act.” Written in antiquated, formal Spanish, the letter is favorable in tone: 
Honorable Mr. Professor:  
In response to your letter dated the 7th of February, I am very pleased to tell you 
that the technique that you use to obtain sperm is valid from the moral point of 
view. It represents, in fact, a real and proper conjugal act. Obviously it also 
represents that an actual possibility of insemination exists; but with respect to this, 
the judgment should be made by your science and knowledge as a researcher, not 
by the authority of the Church. Having told you that, I express my sincere esteem. 
 
Ratzinger’s response maintains the clear boundaries between religion and science insisted 
upon in modernity. As an authority of the Catholic Church, Ratzinger approves Ortiz’s 
invention as morally valid, and defers the “scientific” aspect of the device—the chance of 
insemination—to the authority of science. Hypothetically we might consider the 
implications of what might have happened if Ratzinger had not approved of the semen 
collector. Would Ortiz have found a different means of reconciling his science with his 
morals, or would he have found a less morally-problematic scientific practice to pursue? 
 Guillermo López, gynecologist and director of an assisted reproduction center, 
also wrote to Cardinal Ratzinger as a means of resolving a perceived conflict between his 
Catholic principles and professional inclinations. As a practicing Catholic, López initially 
had serious reservations about doing assisted reproductive techniques, which led him to 
consult the Catholic Church directly. He remembers that in the mid-1980’s he was 
working as medical staff at CREAR and debating whether to become involved in the 
emerging field of ART:  
Initially I had thought ‘no’. And then, when the Pope came here, I had the 
opportunity to interview Monseñor Mejía, who is a Cardinal, a prefect of 
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finances. […] With Monseñor Mejía we discussed doubts and I personally 
brought up the doubts that I had and as I saw it. And he said that it was my 
decision of conscience and that if it seemed okay to me—He told me in that 
context he didn’t see any difficulty. We sent a consultation letter to Cardinal 
Ratzinger, I know he received it because I received feedback from the letter that 
we sent, and we didn’t receive any official response from him. In that letter we 
asked him, if he saw any clear objection to the way of doing things, that he 
answer us if it was wrong. And we didn’t receive any answer. And in terms of 
morality, what isn’t prohibited is authorized…In other words, by default I 
assumed that the way, the way that we proposed it was accepted.  
 
López therefore concluded that since Ratzinger never responded with an explicit 
denunciation of ART directed personally towards López’s inquiry, he could become 
involved in the field without compromising his Catholic values. Notably he declares that 
“what is not prohibited is permitted” in morality, which is actually taken from the legal 
system in Argentina which operates under that rule. He tells me that today he does not 
have any qualms over doing ART, in part because the center that he co-directs, 
Reproductive Medicine Institute (RMI), follows a rigid set of ethical principles. These 
principles allow him to feel at ease with his Catholic conscience.  
 RMI was founded in the late 1990s by three Catholic gynecologists and a 
biologist, including Guillermo López and Fernando Pérez. Like López, Pérez intended to 
operate an assisted reproduction center according to well-defined ethical principles, and 
that is what RMI is today. Theirs was one of the first ART centers in the greater Buenos 
Aires area, located in a reputably upper-class suburb. It is accessible by a 40 minute train 
ride from the center of Buenos Aires or 20 minutes in a car. The center only does 
approximately 200 IVF/ICSI cases per year (and another 200 inseminations), and 
operates according to restricted notions of what is acceptable: gamete donation is not 
available, cryopreservation is only performed in exceptional cases and GIFT is a common 
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practice.104 Single women and lesbian couples will not find this a welcoming place, nor 
will those who want to do PGD or any other type of advanced embryo manipulation. This 
protocol is firmly founded on the notion discussed earlier that infertility is a biological 
disease. The program manager explained the rationale to me:  
Here the center has a very strong philosophical basis that first of all, the cause of 
infertility is a disease, and that is what they are treating. Homosexuals do not have 
a physical disease that prevents them from having children, it is a different issue. 
So here they only work with couples, they don’t necessarily need to have a 
marriage certificate, but they do need to be a couple. 
 
 Everyone involved at RMI agrees on these ethical guidelines of the clinic, and López and 
Pérez insist that their Catholic beliefs guide their ART practice. I come back to the 
influence of Catholicism over ART production in Argentina in a discussion of the moral 
status of the embryo in chapter four. 
 
*** 
Interval: Traveling to Modernity with Medical Tourism 
With the devaluation of the peso in January 2002, prices in Argentina fell 
compared to their previous value in US dollars. For those carrying dollars, services like 
ART were suddenly about three or four times less in Argentina than they would be in the 
US. Shortly after the downfall, some of the directors of ART centers in Buenos Aires 
realized that their economic disaster could translate into a new medical tourism market 
for their services. An article published in La Nacion in July of 2002 reports on the 
attractiveness of assisted reproductive treatments in Buenos Aires for foreigners, saying 
that some foreigners—usually from bordering countries— have always come for ART 
                                                 
104 Out of the total number of cases, about 45-50% are ICSI, 40-45% IVF and 5-10% are GIFT. 
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treatments, but with the crisis there is added potential for reproductive tourism from the 
United States (Castro 2002).  
This propaganda-like piece in La Nación cites that “with their prices converted 
into pesos since January, the leading institutes of assisted fertilization in the Capital wait 
to receive more foreign patients every day, who are tempted not only by the quality of 
medical attention, but also by the difference in prices between Argentina and their origin 
country.” The article goes on to cite that a non-specified treatment of assisted 
reproduction costs between 4000 and 6000 pesos in Argentina—which at the time valued 
between $1000 and $2500 dollars—substantially less than an IVF treatment in the US at 
the time (about $10,000 dollars). Though the prices may be lower, the article’s suggestion 
is that the quality is not. Argentina’s scientific modernity is well-defined in comparison 
to the US: “the four experts in human reproduction indicated that the Argentine centers 
obtain on average pregnancy rates similar to those reached in North American 
establishments.” 
Though the article is careful to interview the directors of the four principal clinics 
in Buenos Aires (Procrearte is not included as a principal clinic at this time by La 
Nación), special attention is given to Chillik, the medical director of CEGyR. Chillik 
attempted to capitalize on the peso’s devaluation by developing a reproductive medicine 
program for foreigners. This program was called “Quality and Warmth” (Calidad y 
Calidez or CC), complete with its own website and tourist packages and the promise that 
“a trip has never had a better destiny.”105 The idea was that foreigners would be attracted 
to the combination of superior medical quality and personal attention, combined with 
                                                 
105 This slogan includes a bit of a wordplay in Spanish, as the noun “destino” means both destiny and 
destination in English. 
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lower prices for services, and a vacation trip. According to the article, Halitus was also 
offering benefits to foreign patients, including promotional hotel rates and discounts on 
medication. The main target of these tourism packages were Argentines and other Latin 
Americans living in the US, Chillik publicized his CC program in Miami. 
 Though enticing foreigners was one strategy of surviving the crisis, not all doctors 
saw this as a desirable option. One of the directors at IFER is quoted in the La Nación 
article as saying, “it doesn’t give us satisfaction. In IFER, we prefer to treat Argentines. 
We maintain these prices precisely because we shouldn’t commercialize the desire to be a 
parent.” This doctor emphasizes the desire of clinics to continue to serve their main 
population—Argentines with infertility problems, for most of whom even the reduced 
prices in pesos were too expensive in 2002. In doing so he also distinguishes his clinic as 
outside of the commercialization of the desire to have a child—that characterization 
belongs to those who are trying to seduce foreign patients. 
However, by the middle of 2003, Navarro tells me that medical tourism for 
assisted reproduction hasn’t become a strong market in Argentina. Some from the US 
come to CREAR, but they are usually Latin Americans who live in the US and have 
family in Argentina. From Navarro’s perspective, potential patients from the US are 
reluctant to travel so far to an unknown country, even for better prices: 
The American is very fearful...and now even more so. They are afraid, they don’t 
know the culture so they automatically imagine that there are Indians everywhere. 
It’s hard for them to think that maybe there are other people who work well 
despite not being in the United States—that is very typical of the American, isn’t 
it? 
 
Navarro’s perception is that the North American who is not familiar with Argentina will 
by default think that the country, and by extension the medicine, is not comparable to the 
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US. When I ask if he thinks the rates are as good as what a potential patient would find in 
the US, Navarro tells me that he doesn’t just think so, he can prove it. At CREAR, they 
take the published average success rates from Fertility and Sterility (the journal by the 
American Society for Reproductive Medicine, ASRM), as well as those by ESHRE 
(European Society for Human Reproduction), and compare these numbers to CREAR’s 
rates. In May 2003, he cites that the average rate for clinical pregnancy in the US, as 
reported by Fertility and Sterility, is approximately 36% using ART and in Europe it’s 
around 26%. CREAR’s annual average for 2002 was 36.6% —right on par with the 
average in the US. Navarro attributes the difference in rates between the US and Europe 
as in part due to the practice of embryo reduction in the US. The higher the number of 
embryos transferred, the more likely a pregnancy will occur and the higher the success 
rates will be. However transferring three or more embryos also carries a high risk of 
multiple pregnancy, as discussed earlier. In the US some practitioners transfer a high 
number of embryos, and if more than two embryos implant in the uterus, they selectively 
“reduce” the “extras.” Most countries in Europe have strict bans against embryo 
reduction, as well as caps on the maximum number of embryos to transfer, with some 
countries following a ‘single-embryo’ transfer rule. ART practitioners in Argentina do 
not use embryo reduction, and so must either transfer fewer embryos and risk low 
pregnancy rates, or transfer more embryos and risk high rates of multiples in order to 
produce comparable success rates. 
 
*** 
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Public Insufficiencies  
 
 
 
Figure 33. Mural outside of a public hospital in Buenos Aires. Photo by Kelly Raspberry, 2004 
 
 
It is 10:15 am on a Thursday morning at the end of December in 2003; I am 
standing in a partitioned medical consultation area in the endocrinology division of 
Hospital Bolivar. I can hear the doctor-patient conversation in the consulting space next 
to mine. These ad-hoc room dividers, though convenient for space-saving, offer no 
clinical privacy. There are two white plastic chairs and a small table in this area. The 
windows are opaque plastic and the entire room is lit by overhead fluorescents. There is 
no air conditioning to temper the humidity of the already-hot summer day. On my way up 
to the third floor at 8 am this morning I passed crowded waiting rooms on each level, 
with patients overflowing into the stone hallways and down the stairwells. Patients must 
arrive early—between 6 and 7 in the morning— to take a place in line in order to receive 
a number to be seen by a doctor. These numbers are passed out at 8 am, those who do 
not get a number must come back another day and try again. The convenience of a fixed-
time appointment made over the telephone is a luxury that does not exist at the public 
hospital. 
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 I go to the main consultation office, which is slightly larger than the partitioned 
rooms and houses a wooden desk, a wooden chair and three plastic chairs. This is where 
the coordinator of the low-complexity assisted reproduction program at the hospital, 
gynecologist Rodrigo Díaz, attends patients. A long sheet of hand-written names posted 
on the wall is the waiting list for microsurgeries. Microsurgeries within the 
endocrinology department have been suspended for the last six months due to over-
demand for the shared surgery rooms in the hospital. I count about 50 names of people 
who wait indefinitely. Another list celebrates pregnant patients in 2003, I count only 14 
names. Another gynecologist has just poked her head in the door and told Díaz that she 
has a patient who has a myoma and needs to consult with him.106 She explains that the 
woman is 36 years old and shows him the woman’s ultrasound test done at SER. Díaz 
also looks over the handwritten index card that serves as the patient’s medical record.  
The couple is asked to come in and sit down. Díaz tells both the man and woman 
that a myoma in the uterus may or may not interfere with getting pregnant. In case, given 
the size of the myoma it probably will have a negative influence. There is a microsurgery 
technique that he can do to take out the myoma, and  this will probably help. The man 
and woman nod, and the woman says that she understands that it’s also possible to look 
and see if she has endometriosis. Díaz agrees and says that dong a laparoscopy would 
allow him to see if there is endometriosis at the same time as taking out the myoma. 
However, they need a specialist like himself to do the microsurgery, not just any 
gynecologist can do it. He asks if they have any health insurance and gives them two 
options. Either he puts them on the waiting list for microsurgery here at Hospital Bolivar 
and they wait, or they find a private center covered by their insurance to do the surgery. 
                                                 
106 A myoma is a benign fibroid tumor in the uterus. 
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It will cost around 200 pesos (about $70 USD) at a private place. He tells them to come 
back on Monday and tell him what they have decided to do. The woman says that she 
wants a uterus that is okay and starts crying. She asks if she undergoes the surgery, for 
how long afterwards does she have to wait to try to become pregnant. Díaz says that he 
can not tell her for sure before doing the surgery because he has to see what the fibroma 
is like, but it should not be more than 10-12 months.  
I am standing against the wall, watching this entire interaction and I register the 
shock that crosses this woman’s face when she hears this time-table of delay. She tells 
Díaz that it has already been three years of trying to get pregnant. He says again that it 
takes at least eight months to recuperate after surgery, and she repeats forcefully that she 
has already endured three years of waiting, and now he is telling her it will be another 
year. Díaz tries to soothe the woman, saying that he knows it is difficult, but this is the 
only thing she can do, this is the only path to take. If she does become pregnant now, then 
she will likely miscarry because of the myoma. She nods and says that she thinks this 
might have already happened during what seemed like a heavy menstrual cycle.  
Díaz says that he is sorry to the couple, and that he knows it is hard and that they 
are grieving. The woman says that the time factor is the hardest part. Díaz agrees but 
says there is no way around this. He can’t offer any other information without knowing 
where in the uterus the myoma is and exactly how big it is; these factors affect recovery 
time. The woman is calmer now and says she understands, but it is hard. Díaz spends a 
few minutes writing notes on her medical chart while the couple sits and waits. Two 
gynecologists come in and discuss a different patient’s case with Díaz. Once again Díaz 
tells the couple that theirs shouldn’t be a hasty decision, but that they need to decide 
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what to do. They agree that they need to do the surgery. The woman has brought a 
booklet of centers covered by her insurance plan and begins looking through it. Díaz 
looks and only finds one center listed at which he is permitted to work. He advises her to 
call and tell them that she needs surgery for a fibroid and she is coming from Hospital 
Bolivar. He then says to come back on Monday and tell him what has been arranged. The 
woman says okay and the couple stand to leave, Díaz kisses the woman’s cheek and 
shakes the man’s hand. 
 
*** 
 
 
Figure 34. Public hospital in Buenos Aires. Photo by Kelly Raspberry, 2004. 
 
 
“I think that it [doing ART] is going to be linked to…whatever the state of public health 
is in Argentina. To think today that a hospital will have this, seems like a utopia. A 
hospital is a place where the priority is to operate on patients with cancer or give priority 
to urgent pathologies. As long as things continue like this, where we don’t have supplies 
necessary to be able to satisfy even the basic needs of emergency medicine, I think that 
we are still far away [from having ART]. If the country really improves and is positioned 
as a country solidly on the way to development, then I think that in the long run it will 
happen.”  Biologist at the low-complexity lab at Hospital Bolivar 
 
 
 213
In the ideal world of ART production in Argentina, all of the state-funded public 
hospitals would provide free high-complexity ART services to anyone who wanted to use 
them, in cities and towns across the nation. In the actual world of ART production in 
Argentina, the only public hospital in Argentina that provides some form of assisted 
reproductive medicine is located in a working-class neighborhood (Almagro) of Buenos 
Aires. Hospital Bolivar is a complex of large, run-down buildings that occupy an entire 
city block, and sits across from a large circular park that includes the Natural Museum of 
History and an Observatory. The hospital is accessible by numerous city buses and a 
subway line about 10 blocks away. Hospital Bolivar’s assisted reproduction offerings are 
housed within the department of endocrinology—composed of a team of dedicated 
physicians and a biologist, but not a clinic in itself—and are limited to infrequent 
microsurgeries (i.e. to remove ovarian cysts, cut away endometriosis) and low-
complexity hormone stimulation and intrauterine insemination treatments.107  
Hospital Bolivar is the reference hospital for the city of Buenos Aires, and 
depends on the Buenos Aires city government for funding. Though it maintains a 
reputation for quality medical care, since the crisis in 2001 the hospital’s budget has been 
cut, and doctors often go on strike, protesting the lack of such basic supplies as sterile 
gloves. In the past, Hospital Bolivar was a middle-class neighborhood hospital. Now the 
majority of patients come from Buenos Aires province. Some are unemployed and in 
general they represent a lower-income group than the patients who used to access the 
                                                 
107 Apparently at one time the public hospitals Hospital Rivadavia, Hospital Fernandez and Hospital de 
Clínicas—all in Buenos Aires—had some form of low-complexity program. At the time of this fieldwork 
the status of those programs was unclear, as they shift with the flux of economic resources and hospital 
staff. Those working at Hospital Bolivar were fairly certain that the other programs weren’t in operation at 
the time. The latest news, at the end of 2006, is that Hospital de Clínicas is beginning a low-cost public 
program of high-complexity ART, the first of its kind in Argentina. Funded by the University of Buenos 
Aires (rather than the city government like Hospital Bolivar), Hospital de Clínicas is fee-based, though the 
fees are lower than at a private center. The details of this new public ART program are not yet public. 
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hospital. The economic crises in the country always hit the middle-class hardest and the 
crisis of 2001 was no exception. In this climate of budget shortages, reproductive services 
are not given much attention. As one gynecologist told me,  
Reproduction in the hospital is not a priority. So, we have a list of patients that are 
waiting to be operated on and they don’t have any other possibilities and they 
have to wait. Imagine a woman that comes because she wants to have a child, and 
while we are examining her, we find that she has a fibroid in her uterus…a 
myoma in the uterus that has to be taken out. The woman wants to do it now, she 
doesn’t want to operate in a year and a half. Well, if you want to do it now, you 
have to find a private doctor that can operate now. […] But people who don’t 
have economic resources can’t do anything else, they have to do it here and so 
they have to wait. 
 
At Hospital Bolivar, all doctor consultations are free, but patients have to pay a small fee 
for any analysis tests (i.e. ultrasounds, x-rays) done at the hospital. They also have to pay 
for medication. For this reason the gynecologists at Bolivar often prescribe the cheaper, 
generic hormone drugs.  
The assisted reproduction team at Bolivar attends to patients three days a week 
(Monday, Tuesday and Thursday), from approximately 8:30 to 11:30 AM. There are 
three gynecologists, two andrologists and a shifting group of residents in training who see 
patients. Returning patients do not meet with the same doctor unless they request to do 
so. Two of the gynecologists volunteer their time; they are not paid by the hospital for 
their work but instead explain that they benefit from the training and collaborative 
environment of working in a public hospital. In a given day, about 30 patients pass 
through the consulting rooms with a variety of reproductive problems. Only about 150 
patients per year ask for assisted reproduction services, and of that number, about 30-40 
per year go on to do IVF or ICSI at a private center. The extent of assisted reproductive 
care provided at Bolivar is therefore very low-tech: it encompasses monitoring ovarian 
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hormone stimulation, sperm diagnosis and analysis, and intrauterine inseminations with 
processed sperm.  
Hospital Bolivar has a referral agreement with two private centers in Buenos 
Aires, Institute of Reproductive Health (ISR) and SER, for high-complexity infertility 
cases.108 Patients referred from Bolivar for an IVF or ICSI cycle will pay a lower cost at 
ISR or SER than if they go to the private center on their own. At Bolivar, the cheapest 
methods of becoming pregnant are tried first; no one is referred to ART until they have 
first attempted three intrauterine inseminations with hormone stimulation. In cases of 
male infertility, the less-expensive option of using a sperm donor is often suggested over 
the high-tech alternative of ICSI. In ART cases, a gynecologist at Bolivar oversees the 
analysis tests and the hormone stimulation while the private center takes care of the 
more-technical egg aspiration and embryo transfer. Even with this reduction in price 
many patients can not afford ART, one gynecologist told me that out of ten patients 
referred to a private center maybe two will be able to pay for an IVF or ICSI treatment. 
An andrologist who works mornings at Hospital Bolivar and afternoons at a private ART 
center told me that though prices of ART have become more accessible, many of the 
people who come to Bolivar still can not afford it:  
It [assisted reproduction] used to be much more expensive, so it was almost 
impossible for our patients to access. But now there are more groups providing it, 
there is more competition, and like everything, with time technology becomes less 
costly, it is cheaper, and it becomes more accessible to everyone. But even so, for 
many couples it is still impossible to pay what they ask for it and they are not able 
to do the techniques. 
 
Though it is better than no program at all, Bolivar’s public low-complexity program is 
not sufficient to address the stratification of access to ART in Argentina. Making ART 
                                                 
108 This informal agreement apparently began around 1999 or 2000. Referral to either ISR or SER depends 
on who is promising the lowest price at the moment (more recently this has been SER).  
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available without any cost to patients would require a major investment on the part of the 
government, a prospect that seems implausible at present. 
 
Daily Difficulties 
“In the United States they have everything all right there, they have a totally different 
economic level in the country, it is a totally different reality than ours. The difference is 
appalling. But not a terrible difference in terms of training and capable people who work 
in the centers, because in fact, in terms of CREAR, we are all very well trained […] we 
are very skilled. And in that I don’t think we have differences. We have the limitations of 
this country that we live in, of the economy in the country where we live…There, down 
below, where the map ends, everything is much more difficult for us.” Marta Romero, 
biologist at CREAR 
 
The realities of performing ART in Argentina, even in the private medical sector, 
include practical difficulties that are not experienced in Northern sites of production. 
While clinging to their credentials of modernity—comparable success rates, ISO 
certification, ethics committees—Argentine doctors also concede that there are 
significant local difficulties in producing ART. These include the instability of the 
national economy and the fluctuation of a patient population that can afford the private 
services; the costly importation of all high-tech equipment and laboratory supplies; the 
influence of Catholic ideologies; and the lack of national funding for research and 
development.  
To begin with, ART is a temperamental technique that often does not “work”; 
twenty-five years after the first IVF baby, general pregnancy success rates in centers 
around the world are still well below 50% (Adamson et al. 2006; Andersen et al. 2006; 
CDC 2006; Gleicher,Weghofer and Barad 2006). There are still many unknowns in the 
field, and research into human reproduction is an ongoing endeavor. The success rates in 
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an ART laboratory are sensitive to minor modifications; dramatic changes can result from 
using a different biological media or Petri dish. I witnessed this first-hand as my 
observation visit to one of the centers in Chile, Santiago Clinic of Reproductive Medicine 
(CERS), in November 2003 coincided with an unexpected and distressing drop in their 
success rates. Though I sensed the tension when I first arrived, I didn’t understand what 
was happening until one of the gynecologists finally explained to me a week after I 
arrived, in the middle of November 2003:  
At the end of the interview, I ask if I might watch an aspiration while I’m here, 
and [doctor] asks if I want to get him killed. Then he explains that I have come at a bad 
time because they have just found out that their pregnancy rate results went from 50% to 
35% and then last month to 28%. Everyone is worried and trying to figure out why this 
extreme decrease in success rates happened. He tells me that is why [center director] is 
so aggressive about not letting me into the lab right now. They are all trying to be extra 
careful and to see if they can get the rates back up.  He then says that possibly I could go 
to an aspiration if it is a Saturday and the husband isn’t there and the boss isn’t there. 
With all these conditions, what he is saying sounds like a polite “no” and indeed I leave 
Chile without observing inside that center’s laboratory.  
The laboratory and the biologists who work inside the lab are vital to an assisted 
reproduction center’s success, and conditions must be carefully controlled. As this 
excerpt from my fieldnotes emphasizes, an unexplained decline in rates is cause for much 
concern. One director of an embryology lab in Buenos Aires was emphatic in telling me, 
“The truth is that the success of an in vitro clinic is fundamentally in the laboratory, it’s 
like a restaurant. It’s important for it to be nice inside, but the most important is the 
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kitchen, isn’t it? In the clinic it’s important that everything work well, but the most 
important is the laboratory.” As this chapter reveals, there difficulties in Latin America to 
running a high-functioning ART laboratory that have more to do with local circumstances 
than with enigmas of the field. 
  Doing assisted reproduction in Argentina implies a substantial amount of 
importation from the United States and Europe—of materials, supplies, equipment, 
techniques and skills. Argentines therefore must not only have considerable financial 
resources to navigate in this Northern-dominated world, but also a facility with English, 
and ingenuity for accommodation. One gynecologist describes the process of importing 
and translating technology from the US, as a “follow the leader” process:  
And what we have to do is to follow the leading societies. The United States is a 
power that is a leader in many things, including in medicine. That is why they do 
the practice and give the results and we assimilate it, we copy it. It is logical that 
we are going to arrive at least three years late with everything. I don’t know, 
before the gap was much greater…It seems to me that globalization not only, in 
the case of Latin American countries, improved their level from the medical point 
of view, but also that the United States lowered a little. 
 
While the influence of the North as key to Argentina’s production is clearly emphasized 
here, so too is that of globalization in narrowing the gap between sites of production and 
importation. This gynecologist sees less difference now between the United States and 
Latin American countries because of the global spread of technologies. However, 
keeping the lab well-stocked with biological media, and the surgery room with necessary 
supplies, is not a simple matter for professionals working in Latin America. Because 
most of these products are fabricated elsewhere—the most commonly used brands are 
made in the United States and Europe—the biologist and clinic coordinator must be 
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vigilant about pre-ordering supplies to allow enough time for their travel and passage 
through customs. This embryologist summarizes,  
You need a new incubator, it costs $9000 dollars. For you [in the US], it is a lot of 
money, I’m not saying that it isn’t a lot of money…But you move in a different 
economy, it is a rich country…it is the number one country in the world. Because 
of that it is totally different for you than for us to obtain $9000 dollars. We are 
totally broke, in debt. 
 
This is a costly business for Latin Americans who earn local currency but must pay for 
the equipment, disposable supplies and required medications in either US dollars or 
Euros.  
The problems involved in importing media and supplies became clear to me one 
day while interviewing the head biologist at a center in Latin America. Our interview on 
a Thursday afternoon was interrupted by several phone calls, one of which was from the 
supplier of biological media used in the laboratory. The biologist was explicit about my 
not recording the phone call, and only talked to me about this problem “off the record”:  
The first interruption seems to be a phone call related to a shipment of culture 
media problem. Apparently an order of media was very late, the first time that this has 
happened in [biologist]’s experience. He tells me all this later. I watch [biologist] make a 
face about what the caller is saying and hear him say that this clinic has better results 
than 80% of the clinics in Latin America. Then he talks to him about the transportation 
problem they’ve experienced and that they used to have a direct transportation 
agreement with the supplier. For the last 1 ½ years they have been going through this 
middle person and the conditions for using this middle person are that things arrive on 
time and fresh, otherwise the work in the lab is trash. This is a paraphrase of what I hear 
him say. Then he tells him that they were in a difficult position, trying to get other media 
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since the ones they ordered hadn’t arrived. He motions me to turn off the microphone 
while this phone call is going on, and is very attentive to protecting the security of what 
he is saying. When I ask him about the phone call afterwards, he tells me that he needed 
to find other ways of getting media, and then adds that these ways aren’t unethical or 
illegal, but it was a complicated situation, and won’t explain anymore than this. He 
makes a few phone calls to someone about this. About half an hour later there is another 
phone call, it seems to be about where he can find some available media and pick them 
up.  
This incident is a telling example of the frustrations and difficulties of doing ART in the 
Southern Hemisphere. In the US the ease of obtaining necessary laboratory materials and 
supplies is taken for granted, but in Latin America it can be a costly obstacle to daily 
work.  
  In addition, ART equipment, such as microscopes, incubators and air filtration 
systems are very expensive. Therefore centers in Argentina do not often buy new 
equipment. They “make do” with last-year’s models until they can save enough for the 
current model. Because of this, they are sometimes at a technological-disadvantage in 
their work, as this gynecologist explains, 
There is a difference in technology, which is very important, isn’t it? Those in the 
United States always have more equipment, and it is newer. We take longer to 
change a piece of equipment. So, in the United States they are going to change the 
incubators as well as the microscopes…maybe every year they change and they 
have a modern, better, new device, and we have the same one for five years. 
When we first buy them they are great and then they begin to be slightly out of 
date. That is a central element. The modernization of equipment and the latest in 
equipment. 
 
In addition to not buying the latest technology every year, centers in Argentina often 
“make do” with less equipment over all, a limitation which can compromise the work 
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itself. A biologist at one center spent two weeks training at Cornell (in embryo 
cryopreservation) in 1999, and returned to Argentina impressed by the high quality of 
work made possible with additional equipment:  
When I was at Cornell, at the time they had ten incubators. Ten, and they had 
three micromanipulators. Here you make an incredible effort to have three 
incubators and one micromanipulator. But maybe the level of quality would be 
much better because the day that you have five ICSI cases to do, you could have 
two people sitting down at two micromanipulators and you can do the work in 
half the time, that otherwise takes you five hours. 
 
In this estimation, the economic restrictions of working in Argentina make it difficult to 
produce the same quality as a place such as the United States where such constraints do 
not exist.  
Because it is exceptional, the introduction of cutting-edge equipment is often 
made into an elaborate affair designed to garner public attention. For example, in January 
2004 the private ART center Halitus bought a 4-D ultrasound machine and paid for an 
announcement in La Nacion to publicize its arrival. The advertisement disguised as a 
piece of journalism, reads:  
The medical institute Halitus at the end of this month will introduce a new 4-D 
ultrasound, of the latest generation in technology, after an investment of $300,000 
dollars. It will be added to the one bought last year. The medical institute, which 
specializes in assisted fertilization, carried out more than 1100 assisted 
reproduction treatments of high complexity in 2003.109 
 
As I discuss in this ethnography, ART professionals in general try to not draw public 
attention to their work in order to avoid potential social conflicts. However, as this 
announcement demonstrates, they would like to be known for their advanced equipment 
and technology. Given these less-than-ideal circumstances, many reproductive medicine 
                                                 
109 See www.lanacion.com.ar/565495. 
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professionals in Argentina agree that if you can manage to do good medicine in this 
environment, it is “because you are really good.”   
Alongside not having local sources of supplies and equipment, there is very little 
funding for original research in Argentina. Because research is not a priority, technical 
advances in the field are imported along with the materials. This reliance upon 
importation—of materials, skills and techniques— is identified as a major disadvantage 
for Argentine professionals, contributing to a sense that they are only replicating what 
others develop: “The big difference between Argentina and Europe or the United States is 
that we can copy technology, but not develop it, because there is no budget allocated for 
research.”  The lack of research and innovative development in assisted reproductive 
techniques contributes to a sense that Argentines are “behind” their international 
colleagues who have more funding for investigation. As a site of production rather than 
innovation, Argentine ART is invariably located far from the center. Argentine 
professionals themselves say that it is necessary for international colleagues to evaluate 
them on an individual basis because otherwise their national and regional reputations as 
Argentine or Latin American lead to indifference and dismissal—as gynecologist 
Leandro Gallo at CREAR, told me, “They think we are good professionals but 
that…well, that we don’t do research, almost none…and that we only work, we copy 
what the others do.” A feature article on scientists in Argentina published in 2006 in 
Clarín’s weekend magazine, Viva, further highlights the problems of doing science in 
Argentina, and echoes what these reproductive medicine professionals told me (Aizen 
2006). A neuroscientist who recently returned from the US and is now working at the 
University of Buenos Aires is quoted as saying,   
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we are behind in being able to do good science, simply because here you spend a 
large part of your time in bureaucracy, materials take time to arrive and cost 
double. The money that they give you only allows you to do science to a certain 
point, with none of the latest technology. The only ones who have the possibility 
of publishing are a small group who has agreements or grants with people abroad 
(Aizen 2006:20). 
 
These sentiments encapsulate precisely the same problems that plague the private sector 
of assisted reproduction. In addition to a lack of funding, a deficiency of systematic 
quality controls also affects the ability to do research and publish. In 2003, Julieta Moretti 
explains to me that putting such controls into place at CREAR has taken time:  
Here [in Argentina] you don’t have everything systematized, like you aren’t 
involved so much in the quality controls and the…the routines to be more 
reproducible. Here you are like, ‘well, today I feel like it, I will check,’ and ‘today 
I don’t feel like it, no.’ Now you are much more trained. It’s the same thing with 
the doctors’ records. Before they didn’t write anything down. We didn’t know if 
the patients were getting pregnant and that is absurd, you have a lot of statistics 
without being able to use them, before we didn’t have any access. With the 
inseminations, let’s say until a year ago when we made a special form, because 
we do about 400, 500 inseminations per year, which is a lot of numbers, a lot of 
work to publish, then they didn’t know anything, not even how they were 
stimulated, so you couldn’t do any type of research from it. So now we ask them 
to fill out this form with all of the information. 
 
Methodically recording and tabulating the daily work of ART allows centers to publish 
articles based on clinical cases, however compiling such statistics requires systemization, 
a component of ART work that must be “imported.” 
The small amount of research that is produced in Argentina (often in collaboration 
with US or European colleagues) is celebrated as a sign of modernity and prestige. For 
instance, an article published in La Nacion in August 2002 begins by announcing a 
research publication on a new technique for detecting problems in sperm, proudly 
declaring that “three Argentines participated in the work which was published in the 
prestigious journal Human Reproduction” (Navarra 2002). The newspaper piece goes on 
 224
to describe the actual technique, called SUTI (Sperm Ubiquitin Tag Immunoassay) and 
the hopes that it will be helpful in resolving cases of what these specialists term 
“infertility without apparent cause”—which makes up 30% of all infertility cases. The 
notable aspect of the article is the emphasis on the publication of this work in a reputable 
journal published in English, and the positive spin on such technical advances. 
Furthermore the US collaboration is downplayed, mentioning only one of the two North 
American researchers (Peter Sutovsky), thereby leaving more credit for the Argentines 
involved.110  
  
Conclusion 
The production of ART in Argentina is a localized blend of particular morals and 
norms and the messiness of daily practice. As I discuss in this chapter, there are ideal 
notions that encompass: who the patients are (the kinds of families being made); the 
economic accessibility of the procedures; the types of regulations in place; the success of 
the procedures; and the prestige of the professionals. But during a typical day of doing 
assisted reproduction techniques, most of these ideals are not realized. Market demands 
are increasing the accessibility of ART for single women, lesbian couples and older 
women, while the high costs of this private medicine continue to exclude the lower 
classes. Regulation continues on an individual, non-standardized basis, with the ever-
present possibility that the Catholic Church’s opposition to these practices may prevail in 
the legislature. The achievement of good success rates are accompanied by problematic 
high multiple pregnancy rates and the burden of imitation rather than innovation.  
                                                 
110 Two of the Argentine authors are from CEGyR (Brugo Olmedo and Rawe) and one is from the public 
Children’s Hospital in Buenos Aires (Chemes). Two of the US researchers are from University of 
Missouri-Columbia and one is from the Oregon Health and Science University.  
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In this chapter I examined the complex field of actors that converge to produce a 
local culture of assisted reproduction in Argentina. This production of assisted 
reproduction practices in Argentina is necessarily one of mutual influence—dependent on 
local conditions, but also shaping them in turn. Although presented here as semi-
disaggregated, these facets of Argentine life—a Latin American “superiority,” the 
importance of family and motherhood, ambiguous legislation, Catholic influences, —are 
intertwined and dynamic forces in the making of assisted reproduction in Argentina. In 
the next chapter I discuss the hierarchy of “choice” in making a family in which adoption 
is the least preferable option, to be considered long after the use of donor gametes. I also 
look at the careful controls ART professionals place on gamete donation in an attempt to 
self-regulate the market aspects of ART in Argentina. 
INTERLUDE III 
 
 Twelve Tries, One Daughter 
 
 
Fernanda Barberis is 45 years old when I meet her in 2003. She is involved in the 
Ethics Committee at one of the centers, and is one of the founders of Argentina’s non-
profit patient support group. The patient group organizes twice-monthly support group 
meetings, and larger informative conferences twice a year for heterosexual couples who 
have infertility problems. I quickly find out that Fernanda has a long personal history 
with assisted reproductive techniques which dates back to the mid-1980s. She has done 
12 high complexity treatments including egg donation twice. One of those attempts 
worked for her—she has a thirteen year old daughter. She thought about, but never tried 
to adopt. Here is her story:  
I began with the treatments in 1985. In reality my problem appeared in 1982 and 
back then I was with a doctor that wasn’t up to date, so I lost two years. That is why we 
counsel couples to go to specialty centers. Whether they are public or private, because at 
the public hospital they don’t do high complexity treatments. That is the issue. Everything 
is for the same reason, that there is no law, there are no subsidies, so…But even so, at the 
[public] hospital when the couple needs high complexity assisted fertilization they refer 
them to private centers with a hospital fee. Times are different now.  
So at the root of my problem…I felt it very alone, with my husband, when we were 
in treatment. Because imagine, that was in 1985, a long time ago, almost 20 years ago, 
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and then it was spoken of less than now. [Kelly: IVF began in 1985.] In 1985, yes. […] 
Gómez was my doctor. He was always my doctor. And so, I felt very alone, you see? 
Apart from that the anguish of not being able to have children like everyone else, which 
is obviously a part of life, and everyone around you—friends, siblings, sisters-in-law, 
they can have them and you see their pregnant bellies moving and well…That is the 
anguish that always comes out in the [counseling] groups. The relationships with family, 
within the couple, it is very powerful. And  it is an issue that wasn’t talked about at that 
time. Imagine that to talk about in vitro fertilization, even though it began in 1978 and 
the first one was Louise Brown, it was still taboo. It was something from science fiction.  
 Well, much later I had my daughter who is old now, she is 13 years old now. 
Thirteen, almost fourteen. She is very little there [points to a photograph]. I have to 
change that one, the photograph is a little behind. After many treatments, because I have 
blocked fallopian tubes, and my problem is endometriosis. So it [IVF] was the only way. 
First, they tried operating on me, they did inseminations.[…] Well, I tried many 
inseminations, many operations. Now they don’t try so many, they try three or four 
inseminations and if they don’t work, you go to an in vitro. But well, times are different. 
And so, at the end…in 1988 I did the first in vitro and they transferred five embryos, and 
I became pregnant. Yes, they used to transfer more embryos, as you see. But one 
implanted. But it wasn’t her [the daughter]. After two months I lost it. Because I had a 
hematoma between the placenta and the fetus and…it stopped developing. It was 
horrible. […] 
 I had already paid for three attempts, because I was paying for every three—it 
was a plan, it was cheaper, I don’t know. The second one didn’t work. And they 
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transferred two embryos in the third attempt, not more than that, and one stayed. Her. 
That was in 1989.  
 Then I tried for a brother with eight more in vitros. [Kelly: Eight?]. Yes, I did 
twelve in total. Don’t look at me like that. (laughs). [Kelly: Wow.] In the middle of all 
that for a second one…I wanted to have a second child, I lost another pregnancy because 
it was an embryonic pregnancy. In other words it implanted but after that it was 
reabsorbed, which was awful because she had already asked me for a brother, and I told 
her that I was pregnant. Her face was so happy, I will never in my life forget that, 
because of course she saw in school that everyone had siblings. And she has many 
cousins because my husband has seven siblings, we are a very large family. I have a lot 
of nephews and she saw that everyone had siblings. So I explained to her, which is a 
whole different issue, to explain it, ‘it isn’t that I didn’t want to but that mom and dad we 
can’t because…’ Well in that moment I explained to her that when I was younger I had a 
blocked tube and that…that the seed couldn’t take root and it couldn’t form the baby.  
 
*** 
In other words, more or less I passed through all the techniques that you know: 
insemination, high, low, middle…with stimulation, without stimulation…fertilization with 
ICSI, without ICSI, egg donation. But okay, I was lucky. In other words, in my ranking 
one child is little because I did so many [attempts], but well, thank goodness I did have 
one. Because there are some women that also did a lot and they never got pregnant. And 
this is a lottery also because the fact of getting pregnant or not, it doesn’t depend on you 
nor on the doctor. Once they do the transfer, what happens inside there no one knows. 
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Because not even the doctors know very clearly when the moment of implantation is, and 
why it implanted or didn’t implant. 
 
*** 
 I was really hooked. In other words, my goal was to have a child. When I married, 
I began with problems, I had a tumor, they had to operate on me, in other words I 
already knew that I was coming with a complicated thing. I wanted to have at least four, 
five children and I got married and I didn’t use protection. I wanted to get pregnant on 
my wedding night, as soon as I came back from the honeymoon. It wasn’t like that…After 
three months I went for a check up and they discovered a tumor this big, benign thank 
goodness, and after that I began the race against infertility. I am going to repeat, I had 
two years with a doctor that said the infertility was my husband, and the problem was 
actually me. I didn’t know to look for a diagnosis. He told me to go on vacation. I went 
on vacation and I came back…Apart from that, 90% of infertility causes are of organic 
origin. Only 5%, no more, can be psychological, the psychologists say. And then, I began 
with a specialist that they recommended. My mom found him, I don’t know who had 
recommended him, in this case it was Gómez, when IGyR  didn’t exist yet. And 
immediately they did a laparoscopy on me, you know when they study you from inside? 
[Kelly: Yes.] And they found endometriosis. And so then they operated on me.  
Everything that he said, I did it, because I wanted to have a child. And in its 
place, in place of having children, I did dentistry classes. In other words I made myself 
busy with my career, and the treatments. The two things. In order to save money, to do 
the treatments, we worked. In that time I was earning more, there was more money 
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everywhere. I spent a lot of money on this. I don’t regret it. And then, when the time came 
that there was no way to get pregnant, I decided…the doctor and I decided to do an in 
vitro. And then, after she was born with the third attempt, I said, ‘okay, if I got pregnant 
once, I can do it again.’ Always with in vitro. I couldn’t naturally, I never could.  
And then one, another…And sometimes I wondered when I was going to say, 
‘enough,’ when I was going to stop. And as long as I had the money, as long as we had 
the money for it…at the end the doctor didn’t even charge me. He didn’t even charge me 
because I was already a friend, you know? And well, when I did the last one…then, of 
course, when my eggs didn’t work any more, the doctor told me, ‘enough.’ He told me 
‘enough, enough, stop now.’ And I said to him, ‘and what else is there?’ ‘Egg donation.’ 
‘Okay, egg donation.’ I did two egg donations that were technically very good because 
they transferred good embryos, but I didn’t get pregnant. So then I said, ‘okay, that’s it.’ 
I was almost 40 years old. I am 45 years old now. And I said, ‘no, enough, I am 
old already.’ My ovary had already started to bother me, I had a cyst, because of the 
many things that they had done to me…I was at the point of being operated on for a 
hemorrhaging cyst that was produced in the…In nature when the follicle, when the egg 
leaves the follicle, if you don’t get pregnant that follicle is reabsorbed. If you get 
pregnant, it transforms into the ‘yellow body’ in order to give you progesterone. Well, in 
my case as I wasn’t pregnant, and didn’t reabsorb, it filled with blood and then when it 
broke…it gave me a hemorrhaging cyst, of blood…and it really hurt! [Kelly: Oh no.] 
They did an ultrasound and my ovary was like this [gestures that it was big]. And there I 
said, ‘okay, enough.’ So much medication, so many things bothering that ovary, the left 
one. And I was at the point of operating on it, and I said, ‘no, enough.’ Luckily, with 
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medication it went down and with an ultrasound check up we saw that it was okay, and 
then we said, ‘enough.’  
That was five years ago that I stopped…And that was my limit. There are some 
who get tired much sooner, they do one or two, they fail and they don’t want any more. 
Others can’t continue for economic reasons. Now that is happening, that happens. They 
can’t…now no one could do twelve in vitros. Speaking economically, it is impossible. You 
have to be a multimillionaire. I had asked for money, you can imagine, from everyone at 
one time: my father, my father in law, my friend…Later I returned it, I could return it. 
But when I was doing the treatment, sometimes I didn’t have the money and the doctor, 
by the end, I’ll tell you again, he didn’t even charge me for them. The last ones he did 
totally free. The last four. Before that he told me, ‘you put the money that you can gather 
together in an envelope for me.’ [Kelly: And all the treatments were with Gómez?] Yes, 
yes. […] 
 
*** 
[Kelly: Did you think about adoption?] I thought about adopting. My daughter 
even told me, ‘mom, why don’t we adopt?’ But my husband didn’t want to. He wasn’t 
interested in adopting, after having her. Before having her, when we had failed, when I 
lost the pregnancy and we had two attempts left already paid for, then we said that if the 
third try didn’t work, we would adopt. We had put that limit. […] But when I became 
pregnant on the third try and she was born, I said, ‘I’m continuing.’ In that moment if the 
third in vitro attempt had not worked, we had decided to adopt. But she was born and I 
said, ‘no, if I had her, I’m continuing.’ And then when I stopped the treatments she said 
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to me, ‘why don’t we adopt?’ and I said, ‘yes,’ and I filled out all the paperwork and 
everything…because a friend of mine did the paperwork for me and sent it to me. And my 
husband wasn’t interested. So, because if had been for him, when our daughter was born, 
he would have ended the treatments. He wanted one child and he already knew it was 
difficult. […] Well, my husband didn’t want to adopt. So, if one of you doesn’t want to, 
we said, ‘okay, that’s enough, that’s it.’ And that is how we stayed.” 
CHAPTER THREE 
 
“THE FERTILE MARKET”: ARGENTINE VARIATIONS ON ADOPTION AND 
GAMETE DONATION 
 
Gamete donation refers to the use of third-party donor sperm and egg in 
combination with insemination, in vitro or ICSI techniques. In most centers in Buenos 
Aires, the use of donor gametes is offered as an additional option for creating a family—
one that is privileged above adoption. However this option is a complicated one, 
involving as it does a third-party (the donor) whose presence is seen as having the 
potential to not only disrupt the social order of heterosexual parenthood, but also to push 
ART irrevocably into the realm of a commercial enterprise.  To minimize the impact of 
this third-party, centers insist on two immutable conditions: that the exchange is 
anonymous, and that it is “voluntary”—not financially-based. Therefore, all aspects of 
the gamete donation are regulated and controlled by the attending doctor and center. 
There is neither known donation, nor donor trait selection, nor are potential donors are 
offered large sums of money. The guiding principle is that so long as health professionals 
dictate the process of gamete donation, the practice is confined within the acceptable 
boundaries of medical treatment and medico-scientific rationality. However, as I discuss 
in this chapter, the flaw in this logic is one that continues to surface: the arena of 
reproductive medicine is not itself a “purely rational” space, but a hybrid of social, 
material, and political circumstances.  
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In this chapter I contextualize gamete donation practices within the local culture 
of assisted reproduction, arguing that the conditions of gamete donation in Argentina are 
tied to particular concepts of family, nature, genetic inheritance, the market, and Catholic 
beliefs. A cultural analysis of gamete donation can speak to a number of areas of 
anthropological interest, including gift-commodity exchange, organ donation and trade, 
commodification of genetic material and body parts, and gendered meanings of donation 
(Becker 2000; Cohen 2003; Scheper-Hughes 2000; Sharp 2000; Titmuss 1997; Waldby 
and Mitchell 2006). For the purposes of this ethnography, here I am most interested in 
examining this hybrid space of gamete donation to understand how ART professionals in 
Argentina reconcile competing scientific, social, moral, and economic claims on their 
practices. I argue that these professionals act as mediators who attempt to contain the 
influence of the market on medicine and science, and to preserve the social/moral order 
of a traditional nuclear family and valorization of parenthood. I begin with an 
examination of adoption, then discuss the conditions and controversies of gamete 
donation, objections to surrogacy, and end with a look at “prenatal adoption” or embryo 
donation. 
 
Adoption: “The Last Step” 
*** 
Augustina: Actually because my husband was still…I was totally convinced and I 
would have already adopted for some time. He was convinced of adoption too but 
he said “let’s burn all the possibilities, let’s try to do it,” for example, “for as 
long as we have the frozen biopsy. After the frozen biopsy, I’m not going to do 
another biopsy, so that’s it. We adopt.” So he agreed with the adoption but he 
wanted…to have all the possibilities of having our own child.   
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Kelly: Yes, but for example, if the last time hadn’t worked, how many times, how 
many times more do you think…? 
 
Augustina: I wouldn’t have tried any more. It was he who continued insisting, and 
there’s enough left of the frozen biopsy for one more attempt, not for much more. 
So… 
 
Kelly: It seems very difficult to decide.  
 
Augustina: To stop here, of course. But it was happening to me and I was already 
tired of everything. Of course, the one who is physically taking it, is the woman. 
Because, okay, the poor guy, he took it himself, in doing the biopsy, but that was 
it. They did it and period. The one who was physically taking it every day, getting 
shots every day, having blood taken…and the time…and thinking about it. 
Because the man, it’s like the man is more practical. And he was seeing that it 
wasn’t working…the beta was negative. Well, yes, he was sad, but that was it. 
‘Okay, let’s try again, that’s it,’ and he was wrapped up in his work, in his golf, 
and that was it. 
 
Kelly: Yes, separated a little. 
 
Augustina: Exactly. On the other hand, it’s like the woman suffers more, she 
suffers differently. For me it was very difficult. But okay, we had resolved that we 
were going to try until the biopsy was used up, and in fact there is enough for one 
more attempt and not much more, and so if it doesn’t work, we will adopt. 
 
*** 
“The last step for me would be adoption.[…] If before a certain thing didn’t exist, well 
you didn’t have another option and you had to do what there was. But now having other 
alternatives, and ones that I agree with, I would exhaust them first before turning to 
adoption.” Julieta Moretti, biologist at CREAR 
 
In Argentina, some say that family is the “pillar” of society. In chapter two I 
discussed the value of parenthood, and the predominant definition of family in Argentina 
as a heterosexual, nuclear one, which thereby excludes non-traditional family forms. Here 
I again examine the notion of family in the context of adoption and gamete donation. 
Why have assisted reproductive techniques—with their relatively low chances of success 
and relatively high costs—replaced adoption as the preferred method for making a family 
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for infertile couples in Argentina? The bureaucracy of the adoption system is a partial 
answer, but a more compelling one is the potent social value of biological parenthood in 
Argentina, illustrated by a common preference for even gamete donation over 
adoption.111 
Adoption is a time consuming and lengthy process in Argentina. There are no 
private adoption agencies in the country; the only way to adopt a child within Argentina 
is by submitting an application to the judicial system. Judges in Buenos Aires city and in 
provinces around the country use a registry of applicants to place children with adoptive 
parents. Waiting lists vary by place and therefore it befits an applicant to register in 
multiple places at the same time. The application materials to adopt include 
psychological and social work evaluations, proof of income and financial stability, proof 
of residence, criminal checks, HIV tests, photographs of the family, and a petition of 
reasons for adopting. There are two avenues to assembling this exhaustive application: 
one is through the state-run organization, El Consejo del Menor de la Familia, which is a 
free but prolonged process. There are also several private agencies—all located in 
Buenos Aires— that charge a fee to put together the required application materials and 
provide advice throughout the process. Though the private agencies shorten the time it 
takes to prepare the required application packet, and aid in signing up on more than one 
registry, they have no influence over the judicial-side of the actual adoption placement.  
Despite changes to the national adoption law in 1997, the adoption system is still 
inefficient and bureaucratic. The law as it stands today does not allow international 
adoptions (there is a residency requirement of 5 years in the country); requires a 
                                                 
111 See Bharadwaj 2003 for a discussion of the preference for secretive semen donation over adoption in 
India due to a social stigma of infertility and a desire to “hide” the disgrace of a third-party involved in 
making a family (which is possible through the secretive use of donor gametes but not through adoption). 
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minimum age of 30 years old (if younger, the applicant must be a married couple with 
either proof of 3 years of marriage or proof of infertility); and does not allow direct 
negotiations between the adoptive and birth parents—the attending judge is the primary 
intermediary. Adopting a child is also more difficult for single women, and prohibited for 
homosexual couples, as I discussed in chapter two. Furthermore the system is quite 
inefficient: though there are hundreds of orphaned and abandoned children living in state 
institutions throughout the country, there are also long waiting lists for adoption 
applicants to receive these children, and applicants must register with each area’s list 
separately. Leonor Wainer, president of Anidar, one of the private organizations, tells me 
that how long the adoption process takes, depends on the age of the child: “It depends on 
different things, if the family wants to adopt a baby who is under one year old, it can be a 
wait of two or three years. With older children it can be a year or less than two years, and 
with children older than six or seven years it is less than a year.” She also says that most 
of the people she sees have already tried several attempts of ART, and are now hoping to 
adopt a baby under two years—which means waiting several more years to make a 
family.  
Recently the adoption system has been under critique, with much media attention 
paid to the continuation of illegal adoptions in the provinces in which a couple will pay a 
judge directly to be given priority in adopting a child.112 These illegal adoptions, while 
motivated by the bureaucracy of legal routes to adopt, are reminiscent of the illegitimate  
                                                 
112 This type of illicit “adoption” takes place mostly in the poorest areas of the country, mainly the Northern 
provinces: Chaco, Misiones, Santiago del Estero, Jujuy. In the last year media attention has been focused 
on the “baby-trafficking” in Santiago del Estero. See Heguy and Rodríguez 2007.  
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Figure 35. “I want to adopt a father, his age doesn’t matter to me. Does my age matter to you?” 
National adoption campaign poster. January 2007. 
 
 
 
 
Figure 36.  “Even though he won’t have your eyes, he is going to be just like you.” National adoption 
campaign poster. January 2007. 
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“adoptions” that took place during the most recent military dictatorship.113  In December 
2003 President Kirchner signed a decree to implement a single national registry of 
adoption. However, since adoption is a matter of civil procedure, the provinces do not 
have to comply with the federal government’s decrees; as of January 2007 there are still 
no national figures for how many adoptions or adoption applicants there are in the 
country (Moreno 2005; Palacios 2007). As recently as January 2007, several of the 
organizations that aid in the adoption process launched a publicity campaign to encourage 
legal adoptions and the adoption of older children and siblings, under the idea that 
“children have the right to have a family.” 
On the other hand, inside the ART clinics, adoption is usually discussed as being 
a last alternative, something to try after IVF, after ICSI, and finally, after ICSI using 
donor gametes. Perhaps understandably, the focus is not on making a family in any way 
possible, but rather on creating a pregnancy and biological parents. For instance, when 
discussing options with a couple who has fertility problems, a doctor may include 
adoption as one alternative to think about, but very little time is spent discussing that 
option. One andrologist tells me that today he recommends semen donation over adoption 
for his infertile male patients, and recognizes that his preference for gamete donation 
influences his patients:  
The majority, now they choose, in my case, they choose donor semen now. Ten 
years ago, it was different. But also because... maybe because I thought 
                                                 
113 During the dictatorship, the children (particularly infants) of those who were captured and tortured—
commonly known as “the disappeared” (los desaparecidos)—were kidnapped and given to military 
families (and those with connections to the military) and illegally registered as their own. Today there are 
several human rights groups in Argentina working to uncover the identities of those “adopted” children: 
Las Abuelas de la Plaza de Mayo (the Grandmothers) and Hijas e Hijos por la Identidad y la Justicia 
contra el Olvido y el Silencio (HIJOS). As of February 2006, the Grandmothers claim to have “reclaimed” 
the identity of 82 of those children (their grandchildren) now in their late twenties through DNA paternity 
tests (see http://www.abuelas.org.ar for more information). This is a controversial issue in Argentina, as 
some of the “adoptees” have refused the DNA tests. See Arditti 1999 for a detailed account. 
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differently about semen donation also. […] If I had to choose myself, I'm going to 
choose donor semen because I'm going to be sure, at least more sure, that the 
genetic is normal, and that everything is normal. 
 
This doctor’s rationale, which he passes on to his patients, is that adoption is a risk as it 
includes many unknowns about the health of the child, whereas the use of gamete 
donation allows for more certainty as genetic testing is possible. Gamete donation is 
construed as providing the ability to be “more sure” about the health of the child. From a 
business point of view, recommending the use of gamete donation also keeps the patient 
inside the ART center, whereas adoption is completely external.  
There is also a pervading view—inside ART centers and without— that 
pregnancy is an inherently fundamental experience for women, one that should be made 
possible using whatever methods are available. This ties in to the social value of 
motherhood discussed in chapter two. The biologist Moretti summarizes: 
They tell you, everyone says that your thinking changes when you have a child 
inside. So I think that is why people try all these options…otherwise you wouldn’t 
get involved, nor spend so much money, nor complicate your life, nor get injected 
every day, you would go to…to adopt a child and that would be it. 
 
Similarly, when I ask Navarro if he thinks adoption is looked at differently in Argentina 
than in other places, because of the history of illegal adoptions, he tells me adoption in 
general is a difficult process, and also emphasizes the “innate” importance of pregnancy:  
Adoption…first it’s difficult, it’s difficult here, it’s difficult in the US, it’s 
difficult in Europe because there aren’t many children to adopt, little children, 
small ones, babies…There are a lot of children, but that isn’t the same. To adopt a 
seven year old child that comes with a history, isn’t the same as adopting a ten-
day old baby. There aren’t so many healthy ten-day old babies. And on the other 
hand, the maternal instinct of pregnancy is very strong. Women in general prefer 
to be pregnant. 
 
In these statements, pregnancy is identified as a “maternal instinct,” a primary aspect of 
female personhood. This cultural value that the experience of pregnancy is an innately 
 241
important life experience for women, works two ways. One is to make adoption a less 
attractive option for couples who want to make a family. Though the end product of 
adoption is parenthood, the woman “misses out” on being pregnant. Though it is not a 
direct experience for him, presumably the man in the couple also has a vested interest in 
sharing the project of his partner’s pregnancy. In this manner then, the assisted 
reproductive technique that can make pregnancy possible becomes preferable, even if it 
requires gamete donation. The use of someone else’s sperm, or someone else’s eggs, to 
create an embryo becomes desirable in the context that this “donation” allows for the 
experience of pregnancy and birth, and also genetic relatedness with one member in the 
couple.  
In this society then biological parenthood is given a priority above other ways of 
making a family. In some circumstances where full-genetic inheritance isn’t possible, 
gamete donation provides an acceptable approximation. Juan De Luca, a gynecologist, 
explains this cultural value of the “biological family,” one that he himself claims not to 
share:  
From a cultural point of view I think it is a mistake because the fact of being a 
mother is not defined through biology. But people still continue to believe that 
most of being a mother comes through biology. […] And that is partly due to 
what we call ‘family,’ and the importance of the family nucleus. I think much is 
due to that. You can see that here the ‘typical’ family, the usual family, normally 
has three children. Three or more.  
 
As illustrated in chapter two, the ideal for a woman is to be a mother—to give birth and 
make a family. Though the shared preference by both partners in a couple is to conceive a 
“biological” child that is genetically related to both parents, the second-best option is to 
pass on the genes of one part of the couple. The third-best option is to be able to gestate 
and give birth to a baby, even if it is not genetically related to either parent (as in the case 
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of embryo donation which I discuss later in the chapter). Because biological parenthood 
and pregnancy is privileged, the least desirable option of making a family in Argentina is 
therefore to adopt a child. In this milieu, the production of ART serves and reproduces 
the desire to have a child “of one’s own.” 
 
Indications for Gamete Donation 
“What happens is there is a certain number of patients who are totally azoospermic [no 
production of sperm]. And they need…In other words their only possibility of being 
parents, the couple, is with the reception of gametes. Sometimes it is the woman who 
doesn’t have eggs, or sometimes it is the man that doesn’t have sperm.” Gaston 
Gonzalez, biologist at CERS 
 
In ART centers in Argentina, the primary justification for gamete donation is to 
“enable” infertile couples to become parents.  As the biologist’s statement quoted above 
illustrates, gamete donation is often presented as “the only” way to resolve an infertile 
couple’s desires to have children. The primary indications for the practice are therefore 
presented as medical ones. The use of a semen donor is usually recommended for 
infertility cases where the male partner does not produce fertile sperm (azoospermia), or 
there is a genetic risk of sex-linked diseases. Egg donation is often suggested for women 
who have non-functioning ovaries or few fertile eggs due to “premature ovarian failure.” 
However, like the definition of ART as a medical treatment for the disease infertility, 
these “medical” indications for gamete donation are themselves based on traditional 
values of heterosexuality and family. The clinic protocols in Argentina follow the same 
principles as those outlined in the Consenso, the original RED-issued set of guidelines 
discussed in chapter two. The Consenso guidelines are unequivocal that gamete donation 
is indicated only for infertile heterosexual couples, in this case if one or both partners 
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lack gametes, or have a severe sex-linked genetic disease. In a clear valuation of the 
pregnancy experience, the Consenso also states that parenthood can be established 
without genetic ties, and that one benefit of gamete donation is in allowing “the future 
child to be delivered by the future mother” (Consenso 1996: 11).  
On the other hand, like in other places around the world, the demand for gamete 
donation in Argentina is not only coming from infertile couples. For instance, older 
women whose decrease in fertility is age-related (and therefore not technically a disease-
related condition) are turning to egg donation in order to become pregnant. In addition, as 
I discussed in chapter two, recently single women are also becoming mothers through the 
use of donor insemination in certain centers of Buenos Aires.114 Clinics have different 
ways of setting limits on these “social” infringements, but slowly consumer demand is 
winning out over moral objections. The case of egg donation for older women provides a 
good example.  
The Consenso guidelines declare that “reproductive medicine has the ultimate 
goal of making it possible for people to express their fertility even when they have been 
affected by a disease that limits this fertility,” and therefore justify an age limit for 
recipients of egg donation to be before the “average age” of menopause (Consenso 
1996:12). Thus, women who suffer premature ovarian failure are appropriate recipients 
for egg donation, but postmenopausal women who no longer have fertile eggs are not. 
Most centers in Argentina follow these Consenso recommendations and restrict eligibility 
for egg donation by age. The rationale is that women need to be “within conditions of 
having a child”—in other words, she needs to be physically able to carry a pregnancy. 
                                                 
114 Notably the main Argentine sperm bank, Cryobank, explicitly states on their website that since there is 
no law prohibiting it, they make donor semen available for purchase by single women. 
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However, the limits of this ‘fitness’ can vary from woman to woman. CREAR’s stated 
upper age limit for women to use egg donation is 50 years old—which they claim 
complies with a recommendation from the Ethics Committee of the American Society for 
Reproductive Medicine (ASRM). Other centers are more flexible and determine the age 
limit on a case by case basis.115 The higher physical risks of pregnancy in older women 
are of concern, as is the social prejudice against older mothers. Most centers agree that 
egg donation for women over 60 years of age is not appropriate both for medical and 
social reasons. Mauricio Lombardi, one of the directors at Fertility Institute, thinks of age 
limits in terms of the restrictions that nature has put into place. Therefore, since women 
“naturally” enter menopause and cease reproductive functions, the center should follow 
this cut-off and not help women over 48 or 50 years old have children: “I have no doubt 
that there should be an age limit because I believe in a dogma which is ‘not everything 
that you can do, you should do.’ […] The only animal that has the privilege of 
menopause is the human. […] So you know that your reproductive ability is over.” Along 
these lines, since “nature” doesn’t limit men, neither should a reproductive center, as 
Lombardi explains: “I think the man is different because naturally, the man has semen 
until he dies. In other words nature armed you with…perpetuity in the man.” Most 
doctors agree that these limits do not apply to men (for sperm donation), particularly 
since the concern is constructed around ensuring a healthy pregnancy and motherhood, 
and less on the lifespan of the father-to-be. As Mateo Capaldo, a director at IGyR tells 
me, “It is different in men because the problems aren’t the same, because actually he 
                                                 
115 An article published in Clarín announcing the birth of twins to a 59 year old woman (using egg 
donation) in the United States in July 2006 quotes an Argentine ART specialist as saying that in Latin 
America the advice is to not provide egg donation to women over 53 years (Galarza 2006).  
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doesn’t run a risk, if he wants to do it, like the example of Chaplin, it’s done. We have 
had couples with very senior men—75 or 80 years old. And it doesn’t worry us much.”  
The ideology at play in justifying gamete donation is again one of “giving nature 
a helping hand” while also preserving a traditional social order. While permitted, these 
“non-medical” requests for gamete donation must be carefully controlled and reined in so 
as not to upset traditional conventions of heterosexual reproduction and the nuclear 
family. The very practice of gamete donation itself—in introducing a third party into this 
family unit—is also potentially disruptive. As I discuss in the following section, ART 
professionals have devised various ways of attempting to limit the potential hazards of 
gamete donation. 
 
Third-Party Anonymity 
“There are some matters that need to be understood and clarified. For example, genetic 
grief: the one who knows that he/she will not contribute a gamete to a child loses the 
possibility of transmitting fundamental physical aspects, but she/he will offer everything 
else, which is a lot, as the father or mother. […] In these cases, it is necessary to work on 
the difference that exists between being a ‘progenitor’ as a biological or genetic concept 
and being a ‘father,’ a bond that is much deeper and implies much more.” Psychologist 
Darío Fernández quoted in La Nación, July 10 2004 (Navarra 2004) 
 
In an ideal context, gamete donation allows a couple to have a child to raise and 
love, and the origins of the genetic material that create the child are downplayed. The 
unique possibility of parenthood is instead emphasized, as this gynecologist summarizes: 
I agree with egg donation. I think that if a woman doesn’t have her own eggs 
anymore, then she can receive donor eggs from another woman. It seems to me 
that…again, it seems like a matter where having a child and being able to raise 
that child and the love that you give is the most important thing, right? Whether 
the egg is from her or is donated, I don’t think that is the central issue. 
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However, for many—both for those professionals who agree with the practice and for 
those who don’t— the presence of the donor is a central issue, one that must be actively 
controlled and minimized. According to the Catholic Church, gamete donation is a 
violation of the married unit: conception should take place within the conjugal union and 
not involve a party outside of the marriage.116 There are a substantial number of 
reproductive specialists who therefore do not recommend gamete donation to their 
patients, whose positions I detail below. Among the professionals who do provide 
donation, minimizing the influence of the third-party is essential to the practice. The 
principal method for lessening the potential impact of a donor is the condition of 
anonymity.  
Almost all ART centers in Argentina agree on the importance of anonymity for 
donation. This means that in Argentina, the attending doctor is the one who obtains and 
matches the donor with the recipient, and is the only one who knows the identities of both 
parties. The Consenso guidelines also advise that donation be anonymous to all parties—
except the attending center which should keep a confidential registry. Reproductive 
health professionals in Argentina explain the necessity of anonymity in terms of 
preventing future complications, and of “protection” for both the donor and recipient.117 
As this gynecologist summarizes, “It is demonstrated that anonymity is healthier from the 
mental point of view. And tomorrow you don’t know, maybe the known donor will go 
crazy…To know ‘who’ predisposes you to greater conflict tomorrow.” There is also a 
                                                 
116 Those who object to assisted reproduction completely consider the attending doctor (necessary for an 
ART procedure) to be a third-party disrupting the conjugal unit.  
 
117 The “healthy” and “protective” qualities of anonymity are not absolute givens, but a local judgment up 
for debate. In fact, some countries—Australia, Holland, Norway, Sweden, Switzerland and the UK— no 
longer allow anonymous sperm donation. 
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concern that in the absence of explicit legislation, the donor may try to find the recipient 
and claim the resulting child as her or his own. The medical coordinator at ISR explains 
the anonymity condition according to that concern, “To better protect the recipient and 
the donor, because as nothing is legislated, you don’t know if at some point she is going 
to reclaim your…your child. So, we have ensured that the program is absolutely 
anonymous.” The ambiguity of the law is indeed a point of concern, as the existing Civil 
Code indicates that the legal mother is the woman who gives birth, and the legal father is 
her husband.118 However this Civil Code—as I discussed in Chapter two—was written 
long before the advent of reproductive technologies, and the creation of a “biological 
mother” distinct from the “genetic mother.” The day that a known donor lays claim to a 
child who was created using her donated eggs, or his donated sperm, there will be 
extensive legal debate in determining his/her rights as a mother/father. This ambiguity 
has bearing on surrogacy arrangements as well, which I discuss later in the chapter.  
These health professionals also claim that anonymity is necessary to ensure a 
straightforward construction of family relationships—again based on the ideal of the 
heterosexual, nuclear family and “treatment” of the couple. The introduction of a third 
party into the scenario of having a baby therefore has the potential to disrupt the “natural” 
order of two biological parents. A biologist summarizes this viewpoint that using a 
known-donor presents a strange variable into the family equation:  
If I decided to accept donation, I would prefer that it were anonymous. I find that 
a known-donation, from your brother, your father, from your uncle or a friend, 
would obstruct in a certain way the relationship of the couple, the child and the 
donor. I think that people are very complex and that even though the donation 
                                                 
118 Determining the ‘legal father’ involves a complicated series of presumptions in the out-dated Civil 
Code, the specifics of which are beyond the scope of this ethnography. They are based primarily on how 
long the husband has been married to the woman who gives birth, and most likely will not hold up in a 
contemporary case trial.  
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may be very altruistic, the donor could, in some way…including if I were the 
donor…if I were the donor and I saw that you have a child that is mine, but not 
from a relationship between us, but from a donation, my behavior would be 
strange in that situation. I think that it would be strange. So, I would prefer that 
the donor is not a known donor. Because the relationship that could develop 
wouldn’t be normal. Because the genetic father could assume certain attitudes that 
he shouldn’t assume. 
 
To prevent the development of a relationship that is “not normal,” the attending doctor 
therefore controls all aspects of the donor-recipient gamete matching. The theory is that 
with anonymity, family relationships can remain pure and unproblematic. The anonymity 
of gamete donation ensures that the donor remains invisible to the recipient party, a non-
entity that need not be accounted for in the designation of mother and father. In contrast, 
the presence of a donor is seen as particularly problematic when the donor is a relative, as 
this biologist at Fertility Institute summarizes:  
When those cases come of ‘no, I am going to ask my sister to donate for me,’ 
okay…if it isn’t anonymous, it is with someone that I know and with a relative. 
Sometimes they think, ‘of course, if it is my sister, she has at least 50% of my 
genes, so it is halfway like if it were my child.’ […] But life together is going to 
be difficult. Because I don’t know if they can separate from the idea, ‘that aunt is 
actually…’ First the imagining that she [the sister] slept with her brother-in-law. 
And then, the other woman is going to know all her life that in reality that child is 
half hers. And the other woman is going to know that the child is half her sister’s. 
It seems complicated. 
 
The potential complications of a family relative-donor presented here recall again the 
standard of anonymity as healthy, protective, and pure—compared to the disturbing, 
dangerous and messy qualities of known donation. I come back to the role of the doctor 
in attempting to purify the exchange—through limiting its commercial aspects—later in 
the chapter.   
For those who disagree with gamete donation for religious reasons, the perceived 
ethical problem of the third-party donor is not resolved through the guarantee of 
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anonymity. For these Catholic doctors, the anonymity requirement does not “erase” the 
fact that there is a third-person involved in what should be an act only between the 
(married) couple. One Catholic doctor at Fertility Institute, Mauricio Lombardi, states 
that though he does not provide nor agree with gamete donation, he does not judge those 
who decide to do it:  
I do not do it for religious reasons. Because I believe that a married couple...their 
union is a sperm and an egg. But I do not judge the person who does it. If you are 
sure of what you are doing, of what you are receiving—the genetic inheritance of 
someone else—and you accept that, then I do not have any objection to you doing 
it. But I do not do it, I refer it to someone else. 
 
Likewise, Guillermo López, one of the directors of RMI—where gamete donation is not 
performed by any of the medical staff—considers gamete donation to be at odds with the 
teachings of the Catholic Church. He nevertheless claims to not judge those who decide 
to try it, and like Lombardi, will refer those patients to another center:  
I recognize that there are decisions that are difficult and I respect those who think 
differently. I don’t judge, nor do I look down on marriages that use donor 
insemination or [egg] donation…On the contrary, I tell them ‘up to this point…’ I 
think that egg donation is an option and I suggest places that they can go to. And I 
explain that in reality, we don’t do it because of some limitations that we have put 
in place, and they [the patients] respect that and understand that very well. 
 
Among those who disagree with gamete donation there is repeated acknowledgement that 
many others find anonymous gamete donation both acceptable and desirable. However 
not everyone is as non-judgmental as Lombardi and López appear to be. Fernando Pérez, 
López’s colleague at RMI, counsels against gamete donation. He instead directly refers 
his patients to adoption, which he thinks of as a “simpler” arrangement: 
I have nothing against gamete donation. But I advise against it. If someone wants 
to aid in the couple’s project to have a child, by using frozen semen—donor 
semen or donor egg, they are free to do so. I don’t participate in that type of 
project because I don’t agree with…I think that the couple who decides to have a 
child, and if at some point one of the two doesn’t have the reproductive potential 
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to do it, then, for example, in the case of the man, the two stop at that point and 
they establish, ‘what are we doing now?’ ‘Let’s adopt.’ The two are on equal 
footing, they adopted a child. If they use donor semen, the woman moves forward 
with her desires, with her pregnancy…the man stays behind. I have seen it, it is 
not that I have seen it a lot, but I have had various patients that I treated up to that 
point, then they resorted to donor sperm and then they divorced during the 
pregnancy. Because having allowed a third person to enter was so much of a 
conflict, that they couldn’t endure it. So personally I advise against it. […] I think 
the most reasonable thing for a couple who can’t have a child, is adoption. 
 
In Pérez’s view, the psychological impact of involving a third-party in making a child is 
disproportionately disruptive. In such a case, adoption—in which both members of the 
couple are equally “estranged” from the child in a biological sense—seems more 
“reasonable.” In this sense the “equal footing” that adoption provides is seen as 
preserving the couple, where as gamete donation is constructed as an “unnatural” 
condition of conflict within the couple’s relationship. One of the scientists at the 
Laboratory for Reproductive Medicine is in complete agreement with this viewpoint:  
I prefer adoption because then the child is 100% separate, not 50% of one, 
because later that impairs a marriage. It is an imbalance within the marriage. […] 
It cannot be an issue where in the first fight, the woman throws in her husband’s 
face, or the husband to the wife, ‘you are not even capable of having a child.’ 
 
These professionals therefore advocate adoption because it presents what they regard as a 
more straightforward and equitable relationship between the adopting couple and the 
child. In comparison, gamete donation is seen as “leaving out” one of the partners—the 
one whose gametes are not used—and introducing a problematic additional party.119 
Regardless of the anonymity of the arrangement then, for these professionals gamete 
                                                 
119In addition, gamete donation is constructed as a gendered experience, and therefore the psychological 
counseling at an ART center is managed distinctly for egg and semen donation. Health professionals 
believe that the woman, even if using donor eggs, feels a parenthood connection through the pregnancy. 
With the use of a sperm donor, the man is more marginalized as a participant, as this gynecologist tells me, 
“the one in general who most decides the issue of egg donation is the woman, and she can compensate her 
doubts with the gratification of being pregnant. On the other hand, with semen donation the man stays a 
little more on the margins of paternity, so it is handled totally differently.” Newspaper articles in Argentina 
also uphold this viewpoint, see for example Navarra 2004. 
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donation remains out of bounds, a practice that creates needless tension and havoc in the 
traditional family order. However, as I discussed earlier, this point of view is in the 
minority in Argentina among both reproductive medicine professionals and their patients. 
 
Consensual but legally ambiguous 
To ensure patient agreement with these policies, most centers that provide gamete 
donation require signed consent forms for both donors and recipients, which state 
voluntary assent to anonymity and the donation. However these consent forms could be 
easily contested in the absence of a national law for ART. Furthermore there is a legal 
document that is potentially in conflict with this anonymity-policy: Article 8 of the 
Convention on the Rights of the Child states that a child has a right to preserve his or her 
identity. This Article also makes the state responsible for protecting and assisting in 
reestablishing the child’s identity when it is in peril. As mentioned in chapter two, this 
international treaty was placed at the level of Constitutional Law in Argentina. The 
Convention has primarily been used by the Grandmother’s of the Plaza de Mayo (Las 
Abuelas) to aid in identifying the children of the disappeared (mentioned earlier)—
relying upon a notion of ‘identity’ as biological in origin. Using a similar interpretation, 
this Convention therefore also has relevance for ART practices using anonymous 
donors—the “biological” parents whose identity could be requested by the child. The 
potential for this right to identity to apply to ART cases is something that most 
reproductive medicine professionals have thought about. Carlos Sanchez, a biologist at 
Fertility Institute relates the need for anonymous gamete donation with the right to 
identity:  
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Why must it be anonymous? Out of respect for…I think that the only one who 
has a right to know the identity is the child. Argentina has a history, in that sense 
tragic and that everyone knows, and I think that in that sense Argentina has a 
factor that is important which is called ‘the right to identity.’ But the right to 
identity that you can exercise, if you want to, is at adulthood. And it seems to me 
very critical to maintain that criteria for the case of children born from assisted 
reproduction where there are donors. It seems okay to me that if the child wants to 
know his/her biological parents, he/she is the only one who can know that 
information. It doesn’t seem okay to me that a couple will know who the donors 
are. Not at all, because they can establish ties that don’t seem…normal. In other 
words, you don’t know, what type of relationship you can establish with a person 
who is not related to you and yet who biologically is related. So it doesn’t seem 
right for donors to know who the receptors were, nor for the receptors to know 
who the donors were. 
 
Though Sanchez is certain that anonymity must be maintained between the donor and 
recipient, he is also in favor of allowing the resulting child access to the donor 
information.  
Further complicating matters, a Supreme Court decision in 1996 approved the use 
of mandatory genetic testing to establish parenthood, against the wishes of both the 
(adoptive) parents and the child (Arditti 1999).120 In addition, Argentina’s adoption law 
allows an adopted child, at 18 years of age, to find out who his or her “biological 
reality.”121 These instances, in which parenthood has been legally defined according to 
biology and genetic origins, could potentially cancel out the Civil Code’s privilege of the 
                                                 
120 Constructions of identity are completely tied up with politics and history in Argentina, particularly 
regarding the events of the most recent military dictatorship (1976-1983). As mentioned earlier, the 
Grandmothers utilize the notion of “genetic identity” to aid their struggle in finding their grandchildren, 
and sponsor a myriad of annual events like Teatro por Identidad and Cine por Identidad, as well as art 
expositions, and memory museums.  Also along these lines, a National Genetic Data Bank was created in 
1987 (within the Immunology Dept. of Hospital Durand) to aid in identifying the DNA of the children of 
the disappeared, and to provide the Grandmother’s “scientific” proof of their biological affiliation with 
those who were illegally adopted. Furthermore, in 1992—with insistence from the Grandmother’s—a 
National Commission for the Right to Identity was also formed to aid in uncovering “the true identity” of 
the children of the disappeared.  For a thorough discussion of such efforts, and the political struggles of the 
Grandmothers to find the children of the disappeared, see Arditti 1999 and the Grandmother’s website: 
http://www.abuelas.org.ar/. Though fascinating, a full discussion of “genetic identity” and the way it is 
being used in Argentina is unfortunately beyond the scope of this analysis. 
 
121 Article 328 of Ley N. 24.779, enacted March 26, 1997. 
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woman who gives birth as the legal mother. However, because there is no specific law for 
ART that resolves this ambiguity, the implications for gamete donation cases is unknown. 
Ana María Picolotti, a lawyer explains:  
…there is no legislation over donation of eggs, of sperm, what is going to happen 
with the affiliation? Whose child is this? Who is the father, can the person who 
donated the sperm make a claim? Or not? […] There is no law that says that you 
lose all rights, so why wouldn’t he be able to make a claim? A judge will have to 
decide that later, but in principle he would be able to make a claim [to paternity]. 
Okay, it is strange that someone who donated his sperm at some point is going to 
claim paternity. That is strange. But do strange people exist in the world? Yes 
they do, so… 
 
Since there is no legislation, there is a possibility that a court case could approve a claim 
to parenthood by a donor. This issue won’t be settled definitively until there is a specific 
law passed. Another professional, Gabriel Ferrari, a biologist at a public hospital who 
does not work in high-complexity ART, also points out the conflict that putting this right 
to identity into practice presents for private centers: 
Of course, the rights of children include the possibility of knowing your origins, 
your roots, no? This stems from what happened after the last military dictatorship, 
when there were many people who were disappeared. I think that they [children] 
can investigate, but what happens is that to investigate here would be very 
difficult, because how are they going to do it, except by going to the institute’s 
archives? […] I really don’t know what happens if a child who knows that he is a 
product of fertilization with donor semen presents a legal request, I suppose that 
he has the right to know, but I think it would be violating the institution’s norms 
that promised anonymity to the donor. So, I don’t know, there it would enter into 
a trial, no? I imagine that the institute wouldn’t give it [the identity] up without a 
fight. 
 
Ferrari brings up the fact that centers will most likely be reluctant to violate the 
anonymity that is the principle of the gamete donation exchange in Argentina. On the 
other hand, the law proposal that the Argentine Society for Reproductive Medicine 
submitted to Congress in 2005 (discussed in chapter two) includes a clause that at 18 
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years of age, the child created using ART and donated gametes has the right to know the 
identity of the donor.   
The hyper-attention to genetic identity and biological origins in Argentina is 
encapsulated by CREAR’s decision in 2002 to provide a “paternity certificate” to couples 
doing ART. This certificate was proposed as a way to sooth patient’s fears of laboratory 
mix-ups, as well as to ensure for the clinic that the said couple is the genetic progenitors. 
For instance, I was repeatedly told a story (whether fact or fiction I can’t say) in which a 
woman brings to the laboratory a sperm sample for an IVF treatment. The sperm sample 
is supposed to be from her husband, but it is actually her lover’s semen, and eventually 
the husband finds out and blames the center. To prevent this from happening, CREAR 
offers couples the option of a paternity certificate, free of charge. Test results of the DNA 
profile of the couple (from blood samples and the semen sample) are kept until the child 
is born, then that child’s DNA is compared with the couple’s. To increase public 
awareness of this service, in June 2002 La Nación ran an article announcing this new free 
service. In what reads as publicity and self-congratulations, Brugo Olmedo is quoted as 
saying “we estimate that this is the first time that this is happening in Latin America. In 
addition the Jones Institute in the US, where the first test tube baby of the country was 
born, confirmed to us that until now they haven’t offered something similar to this” 
(Shapira 2002). However according to one biologist I spoke with, by 2005 only one 
couple had requested the service. 
 
Sources of Gametes and Egg Economics  
“I think that the person who gives should charge for her eggs...Why? Because the doctor 
charges for the procedure, so she should also charge. Like for example, why are you 
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paying the semen donor? Then also pay the woman.” Mauricio Lombardi, gynecologist 
at Fertility Institute 
 
The other contentious side of gamete donation is the perceived encroachment of 
the financial market into this “moral” area of exchange, primarily due to the commercial 
aspect of obtaining the gametes. In this area, gamete donation threatens to push ART out 
of the realm of medicine and into that of commerce. In Argentine centers therefore, there 
is an idealistic dynamic set up between “altruistic” donation and paid donation, even 
though both involve a degree of financial recompense. The Consenso guidelines 
recommend that gamete donation should be without financial incentive, though 
compensation for transportation and missed work is acceptable. With respect to sperm 
donation, financial reimbursement is a fairly standard practice internationally— including 
in Argentina—and is usually a relatively small amount. However egg donation is a more 
complicated and morally-charged matter, as it involves medical intervention and 
substantial time investment. The methods of procuring these gametes also differ. Donor 
sperm samples are usually contracted from a private semen bank while donor eggs are 
obtained within-clinic. [In Argentina, egg donation has not only increased in practice in 
the last five years in Argentina, but has also irrevocably crossed from the realm of 
“altruistic gift” into the economic market.] 
When I first began researching assisted reproductive practices in Argentina in 
2000, the majority of health professionals that I spoke with purported to be morally 
against paying for egg donation, and no clinics offered this option. Those centers that 
offered donor eggs to their patients did so through within-clinic donor programs set up as 
anonymous contributions, directed by the attending doctor, and solely for use within the 
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clinic. Donors therefore were exclusively patients —women whose infertility problems 
were not related to the fertility of their eggs, and who therefore often produced more eggs 
(because of hormone stimulation) than they could use themselves. These patients—
deemed “altruistic” donors— would agree to anonymously give their surplus eggs to 
another patient. At some centers, patient donors received a reduction in their own 
treatment costs, as the recipient would help pay for the medication—though this was not 
openly stated as an incentive for donation.  However, patient donation does not provide a 
constant and abundant source of donor eggs and relying upon this method limits the 
number of potential recipients a center can provide with egg donation. With only patient 
donors to fill the demand for donor eggs, many centers had long waiting lists for 
recipients— for instance at CREAR the minimum waiting time to receive donor eggs 
from patients was about 1 ½ years.  
By 2003, many of the ART centers that provide gamete donation had begun to 
incorporate paid, non-patient donors into their egg donation programs. Paying women to 
donate their eggs, though it allows centers to better meet the consumer demand for 
donors, also involves a dance on the edge of traditional ethics and the border between 
ART as a medical treatment and ART as a business enterprise. If centers are not careful, 
they might fall into the abyss of the profit-motivated market. For instance, Augustín Ortiz 
disagrees completely with gamete donation because it implicates commerce: “‘Donor’ is 
a word that shouldn’t be used because they charge money, so they aren’t donors. 
Donation is selfless and this is not selfless; it is self-interested and it is for money. The 
same with semen. It is exactly the same.” To counteract this type of negative judgment, 
the “altruistic” patient donor is still idealized and privileged at the centers, even though 
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all have incorporated paid donors into their programs. For instance, Constanza Rovere, 
one of the directors at Conceive, claims to use patient donors for egg donation cases, and 
reserves the paid donors for research projects as much as possible. She presents an 
idealized picture of the patient donor:  
The donors, in general I always like to work with anonymous and altruistic donors 
who are part of the in vitro fertilization program, and who in an altruistic way—
that is to say, who want to—sign and accept to donate their excess eggs after 
covering their own possibilities. 
 
Similarly Carlos Sanchez, a biologist at Fertility Institute, explains why he thinks 
voluntary donation is preferable:  
it should be an altruistic gesture. The issue of if donors are paid or not takes you 
to other issues that for me are…are very difficult, like the motivations for which 
someone will donate. And if the motivation is economic, maybe at one time you 
have economic troubles and you accept defined conditions and with time you 
regret it. On the other hand if you do it voluntarily, you don’t regret…or the 
probabilities that you will regret it are less. 
 
The assumption here is that a voluntary patient donor will donate out of a desire to help 
someone else, whereas a paid donor is primarily motivated by money.122  
Of course in practice neither type of donation is so clear-cut. For instance, at some 
centers, patient donors receive a reduction in their own treatment costs, as the recipient 
shares the cost of the medication. According to the doctors, this reduction apparently was 
not explained to a patient donor until after her consent was given, so as not to be an 
incentive for donation, but the anthropologist can wonder. Furthermore, a psychologist at 
one of the centers points out the social implications and dilemmas of the power 
imbalance between doctors and patients: “A physician who can give you the baby you 
want is like God. People who are donating think, ‘how can you say you won’t help this 
                                                 
122 In her work on semen donors in the United States, Tober (2001) argues that “true altruism” does not 
exist, as some form of self-interest is always at play in the donor gamete exchange. 
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person?’ They are ashamed if they don’t help because they are asking for an egg, so they 
should give back.” This example makes clear the power dynamics built into these 
biomedical practices, in which the practitioner’s control is often normalized as a given 
characteristic of this system of “expert” knowledge.  
Alongside these idealized notions of altruism is a market reality that donating 
gametes is a service that demands retribution. Manuel Giordano, another biologist at 
Fertility Institute, in comparing semen and egg donation, points out why paying egg 
donors is practically a necessity: “With respect to the woman, it is much more 
complicated, she has to do a stimulation, go to surgery, it is completely different. The 
problem is that you are not going to find many women available to do that altruistically.” 
The gynecologist Lombardi, quoted above, also agrees that egg and sperm donors should 
be paid, even though for religious reasons he does not do gamete donation cases himself. 
Similarly, Tómas Navarro’s concerns about commerce have grown quieter in the face of 
the demands of the industry. Though he begins by presenting his original objection as a 
religious one, it turns out that it stemmed from the ideal of altruistic donation which he 
has since abandoned:  
Before, I was against semen donation. I thought that…for a religious reason, I 
thought that it wasn’t very ethical, I thought…because it isn’t ‘donation.’ My 
problem was always that no one ‘donates’…Everyone charges money. If your 
boyfriend—you have a boyfriend right?—if he wants to donate semen, he doesn’t 
donate it, he charges…50 dollars, 100 dollars per sample. So, it’s not an altruistic 
donation of gametes. There is money in the middle, and that makes it dirty. And it 
takes away all the possibility of altruism, and converts it into a part of the 
business. That is how it is. I’m not saying that a medical student who donates 
semen will become rich off of that, but he can pay part of his studies with that. 
Simply by masturbating. It doesn’t seem like such an interesting, romantic and 
attractive thing. But this is a reality. The day that I realized that this was the 
reality, and that I couldn’t change it, avanti… 
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Though Navarro prefers altruistic donation, he realizes that this is not a realistic condition 
to work with. He therefore conceded his objections to the monetary, business-side of 
ART—exemplified in the case of gamete donation—when he realized that the activity 
would continue as such with or without him.  
 
The Harvest 
 
Figure 37. University of Buenos Aires School of Medicine. Photo by Kelly Raspberry, 2004. 
 
 
The main source for ART centers in Argentina of donor sperm is through a 
private free-standing sperm bank, Cryobank, which is located in the posh Recoleta 
neighborhood of Buenos Aires.123 Cryobank deals only with Argentine donors, usually 
medical students studying at the University of Buenos Aires School of Medicine. A 
biologist at Cryobank told me in an informal interview in 2005 that the sperm bank posts 
advertisements at the University soliciting male donors between the ages of 21 and 44 
                                                 
123 There are other sources of donor semen samples that some centers use. There is another private sperm 
bank, CEUSA, which is affiliated with one of the infertility centers. I’m not sure if CEUSA is open to the 
public, none of the biologists at other centers mentioned using it.  In addition, one of the centers has its own 
within-clinic sperm donor program for use only by the center’s patients. A third clinic had its own sperm 
bank in 1998, but now uses Cryobank. A fourth center offers patients the option of importing donor semen 
from the Fairfax Cryobank in Virginia, USA.  
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years old. To select healthy donors, a range of basic tests are done—an interview, 
physical exam, spermogram, tests for Hepatitis B, C and HIV, and then the samples are 
cryopreserved for six months. After six months the potential donor is again tested for 
Hepatitis B, C and HIV, and only at that point is the tested sample distributed to the 
public (international standards prohibit the use of fresh donor sperm because of the risk 
of transmitting HIV). Most donors give four to five samples, and are paid a nominal 
amount of 80 pesos per sample (approximately $27 USD). According to the Cryobank 
website, only 20-25% of those interviewed are accepted as donors (in comparison, 
California Cryobank’s website says they accept 1-2% of applicants and Scandinavia 
Cryobank accepts 8%). Apparently the sperm bank sends out 12-15 cryopreserved 
samples a month, but does not track the intended use of the sample—whether for 
inseminations, IVF or ICSI. The only records they keep are the quality of the sperm 
sample, and where it was sent. Like the prices at ART centers, the fee charged for a 
sperm sample changed with the economic crisis of 2001: before the crisis one sample cost 
250 pesos—equivalent to $250 USD—and by 2005 it cost approximately 350 pesos, 
around $175 USD.124 Notably, the Cryobank does not ship sperm samples outside of the 
country—according to the biologist I spoke with this is because the Argentine Customs 
office does not allow this.125 
Egg donation programs in Argentina differ from donor sperm in that they are 
conducted exclusively within-clinic, and therefore particular to each center. There are 
                                                 
124 Fees have increased over time. By November 2006 the price was up to $480 pesos for a basic sample, 
not yet processed. A processed sample costs an additional $150 pesos (approximately). Notably, the 
Cryobank website does not list prices for the semen samples, unlike the sites of large international banks 
like California Cryobank and Scandinavian Cryobank. 
 
125I suspect there is a different reason—not explained to me— for why Cryobank does not ship donor 
sperm internationally. Since there is no law prohibiting the shipment, the refusal on the part of Customs 
could be appealed by Cryobank.  
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also more contingents involved in egg donation as it is a more complicated procedure 
than procuring a semen sample. In general, paid egg donor applicants fit the following 
profile: under 30 years old; proven fertility (usually children of own); a psychological 
evaluation (must not think of eggs as children); in good health (negative medical checks 
for HIV, hemophilia, Hepatitis).126 Patient donors go through all these checks as well, 
though they are on average older in age and in most cases do not already have children. 
After the selection process of a donor, obtaining the eggs entails the month-long process 
of ovarian stimulation and oocyte aspiration described in chapter two. Once they have 
been aspirated from the follicles, these donor eggs must be fertilized immediately with 
the recipient’s sperm sample (usually obtained and cryopreserved ahead of time to ensure 
that it is viable and ready). While donor semen is always cryopreserved for infectious 
disease reasons, donor eggs are not—the technology for freezing eggs is not advanced 
enough to make this viable. Once embryos have developed out of the fertilized donor 
eggs, they can either be transferred right away, or cryopreserved for a later date. Usually 
the menstrual cycles of the potential donor and the recipient are coordinated so that the 
recipient’s uterus can be artificially prepared (with hormone stimulation) to receive a 
fresh embryo transfer. 
Most centers declare they do not agree with advertisements soliciting egg 
donation, instead they rely upon word of mouth—spread mainly through previous donors 
and interested patients—to bring in non-patient egg donors. In some centers donor 
referral has advantages, for instance at CREAR, a patient who finds a suitable donor 
moves ahead on the waiting list for gamete donation (however she will not be matched to 
                                                 
126 As one of the directors at one of the centers is a geneticist, donors at that center are also submitted to 
genetic testing for Cystic Fibrosis, Fragile X and karyotype mutations. 
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this known donor); at IGyR a donor who brings in another donor receives a small 
compensation. This discreet solicitation is in most likely an effort to keep a low profile—
though many centers now include paid egg donors, the issue is still a sensitive one. One 
biologist explains that this quiet consensus among centers is fundamental in this 
community of reproductive medicine:  
It is like with the voluntary donors. Recently now they are using paid volunteers, 
but before no, because you were going to pay in order to give…in order that they 
donate eggs to you. It was something like, you were a monster, the black sheep of 
the institutes. But well, times have relaxed a little, other clinics are doing it, 
everyone is doing it, but no one says it in vox populi because it is like the 
discarding of pronuclear stage, we don’t have any conflict in discarding them but 
we do not go out and say to the whole world, ‘we discard.’ 
 
Controversial practices—like paid egg donation and the disposal of fertilized eggs—are 
done quietly at the centers so as not to raise strong objections. I will come back to the 
problematic of discarding fertilized eggs in chapter four.127 
 
*** 
Interval: Global Harvest, Local Risks 
As I discuss in this chapter, the global side of ART is not just in knowledge, 
equipment, and culture media, but also in genetic material that is often procured in one 
country and used in another. These international flows are particularly common with 
donor semen, and their pathways (though a reversal of the common trajectory of donor 
organs) trace the first colonizers’ travels from North to South. Indeed, California 
Cryobank calls itself a “world wide leader in sperm banking” and among its newest offers 
is “Nordic sperm”—sperm samples from donors in Denmark obtained by a new 
partnership between California Cryobank and Nordic Sperm Bank. This global trade in 
                                                 
127 In Chile egg donation continues to be patient-based, without financial compensation. 
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genetic material raises several issues—among them the ugly specter of new forms of 
colonialism, eugenics, and the “whitening” of South American populations.128 Here I 
confine my discussion of this global travel to an ethnographic incident that illustrates one 
of the dangers involved in donor gametes: that of a medical risk of infection.  
In this “new era” of genetic risk, even the prestigious central site of California 
Cryobank is susceptible. The vulnerability of a sperm bank, even a world-recognized one 
located in the US, was made startlingly clear to me during an interview with a biologist at 
a center in Santiago, Chile in 2003. Even California Cryobank makes mistakes, as this 
series of phone calls makes clear:   
We pause the interview when the phone rings, this call is asking about the use of a 
donor sperm sample back in 2000. I watch as [biologist] takes from a shelf a small 
notebook of handwritten notes on the purchase and use of donor sperm samples. I’m 
surprised this is the system they used just a few years ago—handwritten notes—and I’m 
not clear on if they have continued to do it this way. This particular time period was from 
when another person was director of the lab. When [biologist] gets off the phone he looks 
very upset and he tells me that this was California Cryobank calling and they are looking 
for a sperm sample they sold to the center in 2000. They’ve done some testing and it 
appears that this donor is a carrier for cystic fibrosis. He tells me this is the first time in 
his experience that anything like this has happened before. He then takes out a phone 
directory and looks up the doctor’s name who was the attending doctor for this patient, 
since he doesn’t have a record on whether the woman who used this sperm sample got 
pregnant or not. The doctor is someone who isn’t medical staff here, but has an 
arrangement to bring patients who want ART services to the center. 
                                                 
128 These issues deserve an extensive analytical critique that is beyond the scope of this ethnography.  
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He reaches the doctor and finds out that this woman didn’t get pregnant, it was 
an insemination case. But she does still have a cryopreserved sample from this donor 
because she bought two from him, and one from someone else. [Biologist] makes another 
call to someone to locate the stored sample and to mark “do not use” on it. He leaves the 
room to do this and comes back shortly after. Then he calls the doctor to tell him that 
he’s marked the sperm sample and that if the patient is going to do any further 
inseminations, she will need to use another donor. He tells me later in his view, the most 
important criteria for matching donor and recipient is blood group, all the physical 
characteristic-matching does not matter so much. He also tells me that they have been 
using California Cryobank for years, and that they use it because it is generally a good 
sperm bank. He tells me that the screening procedures that they use are rigorous and that 
makes them worth using even if it is a long way to ship. I ask why not use the sperm 
banks in Buenos Aires, as they are much closer and probably less expensive. He tells me 
that the screening isn’t as good for those banks, that they aren’t as rigorous in their 
testing and so he prefers to go with California. He adds that the cost of shipping (which 
the patient pays for) isn’t very high, maybe an extra $300 USD. He also says that there 
are some good cryobanks in Europe also, and sometimes they use these, but that is even 
farther away so it’s less common.  
The phone rings again, it is the cryobank trying to find out if the woman who 
bought the donor sample was pregnant. [Biologist] speaks in English with the cryobank 
representative and later I ask him why he is doing this. He tells me that they speak 
“Mexican Spanish” and that it is difficult to understand so he prefers to just use English 
instead. He tells the caller that she didn’t get pregnant and that they will not use the 
 265
remaining sample. He asks them to send a letter to him that he can pass along to the 
doctor that will explain what happened and apologize. And that the doctor will share the 
information and the letter with the patient. He says it’s okay to write the letter in English, 
they will be able to understand it. Then he says to send it by email to his address since the 
post in Chile is very slow. He asks them to arrange to either give a refund to the patient 
or give a new sample, depending on what she prefers to do. He hangs up and we resume 
our discussion. 
Five minutes later the phone rings again, it is the cryobank yet again and this 
time they are calling about another donor sample that was sold to someone at this center. 
This donor has also tested positive for being a carrier of cystic fibrosis. [Biologist]’s face 
is very upset at this news. He looks at the notebook again and can’t find the last name of 
the patient they are telling him they sold to. He thinks maybe it wasn’t at this clinic. I 
hear him asking why they are doing this to him. Finally after about three minutes of 
going back and forth on this, and [biologist] scanning through the pages of the notebook, 
he finds out that they are using the wrong last name. It is under the woman’s last name, a 
convention that English speakers don’t understand since they usually only use the 
husband’s last name after marriage. He finds the recipient and agrees to call her doctor 
and find out if she got pregnant. When he hangs up he looks at me writing and asks if I’m 
writing this stuff down. He tells me I should not. He is concerned about the sensitivity of 
this information. I stop my note-taking from then on, and fill in the rest from memory 
later that day. What happens next is that [biologist] calls the other doctor, who is a 
colleague of the first doctor and doesn’t find him. So he calls the first doctor again and 
gives him the message and asks him to find out if the woman became pregnant. This 
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sample request is also from February 2001. There are no more phone calls about this 
today, and we continue the interview. Before resuming, I ask if maybe he’d prefer not to 
continue since he’s a bit shaken up by this news, but he says it’s okay. He also apologizes 
profusely for the interruptions. 
 
*** 
 “El Mercado Fecundo”: The Fertile Market 
“‘It should not have money in the middle, because if it does it is a sale. If the motive is 
economic it degrades the donation, and it also increases the risk that the donor will 
falsely answer very important questions, like if in her family there are antecedents of 
genetic diseases. What I do think is that the woman who donates should not have any 
expense, and that is why she should be given a reimbursement. But not a payment that is 
disguised as a reimbursement.’” Claudio Chillik quoted in Clarín, August 18, 2005 
(Farber 2005) 
 
Since the introduction of paid donors, the quantity of egg donation cases has 
dramatically increased in Argentina. By July 2006, egg donation accounted for between 
12 and 30% of all assisted reproduction cases in the country (as documented in various 
newspapers articles, see Bär 2006; Riós 2006). In an article published in La Nación 
examining this phenomenon, gynecologist Gabriel Fiszbajn is quoted as saying, “Five 
years ago it was used in 10% of the procedures and now that figure reaches 30%” (Bär 
2006). Indeed in an interview in 2003, one biologist explained to me that an increase in 
egg donation cases was one of the ways that the center she works at endured the 
economic crisis of 2001:  
When we began in ’95, ’96 with donation we were doing 10 or 15 donation cases 
per year. Now we have about 120 cases of donation, in other words what we lost 
in normal patients we are gaining in egg donation cases. So actually we 
maintained stability, because of these other things. 
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These increases in the use of egg donation are tied to both the improved accessibility of 
using egg donation—a larger pool of donors means less waiting time for recipients—and 
the relatively good success rates that the procedure promises. Since paid donors are 
selected primarily based on age and fertility, their eggs fertilize well, resulting in a 
pregnancy success rate of approximately 40%.129 
In the face of the growing popularity of gamete donation, there is additional 
impetus to control and monitor the “market” aspects of the practice. Restricting the 
influence of the market takes two primary forms in Argentina: a self-imposed ceiling on 
what is paid for egg donation, and prohibition of donor trait selection.130  
 
Financial Reimbursement, not Incentive 
“This is important because there are, including in the United States, there are agencies 
that accord value to the characteristics of a donor. In reality this is condemned by all the 
ethics committees everywhere because it is like saying, ‘well, I put my own price on my 
material.’ Not here, it is a compensation for the disturbance, the time we are taking away 
from you.” Mateo Capaldo, a director at IGyR  
 
Despite the presence of paid-donors in their within-clinic egg donation programs, 
reproductive medicine professionals cling to the assertion that ART is a medical 
treatment, and not an economic enterprise. Under this logic, paid donors are given a small 
“reimbursement” in order to cover any transportation costs, lost salary and in recognition 
of the time that the donor has invested. The sum is in no way meant to entice women to 
                                                 
129 Capaldo told me during an interview that success rates at IGyR with egg donations are very high—
around 80%, due in part because they match each donor one to one with a recipient. Other centers, like 
CREAR, often maximize a paid donor, dividing up her eggs between as many as three or four recipients. In 
other words if a donor produces 20 viable eggs, at CREAR, each recipient will receive 5 of those eggs. The 
fewer number of eggs that are fertilized, the lower are the chances for good embryos to develop, to implant 
and to become pregnancies. 
 
130 As mentioned earlier, compensation for a sperm sample is already well-established and not a matter of 
concern for most professionals who agree with gamete donation. 
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donate for purely financial motives. As Giordano, a biologist at Fertility Institute states, 
this amount must strike a balance: “international recommendations say that it isn’t 
necessary to pay so much, so that it is not like a salary, but neither [so little] that it 
doesn’t interest anyone.” In what seems an unspoken agreement, the centers that provide 
gamete donation all offer about the same amount to egg donors—between 1000 and 1500 
pesos (between approximately $330 and $500 dollars) for each time the woman donates. 
Most centers also permit the same woman to donate only two or three times total, in part 
to ensure that no one regards donation as “a way to make a living.” Constanza Rovere, 
one of the directors at Conceive explains that non-patient egg donors are not “paid” as 
such, but rather compensated for their effort:  
the economic retribution that they are given is for the time that they lose, for the 
salary they lose. […] The transportation costs, all the costs. It is a retribution that 
justifies all of that, but obviously it is always a little more than that. But nothing 
like what happens in the United States. Because we…Our IRB, our institutional 
advisor…it’s not that retribution doesn’t seem right, but it doesn’t need to be a 
retribution—how can I explain—that is excessive. So that they only donate for the 
money. There has to be a spirit of wanting to do it for another person, wanting to 
give to another person. 
 
The idea is that all donors, paid or not, should be primarily motivated by a desire to help 
someone else, rather than for any economic reasons. The money that is given is 
constructed therefore as compensation and not as a fee. Nicolás García, one of CREAR’s 
directors, is very clear that gamete donation should not be a paid for, though he 
recognizes that this means less people will donate: “From the practical point of view it is 
going to limit it. But I think that in the end, to submit yourself to medication, or to give 
away part of your genetic inheritance for money…it should not be like that. If you do it 
out of goodwill, to help another person, it is welcome.” 
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However, this is not a wholly realistic view of paid egg donation. Receiving 
money for egg donation can be an incentive for some women, particularly given the 
difficult economic situation in the country. Capaldo recognizes this motive, though he 
attempts to present a controlled situation by insisting that the ‘quality’ of the donation is 
not given a price, just the act of doing it: 
…obviously for these women, the motive for donating their eggs I would say in 
this moment, is the compensation that they receive. We do not pay for the quality 
of the eggs, but for the fact of donating them. In other words it is the same to us if 
she is a model, a she has a great figure, or if she is a maid or whatever. This is 
important, it is not that someone says, ‘do you want me to donate your eggs,’ and 
you tell me, ‘I am going to charge you $50,000 dollars.’ No. For everyone, as they 
have to do a treatment that at a minimum is going to be at least twenty days, that 
implies a loss of salary and pause in their activities. So obviously we have to pay 
the transportation costs and the time that we are taking her from her work. 
Obviously as here there is so much unemployment and the salaries are not very 
good, obviously it will be more attractive to receive 1000 pesos in compensation 
and to not be without work, than getting 300 or 400 pesos which really is what 
people earn. 
 
In admitting that money may motivate some women, Capaldo downplays the commercial 
aspect of the exchange. Capaldo, like Rovere, emphasizes that this practice is different 
from that in the US where donors are selected for having certain qualities and the price 
paid for their gametes are adjusted accordingly. From these viewpoints, to pay for (and 
elect) donor gametes has the negative connotation of equating a child with a consumer 
product that is chosen and bought. Whereas “society” in the form of a (scientific-
religious) morality is an acceptable part of medical practice, “society” in the form of an 
economic market is not. This refrain is similar to that given against surrogacy 
arrangements, which are also seen as involving direct market relations, a practice I 
discuss later in the chapter.  
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Medical Matching 
The other primary method of restricting egg and sperm donation from belonging 
to the economic market—and from disturbing the family order— is to not allow for donor 
trait selection. Because matching donors to recipients remains under the direction of 
health professionals, gamete donation can be construed as separate from both the 
potential “chaos” of the free market, and from social influences. In this way, the medical 
professional is an intermediary who controls and neutralizes the exchange, supposedly 
stripping it of commercial context.  
The “matching” that a given center therefore performs between donor and 
recipient is an approximation of similar phenotypical characteristics and blood type, for 
both egg and sperm donation cases. Sanchez, a biologist at Fertility Institute, explains 
how the process works for donor sperm, which is bought from Cryobank Argentina, 
emphasizing the importance of shared physical traits: 
I would say, for 99% of the couples what they want is that the semen donor looks 
similar to them. It is absolutely infrequent for a couple to tell you, ‘I’m not 
interested in what the donor is like.’ What interests them is that the donor has the 
same features as the parents who are going to receive the sample. So you create a 
form, there is a form that you complete with all the information, phenotype, you 
also ask for blood group, height, eye color, hair color, of both, of the couple and 
the grandparents, and the parents also. So with all this information, what we do is 
call Cryobank and we say ‘look, we need a sperm sample whose donor has these 
characteristics.’ And they send you the sample. 
 
In contrast to the service offered by many international sperm banks, at Cryobank donor 
profiles are not available to potential customers to select from, instead the attending 
doctor matches the description of phenotypical characteristics of the donor with those of 
the patient. The same is done with egg donation, though this takes place completely 
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within-clinic.131 At the request of the recipient couple, the attending doctor will often also 
use photographs of the couple and their family, as well as those of the donor, to make this 
phenotypic match. However these photographs remain confidential and are only seen by 
the medical staff.  
With no trait selection and imposed anonymity, the consequential third-party in a 
gamete donation situation thus becomes the “scientifically-neutral” doctor, rather than the 
potentially-disruptive donor. Unlike the known or elected (trait selection) donor, the 
doctor does not threaten the order of the family. Capaldo explains that for this reason, at 
his center they do not provide photographs of donors for recipients to select from:  
We do not work with photographs because it seems to me more like the job of an 
agency and since this is all relatively new, it wouldn’t be very nice for the 
recipient to have an image and then to be on the street, continually trying to see 
which woman is the one who donated her the egg. That is how we see it, maybe it 
is not like that. 
 
By overseeing all aspects of a third-party interaction, the health professionals attempt to 
prevent the possibility of “irrational” emotions and actions that would upset the precise, 
naturalized social order of mother, father, and child.  
In discussing the rational guidelines for gamete donation in their clinics, health 
professionals in Argentina often favorably compare their own programs to the “free for 
all” system in the United States. As mentioned above, practices of gamete donation in the 
United States are deemed as a morally-inferior default model—the probable result of 
society and the market having free reign, as opposed to medicine setting the standards. 
However, the situation in Argentina is not as purified as these doctors claim. To begin 
with, there is an exception to this ban on trait selection: in the form of expensive, 
                                                 
131 At some centers (like CREAR) the within-clinic egg donation program is centralized, with several 
doctors overseeing all donors and recipients. At others (like Fertility Institute) egg donation is more 
individualized with each doctor managing their own list of donors and recipients. 
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imported, foreign sperm donors. Patients at ISR are offered the option of paying for 
Fairfax Cryobank semen samples imported to Argentina from the United States. Using 
Fairfax Cryobank allows the patient to select not only the donor characteristics of their 
choice, but also request sex selection of sperm (for both cases of sex-linked genetic 
disorders and “family planning”). As I mentioned, neither of these selection options are 
available at the local Argentine sperm banks. Notably, the high cost of using Fairfax 
Cryobank—one vial of donor semen costs at least $200 dollars, and international 
shipping of the cryotank costs another $900 dollars—means that the majority of patients 
seeking semen donation rely on the local banks.132 (A doctor at ISR said that sometimes 
several couples join together to pay for a shipment of cryopreserved donor semen from 
Fairfax—one tank can fit several samples at once). As far as I know, ISR is the only ART 
center in Argentina that uses an international sperm bank, however in Chile there is no 
local sperm bank and so almost all the centers use California Cryobank, and patients 
select their own donor profiles.133  This situation suggests that in contrast to preferring 
the currently-idealized system of anonymity and medical oversight, if couples have the 
option to choose donor characteristics, they will probably do so—despite the “mess” this 
might create in family relationships, not to mention inside the rational (not market-
driven) space of the clinic. 
Reproductive medicine professionals therefore strive to minimize the impact of 
the social and economic context within which they work. These boundaries are flexible at 
                                                 
132 Prices taken from the Fairfax Cryobank website: http://www.fairfaxcryobank.com/fees.aspx, accessed 
on January 31, 2007. 
 
133 According to a biologist at CERS in Santiago, Chile is too small of a country to make a sperm bank with 
the proper controls profitable and useful. Furthermore, the biologist says the reason that CERS contracts 
donor semen from California Cryobank rather than from Cryobank Argentina is because the controls at 
Cryobank Argentina are not as rigorous (not because Cryobank Argentina can not ship internationally).  
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times, as the introduction of paid donation reveals. However there are certain lines that 
are not crossed. In the next section I discuss one of these untouchable borders: surrogacy 
arrangements.  
 
 “Madres Prestadas”: Borrowed Mothers  
 “I think the methods of donation—surrogacy was born out of donation and all these 
things, they are absolutely methods of exception. Because…I think that as a doctor you 
are treating a disease. And I am not very convinced that when you use donor gametes, 
you are treating a disease. You are participating in an act of adoption. There are people 
who will propose to a woman, because she is 40 years old and has an FSH level at the 
limit point, or has a poor response of two or three [eggs]…they tell her, ‘no, better to do 
it with donor sperm or donor eggs.’ No. I think that you have to try to struggle so that it 
is the most natural possible within what there is. And of course I am stubborn about 
things like post-mortem inseminations or things between homosexuals because they are 
not part of the history of natural reproduction. So, you make a balance between what is 
natural and what is not natural, because of course it isn’t ‘natural’ to do in vitro 
fertilization. But neither is it ‘natural’ to give penicillin for pneumonia.” Sergio 
Hernández, gynecologist in Santiago, Chile 
 
 
 
 
Figure 38.  "Borrowed Mothers" article published in Las Noticias, Oct 2006 
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Unlike gamete donation, which is practiced within a set of clearly-defined 
medical controls, surrogate arrangements are viewed as impermissible by the 
reproductive medicine community in Argentina, primarily because of its commercial 
connotations. In Argentina, surrogacy is viewed as belonging neither to the realm of 
medicine or nature, but to a commercial arena of consumer practices, of “renting” and 
“buying.” Indeed this market-location is embedded into the language itself—the very 
term in Spanish used most frequently in Argentina to describe a surrogate arrangement is 
“alquiler un  utero,” which translates as “to rent a uterus.” Furthermore, the Roman 
Catholic Church, in Donum Vitae, characterizes surrogacy arrangements as “contrary to 
the unity of marriage and to the dignity of the procreation of the human person” 
(Pellegrino, Harvey, and Langan 1990:23). For these health professionals, surrogacy—to 
an even greater extent than gamete donation—blurs the ethical line between medicine and 
the market/society. In the case of surrogacy, the negotiation of the limits of ‘modern’ 
medicine can only be resolved through absolute rejection of the practice.  
In its basic form, a traditional surrogate arrangement involves one woman 
agreeing to carry a pregnancy and give birth for someone else—the “intended” parent. 
This pregnancy can be created with the use of the surrogate’s eggs, or in the case of 
“gestational” surrogacy, with the eggs of another woman (usually the woman who 
commissions the surrogacy). Traditional surrogacy only involves a sperm insemination, 
while gestational surrogacy requires an IVF procedure and the transfer of the created 
embryos. 
According to those that I talked with, surrogacy is not officially permitted or 
practiced in Argentina by ART professionals for two reasons: because it is a primarily 
 275
economic arrangement, and because there are no legal protections for the agreement. The 
protestations against involvement with surrogacy are therefore founded upon the idea that 
medicine has no place in the purely commercial world of a surrogacy arrangement. A 
professional involved in the Argentine Society of Reproductive Medicine explains why 
the society prohibits surrogacy:  
Because it is a commercial problem. It is to pay a person to carry forward the 
pregnancy. And to submit a woman to the risk of a pregnancy with a commercial 
contract is something that we do not agree with. […] In other words I can not 
obligate you to give me your child, just because I paid you, or because the 
embryos are…[mine]. 
 
This view reduces surrogacy to an entirely commercial transaction in which reproductive 
medicine does not belong. One of the directors of IGyR, Mateo Capaldo, also voices 
common objections to surrogacy: 
Renting a uterus [el alquiler de utero]—I think that it should be discouraged in all 
cases. First, because I consider it illicit, the proposition, because one isn’t 
respecting the other individual as a person, but rather as a thing, ‘you are going to 
do what I say.’ You see? And the other reason is that it doesn’t have legal support. 
 
Surrogacy is therefore problematic not only because of the financially-based relationship 
created between the surrogate and the intended parents, but also because the contract 
drawn up between the interested parties is not recognized as legally binding in Argentina. 
With respect to this legal vacuum, the involvement of an ART center would result in a 
consent agreement that has no legal validity— based on the Civil Code, the woman who 
gives birth will most likely be recognized as the mother, even if the eggs came from 
someone else. Capaldo explains that this is a common problem for surrogacy 
internationally, “If you look at the law around the world, or where it is legislated, priority 
is always given to the woman who gives birth to the child, as the legitimate mother, 
independent of the genes.” Making a surrogacy arrangement legal would most likely 
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entail an adoption on behalf of the non-surrogate woman, however this would not be an 
easy process given the adoption system in Argentina. Without a law to recognize 
surrogacy as a legal (and therefore legitimate) option for making a family, surrogacy 
remains on the margins of society—a financial transaction. It is unlikely that surrogacy 
will be legalized any time soon in Argentina. Most of the legal proposals for regulating 
ART up to now ban surrogate arrangements. For instance, in the law proposal drafted by 
the Argentine Society for Reproductive Medicine (SAMeR) in 2005 (mentioned in 
chapter two), surrogacy is explicitly prohibited and considers a surrogacy contract as null. 
 On the other hand, one professional in Argentina frankly told me that she agrees 
with surrogacy, provided that it is legally regulated. A gynecologist at one of the centers 
in Buenos Aires, this doctor disagrees with the prohibition in SAMeR’s proposal. In her 
view, surrogacy is occasionally necessary to allow a couple to make a family (again, 
there is an apparent dismissal of adoption as an option): 
What I don’t agree with in the current proposal is that they want to prohibit 
gestational surrogacy. I don’t think…For me, the word ‘to prohibit’ in proposal 
from the Argentine Society for Reproductive Medicine, it seems terribly 
inappropriate. I mean, I think that that gestational surrogacy is an extreme 
situation and sometimes it is very necessary. […] There are many women who are 
born without a uterus but they have ovaries. They marry, and they can generate 
their own embryos…So why not? If it is all regulated, if it is done well, with 
antecedents and etcetera… 
Our country has a disadvantage because the mother, according to the legal 
[Civil] Code, is the one who gives birth. So I am not going to do surrogacy here. 
When I have patients—I have many patients that come for surrogacy and who 
need it. Many, because they are born without a uterus, those are the most poignant 
and clearest cases. So, why not? And many, who suddenly have very serious 
problems in the uterus.  
So, what I do, precisely in order to avoid any type of conflict, for my 
patients who have the possibility—obviously, unfortunately, again we return to 
the same issue—it can only benefit those who have economic possibilities. I have 
direct contacts in the United States, I really like to work with those in the State of 
California where they have a lot of ‘know how’ and everything. And so, many 
have done the surrogacy there. They do everything necessary here and then they 
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go over there. Another thing that I have as of recently is the contact for a center of 
surrogates, they can send you the recipient [surrogate] here. So, then they do 
everything here. But the child is born there. But that also has an extremely high 
cost. And with the economic problematic of Argentina in recent years, few 
Argentine patients can access that. Because the cost is very high. 
 
Because surrogacy is not protected by law in Argentina, this gynecologist claims to not 
do it herself, but rather recommends her patients, or at least those who can afford it— to 
places where they can do surrogacy legally. In this view there is again an apparent 
dismissal of adoption as an option for making a family, or at least as a preferable one. 
According to an article published in 2006 in the weekly magazine Las Noticias, this 
gynecologist is not the only person in Argentina who agrees with surrogacy. This rather 
sensationalist article—entitled “Madres Prestadas” or “borrowed mothers” claims that 
there are private parties in Argentina seeking surrogacy arrangements through internet 
chat groups and classified advertisements in newspapers (Bossi 2006).134 The article 
details a classified listing posted in a provincial newspaper by an Argentine business man 
(living in Barcelona) which reads: “Looking for a ‘belly’ [vientre] to rent in order to have 
a child, pretty woman 18 to 28 years.” Apparently the man received 600 emails from 
interested Argentine women.  
 
 Prenatal “Adoption”  
“Now we are more restrictive in terms of cryopreservation than before. For example, if a 
patient had fifteen fertilized eggs, maybe we would let all fifteen develop and then we 
would cryopreserve for three attempts, and then you would have a lot of opinions going 
around [about what to do with the cryopreserved embryos]. So what you could do, which 
is what we are doing now, is to make a better target and do only one frozen transfer. This 
                                                 
134 This article also refers to the surrogate woman as the “mamá rentada”—the ‘rented mother’ and traces 
an Argentine couple’s efforts to find a suitable surrogate in Argentina. There are also  photos of high-
profile celebrities and their relation to surrogacy—Sharon Stone and Jodie Foster supposedly used 
surrogate arrangements to have children, and Argentine Ballet Dancer/Choreographer Julio Bocca (who is 
gay) is said to “fantasize” about using surrogacy to fulfill his desire to have a child. 
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is the institution’s norm now, and the patients who do not want their embryos can donate 
them. It is like adopting a child, it is like donating, actually, the gamete already mixed.” 
Julieta Moretti, biologist at CREAR 
 
I opened this chapter with adoption, and I close by examining a new twist on 
traditional adoptions, made possible through ART: the “adoption”—or donation—of in 
vitro embryos. Unlike gamete donation, accepting a “donor” embryo does not allow 
either member of the couple to pass on their genetic material, however it does allow the 
woman to experience pregnancy, which a “traditional” adoption does not.135 This newly-
emerging practice is not developing so much from the demands of infertile couples, or 
the invention of a new technique, but rather from a practical problem in the laboratory of 
ART centers: the excess amount of unwanted, frozen embryos in storage. In ART centers 
around the world, unclaimed and unwanted cryopreserved embryos are accumulating in 
nitrogen tanks and the case in Argentina is no different. The problem of what to do with 
these stored embryos is a difficult one to resolve, as it requires an agreement over the 
moral status of the in vitro embryo and suitable legal protections, neither of which exist 
in Argentina. I examine the problematic of the moral status of the in vitro embryo, as well 
as the technique of cryopreservation in more detail in the following chapter. Here I look 
specifically at the practice of embryo donation as one proposed “resolution” to this 
storage problem. 
Centers in Argentina today are aware of the stored-embryo dilemma and therefore 
try to cryopreserve the least amount of embryos possible. However there are and continue 
to be many embryos frozen and stored in nitrogen tanks, some dating back to when the 
                                                 
135 In Argentina embryo donation is directed towards heterosexual, infertile couples. However according to 
a local article published in 2004 on embryo donation in Spain, the practice is offered in Spain as an 
“adoption” option not only for infertile couples, but also for single women and couples who are interested 
in traditional adoption (Ricart 2004).  
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centers first began cryopreservation. This is because during a typical IVF or ICSI case, 
more embryos are created in the laboratory than will be transferred at one time. After 
selecting the most viable, best-quality embryos for the fresh transfer, the rest are frozen 
with the idea that the patient will want to transfer them at a later date. While most 
patients decide to thaw and transfer the stored embryos, others do not. The centers are 
thus left with the stored embryos, sometimes without even current contact information for 
the previous patient. Giordano, a biologist at Fertility Institute, explains the different 
options for solving this difficult situation:  
You have three options: you leave them there indefinitely, that is what is 
happening here, some have been there [in storage] since 1994 and they continue 
to be there without any type of decision. Or you discard them, like they do in 
England, but here they are not going to do that because, even though there is no 
law, it would be very poorly seen, very poorly. Or you use them for research, or 
you donate them. Using them for research purposes is also badly seen. 
 
The hypothetical options as Giordano summarizes them are: to leave embryos in the 
storage tanks indefinitely, dispose of them, use them for research, or donate them to 
another couple. However, these different paths depend ultimately on how the in vitro 
embryo is defined, existing legislation, and the social climate for a given practice. As he 
points out, these are morally and legally contentious and unresolved matters in Argentina:  
Of course, here we have the key question: what are they? Because if they are 
persons, I can’t use them for research, and if they aren’t, then I can. If they are not 
persons, why can’t I use them for research? Why can’t I throw them out? For me 
that is the question. Out of all of this, that is the question. […] Now, to donate 
them…okay, yes. Whether they are or are not persons, you can donate them. I 
agree with that. But the problem is that I don’t know if they are persons, and if 
they are persons, it is like an adoption. So, doesn’t a judge have to intervene for it 
to be an adoption? Can they just donate like that? Once a couple donates, is that 
it? The law doesn’t intervene? 
 
The problem with donating an embryo thus returns us once again to the lack of legislation 
in Argentina over ART practices and the ambiguous legal status and rights of an in vitro 
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embryo. As Giordano brings up, if embryo donation is a form of “adoption”—because 
the embryos are considered similar to children— then a judge would need to participate 
to make the exchange legal.  
It would be quite useful for ART centers to be able to donate to other couples 
those embryos that are unclaimed, or unwanted—and therefore empty out their nitrogen 
tanks and lessen their responsibility for these ambiguously-defined entities. However 
there are obstacles to being able to do this on a regular basis. One is a practical limit, 
which has to do with characteristics of the embryo itself. Only embryos created with eggs 
from women under 35 years old are considered eligible for donation. This is because the 
risk of the egg carrying chromosomal abnormalities increases significantly in women 
over 35 years old (or at least that is the medical consensus, such a precise age cut-off is 
difficult to determine on an individual basis).136 This is the same rationale used for the 
age limits of egg donors. A biologist at CREAR explains: 
To do embryo donation I need to be careful with the matter of genetics. There you 
have a quite important limit because our average [female patient] age is more or 
less 35, 36 years old. In other words I have many patients over 35, which is the 
maximum age able to donate. So those embryos that are frozen are a problem 
because the patient doesn’t want them and I can’t donate them either. It is a risk, I 
mean, if I am 37 years old and I want to have a child, well okay. But if I am 
receiving an embryo, I am not going to want to have genetic problems, it is like 
with egg donation. 
 
Given that the median age of female patients at most ART centers is around 35 years old, 
the genetic risk that the majority of embryos may carry immediately reduces the number 
of potential frozen embryos to donate. Embryo donation is therefore only a partial 
solution to the problem of surplus stored embryos. 
                                                 
136 See Berkowitz et al. 2006; Dulitzki et al. 1998; Heffner 2004; Munné et al. 1995. 
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Another significant impediment to embryo donation is the reluctance of former 
patients to donate their embryos, even ones they do not plan to use. Though a center may 
have a long waiting list of women/couples eager to receive a donor embryo, the eligible 
couples who consent to give their embryos to someone else are much fewer in number. 
For example, a year after beginning to offer embryo donation (in September 2003) 
CREAR had done only four cases resulting in two pregnancies:  
Because patients don’t want to donate them. The waiting list for embryo 
recipients is very long. There are a lot of patients who would accept, but the 
patients that have to donate them, it is like they have, I don’t know, more 
problems to donate a single gamete, than something that is genetically complete 
from the family, from the couple. That is why we aren’t doing it so much. 
 
This reluctance stems in part from the meanings being given to genetic material in this 
context. Because gametes carry a copy of a person’s genes, they are thought of as 
embodying part of oneself. The embryo, an already-formed combination of two gametes, 
is even more readily identified with. Viviana Suárez, the program manager at RMI 
explains her aversion to donate gametes, much less embryos:  
I’m very surprised by people who donate eggs or who donate semen because it 
seems to me that they aren’t conscious of what they are donating. So imagine a 
person who donates embryos…It’s like well, I am a mother, I have three children 
and I say, ‘how can you calmly donate sperm, eggs? Because for me they are part 
of me, they are my children. 
 
For Suárez, not only the in vitro embryo, but even the egg alone is thought of as her 
“child.” This position relates to a particular notion of genetic identity, and the view that 
your genetic material defines who you are. From this viewpoint, giving someone else 
your genetic material is necessarily passing on part of yourself to someone else.  
This construction of genetic material is pervasive. Indeed even those professionals 
who agree with gamete and embryo donation—and recommend it to their patients—
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impart their own genetic material with a sense of self-identity. Julieta Moretti, a biologist, 
is a case in point. Though she is in favor of gamete and embryo donation and would 
accept donor eggs if necessary, she is uncomfortable with the idea of donating her own 
eggs:  
One thing is to have in your uterus, something that genetically isn’t yours, that 
doesn’t matter to me because it wouldn’t change the love that I would have for the 
baby that is born. But to have my half-child…I would see it as my half-child 
walking on the streets without knowing, I think that would make me, it would 
make me a little anxious. No, I don’t think so. [Kelly: But you know that they are 
cells, that it isn’t a child.] No, I know that, but it has the potential to be something, 
and if it did become something I wouldn’t know if it was or not, I would keep 
going around the ghost of the question, ‘was it born? Was it not born? Do I have 
[a child]? Do I have [a child] or not?’ 
 
Moretti, even though she knows that her eggs are only cells that carry her DNA, would 
not donate her eggs because her eggs are imbued with a sense of “belonging” and 
personhood. She personifies her eggs to the point of imagining a child created out of 
them as being half-way “belonging” to her because of the genetic tie. Similarly one 
andrologist, when speaking about gamete donation also emphasized genetic identity:  
The problem is that if you start thinking about it, they are half-way your children. 
Part of your genetics is dispersed in the world. That is very strong. And I don’t 
know if I would be so calm donating sperm, knowing that part of my genetics is 
out there, no? Part—they are your half-children. That is powerful. 
 
From this perspective, the genetic material that you give to someone else is still a part of 
you—and therefore any resulting children from your donated sperm or egg will be 
halfway “you.” Given the meaning that gametes alone take on, even for these 
professionals, it is not surprising that in vitro embryos are an even weightier substance 
for patients to donate. 
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Because of this strong identification with genetic material, to give an embryo for 
research purposes, rather than to someone else to make a family, becomes the more 
tolerable option. Rovere, one of the directors of Conceive, speculates on this preference:  
The funny thing is that, statistically, when patients save their embryos made with 
their own gametes, in general when they do not want to use them, they prefer to 
give them for research and not to donate to other women. Because it is a fantasy 
of having…It is logical, you start imagining that you have in another place, in 
some place, there is someone who has a child with the characteristics of the two 
of you. It is not the same to donate eggs or sperm separately, than an embryo that 
is already made. That is why. I don’t know exactly why, but I think it has a lot to 
do with that. And that happens in the whole world. Also in the United States. 
They say that 80% decide to donate to research, and there are few people who 
want to donate to someone else.137 
 
Since the embryo has already been conceived as part of oneself, donation lends to the 
idea that your “child” is being raised by someone else. The lawyer Ana María Picolotti, 
who has triplets from an ICSI procedure, also explains that she would rather give her 
remaining cryopreserved embryos to research than to another couple. She explains her 
preference is based on two things: her understanding of the moral status of an embryo, 
and the meaning her own genetic material has, particularly when there is no law that 
protects her rights: 
I would have more tendency to give it to research in [center] than to donate it. 
[…] And on the other hand, I think that you create a certain tie with your genetic 
part that is there inside, that I don’t know if I would be able to separate that in 
order to give it for adoption. In all respects, the existence of a law would help me. 
I think that in this moment, to give an embryo is risky. […] There is nothing that 
protects it, there is no law, there is nothing that says that you are not going to be 
able to claim from me my maternity, that this child once born, is going to be able 
to do a DNA [test] and is going to be my child…and my husband’s child. It 
doesn’t give me legal security. 
 
The potential that giving this embryo that is “part of you” to someone else, and then later 
to be made legally responsible for the resulting child implies a high legal risk. In contrast, 
                                                 
137 See Parry 2006 for a discussion of patient opinions concerning embryo research and donation in 
England. 
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embryo research would absolve the donor of all potential responsibility, since that 
embryo will never become someone else’s child. However, as I discuss in chapter four, 
embryo research is not as of yet a permissible practice for ART centers in Argentina. 
On the other hand, under the construction that embryo donation is a form of 
“prenatal adoption” of a potential child, it becomes acceptable to those who would 
otherwise disagree with a “third-party” intervention. For instance, Fernando Pérez, who 
because of his Catholic principles advises couples against the use of gamete donation, 
and recommends adoption instead to his patients. As mentioned earlier, his center, RMI, 
does not provide gamete donation and only allows cryopreservation in exceptional 
circumstances. However, he is in full agreement with embryo donation:  
I think it is acceptable. I think it is one of the possibilities where…it is a mature 
and concrete possibility, in which the person who decided to freeze embryos and 
is not going to use them, permits those embryos to evolve towards life. That is 
with respect to the embryo. With respect to the couple, I think it is…I don’t know 
the statistical results of how many people accept to do it, but I know that there are 
very few people who accept donating their own embryos. In practice the 
technique evolves…the concept of donor embryos evolves very slowly, because 
for the people that already had a pregnancy and already have children it is very 
difficult to accept donation of their own embryos. […] It seems to me like a—as it 
is called in some cases, prenatal adoption.  
 
Pérez supports embryo donation for two primary reasons. The first is that it allows the 
frozen embryo the chance to be born, and the second reason is because he views it as a 
form of ‘prenatal adoption’—the couple ‘adopts’ an embryo, and therefore gives it life 
and parents. However he also realizes that the very construction of the frozen embryo as 
already someone’s ‘child’—which facilitates the view that it is an adoption—also makes 
it more difficult for couples to choose to donate their embryos. For some ART 
professionals, the characterization of embryo donation as “prenatal adoption” creates a 
complicated situation with regards to the embryo. The term prenatal adoption confers a 
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status of “personhood” on the embryo, which has implications for other ART practices, 
as I discuss in the following chapter. In contrast, for the recipients of an embryo, the 
concept of “adoption” can be a powerful incentive. For instance, in November 2006 La 
Nación ran a series of related pieces on a Catholic couple from Buenos Aires who 
received a donor embryo from an ART center in Barcelona, and are now expecting a 
child. The woman is quoted as referring to this as an adoption: “For us an embryo is a 
person. What we did was to adopt a child who was waiting, in the cold, for the 
opportunity to live” (Pisani 2006).  
 
 Conclusion 
In the context of valorized heterosexual reproduction in Argentina, assisted 
reproduction practices are calling into question the meaning of genetic material while 
also reproducing and reflecting certain values of family. Rather than belonging to a 
neutral zone of reason, specialists in assisted reproduction are not separate from the social 
worlds they serve. The very practices of assisted reproduction themselves enact and 
reproduce power dynamics and social hierarchies, in which “scientific” values vie for 
prominence alongside and in relation to other influences, like market conditions, 
ideologies of family and biological inheritance, and Catholic ethics. In controlling gamete 
donation, the medical doctor as double-mediator neutralizes and replaces the alternative 
of a more social (personal and market-based) relationship between donor and recipient. 
Taken as a whole, medical intervention in reproduction appears to follow a continuum of 
acceptability, in which blatant market-derived practices—like surrogacy—are less 
favored than both more “technological” (clinical) and “naturalistic” ones. In this way, the 
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“technomedicine” apparatus of ART mediates between society and nature—at times 
standing in for nature as the neutral absolver of unacceptable social relations, at others 
enabling a “more natural” process to take place (as with embryo donation). The 
fundamental key in this case, is that medical professionals prevent society—in the form 
of market-driven values—to determine the conditions for human reproduction.  
 In the following chapter I look at the problematic of the unresolved and 
ambiguous moral and legal status of the embryo in Argentina. In particular I examine 
how this ambiguity plays out through the practice of two ART techniques: embryo 
cryopreservation and preimplantation genetic diagnosis (PGD).  
INTERLUDE IV 
“I Would Not Freeze My Children”:  
Cryopreserved Embryos and a Legal Guardian in Buenos Aires 
 
“Rabinovich belongs to the Opus Dei. He is tremendously Catholic. It is all madness, 
that an embryo be considered a child, that a judge appoint him as a guardian from those 
children, that no one listens to the ‘voice’ of the parents or of those that have created the 
embryos. It is all madness. It’s not only Rabinovich, there are a lot of crazy people. […] 
Rabinovich is not a reflexion of Argentine society. Rabinovich is a reflection of a sector 
of the Church who is against assisted reproduction techniques and wants to define the 
embryo as a child. Society in any part of the world divides into those who have an 
infertility problem and those that don’t have an infertility problem. The vision of the 
techniques, or of what is an embryo, or of what is permitted or not, is very different for 
those who have infertility problems and those who do not. And usually what is heard from 
the least is the opinion of patients who have infertility problems. They are the ones who 
should have the most ‘voice’ in this.” Nicolás García, gynecologist and clinic director, 
August 2005  
 
In November 2004, a judge in Buenos Aires appointed the Catholic lawyer 
Ricardo Rabinovich-Berkman—a member of the Catholic group Opus Dei— to be a legal 
guardian over the cryopreserved embryos stored in ten ART centers in Buenos Aires.138 
Rabinovich, who believes that these cryopreserved embryos are children who have been 
abandoned, has been petitioning the court since 1993 to protect the human rights of all 
fertilized eggs and embryos that are created using assisted reproduction. In his view, 
human life and personhood begins at fertilization, therefore fertilized eggs and in vitro 
embryos have the same human rights as a person already born. In requesting the 
appointment as legal guardian, he claimed that the embryos need a “special guardian” to 
                                                 
138 Opus Dei is a global organization of the Catholic Church (a personal prelature), founded in Spain in 
1928, that “helps people find God in daily life.” (see website www.opusdei.org). 
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ensure these rights, and offered to be their legal protector (he also said that the Advocate 
for Minors (Defensor de Menores) was too busy to take on this responsibility). According 
to Rabinovich, people should not be frozen, therefore neither should embryos. In an 
interview with Clarín after he was appointed guardian, Rabinovich declared, “I would not 
freeze my children” (Giubellino 2005). Rabinovich then made clear he favored a 
widespread “prenatal adoption” program to give these frozen embryos to women who 
would give the stored embryos a chance at life, as soon as possible. What is most striking 
about this legal guardian case is not that Rabinovich wants to protect the human rights of 
embryos, as that perspective follows from his traditional Catholic beliefs. Nor is the fact 
that the courts in Argentina finally agreed with Rabinovich so surprising. Rather the 
remarkable side of this story is that through a united refusal to cooperate, the 
reproductive medicine community in Buenos Aires essentially rendered the power of the 
court system ineffectual.  
The ineffectuality of the courts in this matter has a ten-year history. Rabinovich 
began appealing for human rights protections for embryos in 1993, and a judge (Miguel 
Ricardo Güiraldes) agreed with him in 1995. Several of the ART centers, working 
together, appealed the lower-court decision. In 1999 the Civil Appellate court of Buenos 
Aires (Sala I) upheld the judicial decision. As I discussed in chapter two, this appellate 
ruling gave embryos personhood rights, explicitly pronouncing that: personhood begins 
at conception, even if outside the uterus; all rights begin at conception (while implying 
that conception is when the sperm penetrates the egg); fertilized eggs and embryos are 
prohibited from being destroyed or used for experimentation. In addition to outlining the 
moral status of an embryo, this ruling further demanded the following actions: 1. that 
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within 30 days of the ruling (which would have been by the beginning of January 2000) 
the secretary of public health of Buenos Aires city must conduct a census of how many 
cryopreserved embryos exist (up to December 1999) in all public and private centers 
within the city (also that once this census is made, all interested parties must be 
informed); 2. the identity of the contributors of the gametes must be revealed; 3. that any 
action other than the transfer of embryos to the original genetic contributors (cannot be 
donated) must be approved and decided by the lower-court judge; 4. the Ministry of 
Justice of the Nation must be informed that a law is necessary. Though this 1999 
appellate decision—which applies only to the city of Buenos Aires— would seem to 
clarify the legal and moral status of the embryo, it has never been complied with by the 
reproductive medicine community in Buenos Aires. None of the actions demanded by the 
ruling were ever carried out, in part due to passive resistance on the part of the ART 
centers. 
Since the ruling in 1999, every year a statement has arrived at the centers of 
assisted reproduction, requesting them to fill out a census of how many embryos they 
have and to whom they belong. From the beginning, the centers tacitly agreed among 
themselves not to fill out this information—if any one of them had complied, they would 
have all had troubles. Nor did any of the centers inform the judge of procedures done the 
embryos. To give an idea of how many embryos are at stake, suppose that in 2005 
CREAR had roughly 5,000 “preembryos” cryopreserved (for each case of IVF/ICSI there 
are on average three embryos frozen for later transfer). Other centers that follow a similar 
freezing policy must have equivalent numbers of frozen embryos, making the total in 
Buenos Aires close to 15,000 frozen and stored embryos. In 1995, the Argentine Society 
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of Reproductive Medicine reported that there were 1,333 fertilized eggs frozen in Buenos 
Aires (from 295 patients) and since this was the last reported figure, this is the number 
that the media continues to cite. For five years the situation did not change: the census 
form was ignored, the ruling stood on the books, and the professionals continued to 
follow their own self-imposed protocols of practice. However when Rabinovich was 
made guardian at the end of 2004, circumstances became more complicated for the 
centers. Suddenly the frozen embryos had a vociferous legal guardian who pledged to 
protect their rights. Over the next year, and amidst sensationalist media attention, the 
centers continued to resist compliance with any of the court’s demands. In February 
2005, the same judge who appointed Rabinovich guardian, ordered the ART centers once 
again to reveal how many embryos were stored, and the identities of the patients who had 
consented to cryopreserve them (directives based on the 1999 ruling). This time judge 
Güiraldes also applied a fine of 2000 pesos per day (approximately $700 USD) to begin 
in February 2005. Despite the imposing fine, the centers appealed the decision, citing the 
patient’s right to privacy and the preservation of the physician-patient privilege.   
By mid-2005, with the centers not cooperating with the judicial decree, and 
Rabinovich unable to act on his long-awaited legal status as guardian, the fate of the 
frozen embryos was still unknown. The entire situation, particularly the unresolved 
controversial status of the embryo, became the center of a series of newspaper articles 
published from June to August (see Cappiello and Bossi 2005a; Cappiello and Bossi 
2005b; Chillik 2005; Giubellino 2005; Lafferiere 2005; Peker 2005; Román 2005). In 
these articles, the clinic directors repeatedly reject both the notion that embryos have 
personhood rights, as well as the characterization that the stored embryos are unwanted 
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and abandoned. For instance, in his position as president of the Argentine Society of 
Reproductive Medicine (SAMeR), Claudio Chillik declares to the public: 
‘The pre-embryo is a product of an egg with a sperm and until implantation in the 
uterus it cannot in any way be considered as a child, like Rabinovich claims. The 
pre-embryo has the potentiality to implant in the uterus and be an embryo that 
eventually will give origin to a child and that potentiality gives it an ethical status 
that prevents it from being thrown out or used for research, but to consider it a 
child is completely far from the reality. But, in addition, if the judge considers the 
pre-embryos children, then what corresponds to that decision is an intervention on 
the behalf of the judge for minors. Because of that, it is even more absurd to 
designate Rabinovich as a guardian of the preembryos.’ (Peker 2005) 
 
Chillik refutes the notion that the embryos have the same rights as a child, as well as the 
judicial declaration of Rabinovich as their guardian. In another newspaper piece, the 
director of Halitus, Sergio Pasqualini counters the notion that the stored embryos are 
unwanted, saying, “‘It is an absurd decision. The frozen pre-embryos have their 
progenitors. They were not abandoned, so they do not need a special guardian’” (Román 
2005). The perspectives of some of the patients who have cryopreserved embryos stored 
at the centers are also included in these newspaper articles—not surprisingly these 
couples do not agree with the appointment of a guardian, nor for their identity to be 
revealed (Cappiello and Bossi 2005b). In addition, Clarín ran a series of interrelated 
position pieces examining the rights of embryos, written by a philosopher, a director of 
bioethics at the Catholic University of Argentina and a bioethicist at FLACSO (Bochatey 
2005; Cohen Agrest 2005; Vattimo 2005). Also in 2005 the centers notified their patients 
with cryopreserved embryos in storage of Rabinovich’s appointment, but in all respects 
work carried on as usual. 
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Nearly a year later, and with little explanation as to why, Rabinovich resigned as 
the guardian of the cryopreserved embryos on April 28, 2006.139 He also apparently 
withdrew his license to be a lawyer for 5 years (it is not clear whether he did this before 
or after resigning as guardian from the media reports). A few months later, in October 
2006, after little public attention to the matter for many months, the debate was touched 
off once again with the report of a pregnancy in Argentina using embryos that had been 
cryopreserved for 10 years (Román 2006). The woman, who lives in Buenos Aires, had 
eight embryos stored since 1996, and a nine year old son. At 47 years old, she decided to 
have a second child, and through a frozen embryo transfer, she became pregnant. This 
case caught the media’s attention once again over the unresolved “destiny” of frozen 
embryos, their ambiguous rights, and the lack of a completed census. With Rabinovich no 
longer in the picture, the Advocate for Minors stood up to bring attention once again to 
the unfulfilled appellate court decision of 1999, and its reissuing in 2005. The centers 
finally responded, and a series of meetings were conducted over several months between 
the counsel and directors of the major clinics in Buenos Aires.140 La Nación announced 
an agreement on Christmas Eve of 2006: the clinics consented to give a census of how 
many embryos they had in storage by the end of the year, though the identity of the 
patients would remain undisclosed and private (Cappiello 2006). Until a law is in place to 
regulate ART, the centers agreed to continue to report this information every six months 
(every May and November). In addition, starting in June 2007, the centers must report for 
each six month period how many embryos are transferred; how many new embryos were 
                                                 
139 I was not able to find out why Rabinovich resigned, those in the reproductive medicine community that I 
spoke with had no additional insight on this. 
 
140 According to La Nación the centers are Fecunditas, Fertilab, Fertimed (CEGyR), Halitus, Hospital 
Italiano, IFER and Procrearte (Cappiello 2006). 
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created; and what the new total of embryos is. Furthermore, the Advocate for Minors was 
named guardian of the cryopreserved embryos.  
However despite this long-awaited cooperation between the law and the assisted 
reproduction centers, little appears to have changed as of this writing. As of February 
2007, no further media articles have reported on whether the centers did in fact comply 
with their agreement to provide the number of frozen embryos in storage. The legal and 
moral status of the embryo in Argentina remains ambiguous and controversial, and in the 
absence of a specific national law, ultimately up to each clinic director to decide. 
CHAPTER FOUR 
THE GENESIS OF EMBRYOS AND ETHICS IN VITRO: EMBRYO 
CRYOPRESERVATION AND PGD 
 
 
 
Introduction 
When does human life begin? What protections should be afforded a Day Three 
human embryo created in an embryology laboratory? Should an in vitro embryo be 
frozen and stored, given for a “donation,” or used for research purposes? What should be 
the fate of an in vitro embryo diagnosed with chromosomal defects? Who has ownership 
and responsibility for an in vitro embryo? Who has the right to decide these matters? 
These questions and the ways in which they are approached and resolved point to a 
fundamental problematic of doing ART in Argentina today: the ambiguous legal and 
moral status of the in vitro embryo. In this chapter I examine this problematic as it relates 
to the debate in Argentina over two controversial ART procedures: embryo 
cryopreservation and preimplantation genetic diagnosis (PGD). First developed in 
Australia in 1983, embryo cryopreservation, which is a method of viable freezing, has 
become a basic and common means for storing embryos in assisted reproduction 
laboratories around the world.141 Argentina is no exception where despite debate over the 
                                                 
141 First report of successful human embryo cryopreservation in 1983 in Australia, though pregnancy ended 
in miscarriage (Trounson and Mohr 1983). First birth after embryo cryopreservation one year later in 1984, 
also in Australia (see Downing et al. 1985). 
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protection due to frozen embryos, the majority of centers cryopreserve at some stage of 
embryonic development. On the other hand, preimplantation genetic diagnosis, a 
technique which identifies genetic abnormalities in the in vitro embryo, is among the 
most recent and cutting-edge developments in the field, and as such is not (yet) widely 
practiced. In Argentina, over the last six years the largest centers have incorporated PGD 
into their repertoire of techniques, amidst an on-going controversy over the rights of the 
embryo. 
As I have discussed throughout this ethnography, part of the dilemma of doing 
ART in Argentina is the lack of a legal consensus on the rights and protections due to an 
in vitro human embryo. In the absence of specific instructive national legislation, the 
proper legal and ethical treatment of an in vitro human embryo is undefined and open to 
interpretation. However, alongside this legal vacuum is the influential Roman Catholic 
position that unequivocally requires the protection of human life from the point of 
conception. How to define and treat the in vitro embryo is therefore a matter of moral 
weight as well as of medical practice. At the center of this negotiation is the apparent 
incongruity between (religious) valuation of the embryo as sacred human life and 
advanced scientific techniques that permit the creation and manipulation of the embryo. 
This chapter examines these professionals’ attempts at reconciling this conflict, focusing 
specifically on cryopreservation and PGD, revealing that technology in practice is both 
messy and contradictory.  
 
(Not So) Strictly Science  
“In the beginning I thought that those embryos were going to die because they weren’t 
going to implant. If I put three embryos [in the uterus] maybe only one will implant, or 
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two, but the most probable is that at least one of them will die, right? So, I had the idea 
that if I baptized them with the culture media then it was a form of…Are you Catholic? 
[Kelly: No.] Well, in the Catholic Church when a good person dies, that person goes to 
heaven. When an unborn child dies, because there was a miscarriage, then the child goes 
to limbo. Limbo is something that exists, that is a type of heaven for the unborn. […] 
Then I changed my mind about many things, including the fact of thinking that a four-cell 
embryo is a human person, which I don’t believe anymore. I think it is a project. I think it 
is a serious matter, it isn’t the same as just any type of cell, but it isn’t a person either.” 
One of CREAR’s clinic directors 
 
The ways in which Argentine reproductive experts approach this responsibility for 
defining the treatment and rights of the embryo correspond to particular understandings 
of the process of embryo development, largely based on religious and scientific 
convictions. Those professionals in Argentina who hold more orthodox Catholic beliefs 
argue that human life begins at conception, and personhood rights begin at the moment of 
fertilization. On the other side of the spectrum, are those who view the life potential of a 
human embryo as a sequential, gradual process of biological development, in which the 
embryo implanted into the uterus at Day 14 deserves different moral considerations than 
the in vitro “pre-embryo” and of course, of the child born after 9 months gestation. 
Granted there are also many gradations in between.  
Inside the ART center, this variability in definitions of at what stage an embryo is 
viable, human life, or when it should be considered a human person, translate into 
differences in actual laboratory practices with the human embryo. Those who believe 
human life begins at fertilization are thus opposed to doing any potentially damaging 
techniques after insemination of the egg, including the cryopreservation of embryos. On 
the other hand, a position based on biological ontology allows for various embryo 
manipulation procedures, including cryopreservation of blastocysts. However all 
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professionals—whether in agreement with the Catholic Church or not—must conform to 
a certain extent with the social and moral norms in which they work and live. 
In Argentina, most centers attempt to strike a balance between appeasing the 
Catholic Church and conducting the work of ART in a profitable and modern manner. 
One way of doing this is by compartmentalizing their “scientific” practice as separate 
from complicated “philosophical and religious” matters. For instance, SAMeR guidelines 
specifically caution that the “moral status of pronuclear eggs, pre-embryos and embryos 
is a criterion that can not be deduced from a scientific analysis” and insist that from a 
scientific point of view an embryo is neither a child, nor a person (SAMeR 2005). These 
SAMeR guidelines closely follow those proposed originally in the Consenso, which 
include a declaration that personhood, and its commencement, is not a definition that can 
be arrived at through biology and the scientific community. In a conciliatory move, the 
Consenso like SAMeR, also concedes that “the path to becoming a person” begins from 
the point of fertilization, and for this reason in each stage of development the embryo 
must be treated with respect. However despite these formal guidelines, being “modern” 
continues to be a lived concern for these specialists, who struggle with the seepage of 
religion into their scientific and medical practices (Latour 1993). Tómas Navarro, an 
andrologist and a practicing Catholic, explains how he views the conflict between science 
and religion as related to embryonic development:  
You can’t argue with religious faith. But if you don’t have faith, you can say 
scientifically, for me, life begins here, or here…If religion is in the discussion, 
there is no discussion, because you believe or you don’t. If you take religion out, 
then you can argue and think of [personhood as beginning with] either two 
pronuclei, syngamy, cleavage or implantation. 
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This statement underscores what this specialist sees as an invisible boundary between 
“biology”—what medicine is concerned with— and “society,” here presented as religious 
conviction—which is outside the realm of science and medicine, and in fact is disruptive 
if let in. Navarro resolves the possible contradiction between his work and his religious 
faith by attempting to contain the two in separate domains. In this divisible world, only 
scientific discourse allows for a debate over the beginning of personhood, based on 
“biological facts.” However, the local morality within which Navarro works is 
perceptible in his science, as Navarro’s “religion-out” characterization still places 
personhood at very early stages of embryonic development. By proposing to separate out 
the work of “science” from that of “faith” these professionals strive to perform modern 
medicine without raising objections from the conservative and religious sectors of 
society. As I describe in this chapter however, in practice these black-and-white boxes 
become shades of ambiguous grey, in which science and morality are thoroughly mixed. I 
begin with the case of cryopreservation. 
 
A Cold Calculation 
“The Argentine Society of Reproductive Medicine [SAMeR] considers that conception 
begins with the implantation of the pre-embryo in the uterus (6 or 7 days after 
fertilization). Although, in agreement with this definition, the pre-embryo should not be 
considered a human person, its eventual potential to become one prevents it from being 
discarded even if the couple decides not to receive it. In such case the only alternative is 
donation.” Claudio Chillik published in Clarín, November 10, 2006 (Chillik 2006) 
 
According to the field of reproductive medicine, during a spontaneous 
reproductive cycle, approximately 75% of eggs fertilized inside the ovarian tract are not 
viable and stop embryonic development before they reach implantation stage, a situation 
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that also occurs inside the laboratory. Because of this low rate of spontaneous human 
reproductive efficiency, several methods are employed inside the embryology laboratory 
to increase the chances of pregnancy. To begin with—as described in Interlude II—the 
biologist can inseminate a handful of eggs at once. The greater number of eggs that are 
inseminated, the higher the chances that at least one of them will develop into a healthy 
embryo, implant in the uterus, and continue through to a normal gestation and birth (the 
desired result of an ART procedure). For instance, if a biologist inseminates nine eggs, 
perhaps by Day Two, five embryos will have formed. The biologist can then select the 
two or three “healthiest” ones—those with four non-fragmented cells—for transfer. To 
reduce the risk of multiple pregnancy (as discussed in chapter two), more than three 
embryos will not be transferred (depending also on the age of the woman and quality of 
the embryo). This leaves the problem of what to do with the two embryos that remain in 
the laboratory incubator. Hypothetically the options are to freeze them, let them continue 
to develop to blastocyst, use them for research, or discard them. In actuality, the 
destination—and creation in the first place—of those embryos depends largely on the 
definition of the personhood and rights of the embryo in place at the given ART center.142  
The majority of centers in Argentina do not confer the status of “personhood” on 
the fertilized egg that forms one day after insemination. Not until after at least 48 hours 
of cell development, are the developing group of cells considered a “pre-embryo” or an 
“embryo,” and regarded in terms of their potentiality to become a human person (see 
Table 2). The crucial demarcation point in Argentina is thus designated as between the 
fertilized egg, which has two separate pronuclei, and the pre-embryo, which is a diploid 
                                                 
142 If the laboratory with those two “extra” embryos in located in the United States, any of those methods 
may be employed, as both disposal and research on day 2 embryos is common practice. 
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DAY STAGE OF (Normal) IN VITRO EMBRYO DEVELOPMENT  
Day 0 Egg aspiration day; Insemination of the egg using IVF or ICSI  
Day 1 
(24hrs) 
Fertilization checked: two pronuclei (2pn), called “pronuclear stage” or 
“zygote” or “fertilized egg” (2 sets of 23 chromosomes separate) Note: 
approx. 20% of total inseminated/injected eggs are arrested by this point: 
15% do not fertilize at all and 3-5% fertilize abnormally (e.g. 3pn) 
Day 2 
(48hrs) 
Embryo cleavage and cell division checked: called “pre-embryo” or 
“embryo,” has 2-4 cells (46 combined chromosomes) Note: approx. 3% of 
the normally-fertilized eggs on Day One have arrested by Day Two (still at 
2pn) 
Day 3 
(72hrs) 
Embryo cleavage and cell division checked: called either “pre-embryo” or 
“embryo,” has 5-8 cells  
Day 4 Do not check development: called either “pre-embryo” or “embryo,” in 
the morula stage and very sensitive to environment 
Day 5 
(morning) 
Differentiation checked: called “early blastocyst” looks for the first time 
like 2 different types of cells, not like a clump of 8 cells 
Day 5 
(afternoon) 
Differentiation checked: called “blastocyst” growth in mass, zona pellucida 
thinner 
Day 6 Hatching checked: called “hatching blastocyst”  
 
Table 2. Biological developmental stages of the in vitro embryo 
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cell made up of a unique combination of the egg and sperm cells. As such, the pre-
embryo is classified as a “potential” human person, deserving of respect and protection. 
(After the formation of the zygote, the terms “pre-embryo” and “embryo” are often used 
interchangeably within most reproductive medicine centers in Argentina). Under this 
rubric, inside the embryology laboratory, a fertilized egg of one day may be manipulated 
or destroyed or used for research as appropriate for the particular procedure at hand, 
while the life potential of an embryo of two days or more will be treated with care—
above all not discarded. This position is promulgated by the Argentine Society for 
Reproduction (SAMeR), in their guidelines for cryopreservation. Issued in 2005 and 
created with the intention that they be used by local reproductive medicine professionals, 
these guidelines define a “pre-embryo” as the biological stage that begins after formation 
of the zygote (Day Two) and ends with implantation into the uterus.143 Therefore, among 
those that follow this definition, any procedure that directly jeopardizes an embryo’s 
ability to continue developing—like disposal—is not allowed, while those that present 
“minor” risk or damage—like cryopreservation—are usually permitted.  
To return then to the example of the two “extra” embryos in the laboratory that 
are not transferred, the options at most centers in Argentina are therefore (self) limited to 
either cryopreserve at this Day Two stage, or to wait to see if the embryos develop to 
blastocyst stage, and cryopreserve them at that point (see Table 3). Because of the 
designated personhood potentiality of the viable embryo, neither research nor disposal are 
regarded as a permissible. In this instance, cryopreservation thus presents a suitable 
                                                 
143 In an attempt to clarify the nomenclature, SAMER defines the “pre-embryo” for all stages prior to 
implantation in the uterus, after implantation it is an “embryo.” However this convention of the “pre-
embryo” is not commonly followed by Argentine professionals. The most important differentiation is that 
between the fertilized egg/pronuclear stage (day 1) and the embryo (day 2). 
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“solution” for protecting the life potential of the embryo, while also permitting the 
creation of multiple fertilized eggs, and the selection of the best embryos for immediate 
transfer. Because of the embryo’s potentiality, a key component of the legitimization of 
embryo cryopreservation is also the intention that the frozen embryos will transferred in a 
future cycle—either to the original couple or donated. However as I discussed in chapter 
three, this “intended transfer” often does not become a reality, hence the issue of “excess” 
stored embryos. 
   Indeed SAMeR justifies the method of embryo cryopreservation for the following 
reasons: to avoid discarding a pre-embryo that is not transferred immediately; to reduce 
the probability of a multiple pregnancy; to offer the patient maximum efficiency in the 
treatment (SAMeR 2005). This rationale is similar to that of the Consenso created ten 
years earlier. However there is a slight difference in emphasis between the two 
guidelines. The two primary objectives for cryopreservation outlined in the Consenso are 
that: it allows for an efficient treatment—the patient can do a new transfer cycle without 
going through stimulation and aspiration; it reduces the risk of multiples because not all 
the fertilized eggs will be transferred at once. The “efficiency” of cryopreservation in the 
Consenso is therefore centered on the “considerable economic, physical and economic 
savings” that having frozen embryos to transfer brings (Consenso 1996: 13). In contrast, 
today in Argentina the main rationale for cryopreservation is the other way around—the 
“efficiency” provided is framed in terms of being able to select the best embryos for 
immediate transfer and thereby avoid a multiple pregnancy. A secondary benefit 
presented is the potential for frozen transfer without the need for a full-blown cycle of 
hormone stimulation and egg aspiration. This shift in emphasis most likely has to do with 
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increased international attention to the risks of multiple pregnancy, and the worsening 
problem of excess embryos saved in frozen storage. In a short statement published in 
Clarín (quoted above), Claudio Chillik, then-president of SAMeR, responds to the 
problem of the “unwanted” frozen embryo. He presents the scenario of a couple no 
longer wanting to transfer a frozen embryo—because they already have one through 
ART, because the couple split up, or because one of them have died—and suggests that 
in such case embryo donation is the best solution for these frozen embryos (Chillik 
2006). He also emphasizes the principal advantage of cryopreservation as providing a 
way to only transfer two embryos and thus reduce the risk of a multiple pregnancy. In 
Argentina the alternatives to cryopreservation of embryos are thus presented as either a 
high risk of multiple pregnancy (because once created the multiple embryos must be 
transferred, they cannot be destroyed), or low success rates (because selection won’t be 
possible, fewer eggs will be inseminated from the beginning with a lower chance that one 
will fertilize and implant). Cryopreservation of embryos—always with the intent of 
eventual frozen transfer—is thus validated as a beneficial and morally-licit procedure.144 
                                                 
144 In contrast, in Chile personhood is regarded as beginning at the pronuclear stage and therefore 
cryopreservation beyond Day One is not morally-condoned or accepted. This is a self-imposed restriction, 
as like in Argentina, in Chile there is no national legislation. However, the Catholic Church has much 
influence in Chile, and some centers do not allow any cryopreservation at all. A biologist at one of the 
centers in Santiago explains the practical disadvantages of this moral protection of the Day Two embryo:  
“I think that it is pretty fair for the patient to be able to choose embryos and freeze embryos. What 
I find unfair is to throw away embryos. But yes, to give the possibility that in the first instance 
they are using their best embryos. Unfortunately, in proncuclear stage we don’t know enough to 
choose well. […] It is a limitation. Because we…we have done a study, we have seen what 
possibilities there are in the characteristics of a zygote, of a pronuclear stage, that permits us to 
extrapolate on what is a good embryo, but it doesn’t give us the results. Therefore at least up to 
now, as we work here we can’t choose the best embryo, by choosing the best pronculear stage. For 
us the two don’t coincide. And more than anything, because in the majority of cases we have very 
good embryos, but if I am going to cultivate to the third day, up to eight cells, and I can choose at 
that point the best embryo, I think that would be easier for me than choosing on the first day. But 
what I do not agree with is if I have a embryo that isn’t very nice, that I throw it out. Because you 
also have to give that not very nice looking embryo the opportunity to get to the uterus.” 
As this biologist explains, given the limits of biological understanding of embryo development, it is a clear 
disadvantage practically-speaking to choose day 1 fertilized eggs for transfer and cryopreservation. Though 
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DAY LAB PROCEDURES ACCORDING TO IN VITRO EMBRYO 
STAGE  
 
 
Day 0 
(morning) 
 
 
Egg aspiration, sperm preparation and capacitation 
Day 0 
(afternoon) 
 
 
Insemination of the egg using IVF or injection of the egg using ICSI 
Day 1 Pronuclear stage: transfer (rarely), cryopreserve, discard, research, or place 
in special sequential media to continue to develop 
 
 
Day 2 “Pre-embryo/Embryo”: cryopreserve, transfer, or leave to continue to 
develop 
 
 
Day 3 “Pre-embryo/Embryo”: cryopreserve, transfer, leave to develop to 
blastocyst (day to take biopsy of blastomere for PGD) 
 
 
Day 4 Morula: leave alone 
 
 
Day 5 Blastocyst: cryopreserve, transfer (PGD results ready) 
 
 
Day 6 Blastocyst: cryopreserve, transfer  
 
 
Day 7 Hatching blastocyst: transfer (rarely)  
 
 
 
Table 3. Laboratory procedures in Argentina based on the biological stages of embryo development  
 
                                                                                                                                                 
objecting to this limitation, this biologist also upholds the idea that any embryo created should be given the 
chance to implant in the uterus. 
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Figure 39. Day One: 2pn (pronuclear stage), normal fertilization. One pronucleus is from the egg, 
one from the sperm, each contains 23 chromosomes. Photo courtesy of Sabrina de Vincentiis, 
2006. 
 
 
 
 
 
 
 
 
 
 
Figure 40. Day One: 3pn, abnormal fertilization. Photo courtesy of Sabrina de Vincentiis, 2006. 
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Figure 41. Day Two (morning): Normal embryo, good quality, Class IV, two cells. Photo courtesy of 
Sabrina de Vincentiis, 2006. 
 
 
 
 
 
 
 
 
 
Figure 42. Day Two (afternoon): Normal embyro, 10% fragmentation, Class III, four cells. Photo 
courtesy of Sabrina de Vincentiis, 2006. 
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Figure 43.  Day Three: Three Embryos, good quality, all Class IV. From bottom, clockwise: six cells; 
eight cells; eight cells. Photo courtesy of Sabrina de Vincentiis, 2006. 
 
 
 
 
 
 
 
 
 
 
 
Figure 44.  Day Three: Embryo, good quality (Class IV), eight cells. “Lindo.” Photo courtesy of 
Sabrina de Vincentiis, 2006. 
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Figure 45. Day Three: Embryo, good quality but because of fragmentation (<5%) and granulation is 
Class III, eight cells. Photo courtesy of Sabrina de Vincentiis, 2006. 
 
 
 
 
 
 
 
 
 
Figure 46.  Day Three: Embryo, 10% fragmentation, granulation, Class III. Eight cells. Photo 
courtesy of Sabrina de Vincentiis, 2006. 
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Figure 47. Day Three: Embryo, multinucleated (five nuclei), arrested; has not evolved from this stage 
since Day Two.  Not viable. Photo courtesy of Sabrina de Vincentiis, 2006. 
 
 
 
Social Conventions and Laboratory Pragmatics 
*** 
May 2003, conversation about embryo cryopreservation with a biologist at one of 
the centers in Buenos Aires: 
Biologist: I calculate that it [frozen embryo storage] is going to be a problem, but 
I don’t know very well how to solve it because I recognize, especially from 
working inside the laboratory, that cryopreservation gives you the opportunity to 
better select the embryos that you are going to transfer. Because as I have several 
to select from, I can elect the best ones, and then I transfer those.  
 
But maybe what I would do is to be more selective in what I cryopreserve and 
cultivate more to the blastocyst stage. What happens is that it is a double-edged 
sword, because to cultivate to blastocyst implies being more dependent on the 
laboratory conditions. If the laboratory is not good, the embryos that have good 
potential to develop, you are giving them over to death. So, you have many things 
up in the air. That is why if they are good quality, what we do is to freeze in Day 
Two, or in Day Three and if they are bad quality, since we don’t discard embryos, 
we take them to blastocyst stage and if they make it, we freeze them at that point. 
We know that if they arrive [to blastocyst] it is because in reality their bad quality 
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has an effect, it but not a serious one. What is going to be a problem is going to 
be a problem. We have a lot of frozen embryos, with a lot of patients who some 
don’t respond, others don’t know what to do, others know what to do but they 
don’t want to do it… 
 
Kelly: What is going to happen with those? 
 
Biologist: We have them there. We can’t take... 
 
Kelly: But for how long? 
 
Biologist: Oh, no, indefinitely. We can’t do anything because of the mentality that 
exists here. For the country that is…for example England discarded 5,000 
embryos because they said, ‘if after a month they don’t respond, we will throw 
them in the trash,’ and so they threw them away. We can’t do that, because 
everyone will come after us. Maybe you want to, I don’t know, but maybe there 
are people that say, ‘look, if it has been eight years and the person has not taken 
responsibility, why do I have to assume responsibility?’ But we wouldn’t ever do 
it because the media, everyone, would come after you, here in Argentina. 
  
Kelly: And neither is anyone paying for the storage… 
 
Biologist: And in fact they don’t pay. There are many that we lost contact with. 
Many. And they [the embryos] are there, stored... 
 
Kelly: And you can’t use the embryos for research purposes? 
 
Biologist: No, you can’t, because the consent form authorizes you, [the center], to 
transfer them to the patient herself, or to transfer them in an embryo donation. 
That is the only thing that the consent form authorizes you to do. Because it isn’t 
that you can research the human embryo, it almost isn’t even that you can touch 
the embryo, you see? To do research with embryos would be spectacular because 
you have a lot of material that, in reality, no one wants and some are of bad 
quality, in other words you could use them. But here you can’t because the patient 
would have to sign a consent form, and I don’t know, actually, maybe many would 
accept it because in the survey that we did with [psychologist] on PGD, ‘what 
would you do if…?’ the majority said, if they [the embryos] were abnormal, they 
would give them to research or they would discard them without any problem. But 
the issue is that what the patient would do is one thing, and it is another thing 
what the institution does and stays tied to, you understand? Because you are in a 
sociocultural, religious environment where the Church has a lot of weight and if 
they find out that you are doing research with human embryos you will end 
up…you will more or less have to close the clinic. 
 
*** 
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Like other ART practices, embryo cryopreservation is an artifact of laboratory 
pragmatics, social conventions, and moral values. As outlined earlier, there are tangible 
benefits for both the professional and the patient to using embryo cryopreservation. These 
benefits are drawn on to rationalize the technique. However, since the legal rights and 
personhood of the embryo are not defined or regulated in Argentina, embryo 
cryopreservation is not without drawbacks. For instance, the Rabinovich-guardian case 
described in Interlude IV provides a preview of the difficulties that centers could 
encounter in the future if embryos are legally given full human rights protections. For 
now, in order to make embryo cryopreservation palatable, the centers promise that all 
frozen embryos will someday be transferred—patients sign a consent form agreeing to 
this. Despite this transfer-intention though, the accumulation of unwanted embryos in 
nitrogen tanks—discussed briefly in chapter three—is cause for concern. Manuel 
Giordano, a biologist at Fertility Institute, explains, noting the implicit contradiction in 
“saving” the unselected ones:  
Yes, we select them…we select the best quality ones to transfer. And the rest we 
freeze. It is like discarding them. It is another means of selection, you don’t 
discard them, but you freeze them. [Kelly: And then you have the problem of 
many frozen embryos?] Yes, exactly, a super-population of frozen embryos. 
 
Giordano admits that in some ways, cryopreservation is akin to a socially-acceptable 
method of “discarding” low-quality embryos that no one will want to transfer—they will 
be safeguarded in liquid nitrogen indefinitely. There are no agreed-upon time-limits for 
embryo storage in Argentina, unlike in other countries. I examine again this deferment-
aspect of cryopreservation with respect to PGD later in the chapter, but here it shows the 
negotiations between scientific efficiency and social mores that are implicit in producing 
assisted reproduction practices. ART professionals work within—and reproduce—certain 
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social boundaries between science and (religious) morality. As such, ART procedures 
follow a continuum of acceptability, and it is up to the professional to optimize social and 
material constraints to their advantage. One such method of “optimization” is the 
technique of cultivating the embryo to blastocyst. 
To cultivate an in vitro embryo to the blastocyst stage, the biologist first places 
the Day One fertilized egg in a specially-designed nutritive media called P1 until Day 
Three, then the embryo is transferred to a new dish of (expensive) blastocyst medium to 
develop until Day Five (see Figure 2). These five days of incubated development are in 
effect a screening-test, as poor-quality embryos that may have endured up to Day Two or 
Day Three with minimal cell divisions, will not survive two more days in the less-than 
ideal laboratory conditions, and will arrest along the way. On the other hand, a viable 
embryo—one with potential to implant— will develop inside the incubator and reach the 
differentiated blastocyst stage on Day Five.145 Blastocyst cultivation thus serves as an 
additional method of selecting the best embryos—either for transfer or for 
cryopreservation—while still conforming to the principle of protecting the life potential 
of the embryo. 
For professionals and patients, cryopreservation at the blastocyst stage provides 
distinct advantages over earlier-stage freezing. Waiting until Day Five to cryopreserve 
allows the biologist to only save the few embryos that reach blastocyst—a much smaller 
proportion than those that develop to Day Two or Day Three—and thus reduce the 
numbers of embryos that are being frozen every day. Centers that are concerned about 
how many embryos they have in storage are therefore employing blastocyst cultivation as 
                                                 
145 If laboratory conditions are not controlled—for example, if the CO2 level or temperature in the 
incubator are not regulated—then even otherwise-viable embryos will not survive to blastocyst. This can 
happen in mediocre laboratories, as pointed out  in the conversation quoted above. 
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a form of “embryo-bank” prevention.  This is the case at CREAR where by January 2005, 
the laboratory started cultivating to blastocyst all poor-quality embryos not immediately 
transferred. Many of these embryos arrest along the way and therefore qualify to be 
discarded since they are no longer developing. This allows the laboratory to continue to 
select the best embryos out of many, while also reducing the overall numbers of embryos 
cryopreserved. There are also advantages for the patient in cultivating to blastocyst. At 
CREAR for example, patients pay a one-time fee of $500 USD to cryopreserve viable 
embryos, and a yearly maintenance fee of $100 USD to keep them in frozen storage, 
regardless of the embryo’s quality. Therefore it is to the patient’s benefit to freeze a 
viable blastocyst that can be transferred at a later date, rather than a poor-quality Day 
Two embryo that might not survive the cryopreservation and thawing process.  
Though an “optimization” strategy in many ways, blastocyst cultivation is also a 
costly alternative, and is not a procedure that can be adopted by any laboratory, at any 
time. To begin with, the blastocyst media needed is more expensive than that used for 
Day Two or Day Three embryos. In addition, because the embryo stays in the laboratory 
longer, it takes up valuable space in the incubator. If there are not enough incubators to 
comfortably fit the number of cases on a given day, the incubator will become over-full. 
Four aspiration cases in one day is the comfortable limit for one incubator, provided the 
laboratory uses compartmentalized glass doors for each inner shelf (see photograph x 
below). To develop in the incubator, an embryo needs stable conditions, particularly to 
pass through the morula stage at Day Four. Constantly opening and closing the incubator 
doors to attend to different-stage embryos from different aspiration cases puts all the 
embryos at risk. Transfer and cryopreservation of embryos at Day Two or Day Three 
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allows for a quick turn-over in the incubator, a more efficient method for resource-
squeezed laboratories.146 Blastocyst cultivation is therefore only practically-beneficial for 
those laboratories that have few cases (and therefore a relatively empty incubator), or 
those with many incubators that can be designated for distinct purposes.  
 
 
Figure 48. Incubator in IVF lab. Photo courtesy of Sabrina de Vincentiis, 2006. 
 
Frozen Life  
“In the first version of Ratzinger’s document, he said that in reality it begins to be a 
human being at syngamy. As such, in the pronucleus the paternal genes have not yet 
joined with the maternal, and so naturally it is not yet an embryo. The pronuclear eggs 
are pronuclear eggs, they are not embryos. And what I believe is that one must not harm 
the embryo, which is a human being but does not have any rights given to it. It doesn’t 
have any rights protecting it nor can it defend itself. So it’s at the mercy of an individual 
who can do what he wants with it.” Augustín Ortiz, scientist at Laboratory for 
Reproductive Medicine 
 
As this cultural analysis makes clear, the limits of acceptable ART practice follow 
a continuum, subject to shifts in social and personal moral values and practical 
requirements. Though cryopreservation of Day Two or Day Three embryos, and 
blastocyst cultivation  have become standard practices in Argentina, it hasn’t always been 
                                                 
146Many laboratory differences in procedures that I observed in Argentina are based on a combination of 
practical calculation and moral preference. For instance at CREAR, where no moral distinction is made 
between a day 2, day 3, or blastocyst embryo, practical considerations come first: 95% of their transfers are 
done on day 2 because their results for pregnancies are very similar between day 2 and day 3 transfers, and 
transferring on day 2 frees up the incubator sooner.  
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that way and in fact, there are still some reproductive medicine professionals who 
disagree with exposing the embryo to any type of potential damage, regardless of its 
practical benefits.147 Cryopreservation first began in Argentina around the same time as 
IVF, in 1987 at CREAR. At that time only Day One pronuclear stage were frozen, not 
embryos, mainly because the center’s directors at the time did not want to subject the 
embryo to any type of potential harm. In 1996, CREAR began cryopreserving Day Two 
embryos—a decision that represents a potent mixture of practicality, “scientific 
reasoning,” and changes in personal moral values. Romero, a biologist at CREAR and a 
practicing Catholic, explains this continuum:  
…as the years passed I became more open-minded, I matured or whatever you 
want to call it. I realized that in reality an embryo with four cells is not a baby. 
Potentially it is a baby, but it is not a baby. So I began to accept cryopreservation. 
In the beginning we were freezing—the same thing more or less happened to 
Tómas [Navarro], but over a longer time because he began working earlier—but 
we were freezing pronucleus stage eggs, not embryos, and then we began to 
freeze embryos, and then we began to cultivate embryos up to the blastocyst 
stage. In other words, there were stages over time and I think that we matured not 
only professionally but also personally, and we began to see things in another 
way. 
 
Romero explains that over time and through laboratory work, she—and her Catholic 
colleague in the lab, Navarro, have learned to define the early stages of the embryo 
differently, making embryo cryopreservation more acceptable than before. Though she 
does not mention the practical benefits of cryopreserving at Day Two or Three (discussed 
earlier), they undoubtedly also factor in to this shift in laboratory policy.  
On the other hand, there are some ART specialists who despite the practical 
benefits and increasing social acceptability of embryo manipulation, refuse to put the 
embryo’s viability in jeopardy. These specialists concur with the normatized moral and 
                                                 
147 For 2003, the Latin American Registry reports a total of 2,024 transfers of frozen embryos—this is 11% 
of all transfers (Zegers-Hocschild and Galdames 2004: 25). 
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scientific differentiation made between the pronuclear stage and the Day Two embryo in 
Argentina (explained earlier). However, they also insist that the embryo, beginning on 
Day Two, deserves utmost “respect” and protection. The scale of acceptable procedures 
performed on an embryo therefore varies, usually by degree of religious convictions.  
For instance, at RMI, where the directors are strictly-practicing Catholics, there 
are strict limits on cryopreservation. Cryopreservation is reserved for exceptional cases, 
and only done at the blastocyst stage. Guillermo López, one of the directors, believes that 
fertilized eggs are human life and that personhood begins at Day Two in a 4-cell embryo. 
He therefore prefers to fertilize fewer eggs from the beginning, and to transfer all that 
reach blastocyst stage. The idea is to avoid freezing embryos—human life—and 
committing them to indefinite storage. In López’s mind, the morally-appropriate 
alternative is to inseminate four or five eggs in a given case, out of which perhaps two 
will develop to blastocyst, and be transferred immediately.  
Gabriel Ferrari, a Catholic biologist at a public hospital, also believes that human 
life begins from the moment of fertilization, and agrees with the approach taken at RMI. 
In his mind, cryopreservation should be avoided in all cases, as it is “frozen life”:  
I think that for me there is no room for the idea of having a life frozen. If I start 
from the concept that life begins at the moment of fertilization, then evidently I do 
not agree with this, where the embryos stay stored in a ‘freezer’ for years, or they 
are thawed and thrown out. Because for me they are life from the moment... 
[Kelly: And if they are thawed and transferred?] Well, I think that the current 
technique is to transfer three embryos, because statistically it is seen that of the 
three that they transfer, in general one, or at the most two, progress and transform 
into children. It seems okay to me to limit the number of embryos that you can 
transfer. But it also seems okay to me to limit the number of embryos that you can 
try to have in the first place. Because, if three are going to be transferred and five 
go to the freezer, I don’t like that. I would like for all that are formed to be 
transferred, with everything that that implies. That is why it is a delicate area 
where the moral, the religious and daily medical practice collide.    
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Ferrari himself does not do high-complexity treatments, and so does not have to confront 
the practical results in the laboratory of “protecting” embryos from the pronuclear stage. 
Ferrari’s perspective on cryopreservation echoes that held up in the Rabinovich case, 
where frozen embryos are discussed as human persons, rather than as “potential” human 
life.148  
The ambiguity of the embryo’s rights therefore creates a situation in which 
Argentine medical professionals are de facto responsible for articulating philosophical 
and ethical positions that most Argentines deem as fundamental regarding when human 
life begins and what moral status an embryo holds. In the following section I look again 
at this ambiguity, this time in terms of the advanced technique of preimplantation genetic 
diagnosis. 
 
Preimplantation Genetic Diagnosis 
 “…what do we do if…you know, what do we do with an embryo that has abnormal 
chromosomes? Do we throw it away? And you know, there’s all this sense of the Catholic 
Church being involved in every step of Argentinean life and that’s, people are afraid of 
that.” Alberto Ruiz, gynecologist at Fertility Institute (May 2003) 
 
Positioned at the meeting point of ART and medical genetics, preimplantation 
genetic diagnosis (PGD) is an advanced laboratory technique used to analyze the 
chromosomal makeup of the in vitro embryo. The primary application of PGD is 
                                                 
148The media often also promotes the view that embryos are children, as exemplified in a story that ran in 
November 2006 in Clarín (Iglesias 2006). The article discusses a Catholic couple’s use of IVF and embryo 
cryopreservation, and their subsequent transfers of the seven frozen embryos over a period of seven years 
resulting in four children (the last transfer resulted in twins). The journalist quotes the woman as saying 
that after having the first two children, she didn’t want to leave the remaining three embryos in storage 
because: ““Morally we had to do it. They had the same rights as the other two siblings.” The couple also 
profess to not have any conflict between their Catholic beliefs and doing ART, in much the same manner as 
Catholic professionals. The woman says that in their case, science gave nature a helping hand: “We turned 
to science so that it would give us a hand. In our case science gave nature a push, nothing more. We used 
science in an absolutely responsible manner.”    
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therefore as a pre-pregnancy screening test for genetic disorders, in which 
chromosomally normal embryos can be selected for use in subsequent pregnancy 
attempts. The PGD International Society estimates that there have been 7000 cases of 
PGD performed in more than 50 centers around the world since the technique was first 
successful in 1990, with approximately 1,000 babies born after its use.149  
Following this international trend, over the last six years, five private assisted 
reproduction clinics in Buenos Aires have also begun offering PGD to the public. The 
first clinic in Buenos Aires to perform PGD did so for research purposes in 1998, 
implementing the technique as a clinical service about one year later. Indicative of their 
palpable desires to provide the latest innovations in reproductive medicine, four more 
centers in Buenos Aires have incorporated PGD into their repertoire of ART services as 
of late 2006. However legitimizing PGD as a valuable and recommended service has 
been a complicated, and as yet unresolved, process for Argentine reproductive medicine 
practitioners. Several factors make the acceptance of PGD difficult in Argentina, 
including the high cost of necessary equipment and training. But the principal reason is 
again, the problematic legal and moral status of the in vitro human embryo in Argentina. 
PGD by nature of the technique requires not only embryo manipulation, but also a 
protocol for what to do if that embryo is chromosomally abnormal. In this section I 
examine professionals’ attempts at “resolving” this problematic. 
 
                                                 
149 See http://www.pgdis.org, accessed November 29, 2006. The European Society for Human 
Reproduction (ESHRE) reports even higher numbers of PGD procedures around the world than the PGD 
International Society. According to its most recent report, there are 66 centers registered with the ESHRE 
consortium, with 45 centers reporting data for 2002-2003 (Harper et al. 2006). The only Latin American 
center to report procedures to ESHRE in this report is from Argentina. 
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The Problematic of PGD 
“I wouldn’t do the diagnostic testing, because in the case of an abnormal embryo, I 
wouldn’t destroy it.” Fernando Pérez, gynecologist and one of the directors of RMI (July 
2004) 
 
After more than two years of laboratory preparation and training, in May of 2003, 
the Center of Reproduction and Gynecology (CREAR) became the third clinic in 
Argentina to provide PGD as a routine clinical service. These two years entailed a 
considerable investment of capital and training time. The laboratory equipment and 
materials necessary to do PGD, as well as the actual technical knowledge and skill 
required, are not those used in day-to-day ART services. The requisite equipment 
includes a fluorescent microscope (for fluorescent in-situ hybridization (FISH) analysis), 
Hybrite warming machine, probes, special slides and filters.150 In Argentina, this 
equipment is all imported, with minimum costs to begin the service totaling between 
$33,400 USD and $90,000 USD, depending on if the clinic already has the 
micromanipulator microscope used for ICSI, which most centers in Argentina do. 
Once the equipment is properly set up, technical mastery of PGD calls for months 
of practice, as it is a complicated technique that involves much skill with the microscope 
and specialized knowledge of chromosomes. There are four essential stages of PGD 
following the initial in vitro fertilization process (creation of the embryos). Learning to 
correctly perform each of these steps requires three to four months of daily practice in the 
laboratory. The technique begins with an embryo biopsy, performed on a Day Three in 
                                                 
150There are two main techniques for chromosomal analysis: FISH (fluorescent in-situ hybridization) and 
PCR (polymerase chain reaction). Since only one clinic in Argentina uses PCR, and the rest use FISH, I 
discuss only FISH in this chapter. A different (and more expensive) set of equipment is needed to do PCR. 
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vitro embryo that will ideally have developed eight cells.151 Each of these cells, called 
blastomeres, contains a complete set of the chromosomes. A small hole is carefully made 
in the outer covering of the embryo and one cell (blastomere) is extracted, leaving the 
other cells in the embryo to continue development. The second step is the fixation of the 
blastomere onto a special slide. The third phase is the FISH process, the hybridization of 
the probes with the blastomere DNA. Finally, the tagged chromosomes are analyzed 
under the fluorescent microscope, known as “reading” the fluorescent probes. Only five 
chromosomes can be analyzed at a time using FISH, usually in the following 
combinations: 13, 18, 21, X, Y or 13, 16, 18, 21, 22. These sets of five chromosomes are 
identified as the most frequent carriers of abnormalities, however testing both sets 
encompasses only a total of 7 chromosomes out of 46 total (using 2 rounds of FISH).152 
Because of this technical constraint on the number of chromosomes that can be tested, the 
“normal” embryos identified through the use of PGD may also carry undetected 
abnormal chromosomes. Among reproductive experts, this limitation is regarded as par 
for the course; it is not part of the debate over PGD in Argentina. The entire process of 
PGD takes 2 days to perform; therefore results are available at the maximum point of 
viable in vitro incubation, when the in vitro embryo has developed into a blastocyst at 
Day Five after fertilization. 
To ensure proper laboratory set-up and training, CREAR sent a biologist first to 
Sao Paolo, Brazil to learn the fundamentals of laboratory preparation, embryo biopsy and 
                                                 
151 An alternative to doing PGD on an embryo is to instead biopsy the polar body of the fertilized egg on 
the day of fertilization (this is done in Chile where embryo manipulation is prohibited). However since only 
the chromosomes from the egg are analyzed, this technique only reveals information from the female side. 
 
152 In Argentina only 7 chromosomes are tested, however some centers in the world test 2 additional 
chromosomes, numbers 15 and 17 (using FISH twice), bringing the total to 9 chromosomes tested.  
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fixation of the embryo from a specialist (now practicing in the US). A year later, with the 
laboratory ready and equipment in place, CREAR flew in an expert embryologist from 
Italy for a week of hands-on laboratory instruction in the technique, after which 
CREAR’s biologists and embryologists continued to practice on their own. This second 
training session focused specifically on chromosome analysis and “reading” the 
fluorescent probes, skills previously more familiar to geneticists than embryologists and 
biologists in a traditional ART lab.  
The cost of doing PGD is not only one of finances and training, but also requires a 
shift in thinking about the embryo. At CREAR, resistance to “paying this fee” and 
revising notions of embryo manipulation delayed the introduction of PGD for several 
years. Julieta Moretti, the biologist at CREAR who trained in Sao Paolo, explained this 
reluctance to me in September 2003:  
PGD for a long time was on hold because some of the associates didn’t agree with 
it, specifically with doing something that would invade the embryo…When I 
came back from Cornell in 1999 I brought the techniques of fragment removal 
and assisted hatching [techniques that are similar to PGD in manipulating the 
embryo]. Only recently we started using these because before, they had objected. 
A few had the philosophy that the less you do to an embryo, the better. 
 
These objections to “invading the embryo” represent a key conundrum of PGD in 
Argentina, and ART in general, with respect to the in vitro embryo: religious/social 
morality vs. technical efficacy. While doing “less” to the embryo translates as preserving 
the sanctity of human life, doing “more” holds the promise of selecting a ‘better quality’ 
embryo, improving success rates of pregnancy, and preventing genetic disease. Though 
CREAR’s board of directors had finally approved PGD as a clinical technique, the 
problem of the embryo was far from resolution. Indeed, over the next year the process of 
accepting PGD as a valuable procedure entailed an entire revision of the center’s policy 
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on the moral status of an embryo, a modification which has implications not only for 
other assisted reproductive practices at this clinic, but wider social and cultural 
ramifications as well. 
In Argentina, the centers that are providing PGD as a clinical service do so 
according to specific medical criteria. The medical rationale for offering PGD 
corresponds with three objectives: 1.To reduce repeat miscarriage rates; 2.To increase the 
implantation (and therefore pregnancy) rates of IVF/ICSI; and 3.To prevent inheritable 
genetic diseases from being passed on in families with known genetic risks. Some of the 
genetic disorders that PGD can be used to identify are Down’s Syndrome, Tay-Sachs, 
cystic fibrosis, Duchene muscular dystrophy, hemophilia, and Huntington’s Chorea. 
However as mentioned earlier, doing PGD does not guarantee the development of a 
healthy fetus. Indeed, reproductive specialists in support of PGD internationally and in 
Argentina also recommend prenatal testing for post-PGD pregnancies.  
At least for now, practitioners in Argentina are careful to advocate using PGD 
only for specific cases, given the debate it provokes and the financial expenses that come 
with it. Therefore PGD is not recommended to all couples who are referred for infertility 
problems, but rather confined to a target population of those who have a family history of 
genetic disease, repeat miscarriages, failed implantation attempts, azoospermia (lack of 
sperm), or where the woman is over 37 years of age. The utility of PGD for this specific 
group of potential patients is emphasized, as Nicolas García, gynecologist and one of 
CREAR’s directors, told me in August 2005:   
For patients with genetic disorders, without a doubt PGD is fundamental. It is 
fundamental to assure the birth of a child that won’t have a genetic disorder, that’s 
what PGD is for. But I don’t think, and I might be wrong, that in the future PGD will 
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be done routinely…because it doesn’t make sense to do that…It will instead be done 
according to specific indications. 
 
Most proponents of PGD in Argentina do not foresee PGD becoming a widespread 
technique, available to all ART patients in Argentina. They agree with García about its 
utility for a select population, and in doing so underscore that this is a technique for 
preventing the expression of a genetic disease, not for enhancing “choice” or improving 
the embryo beyond a standard of “normal.” Indeed, at present, the professional debate 
over the technique dwarfs the actual number of PGD clinical cases that these centers 
perform. For this technique in transition, the patient caseload is still light, ranging 
between 6 and 15 cases per year at most of the clinics.153 In Argentina, the international 
prestige of PGD as a cutting edge technique is such that to be recognized as a center that 
provides PGD is, for now, reason enough. Public demand is sure to follow.  
In the international reproductive medicine community, controversy over PGD 
focuses primarily on defining the appropriate uses of the technique.154 In contrast to 
Argentina’s restrictive clinical rationale, some tout PGD as beneficial for improving the 
efficiency of ART in general, claiming that it is “surely evolving to become the standard” 
(Verlinsky et al. 2004a: 294). In recognition of the growing use of PGD around the 
world, these international ART specialists have convened international symposiums on 
the ethical issues of PGD, as well as task forces and ethical committees to provide 
                                                 
153 As of 2007, there are no published data on exactly how many PGD procedures are being performed in 
Argentina, most likely due to the recentness and rapidity with which it has been taken up by the infertility 
clinics. The most recently published Latin American registry on ART, with data from 2003, makes no 
mention of PGD practices in Latin America. Numbers on PGD given here are thus based on personal 
communication and observation by author.  
 
154 In referring to the “international community” I do not mean to present a monolithic version of this 
community, but rather refer to a group of reproductive medicine professionals from around the world who 
meet regularly at congresses such as the European Society for Human Reproduction (ESHRE) to share 
expertise and create guidelines for practice (e.g. ESHRE Ethics Task Force and ESHRE PGD consortium).  
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guidelines for the proper application of the technique (ASRM 1999; Edwards 2002; 
Hudson 2006; Klipstein 2005; Shenfield et al. 2003; Thornhill et al. 2005). In many other 
countries the legal status of the in vitro embryo has already been resolved by state 
legislation, and the principle concerns about PGD have been the potentially eugenic and 
discriminatory undertones and uses of PGD.  In Japan for instance, PGD is prohibited on 
the grounds that it enables a form of genetic discrimination by selecting out only those 
embryos that are “genetically” normal, thereby discriminating against individuals with 
chromosomal disorders (Munné and Cohen 2004). Disability rights groups are also wary 
of the potential genetic discrimination implicit in PGD, as it extends pre-natal testing 
even earlier in embryonic development (Parens and Asch 2000). There is also debate over 
whether PGD should be allowed for human leukocyte antigen (HLA) typing, in which an 
in vitro embryo is selected for its ability to be an HLA match able to provide 
haematopoietic stem cells to a child who suffers a serious congenital disease (de Wert 
2005; Edwards 2004; Verlinsky et al. 2004b). In addition, PGD can also be used for sex 
selection of the embryo for non-medical reasons, sometimes known as “family 
balancing.” Preference-based sex-selection is widely controversial both because of its 
discriminatory potential and also because it entails the possibility that a chromosomally 
normal embryo will be discarded if not of the preferred sex (Edwards 2002; Malpani and 
Malpani 2002; Shenfield et al. 2003).  
Taking these international concerns over PGD into consideration, what is most 
striking about the case of PGD in Argentina is that the controversy is focused almost 
entirely on the nebulous status of the human embryo itself. In this sense, the debate in 
Argentina over PGD shares much in common with the global debate over stem cell 
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research and cloning, which also calls into question the protections due human life. In 
Argentina where fundamental anxieties over assisted reproduction and the status of the 
embryo have yet to be resolved, concerns surrounding genetic testing and the proper use 
of PGD are not yet as pressing. The circle of inquiry in Argentina is therefore drawn 
around what rights and protections should be afforded to an in vitro human embryo of 
eight cells whether chromosomally normal or not, rather than on potential genetic or sex 
discrimination. Genetic testing issues are undoubtedly potential concerns in Argentina, 
but the critical issue for objection to PGD in Argentine clinics—what to do with the 
abnormal embryo—at present precedes the resulting conflict in other places. As this 
chapter illustrates, in the unregulated private market of ART in Argentina, the ambiguous 
status of the in vitro embryo is a source both of anxiety and promise for practitioners who 
support the practice of PGD.  
 
Modernizing Practices in Argentina 
 
“Technology progresses much faster than our thinking does. You don’t know if that’s 
good or bad. Even more than that, you don’t know the consequences.”  Manuel 
Giordano, a biologist at Fertility Institute (June 2004) 
 
For a couple undertaking ART in Argentina, PGD costs an additional $500 USD 
per IVF-ICSI cycle. In this scenario, consumer “demand” for a given technique is often 
created by the centers themselves through physician referrals, and subsequently through 
patient familiarity and desire for the procedure. This is precisely the situation with PGD. 
By 2005, all five of the principal clinics were providing some form of PGD, and yet the 
actual number of patients requesting PGD was negligible (especially compared to those 
asking for IVF). For the time being, PGD is being performed only at these larger 
 326
infertility clinics in Buenos Aires. It is not viable for the smaller clinics in Argentina, 
because they do not perform enough patient cases of assisted reproduction treatments in 
general, to make it worthwhile to invest in the high-priced training and equipment 
required for PGD. 
The incentive to begin offering PGD is not only a market-based competitive one, but 
perhaps more importantly is related to the appeal of this technology as a scientifically 
advanced technique for professionals in Argentina. As discussed earlier, Argentine 
specialists are participants in an international community of reproductive medicine 
experts, a milieu in which it is of utmost importance to be perceived as “modern” and up 
to date with the latest medical technology and procedures. These include basic embryo 
cryopreservation as well as advanced embryo-manipulation techniques like PGD and 
assisted hatching.  Successfully providing high-tech reproductive technologies including 
PGD, can therefore be read in Argentina as vital to maintaining this highly desired and at 
times precarious modernity. 
 In the unregulated market environment, some ART procedures are done quietly, 
while others are not even discussed. For example, until PGD made the issue unavoidable, 
the disposal of an in vitro embryo was considered a question too taboo for dialogue 
within the medical community. The fear of generating negative commentary from the 
Catholic Church on assisted reproductive practices in general imposed a code of silence. 
Indeed, in May 2003, as public debate over PGD was just stirring, Navarro spoke to me 
of the caution necessary to deflect negative public attention and misunderstanding:  
When it [PGD] becomes more public I think that there could be people that would 
denounce us and [name of a clinic in Buenos Aires] and other institutes that do PGD, 
because of what we do with abnormal embryos, which are “sick children” according 
to them. And as you can’t murder a 5 year child that has Down’s Syndrome, neither 
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can you murder a 6-cell embryo because it carries Down’s Syndrome. That’s the idea. 
I think that you have to be very careful. 
As this statement exemplifies, the ambiguity of existing legal statutes and the lack of 
state oversight therefore places the responsibility for laboratory and clinical actions on 
reproductive medicine professionals. This legal uncertainty is therefore experienced by 
these professionals as both a liability and an opportunity: it does not provide any 
safeguards for ethical anxieties, but it does allow practitioners the flexibility to decide the 
extent of embryo manipulation they wish to pursue.155 
 
Ethical and Embryonic Developments  
“It is an expensive technique. The truth is that in Argentina the technique is still being 
tinkered with to perfect it. And apart from that, imagine how doing PGD implies the 
selection of embryos to transfer. Imagine how here [at this clinic] they don’t even want to 
cryopreserve, even less will they want to select in order to discard the rest of them 
[embryos]. Because they tell you, ‘yes, we are cryopreserving them for the day in the 
future, in 30 or 40 years, when a therapy is made for these embryos and we will unfreeze 
them.’ It’s a little…It’s a chimera, isn’t it?” Diego Ramos, a biologist at RMI (March 
2004) 
 
  As mentioned earlier in this chapter, by May 2003, proponents of PGD at CREAR 
were able to convince the center’s directory board that the value of the technique offset 
its financial costs. However the moral “cost” of PGD—what to do with the abnormal in 
vitro embryo—was not resolved for another year. It is the process and product of this 
“resolution” and its implications for understandings of science and morality that are of 
interest here. 
At the time PGD was first being considered as a treatment service, CREAR 
upheld a within-clinic policy of protecting all in vitro embryos after the pronuclei stage, 
                                                 
155 As far as I can tell, this legal uncertainty has not resulted in the prosecution of any cases of negligence 
related to ART procedures in Argentina. 
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regardless of their chromosomal normality. While not as stringent as the Catholic 
Church’s decree that life begins at conception, the directors at this clinic define an 
embryo as a minimum of 48 hours or 2 days of development post-fertilization, as I 
discussed earlier in the chapter. At two days post-fertilization, they consider the 
developing cells to be viable life that requires protection. According to this principle, a 
fertilized gamete of one day is a group of undifferentiated cells, and may be destroyed or 
manipulated as necessary for the particular procedure at hand. The human life potential of 
an embryo of two days or more will be protected. In not discarding or damaging an 
embryo, CREAR viewed itself as compliant with a liberal interpretation of a person’s 
legal right to life.  
As discussed earlier, the results from PGD are available after the 5-day in vitro 
embryo has already differentiated into a blastocyst. CREAR’s embryo policy therefore 
created a problematic situation with respect to PGD: the obligatory protection of a 
potentially chromosomally abnormal embryo. In the event that PGD revealed the tested 
embryo as abnormal, the only morally acceptable option was to protect the life potential 
of this embryo by cryopreserving it. Discarding an embryo was prohibited by the clinic’s 
policy, and transferring it to the uterus would defeat the purpose of PGD in the first 
place.156  
To resolve this technical dilemma, CREAR’s professionals initially agreed, as an 
institution, that the abnormal embryos would be cryopreserved and stored, either until 
gene therapy was feasible, or until a national law defined an embryo as not requiring 
                                                 
156As with other clinic protocols, patients were not involved in the decision-making process of what to do 
with abnormal embryos. Before undertaking any ART procedure, patients must sign consent forms 
agreeing to the clinic’s policy on embryos and cryopreservation. Though relevant, the patient perspective 
on the dilemma of PGD in Argentina is beyond the scope of this chapter. 
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protection (therefore overruling the clinic’s prohibition against discarding an embryo). 
One of the gynecologists at CREAR, Matías Serrano, whose personal position was to 
discard a chromosomally abnormal embryo post-PGD, explained to me in 2003 that 
CREAR couldn’t do that out of fear of negative public opinion: 
It’s a question of…We are afraid that the newspaper will publish that we are 
throwing away abnormal embryos, given the idiosyncrasy of this country. I would 
discard them, but the idiosyncrasy of this country and the religious question 
influences public opinion a lot. We can avoid this type of problem, of the 
sensational press in this way [by cryopreserving the embryos]. 
 
Though to freeze these embryos was a form of deferral rather than a solution, it was 
easier to for CREAR’s professionals to agree on than any other option at the time. 
Cryopreservation of an abnormal embryo avoided negative press, but it was a short-term 
solution at best, and one that cost the center approximately $300 USD per patient.157 
Marta Romero, a biologist and practicing Catholic, recognized the limited value of 
cryopreservation as a solution, but unlike her colleague at CREAR, she did not agree with 
the disposal of an abnormal embryo, as she told me in June 2003: 
The issue is what to do with the abnormal embryos. Depending on what the 
disorder is, if it is a disorder that is going to take away quality of life. For 
example, Down’s Syndrome, I wouldn’t throw away an embryo carrying Down. 
But they end up on the streets, poor things. Obviously if you ask me, do I prefer to 
have a healthy child or a child with Down’s, a healthy child. But the disorders that 
involve a life or the quality of life as being terrible, or that they live a few years 
and then die, for those things, I wouldn’t transfer them. I wouldn’t transfer a 
Down’s Syndrome embryo either but I wouldn’t discard the embryo, I would 
cryopreserve it. And the act of cryopreservation, it is postponing the problem for 
the future. 
 
Marta raises a whole host of issues here, one of them being the fact that the controversy 
of PGD is in part a controversy over “undesired” embryos that no one actually wants to 
                                                 
157 During the time that CREAR mandated the cryopreservation of abnormal embryos post-PGD, the center 
did not charge patients for cryopreservation post-PGD.  
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transfer, but that everyone wants to protect (for different reasons). In fact, the very 
technique of PGD—opening a hole in the zona pellucida of the embryo to take out the 
chosen blastomere (the biopsy)—leaves the embryo vulnerable to the cryoprotectant used 
in cryopreservation. This direct contact between the exposed cell and the 
cryopreservation medium is very harmful and causes cell degeneration in the embryo, 
thus damaging the embryo’s viability. This is not a secret for those who advocate 
cryopreservation of the abnormal embryo. One of CREAR’s biologists, Julieta Moretti, 
assured me in August of 2006 that:   
Everyone who cryopreserves a biopsied embryo knows that the chance is very 
low that this embryo will be viable after thawing, because of the cryo-damage due 
to the removal of a piece of the zona pellucida. 
 
Cryopreservation therefore may have been an easier moral solution for CREAR to adopt, 
but in technical terms the “protection” that it affords the post-PGD embryo is not very 
great. The solution of cryopreservation can be seen as just one more means of postponing 
the inevitable choice that must be made in doing ART between embryo manipulation and 
the inviolability of human life.  
In August 2004, after one year of providing PGD to patients, CREAR’s directors 
approved a change in clinic policy on the moral status of an in vitro embryo. Partly in 
response to the impracticality of protecting abnormal embryos through cryopreservation, 
the directors agreed to a recommendation from CREAR’s ethics committee. This 
committee, which provides the clinic non-binding counsel from ethical, legal and 
psychological perspectives, devoted several months of debate and inquiry to the status of 
the embryo, resulting in a written and published formal statute on the moral status of the 
embryo. According to this document, the beginning of human life is a process, and 
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cannot be pinpointed to a particular stage in development. Therefore regardless of having 
2, 3 or even 5 days of development, an in vitro embryo has the potential for human life, 
but does not merit the full rights of an actual person. The committee’s assessment is that 
an in vitro embryo’s life potential should be respected, but that a reason of serious moral 
consequence (“una razón moral de peso”) can override this protection. This conclusion 
is necessarily ambiguous, in that it allows for a subjective decision regarding the 
treatment of the embryo to be made according to the particular situation at hand. In terms 
of PGD, this judgment can be interpreted to mean that a chromosomal abnormality is a 
reason with significant moral consequence, and therefore discarding an abnormal embryo 
is morally acceptable. Although public backlash from the Catholic Church is still a 
possibility, with this bioethical ruling, and in the continued absence of a law saying 
otherwise, the official policy at CREAR is now that discarding an abnormal embryo post-
PGD testing is morally permissible.  
Yet this change in policy remains largely symbolic. As of October 2005, the clinic 
had had no opportunity to practically implement this change of policy. This is due to 
some extent to technical aspects of the procedure. Despite technical know-how, a center’s 
caseload of PGD depends partially on the morphological quality of the embryos to be 
tested. At times PGD is not a possible technique for an indicated case—as when an 
embryo has very few cells or when the cells are fragmented and granulated, conditions 
which make embryo biopsy not feasible. From the initial week of training in 2003 (during 
which time six cases were performed by the Italian expert), until October 2005, only six 
additional patient cases of PGD were performed. Only one of these cases came up after 
the bioethics committee’s recommendation. In that instance, the embryos arrested in 
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development before reaching the blastocyst stage, at which point the decision to 
cryopreserve or transfer would have been made. In other words, by the time the results of 
the preimplantation testing were available and a decision on whether to discard the 
abnormal embryos would have been taken, the embryos were no longer “viable” and no 
decision was required.158  
In contrast to CREAR’s first adopting the technology and second resolving the 
moral dilemmas it poses, other centers in Argentina are resolutely against providing PGD 
until the status of the abnormal embryo is resolved legally, on a national level. This is the 
case at a smaller clinic in the greater Buenos Aires area where one of the gynecologists 
explained to me that he considers PGD to be a great advance of science as it brings the 
technological ability to prevent the inheritance of genetic diseases. However, this 
gynecologist is a practicing Catholic and considers embryos, even abnormal ones, to be 
human life with the potentiality to become a person. Because PGD creates the potential 
situation of an unwanted embryo, without a chance for transfer and development in the 
uterus, he will not advocate for a PGD program at his clinic. Following this logic, he is 
also against cryopreservation of embryos without the intent to transfer them, and only 
offers this service for exceptional cases. 
Indeed, the option of cryopreserving the embryos diagnosed with chromosomal 
abnormalities is not viewed as a solution by many in this community, but rather a 
postponement of dealing directly with the issue. Manuel Giordano, a biologist at Fertility 
                                                 
158At the time of this writing, it is unlikely that CREAR has yet needed to enact their policy on the 
abnormal embryo. In late 2005, some of the laboratory staff skilled in PGD (the head of the embryology lab 
and one of the PGD-trained biologists) left the center, taking their expertise with them. Though CREAR 
continues to claim to provide PGD as a patient service, as of early 2007 it is doubtful that they have 
performed many (if any) cases in the last year. 
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Institute here provides a common criticism to this deferred approach to PGD, though he 
is an avid supporter of the technique: 
We don’t even know what we’re going to do here [at this clinic], we still have to 
discuss it. They are going to cryopreserve them [embryos], probably they will be 
cryopreserved. But no one wants to transfer them, you know. And neither can 
they fix or cure them, not now, not now or in 50 years. Not even in 100. The truth 
is that I don’t see that happening. Besides, who is going to cure an embryo 100 
years from now, it seems ridiculous. So to cryopreserve them is synonymous with 
discarding them. It is like sweeping the dirt under the rug. 
 
Projecting into the future, Giordano in June 2004, concludes that the frozen storage of 
these undesired embryos today is “synonymous with discarding them”—given the 
likelihood that even if gene therapy does exist in one-hundred years, it would not be used 
to “cure” this population of highly-defective embryos. Even so, at many of these centers, 
cryopreservation represents a more socially and morally acceptable option than outright 
disposal. Such dilemmas and “resolutions” highlight the intimacy between medicine and 
morality, revealing that the tensions of doing PGD are experienced here as a mutually 
exclusive choice between the sanctity of human life and scientific modernity. The 
delaying tactic of cryopreservation allows an avoidance, if only temporary, of this 
conflict-charged “choice.”  
 
Conclusion  
In this chapter I argue that performing both cryopreservation and PGD in 
Argentina signifies much more than providing patients access to ART techniques. The 
practice of both clearly exposes one of the problematics at the core of ART in general in 
Argentina: the legal and moral status of the human in vitro embryo, and by extension the 
definition and value of human life. As such, this is a local dilemma that reaches far 
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beyond the borders of Latin America, and speaks to widespread concerns over “global 
human rights” and the “ethical uses” of biomedical technologies.  
This variation in the interpretation of the embryo’s life potential also exemplifies 
how complex the adoption of a new medical technology can be, regardless of the high 
standards of scientific development in place. For instance, although the machines may be 
in order and the scientific procedures mastered, the local context—in the form of social 
and moral values and codes of practice—can impede “technological progress.” The 
techniques of cryopreservation and PGD illustrate this precisely. Embryo 
cryopreservation in Argentina, while a fairly common practice today, continues to be at 
the center of a public debate over the personhood rights of the in vitro embryo—decisions 
that could prevent the cryopreservation of Day Two embryos in the future. In addition, 
given the dilemmas that PGD raises for Argentine providers and consumers, its 
incorporation into the repertoire of assisted reproduction services has been much slower 
in Argentina than in countries like the United States where such incertitude doesn’t exist. 
In Argentina, the techniques of cryopreservation and PGD require confronting 
and resolving the apparent contradictions between wanting to “do less” to the in vitro 
embryo and desiring to perform and provide the latest in ART techniques, which 
invariably entail embryo manipulation. Providing these services to the public therefore is 
not just an issue of adding another laboratory technique to the list of possible options for 
infertile couples, but is also an important stake in Argentine practitioner’s claims to 
modernity and scientific rationality. Reproductive medicine is a rapidly advancing field, 
and new techniques bring new knowledge. This chapter illustrates that with this “new 
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knowledge” also come contemporary applications of familiar deliberations over human 
life, science, morality and modernity.  
  The application of PGD in particular also highlights concerns over genetic 
discrimination and the medicalization of difference. PGD, like other technologies that 
identify genetic risk, scans for potential “defects” in the embryo. What is a “normal” 
embryo and consequently what is a “normal life worth living” is therefore being decided 
by a group of authoritative experts creating PGD protocols and performing the technique. 
However definitions of “normal” vary, and are slippery at best. This ambiguity is 
exemplified with the hypothetical case of a deaf couple who desire PGD in order to select 
an embryo carrying the genes for deafness, a situation which is opposed by many in the 
international reproductive medicine community. Indeed, many medical professionals 
disagree with using PGD to select for (rather than against) an affected embryo, and the 
European Society for Human Reproduction ethics task force disallows it (Edwards 2004; 
Shenfield 2003). In Argentina the potential discriminatory tones of using the technique 
are not yet part of the current discussion, as the overriding concern is for the moral 
ambiguity of the embryo. Though not the focus of this chapter, the potential global use of 
genetic technologies as “preventative” methods—employed to lessen the weight of a 
“global burden of disease” that chronic illnesses and conditions place on nations around 
the world—is a prospect that requires further examination. 
Like other medical techniques, cryopreservation and PGD are embedded in social 
relations that are activated and transformed in the practice of the technology and as such 
involve a myriad of competing desires, choices and requisites. The variability in 
resolving this problematic in Argentina is a revealing example of how cultural matters, 
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such as the “right to life” of an embryo, are both governing of, and negotiated through, 
medical technologies
INTERLUDE V 
 
“God Answered Our Prayers”:  
The Miracle of IVF at a Reduced Cost 
 
 
 
In this final interlude, I give voice to a woman, Marcela, who tried in vitro 
fertilization once at one of the principal ART centers in Buenos Aires, and failed to 
become pregnant. Although she wanted to make another attempt, Marcela, who lives in 
the northern province of Salta in Argentina, could not financially afford another 
treatment. She applied to the clinic’s non-profit foundation for financial assistance, and 
was granted a second treatment, this time at a minimal cost, to be paid in quotas over six 
months. I learned about Marcela through talking with the woman in charge of the 
foundation at this particular clinic, Graciela Martinez. Graciela told me that her 
relationships with these low-income couples become very personal and intimate at times, 
particularly because Graciela experienced infertility herself and went through GIFT twice 
at this same clinic. She now has a 12 year old son. Graciela shared with me a thick stack 
of hand-written letters, written to her by grateful patients over her fifteen years of 
(voluntarily) overseeing the foundation’s assistance program. Marcela’s letter of gratitude 
gives us a glimpse into the hope, faith, and sadness that accompany a patient’s 
experiences of infertility and in assisted reproduction treatment.  
 
***
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Buenos Aires, November 21, 2003 
 
Dear Mrs. Graciela Martinez: 
I am writing this letter even without having the pleasure of knowing your face, but I feel 
that I know something even more important about you: your heart. I don’t know if I will 
be able to express what I actually feel with words—personally I don’t think so—but I 
would like to be able to convey to you with these very simple words the profound 
gratitude that my husband and I have in our hearts for everything that you have done for 
us, and continue to do. 
 
Our entire lives have been dedicated (as much mine as my husband’s) to working on 
behalf of children, we live surrounded by children whom we love deeply, children who 
need God in the first place, and also a hug, affection, caring, and support. We feel and 
hope we are able to give them that.  
 
We feel a deep joy in knowing that we are fulfilling the “mission” that God gave us in 
life. Even so, when we come back home or when we sit on Sundays in the park and we see 
children with their parents, we feel that deep pain of knowing that there is a wide 
emptiness in our hearts, which is destined to be filled only by a child. 
 
My husband and I are like every married couple (I’m sending you a photograph so you 
can meet us), of course after eight and a half years of marriage we carry around more 
kilos and have less hair. But our God has united us for life, that is our belief and desire, 
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and we love each other deeply. We know that we have many things to be grateful for and 
we still have a very very long path ahead of us. Nevertheless we have prayed to God so 
much for a miracle and we give thanks to God for having permitted us to receive it. We 
believe this is God’s answer to our prayers. I know Mrs. Graciela that as you told us, 
everything is in God’s hands and we really believe that, but we are convinced that we 
want ‘to fight for the dream of having the privilege to carry our child in our arms, to see 
him grow, to take his first steps, to wake us up at night (even though we haven’t decided 
who goes first), to give him a bottle, to change his diapers, in summary that he be a living 
extension and expression of the love that units us.  
 
There is an author that I like very much, Paulo Cohelo. He once wrote, “our path is full 
of tests. To fulfill our Personal Legend and our dreams requires courage, steadiness and 
faith. It is natural to feel that we are weakening. But it is also natural for our interior 
strength to carry us forward.” 
 
Thank you Mrs. Graciela for your call, for your words at a time in our lives so difficult 
and sad. And from my experience as a woman, thank you for caring for and supporting 
me, cheering me up, and making me feel that it is possible to dream again, above all 
thank you for concretely giving me the possibility today of doing it [dreaming again: 
through doing an ART treatment]. Thank you because without knowing me personally, 
you gave me your hand. And you know what? I believe that all of life is a feedback and I 
pray to God that all your generous consideration and help will be multiplied and 
returned to you through God. Thank you for letting me hear your son’s tiny voice on the 
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phone, you can’t imagine how precious and encouraging that was for me, please give him 
a kiss from me. Talking to him made me believe that some miracles aren’t just dreams, 
they become real. 
 
Well Mrs. Graciela, I do not want to give you a letter so long as to be like a testament but 
you know that this comes from my heart and I wanted to share it with you.  
 
In these moments, my husband and I are left to believe and hope in God’s will for our 
lives. But yes, we are going to fight for a little child, until in our hearts we feel that God 
has whispered to us, that it is enough. 
 
As you will see, we are common people in search of a fulfilling a dream, a dream that 
will make us feel happier and more complete. Thank you for giving us this opportunity. 
God bless you and your family, and do not ever stop encouraging people who like us 
must pass through these moments (I do not know why, but that is not for us to know, but 
is in the hands of God). 
 
If you allow me, I would like to leave you with a short piece from the Bible that gives me 
much encouragement at this time, after my first failed in vitro. It says the following:  
“For which cause we faint not; but though our outward man perish, yet the inward man 
is renewed day by day. For our light affliction, which is but for a moment, worketh for us 
a far more exceeding and eternal weight of glory; While we look not at the things which 
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are seen, but at the things which are not seen: for the things which are seen are 
temporal; but the things which are not seen are eternal.”  
Letter from apostle Saint Paul to the Corinthians, chapter 4, verse 16 to 18.   
 
God bless you, 
Marcela R. 
 
I am giving you my business card and my address. You will always be welcome to Salta, 
to visit “La Linda” and to eat our famous empanadas159, my house is your house Mrs. 
Graciela. 
                                                 
159 “La Linda” refers to the beautiful city of Salta. Empanadas are a traditional food in Argentina, savory 
filled pastries that vary slightly by region. 
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CONCLUSION 
LIFE BEYOND THE MICROSCOPE 
 
 
 
Figure 49. The city and the Pampas: Sunset over Buenos Aires, Photo by Kelly Raspberry, May 2003. 
 
“The first photo of my children, in the album, is from when they were embryos, before 
they were in my uterus.”  Ana María Picolotti, family lawyer in Buenos Aires who works 
on ART issues and gave birth to triplets in 2000, after her third ICSI attempt160 
 
My intention throughout this ethnography has been to render visible a local 
culture of assisted reproduction practices in Argentina, in order to better understand how 
assisted reproductive technologies are transformed according to local conditions of 
practice, as well as how they are transformative of the societies they newly inhabit. I
                                                 
160 When the biologist checks the quality of the embryos under the microscope in the laboratory, a digital 
picture is taken of each developing embryo. The patient is later given an information form that includes 
these black and white photographs of the embryos that were transferred. 
 
suggested that the entire process of assisted reproduction—which includes embryology 
laboratories, clinical tools and encounters, religious faith, scientific protocols, and a 
myriad of embodied desires, motivations, and aspirations—is fundamentally cultural and 
contingent on local histories, understandings and practices. My aim in these chapters has 
therefore been to illustrate the slew of competing interests and ethics involved in 
practicing ART, and to elucidate the many entities that are created as a result. Ana 
María’s statement quoted above points to the variety of entities produced through the 
performance of ART, in this case the transformation of a microscope’s gaze at a 
developing in vitro embryo into a cherished photograph in a baby album. Throughout this 
ethnography I argue that reproductive medicine experts in Argentina are producing not 
only embryos and babies in their infertility centers, but also reproducing and reflecting 
particular ideologies of family, health, modernity, morality, and life.  
 
Modern Hybrids of Technomedicine 
In previous chapters I illustrated how these reproductive medicine specialists 
perceive the social worlds of their practice as a hindrance to the medical and scientific 
modernity they are capable of in a purely rational and modern world. In particular they 
cite economic pressures, orthodox Catholicism, and geographical marginality (i.e. not 
being in the US or Europe), as impinging on their ideal strategies of practice. To make 
sense of this repeated assertion, I find it useful to think of ART practices in Argentina as 
a local strand of “technomedicine”—kinfolk of Haraway’s (1997) “technoscience”—
which produces certain narratives of modernity and progress, and relies upon the 
complicity of practitioners and patients for its enactment. The historical and political 
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circumstances of Argentina as a “subordinated West” make this a particularly revealing 
site to examine such juxtaposed and hybrid creations of “modern” and “traditional” 
ideologies and practices. I suggest that health professionals in the infertility clinics of 
Argentina are daily attempting “purification” processes to keep medicine and science 
separate from—and inoculated against the effects of—society and religion. However 
through engaging in this modernist project of “technomedicine,” professionals also 
optimize nature for the benefit of the social order—they “trick” the sperm to fertilize the 
egg under the microscope, and the embryo to develop in the incubator, and in so doing, 
make possible the formation of the traditional nuclear family. As they strive to distill a 
modern rationality out of intimately-felt desires, uncooperative reproductive systems, and 
deeply entrenched traditions of Catholic social morality, these professionals also produce 
local hybrid entities and networks.  
As players in a transnational game of professional prestige and pregnancy success 
rates, these reproductive medicine experts attempt to protect and purify their medical and 
scientific practices from the “mess” and conflict of society, and in doing so, develop a 
view of their own culture as something regrettable—a “drag” on progress. The local 
translation of the global apparatus of ART is one in which Argentine professionals are 
constructing bodies, health, and the very technique of assisted reproduction in ways that 
are dependent upon a local genealogy of high-tech medicine. This translation is thus 
inseparable from the specificities of Latin American Catholicism, a “Third-World” 
economy, the absence of ART regulation, and pronatalist values.  
In Argentina, ART is defined as a biomedical treatment for the diseased infertile 
body, which thus provides the means by which nature’s “failures” can be bypassed, and 
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the traditional social order preserved. At the crux of this paradigm is the assertion that 
infertility is a biological disease that requires the medical intervention of ART. In 
defining ART in this manner, health professionals actively engage in the modernist 
project of purification (Latour 1993). These professionals attempt to reduce ART to a 
medical treatment for a purely biological disorder—removed from a bounded social order 
where religious beliefs, economic considerations and social values carry weight. The 
“healthy” body becomes as much a social as a medical designation, as infertility 
specialists attempt to separate out social deviants (single women, lesbian couples, women 
over 50 years old) from those “worthy” of biomedical fertility care. Professionals in 
Argentina thus entertain a contradiction between containing the social order and its 
obstacles to modernity, and preserving it. Within the clinic, traditional social values are 
thus protected and reproduced, out of fear of public critique and the dismantling of the 
entire modernist project of ART. 
Through their purification attempts, these reproductive medicine experts move 
between modern and traditional orders, producing science-society hybrids. This model 
depends upon the “double purification” of science as neither social nor natural, but as a 
mediator between the two. In other words, like Latour’s “modern” scientists, these 
clinicians and biologists conceive of assisted reproduction in its purified form as the 
mastery of nature, and separate from all that is social. As this ethnography illustrates, the 
very problems of this specific “translation” of assisted reproduction in Argentina depend 
fundamentally on the specific varieties of “modernity,” “nature,” “culture,” “science,” 
and “religion” that are in play. For example, this local culture of ART includes certain 
assumptions about the “modernity” of medical technology, the “sacredness” of life, and 
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the “naturalness” of heterosexual nuclear families. The very negotiation of which ART 
practices are and are not “medically” acceptable, generates hybridity, in which tangible 
contradictions and conflicts reveal the confluence of categories in practice. As productive 
actors who move within this confluence, Argentine reproductive medicine professionals 
are themselves hybrid products of science-society. 
 
Specific Narratives 
I began this research with the objective of examining the local specificities 
involved in producing the global apparatus of assisted reproduction in Argentina. In her 
recent book examining upper-class consumption of reproductive technologies in Egypt, 
Marcia Inhorn writes: “The examination of these Western reproductive technologies in 
non-Western societies offers a heuristic case study of local-global intersections and 
elucidates the importance of interrogating what is ‘local’ in an increasingly ‘global’ 
world” (Inhorn 2003: 273). Based on my cultural analysis of assisted reproduction 
practices in Argentina, I would add that the local/global is not an exclusive binary of 
opposites, but is itself also a hybrid creation of interactions, like nature/culture and 
science/society. Specifically, I suggest that the local culture of assisted reproduction in 
Argentina is located at the intersection of the local and the global—straddling both the 
local and the global, and again mediating between the two.  
To historically situate current ART practices in Argentina, in chapter one I first 
located today’s Argentine infertility specialists within a transnational network of training, 
scientific prestige, innovation and competition. I argued that within this network, assisted 
reproductive technologies are not neutrally transferred, but rather translated into local 
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idioms—and hybrids—of practice. The historical mapping of the global network that 
these Argentine professionals participate in divides along predictable correlates of status 
and modernity, with the United States and Western Europe at the “center” and Latin 
America, including Argentina, on the “periphery.” Within this peripheral site of Latin 
American production, Argentina holds a privileged position of local influence and 
recognition. The reproductive medicine professionals in Argentina that I focus on in this 
ethnography both contest and reproduce this “hegemony of the north.” Though they 
actively work to overcome their marginality, they also tacitly reaffirm it by using 
northern sites of ART production as the standard model of “successful ART.” I argued 
that like their Northern colleagues, health professionals in Argentina are well-versed in 
the biomedical modern lingo of “science as rationality,” which they struggle to reconcile 
with deeply-held Catholic beliefs. 
In chapter two I examined more closely the production of local hybrids and 
translations created through ART practices in Argentina. As I discuss throughout this 
ethnography, the majority of practitioners within the reproductive medicine community 
in Buenos Aires attempt to purify their “science,” one way of doing this is to frame their 
professional practices purely in medical and scientific terms. Therefore assisted 
reproduction is defined as a medical treatment for the biological disease of infertility. 
This medical treatment is therefore produced in the service of a “universal right to 
reproduce.” However as I discussed in chapters two and three, these same professionals 
impose social criteria on this (not so) “universal right.” In chapter two I discussed how 
single women and lesbian couples are denied access to ART on the grounds that they are 
not “biologically infertile,” while heterosexual couples are encouraged to have biological 
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children. I argue that this insistence on assisted reproduction as a “disease treatment” also 
represents a means of “treating” the social order by ensuring the reproduction of 
normative values of heterosexual, nuclear families. As visible players within a 
conservative milieu, reproductive specialists promote traditional values of family and 
health in part in order to legitimize their work in assisted reproduction. They are also 
careful of preserving the traditional social order so as to prevent forceful public outcry—
particularly from the Catholic Church—that could lead to an upset in the whole enterprise 
of ART. 
I also looked at how high the stakes are for these professionals to achieve their 
much-desired credentials of scientific modernity in chapter two. These reproductive 
medicine experts in Argentina must carefully choreograph their dance of modernity, 
taking stage cues from the Catholic Church, traditional social values, economic shifts, 
and international clinical protocols. In order to be enlightened doctors and scientists of 
ART, these specialists downplay traditional Catholic ethics towards reproduction and 
family in the wider Argentine society. In the absence of national legislation, they strive to 
establish an “orderly” world of medicine and science, through self-regulations such as 
clinic protocols, RED accreditation, ethic committees, and more recently, ISO 
certification. Yet they can not push the traditional boundaries too far, for fear of negative 
legal and social repercussions. They also contend with practical difficulties not 
experienced in the North: the instability of the national economy and the unsteadiness of 
a patient population who can afford the private services; the costly importation of all 
high-tech equipment and laboratory supplies; and the lack of national funding for 
research and development. As a point of comparison, I also briefly examined the extreme 
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side of practical difficulties to producing ART in Argentina, illustrated by the presence of 
only one assisted reproduction program—which does not offer IVF or ICSI—provided at 
a public hospital in Buenos Aires.  
In chapter three, I examined the intersection of options to make a family, beliefs 
about genetic inheritance, and the market-side of assisted reproduction through an 
analysis of the practice of gamete donation in Argentina. The preference for using gamete 
donation with ART over adoption derives from a privileging of genetic inheritance (at 
least one person will share their genes with the child) and the pregnancy experience. I  
also argued that the practice of gamete donation illustrates the commodification aspects 
of ART, even while professionals work to contain market influences—for example by 
placing the limit at surrogacy arrangements. However the market in Argentina now 
includes paid egg donation—a practice disparaged seven years ago—though all 
exchanges remain anonymous and overseen by the clinician. Gamete donation is made 
acceptable under the theory that so long as health professionals carefully control and 
mediate the process of gamete donation, the practice is confined within the acceptable 
boundaries of modern medicine and scientific rationality. However, as the examples of 
gamete donation and embryo donation evocatively illustrate, the arena of reproductive 
medicine is not itself a “purely rational” space, but a hybrid of conflicting desires, 
motivations, and demands.  
To further examine how medical and scientific protocols are translated to fit local 
conditions of practice, in chapter four I focused specifically on two problematic 
techniques in Argentina’s ART centers: embryo cryopreservation and preimplantation 
genetic diagnosis. In these clinics, the legal and moral status of the in vitro human 
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embryo is one of contested ambiguity. Whereas infertility specialists are able to navigate 
around this ambiguity to provide cryopreservation, the procedure of PGD necessitates the 
direct confrontation of the meaning of the in vitro embryo in order to proceed with the 
technique. With neither legal guidelines, state regulation, nor a medical consensus on 
what is permissible, practitioners are left to sort out amongst themselves the thorny issues 
of viability and personhood of a human embryo, and the value of human life. These 
scientific definitions of when an embryo is viable and what that means in terms of 
respecting the potential for “the right to life,” are by no means absolute. These 
differentiations between Day One pronuclear stage and Day Two embryos, Day Three 
embryos and Day Five blastocysts, in turn dictate the limits of acceptability of different 
procedures that manipulate the in vitro human embryo. For now, practicing 
cryopreservation and PGD in Argentina requires the deferral of a decision that cannot be 
made, a conflict that is without resolution. As the examples of cryopreservation and PGD 
illustrate, the production of these technologies are shifting deeply rooted beliefs about the 
sanctity of human life and the role of technology in manipulating that life. 
 
Moral Guardians at the Gates of Argentine Modernity  
Who stands at the gates of these critical junctures of modern medicine and 
morality is a matter of some consequence. Currently in Argentina the reproductive 
medicine professionals who provide ART to the public are society’s moral guardians, 
diagnosing the healthy body and family, defining when personhood begins, and dictating 
what protections are due human life. Rather than through a social process of discussion, 
these cultural, philosophical and ethical matters in Argentina are being decided in private, 
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behind the closed doors of medical consultation rooms. To date the Catholic Church in 
Argentina has not stirred up extensive controversy over ART, nor even over the 
potentially-inflammatory technique of PGD. Over the twenty years that ART has been 
practiced in Argentina, the legislature has dawdled over various proposed legislation to 
regulate ART. The absence of a national law regulating ART in Argentina therefore 
places the reproductive medicine practitioner in a powerful moral position. This is 
experienced as both a burden and an opportunity for these professionals working in 
reproductive medicine. Though clinical and laboratory assisted reproductive practices are 
not “protected” under a law, neither are they prohibited. Thus professionals can decide 
for themselves what falls under the rubric of “ethical” and acceptable procedure, often on 
a case by case basis based on clinical circumstances and economic incentives. As I 
discussed throughout this ethnography, such decisions are dynamic and based on many 
factors, including desires to be “modern,” fears of inciting the wrath of the Catholic 
Church, competitive market concerns, and anxieties about missing out on the progress of 
science.  
However the issues that ART practices like embryo cryopreservation and PGD 
raise in Argentina are not limited to that part of the globe, and indeed share much in 
common with current controversies over stem cell research and abortion around the 
world. At the center of inquiry in these “embryo debates” is “the ontological and moral 
status of the embryo and the uses to which it may be put” (Halliday 2004: 40). Such 
questions over when human life begins and its inviolability raise the specter of global 
“human rights.” If human life is conflated with personhood, the “human rights” of in 
vitro embryos will merit protection, regardless of whether the practice in question is 
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cryopreservation, PGD, abortion, or stem cell research. However, just as Lock (2002) 
compellingly argues that the end of life is a threshold that “will not be pinned down once 
and for all” so too is the beginning of life. With respect to assisted reproductive 
technologies, any limit placed on when life begins will be an intrinsically social 
designation, developed through the local conditions of medical technology practice. 
 353
BIBLIOGRAPHY 
 
 
Adamson, David, de Mouzon, Jacques, Lancaster, Paul, Nygren, Karl-G., Sullivan, 
Elizabeth, and Fernando Zegers-Hochschild. 2006. “World Collaborative Report on 
In Vitro Fertilization 2000.” Fertility and Sterility 85:1586-1622. 
 
Aguilar, Paola. 2005. “Infertilidad: El Dolor de no Poder. (Infertility: The Pain of Not 
Being Able To.” Clarín (November 29).  
 
Aizen, Marina. 2006. “Volver a Apostar (To Make a Bet Again).” Viva (October 8), no. 
1588:14-28. 
 
Aizpeolea, Horacio. 2002. “Una Pareja de Lesbianas Tendrá un Hijo por Fertilización 
Asistida. (A Lesbian Couple Will Have a Child By Assisted Reproduction).” Clarín 
(June 18).  
 
Amarin, Zouhair O., and Basil R. Obeidat. 2004. “Bed Rest Versus Free Mobilisation 
Following Embryo Transfer: A Prospective Randomised Study.” BJOG: An 
International Journal of Obstetrics and Gynaecology 111:1273-1276.  
 
Andersen, A. Nyboe, Gianaroli, Lucas, Felberbaum R., de Mouzon, Jacques, and Karl-G. 
Nygren. 2006. “Assisted Reproductive Technology in Europe, 2002. Results 
Generated From European Registers by ESHRE.” Human Reproduction 21:1680-
1697. 
 
Appadurai, Arjun. 1996. Modernity at Large: Cultural Dimensions of Globalization. 
Minneapolis: University of Minnesota Press. 
 
Aranovich, Laura, Pardo, María Laura and María Valentina Noblia, eds. 2000. 
Globalización y Nuevas Tecnologías (Globalization and New Technologies). Buenos 
Aires: Biblos. 
 
Arditti, Rita. 1999. Searching for Life: The Grandmothers of the Plaza de Mayo and the 
Disappeared Children of Argentina. Berkeley: University of California Press. 
 
Arenes, Carolina. 2003. “Las Nuevas Familias (The New Families).” La Nación 
(December 7).  
 
Armus, Diego, ed. 2003. Disease in the History of Modern Latin America: From Malaria 
to AIDS. Durham: Duke University Press. 
 
Asch, R.H., Ellsworth L.R., Balmaceda J.P., and P.C. Wong. 1984. “Pregnancy After 
Translaparoscopic Gamete Intrafallopian Transfer.” The Lancet 2:1034. 
 
 354
ASRM. 1999. “Sex Selection and Preimplantation Diagnosis.” Fertility and Sterility 
72:595-598. 
 
Atkinson, Paul. 1995. Medical Talk, Medical Work: The Liturgy of the Clinic. Thousand 
Oaks: Sage. 
 
Baker, Stephen R. 1979. “The Diffusion of High Technology Medical Innovation: The 
Computed Tomography Scanner Example.” Social Science and Medicine 13D:155-
162. 
 
Banta, David H. 1980. “The Diffusion of the Computed Tomography (CT) Scanner in the 
United States.” International Journal of Health Services 10:251-269. 
 
Bär, Nora. 2006. “Crece en el País La Donación de Óvulos (Egg Donation Increases in 
the Country).” La Nación (July 2).  
 
Becker, Gay. 2000. The Elusive Embryo: How Women and Men Approach New 
Reproductive Technologies. Berkeley: University of California Press. 
______. 1997. Disrupted Lives: How People Create Meaning in a Chaotic World. 
Berkeley: University of California Press. 
 
Benagiano, Giuseppe, and Luca Gianaroli. 2004. “The New Italian IVF Legislation.” 
Reproductive BioMedicine Online 9:117-125. 
 
Berg, Marc. 1997. Rationalizing Medical Work: Decision Support Techniques and 
Medical Practices. Cambridge: MIT Press. 
 
Berg, Marc and AnneMarie Mol, eds. 1998. Differences in Medicine: Unraveling 
Practices, Techniques and Bodies. Durham: Duke University Press. 
 
Berkowitz, Richard, Roberts Jaclyn, and Howard Minkoff. 2006. “Challenging the 
Strategy of Maternal Age-Based Prenatal Genetic Counseling.” Journal of the 
American Medical Association 295:1446-1448. 
 
Bharadwaj, Aditya. 2003. “Why Adoption is Not an Option in India: the Visibility of 
Infertility, the Secrecy of Donor Insemination, and Other Cultural Complexities.” 
Social Science and Medicine 56:1867-1880.  
______. 2002. “Conception politics: Medical Egos, Media Spotlights, and the Contest 
Over Test-Tube Firsts in India.” In Infertility Around the Globe: New Thinking on 
Childlessness, Gender, and Reproductive Technologies, eds. Marcia Inhorn and Frank 
Van Balen, 315-333. Berkeley: University of California Press.  
 
Bochatey, Alberto. 2005. “Los Embriones Son Vidas Humanas y Tienen Identidad. 
(Embryos are Human Life and Have Identity).” Clarín Revista Ñ (August 6).  
 
 355
Botta, Giuseppe, and Gedis Grudzinskas. 1997. “Is Prolonged Bed Rest Following 
Embryo Transfer Useful.” Human Reproduction 12:2489-2492. 
 
Bouvard, Marguerite. 1994. Revolutionizing Motherhood: The Mothers of the Plaza de 
Mayo. Wilmington, DE: Scholarly Resource Books. 
  
Brown, Andrew J. 2005. Test Tube Envy: Science and Power in Argentine Narrative. 
Lewisburg: Bucknell University Press. 
 
Browner, Carole H. and Nancy Ann Press. 1995. “The Normalization of Prenatal 
Diagnostic Screening.” In Conceiving the New World Order: The Global Politics of 
Reproduction, eds. Faye Ginsburg and Rayna Rapp, 307-322. Berkeley: University of 
California Press. 
 
Canclini, Néstor García. 1995. Hybrid Cultures: Strategies for Entering and Leaving 
Modernity. Minneapolis: University of Minneapolis Press. 
 
Cappiello, Hernan and Jescia Bossi. 2005a. “Indignación con La Justicia de Las Familias 
Poseedoras de Embriones (Indignation with the Court by Families who Possess 
Embryos).” La Nación (June 26).  
______. 2005b. “Nadie Controla el Destino de Los Embriones Congelados (No One 
Controls the Fate of Frozen Embryos).” La Nación (June 26).  
 
Cappiello, Hernan. 2006. “Vigilará La Justicia el Destino de Los Embriones Congelados 
(The Court Will Oversee the Fate of Frozen Embryos).” La Nación (December 24).  
 
Castro, Angeles. 2002. “Los Centros de Fertilización Tientan a Parejas Extranjeras 
(Assisted Reproduction Centers Tempt Foreign Couples).” La Nación (July 3).  
 
Centers for Disease Control and Prevention. 2006. 2004 Assisted Reproductive 
Technology Success Rates: National Summary and Fertility Clinic Reports. Atlanta, 
Georgia: National Center for Chronic Disease Prevention and Health Promotion, 
Division of Reproductive Health in collaboration with the American Society for 
Reproductive Medicine and the Society for Assisted Reproductive Technology. 
 
Chang, M.C. 1959. “Fertilization of Rabbit Ova In Vitro.” Nature 184:466-467. 
 
Chillik, Claudio. 2006. “Una Técnica Exitosa Al Nivel Mundial (A Successful Technique 
at the Global Level).” Clarín (November 10). 
 ______. 2005. “En Busca de Un Marco Legal (In Search of a Legal Standard).” La 
Nación (June 26).  
 
Cohen Agrest, Diana. 2005. “Un Embrión Humano ¿Posee Derecho a La Identidad? 
(Does a Human Embryo Have the Right to Identity?)” Clarín Revista Ñ (August 6).  
 
 356
Cohen, Lawrence. 2003. “Where it Hurts: Indian Material for an Ethics of Organ 
Transplantation.” Zygon 38:663-688. 
 
Colen, Shellee. 1995. “‘Like a Mother to Them’: Stratified Reproduction and West 
Indian Childcare Workers and Employers in New York.” In Conceiving the New 
World Order: The Global Politics of Reproduction, eds. Faye Ginsburg and Rayna 
Rapp, 78-102. Berkeley: University of California Press. 
 
Cussins, Charis. 1998a. “Ontological Choreography: Agency through Objectification in 
Infertility Clinics.” Social Studies of Science 26:575-610. 
______. 1998b. “‘Quit Sniveling, Cryo-Baby, We’ll Work Out Which One’s Your 
Mama!’” In Cyborg Babies: From Techno-sex to Techno-tots, eds. Robbie Davis-
Floyd and Joseph Dumit, 40-66. New York: Routledge. 
 
Davis-Floyd, Robbie and Joseph Dumit, eds. 1998. Cyborg Babies: From Techno-sex to 
Techno-tots. New York: Routledge. 
 
Davis-Floyd, Robbie and Carolyn Sargent. 1997. Childbirth and Authoritative 
Knowledge: Cross-Cultural Perspectives. Berkeley: University of California Press. 
 
Dodge, Mary and Gilbert Geis. 2003. Stealing Dreams: A Fertility Clinic Scandal. 
Boston: Northeastern University Press. 
 
Downes, Patricio. 2005. “Los Mellizos de La Pareja Gay Ya Tienen Colegio Para 2006 
(The Gay Couple’s Twins Already Have a School for 2006).” Clarín (August 19).  
 
Downey, Gary Lee, and Joseph Dumit, eds. 1997. Cyborgs and Citadels: 
Anthropological Intervention in Emerging Sciences and Technologies. Santa Fe: 
School of American Research Press. 
 
Downing, B.D., Mohr L.H., Trounson A.O., Freeman L.E., and C. Wood. 1985. “Birth 
after Transfer of Cryopreserved Embryo.” Medical Journal Australia 142:409-411. 
 
Dulitzki, Mordechai, Soriano, David, Schiff Eyal, Chetrit Angela, Mashiach Shlomo, and 
Daniel S. Seidman. 1998. “Effect of Very Advanced Maternal Age on Pregnancy 
Outcome and Rate of Cesarean Delivery.” Obstetrics and Gynecology 92:935-939. 
 
Duster, Troy. 1990. Backdoor to Eugenics. New York: Routledge. 
 
de Wert, Guido. 2005. “Preimplantation Genetic Diagnosis: The Ethics of Intermediate 
Cases.” Human Reproduction 20:3261-3266. 
 
Edwards, Jeanette, Franklin, Sarah, Hirsch, Eric, Price, Frances and Marilyn Strathern. 
1993. Technologies of Procreation: Kinship in the Age of Assisted Conception.  
 Manchester: Manchester University Press. 
 
 357
Edwards, Robert G. 2004. “Ethics of PGD: Thoughts on the Consequences of Typing 
HLA in Embryos.” Reproductive BioMedicine Online 9:222-224. 
______. 2002. “Ethics of Preimplantation Diagnosis: Recordings from the Fourth 
International Symposium on Preimplantation Genetics.” Reproductive BioMedicine 
Online 6:170-180. 
 
Edwards, Robert G., Steptoe, Patrick C., and J.M. Purdy. 1980. “Establishing Full-Term 
Human Pregnancies Using Cleaving Embryos Grown In Vitro.” British Journal of 
Obstetrics and Gynaecology 87:737-768.  
 
Ehrich, Kathryn, Williams, Clare, Scott, Rosamund, Sandall, Jane, and Bobbie Farsides. 
2006. “Social Welfare, Genetic Welfare? Boundary-work in the IVF/PGD Clinic.” 
Social Science and Medicine 63:1213-1224. 
 
Elustondo, Georgina. 2005a. “Una Pareja Gay Fecundó Óvulos, Alquiló Un Vientre y 
Tuvo Mellizos (A Gay Couple Fertilized Eggs, Used a Surrogate and Had Twins).” 
Clarín (August 18).  
______. 2005b. “Mujeres Solas Que Hacen de Todo Para Tener Un Hijo (Single Women 
Are Doing Everything to Have a Child).” Clarín (August 21).  
 
Escobar, Arturo. 1995. Encountering Development: The Making and Unmaking of the 
Third World. Princeton: Princeton University Press. 
 
Farber, María. 2005. “Mercado Fecundo (The Fertile Market).” Clarín (August 18).  
 
Feitlowitz, Marguerite. 1998. A Lexicon of Terror: Argentina and the Legacies of 
Torture. New York: Oxford University Press. 
 
Finkler, Kaja. 2000. Experiencing the New Genetics: Family and Kinship on the Medical 
Frontier. Philadelphia: University of Pennsylvania Press. 
 
Foucault, Michel. 1978. The History of Sexuality. Volume I: An Introduction. New York: 
Vintage Books. 
 
Franklin, Sarah. 2003. “Re-thinking Nature-Culture: Anthropology and the New 
Genetics.” Anthropological Theory 3:65-85. 
______. 1997. Embodied Progress: A Cultural Account of Assisted Conception. New 
York: Routledge. 
  
Franklin, Sarah, and Margaret Lock. 2003. Remaking Life and Death: Toward an 
Anthropology of the Biosciences. Santa Fe: School of American Research Press. 
 
Franklin, Sarah, and Helena Ragoné, eds. 1998. Reproducing Reproduction: Kinship, 
Power and Technological Innovation. Philadelphia: University of Pennsylvania Pres 
 
 358
Franklin, Sarah, and Celia Roberts. 2006. Born and Made: An Ethnography of 
Preimplantation Genetic Diagnosis. Princeton: Princeton University Press.  
 
Freidson, Eliot. 1970. The Profession of Medicine: A Study of the Sociology of Applied 
Knowledge. New York: Harper and Row.  
 
Galarza, Eliana. 2006. “Una Mujer de 59 Años Dio a Luz Mellizos en Los Estados 
Unidos (A 59 Year Old Woman Gave Birth to Twins in the United States).” Clarín 
(July 6).  
 
Gaonkar, Dilip Parameshwar, ed. 2001. Alternative Modernities. Durham: Duke 
University Press. 
 
Giberti, Eva. 1987. La Adopción (Adoption). Buenos Aires: Sudamericana. 
 
Ginsburg, Faye, and Rayna Rapp, eds. 1995. Conceiving the New World Order: The 
Global Politics of Reproduction. Berkeley: University of California Press.   
 
Gioberchio, Graciela. 2004. “Intiman a Las Prepagas a Cubrir Partos Por Fertilización 
Asistida (Insurance Companies are Told to Cover Assisted Reproduction 
Deliveries).” Clarín (July 14).  
 
Giubellino, Gabriel. 2005. “Yo No Congelaría a Mis Hijos (I Would Not Freeze My 
Children).” Clarín (July 26).  
 
Gleicher, Norbert, Weghofer, Andrea, and David Barad. 2006. “A Formal Comparison of 
The Practice of Assisted Reproductive Technologies Between Europe and the USA.” 
Human Reproduction 21:1945-1950. 
 
Gray, Chris H., Figueroa-Sarriera, H.J., and S. Mentor, eds. 1995. The Cyborg Handbook. 
New York: Routledge. 
 
Guerrino, Antonio Alberto. 2001. Bibliografía Histórica de la Medicina Argentina 
(Historical Bibliography of Argentine Medicine). Buenos Aires: Editorial Dunken.  
 
Gupta, Akhil. 1998. Postcolonial Developments: Agriculture in the Making of Modern 
India. Durham: Duke University Press. 
 
Halliday, Samantha. 2004. “A Comparative Approach to the Regulation of Human 
Embryonic Stem Cell Research in Europe.” Medical Law Review 12:40-69. 
 
Handwerker, Lisa. 2002. “The Politics of Making Modern Babies in China: Reproductive 
Technologies and the ‘New’ Eugenics.” In Infertility Around the Globe: New 
Thinking on Childlessness, Gender, and Reproductive Technologies, eds. Marcia 
Inhorn and Frank Van Balen, 298-314. Berkeley: University of California Press. 
 
 359
Haraway, Donna.1997. Modest Witness@Second Millennium.FemaleMane Meets 
Oncomouse. New York: Routledge. 
______. 1991. “Situated Knowledges: The Science Question in Feminism and the 
Privilege of Partial Perspective.” In Simians, Cyborgs, and Women,183-202. London: 
Free Association Books.  
______. 1985. “A Manifesto for Cyborgs: Science, Technology, and Socialist Feminism 
in the 1980s.” Socialist Review 80:65-107. 
 
Harper, J.C., Boelaert, K., Geraedts, J., Harton, G., Kearns, W.G., Moutou, C., 
Muntjewerff, N., Repping, S., SenGupta, S., Scriven, P.N., Traeger-Synodinos, J., 
Vesela, K., Wilton, L., and K.D. Sermon. 2006. “ESHRE PGD Consortium Data 
Collection V: Cycles from January to December 2002 with Pregnancy Follow-up to 
October 2003.” Human Reproduction 21:3-21. 
 
Heffner, Linda J. 2004. “Advanced Maternal Age—How Old is Too Old?” New England 
Journal of Medicine 351:1927-1929. 
 
Heguy, Silvina and Julio Rodríguez. 2007. “Crónicas Sobre el Tráfico de Bebés en 
Santiago del Estero (Chronicles On the Trafficking of Babies in Santiago del 
Estero).” Clarín (January 28).  
 
Henig, Robin Marantz. 2004. Pandora’s Baby: How The First Test Tube Babies Sparked 
The Reproductive Revolution. Boston: Houghton Mifflin Co. 
 
Hess, David J. 1997. Science Studies. New York: New York University Press.  
 
Hudson, Kathy L. 2006. “Preimplantation Genetic Diagnosis: Public Policy and Public 
Attitudes.” Fertility and Sterility 85:1638-45. 
 
Iglesias, Mariana. 2006. “La Historia de La Familia Que Tuvo Sus Cuatro Hijos Por 
Embriones Congelados (The Story of the Family Who Had Four Children Using 
Frozen Embryos).” Clarín (November 10).  
______. 2004. “Los Primeros Bebés Gestados en El País Por Fertilización Cumplen 18 
(The First Babies Created by Fertilization in the Country Turn 18).” Clarín (February 
7). 
______. 2003. “Buscan Que La Obra Social Cubra La Fertilización Asistida (Looking to 
Make Health Insurance Cover Assisted Reproduction).” Clarín (July 1).  
 
Inhorn, Marcia. 2003. Local Babies, Global Science: Gender, Religion, and In Vitro 
Fertilization in Egypt. New York: Routledge. 
______. 2002. “The ‘Local’ Confronts the ‘Global’: Infertile Bodies and New 
Reproductive Technologies in Egypt.” In Infertility Around the Globe: New Thinking 
on Childlessness, Gender and Reproductive Technologies, ed. Marcia C. Inhorn and 
Frank Van Balen, 263-282. Berkeley: University of California Press. 
______. 1996. Infertility and Patriarchy: The Cultural Politics of Gender and Family 
Life in Egypt. Philadelphia: University of Pennsylvania Press. 
 360
______. 1994. Quest for Conception: Gender, Infertility and Egyptian Medical 
Traditions. Philadelphia: University of Pennsylvania Press. 
 
Inhorn, Marcia and Frank Van Balen, eds. 2002. Infertility Around the Globe: New 
Thinking on Childlessness, Gender and Reproductive Technologies. Berkeley: 
University of California Press. 
 
Jones, Howard W. 1995. “The Norfolk Experience: How IVF Came to The United 
States.” In Pioneers in In Vitro Fertilization: The Proceedings of a Symposium Held 
in Oss, The Netherlands, November 5, 1993, eds. A. Th. Alberda, R.A. Gan and H.M. 
Vemer, 25-43. New York: The Parthenon Publishing Group. 
 
Kahn, Susan M. 2000. Reproducing Jews: A Cultural Account of Assisted Conception in 
Israel. Durham: Duke University Press. 
 
Klipstein, Sigal. 2005. “Preimplantation Genetic Diagnosis: Technological Promise and 
Ethical Perils.” Fertility and Sterility 83:1347-53. 
 
La Nación. 2005. “Una Pareja Gay Presentó a Sus Hijos (A Gay Couple Introduced Their 
Children).” La Nación (August 19).  
 
Larrain, Jorge. 2000. Identity and Modernity in Latin America. Cambridge, UK: Polity 
Press. 
 
Latour, Bruno. 1993. We Have Never Been Modern. Cambridge: Harvard University 
Press. 
______. 1987. Science in Action: How to Follow Scientists and Engineers Through 
Society. Cambridge, MA: Harvard University Press. 
______. 1988. The Pasteurization of France. Cambridge: Harvard University. 
 
Latour, Bruno and Steve Woolgar. 1986[1979]. Laboratory Life: The Construction of 
Scientific Facts. Princeton: Princeton University. 
 
Lafferiere, Nicólas. 2005. “La Dignidad Del Niño Por Nacer (The Dignity of the Unborn 
Child).” La Nación (June 26).  
 
Leeton, John. 2004. “The Early History of IVF in Australia and Its Contribution to The 
World (1970-1990).” Australian and New Zealand Journal of Obstetrics and 
Gynaecology 44: 495-501. 
 
Lloyd-Sherlock, Peter, ed. 2000. Healthcare Reform and Poverty in Latin America. 
London: University of London. 
 
Lock, Margaret. 2002. Twice Dead: Organ Transplants and the Reinvention of Death. 
Berkeley: University of California Press. 
 
 361
Lock, Margaret and Patricia Kaufert, eds. 1998. Pragmatic Women and Body Politics. 
Cambridge, UK: Cambridge University Press. 
 
Malpani, A. and A. Malpani. 2002. “Preimplantation Genetic Diagnosis for Gender 
Selection for Family Balancing: A View from India.” Reproductive BioMedicine 
Online 4:7-8. 
 
Moreno, Liliana. 2005. “Crearon Un Registro Único de Adopción Para Todo el País 
(They Created A Single Adoption Registry For the Entire Country).” Clarín (April 
29).  
 
Morgan, Lynn and Meredith Michaels, eds. 1999. Fetal Subjects, Feminist Positions. 
Philadelphia: University of Penn Press. 
 
Munné, Santiago and Jacques Cohen. 2004. “The Status of Preimplantation Genetic 
Diagnosis in Japan: A Criticism.” Reproductive BioMedicine Online 9:258-259. 
 
Munné, Santiago, Alikani, Mina, Tomkin, Giles, Grifo, Jamie, and Jacques Cohen. 1995. 
“Embryo Morphology, Developmental Rates, and Maternal Age are Correlated With 
Chromosome Abnormalities.” Fertility and Sterility 64:382-391. 
 
Navarra, Gabriela. 2004. “Cómo Afrontar Las Nuevas Formas de Ser Padres y Madres. 
Falta de Cubertura (How to Face the New Forms of Being Fathers and Mothers. The 
Lack of Insurance Coverage).” La Nación (July 10).  
______. 2002. “Describen Un Método Que Permite Detectar Fallas en Los 
Espermatozoides (They Describe a Method that Allows for Detection of Defects in 
Sperm).” La Nacion (August 19).  
 
Novas, Carlos and Nikolas Rose. 2000. “Genetic Risk and the Birth of the Somatic 
Individual.” Economy and Society 29:485-513. 
 
Ochoa, Sebastián. 2005. “‘Acá Se Impresionan Porque Nunca Vieron Una Familia Como 
La Nuestra’ (‘They are Impressed Here Because They Have Never Seen a Family 
Like Ours Before’).” Página 12 (August 19).  
 
Palacios, Cynthia. 2007. “Una Campaña Reavivó el Debate Sobre Adopción en La 
Argentina. (A Campaign Revived The Debate Over Adoption in Argentina).” La 
Nación (January 24).  
 
Parens, Erik and Adrienne Asch, eds. 2000. Prenatal Testing and Disability Rights. 
Washington DC: Georgetown University Press. 
 
Parry, Sarah. 2006. “(Re)constructing Embryos in Stem Cell Research: Exploring the 
Meaning of Embryos for People Involved in Fertility Treatments.” Social Science and 
Medicine 62:2349-2359. 
 
 362
Peker, Luciana. (2005). “Un Elefante en El Bazar (An Elephant in the Bazaar).” Página 
12 (July 29). 
 
Pellegrino, Edmund D., Harvey, John Collins, and John P. Langan, eds. 1990. Gift of 
Life: Catholic Scholars Respond to the Vatican Instruction. Washington DC: 
Georgetown University Press.  
 
Pickering, Andrew, ed.1992. Science as Practice and Culture. Chicago: University of 
Chicago Press. 
 
Pincus, G. and E.V. Enzmann. 1934. “Can Mammalian Eggs Undergo Normal 
Development In Vitro.” Proceedings of the National Academy of Sciences 20:121-2. 
 
Piqué, Elisabetta. 2004. “Una Ley Controvertida (The Controversial Law).” La Nación 
(February 29).  
 
Pisani, Silvia. 2006. “Argentinos Adoptan un Embrión Español (Argentines Adopt a 
Spanish Embryo).” La Nación (November 8).  
 
Rabinow, Paul. 1996. Making PCR: A Story of Biotechnology. Chicago: University of 
Chicago Press. 
 
Rapp, Rayna. 1999. Testing Women, Testing the Fetus: The Social Impact of 
Amniocentesis in America. New York: Routledge. 
 
Ricart, Marta. 2004. “España: Ofrecen en Adopción Miles de Embriones Congelados 
(Spain: Offering Thousands of Frozen Embryos For Adoption).” Clarín (October 20), 
2004. 
 
Riós, Sebastián. 2006. “No Sólo Por Dinero Se Entregan Los Óvulos (They Give Eggs 
Not Only To Make Money).” La Nación (August 11).  
______. 2004. “Medida a Favor de La Fertilización Asistida (Legal Measure In Favor of 
Assisted Reproduction).” La Nación (July 14).  
 
Roberts, Elizabeth F.S. 2006. “God’s Laboratory: Religious Rationalities and Modernity 
in Ecuadorian In Vitro Fertilization.” Culture, Medicine and Psychiatry 30:507-536. 
 
Rodriguez, Julia. 2006. Civilizing Argentina. Chapel Hill: University of North Carolina 
Press. 
 
Román, Valeria. 2005. “Embriones Congelados: Se Niegan a Revelar Quiénes Son Sus 
Dueños (Frozen Embryos: They Refuse to Reveal Who the Owners Are).” Clarín 
(July 26).  
 
 363
Román, Valeria. 2006. “Logró Quedar Embarazada Con Un Embrión Congelado Hace 10 
Años (Pregnancy Achieved With an Embryo Frozen For 10 Years).” Clarín (October 
4).  
 
Rose, Nikolas. 2001. “The Politics of Life Itself.” Theory, Culture and Society 18:1-30.   
 
SAMeR. 2005. Guias y Normativas Criopreservacion de Preembriones (Guides and 
Standards for Cryopreservation of Preembryos). 
http://www.saef.org.ar/novedades.asp?Accion=VerCompleto&IdNoticia=125, 
accessed on the Internet 11/19/2005. 
 
Sandelowski, Margarete. 2000. Devices and Desires: Gender, Technology, and American 
Nursing. Chapel Hill: University of North Carolina. 
______. 1993. With Child in Mind: Studies of the Personal Encounter with Infertility. 
Philadelphia: University of Pennsylvania Press.  
 
Sebastián, Jesús, ed. 1993. Los Sistemas de Ciencia y Tecnología en Iberoamérica 
(Systems of Science and Technology in Iber-America). Buenos Aires, Argentina: 
Editorial Universitaria de Buenos Aires. 
 
Shapira, Valeria. 2002. “Certificado de Paternidad Para Los Nacidos Por Fertilización 
Asistida (Paternity Certificate For Births from Asssisted Reproduction).” La Nación 
(September 11).  
 
Shumway, Nicolas. 1991. The Invention of Argentina. Berkeley: University of California 
Press. 
 
Scheper-Hughes, Nancy. 2000. “Global Trafficking in Organs.” Current Anthropology 
41:191-224. 
 
Sharif, Khaldoun, Afnan, Masoud, Lashen, Hany., Elgendy, Manal., Morgan, Christine, 
and Sinclair Lucinda. 1998.  “Is Bed Rest Following Embryo Transfer Necessary?” 
Fertility and Sterility 69:478-481. 
 
Sharp, Lesley A.  2000. “The Commodification of the Body and Its Parts.” Annual 
Review of Anthropology 29:287-328. 
 
Shenfield, F., Pennings, G., Devroey, P., Sureau, C., Tarlatzis, B. amd J. Cohen. 2003. 
“Taskforce 5: Preimplantation Genetic Diagnosis.” Human Reproduction 18:649-651. 
 
Sommer, Susana. 1998. Genética, Clonación y Bioética: ¿Cómo Afecta La Ciencia 
Nuestras Vidas? (Genetics, Cloning and Bioethics: How Does Science Affect Our 
Lives?). Buenos Aires: Editorial Biblos. 
______. 1994. De la Cigüeña a La Probeta: Los Peligros de La Aventura Científica 
(From the Stork to the Test Tube: The Dangers of the Scientific Adventure). Buenos 
Aires: Planeta. 
 
 364
Soraci, Monica. 2005. ¿Hijos? No, Gracias. Cuando Las Mujeres Deciden No Ser 
Madres (Children? No Thanks. When Women Decide Not to Be Mothers). Buenos 
Aires: Longseller S.A. 
 
Stepan, Nancy Leys. 1991. The Hour of Eugenics: Race, Gender and Nation in Latin 
America. Ithaca: Cornell University Press. 
 
Steptoe, Patrick C. and Robert G. Edwards. 1978. “Birth After the Reimplantation of A 
Human Embryo.” The Lancet 2:366. 
 
Strathern, Marilyn. 1992. Reproducing the Future: Anthropology, Kinship and the New 
Reproductive Technologies. New York: Routledge. 
 
Taylor, Diana. 1997. Disappearing Acts: Spectacles of Gender and Nationalism in 
Argentina’s ‘Dirty War.’  Durham: Duke University Press.  
 
Taussig, Karen Sue, Rayna Rapp, and Deborah Heath. 2003. “Flexible Eugenics: 
Technologies of the Self in the Age of Genetics.” In Genetic Nature/Culture: 
Anthropology and Science beyond the Two-Culture Divide, eds. Alan H. Goodman, 
Deborah Heath, and M. Susan Lindee, 58-70. Berkeley: University of California 
Press. 
 
Teixeira, Sonja M. Fleury, Belmartino, Susana and Enis Baris, eds. 2000. Reshaping 
Health Care in Latin America: A Comparative Analysis of Health Care Reform in 
Argentina, Brazil, and Mexico. Ottawa: International Development Research Center. 
 
Thompson, Charis. 2005. Making Parents: The Ontological Choreography of 
Reproductive Technologies. Cambridge: MIT Press. 
______. 2001. “Strategic Naturalizing: Kinship in an Infertility Clinic.” In Relative 
Values: Reconfiguring Kinship Studies, eds. Sarah Franklin and Susan McKinnon, 
175-202. Durham: Duke University Press. 
 
Thornhill, A.R., de Die-Smulders, C.E., Geraedts, J.P., Harper, J.C., Harton, G.L., 
Lavery, S.A., Moutou, C., Robinson, M.D., Schmultzler, A.G., Scriven, P.N., 
Sermon, K.D.,  and L. Wilton. 2005. “ESHRE PGD Consortium ‘Best Practice 
Guidelines for Clinical Implantation Genetic Diagnosis (PGD) and Preimplantation 
Genetic Screening (PGS)’.” Human Reproduction 20:35-48. 
 
Titmuss, Richard. 1997. [1971]. The Gift Relationship: From Human Blood to Social 
Policy, ed. Ann Oakley and John Ashton. New York: The New Press. 
 
Tober, Diane M. 2001. “Semen as Gift, Semen as Goods: Reproductive Workers and the 
Market in Altruism.” Body and Society 7:137-160. 
 
Trajtenberg, Manuel. 1990. Economic Analysis of Product Innovation. The Case of CT 
Scanners. Cambridge: Harvard University Press 
 365
 
Traweek, Sharon. 1988. Beamtimes and Lifetimes: The World of High Energy Physics. 
Cambridge: Harvard University Press. 
 
Trounson, Alan, and Linda Mohr. 1983. “Human Pregnancy Following Cryopreservation, 
Thawing, and Transfer of An Eight-Cell Embryo.” Nature 305:707-709. 
 
Vallejos, Soledad. 2006. “La Fertilización Asistida Será Regulada Por Ley (Assisted 
Reproduction Will Be Regulated By Law).” La Nación (August 20).  
 
Vattimo, Gianni. 2005. “La Vida Humana Comienza Cuando Nace Un Objeto Capaz de 
Tener Derechos y Deberes (Human Life Begins When a Subject Capable of Having 
Rights and Protections is Born).” Clarín Revista Ñ (August 6).  
 
Verlinsky, Yury, Cohen, Jacques, Munné, Santiago, Gianaroli, Luca, Simpson, Joe Leigh, 
Ferraretti, Anna Pia, and Anver Kuliev. 2004a. “Over a Decade of Experience with 
Preimplantation Genetic Diagnosis: A Multicenter Report.” Fertility and Sterility 
82:292-294. 
 
Verlinsky, Yury, Rechitsky, Svetlana, Sharapova, Tatyana, Morris, Randy, Tranissi, 
Mohammed, and Anver Kuliev. 2004b. “Preimplantation HLA Testing.” Journal of 
American Medical Association 291:2079-2085.  
 
Waldby, Catherine, and Robert Mitchell. 2006. Tissue Economies: Blood, Organs, and 
Cell Lines in Late Capitalism. Durham: Duke University Press. 
 
William, Jack. 2000. Health Insurance Reform in Four Latin American Countries: 
Theory and Practice. Washington, DC: World Bank, Development Research Group, 
Public Economics. 
 
Woolcott, Robert, and James Stanger. 1998. “Ultrasound Tracking of The Movement of 
Embryo-Associated Air Bubbles on Standing.” Human Reproduction, 13:2107-2109. 
 
Zegers-Hochschild, Fernando and Veronica Galdames. 2004. Registro Latinoamericano 
de Reproducción Asistida (Latin American Registry of Assisted Reproduction). 
Santiago, Chile. 
 
